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This thesis describes a novel approach to the rational design of artificial esterases and 
aldolases.
The  Introduction provides  a literature  summary of the  previous  approaches  that have 
been employed towards the design and synthesis of artificial enzyme systems.
Chapter  2  describes  the  preparation  and  reactivity  of  a  number  of  polymer  based 
artificial  enzymes,  which  are  capable  of catalysing  ester  hydrolysis.  The  study  has 
involved  the  incorporation  of  a  histidine  catalytic  group  together  with  specifically 
designed  peptide  binding  groups  within  a  polymeric  backbone.  The  binding  groups 
were  specifically  selected  according  to  their  binding  affinity  towards  an  appropriate 
transition state analogue.  The synthesis of peptide binding sites and thus incorporation 
of these,  together  with  the  histidine  catalytic  group  into  a  polymer  backbone,  using 
standard  peptide  chemistry  has  been  outlined.  The  results  to  an  investigation  of the 
influence of different pH, solvent and substrate concentration on the activity of artificial 
esterases are presented.
Chapter 3  describes preliminary work undertaken towards the design  and synthesis of 
artificial  aldol  catalysts.  The  aldolases,  which  feature  a proline  residue  attached  to  a 
polymer  backbone  are  shown  to  selectively  catalyse  aldol  reactions  using  aromatic 
aldehydes as electrophilic partner.
Chapter 4 describes the detailed experimental procedures used.
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21CHAPTER 1 
INTRODUCTION
221.1  Introduction
Enzymes are highly evolved catalysts that have been developed by nature over billions 
of years.1   The capability of enzymes to catalyse reactions with remarkable regio- and 
chemo  stereoselectivity has  inspired chemists to  investigate  synthetic  equivalents.  An 
understanding of the underlying principles behind enzyme catalysis would enable us to 
develop  ‘artificial  enzymes’,  which  would  rival  natural  enzymes  in  terms  of  rate 
accelerations,  turnover  and  specificity.  Furthermore,  research  into  artificial  enzymes 
provides us with a unique opportunity to design a catalyst for reactions for which there 
is no natural enzyme equivalent.
Since  the  present  thesis  is  concerned  with  the  synthesis  of artificial  enzymes,  it  is 
appropriate  to  place  the  present  study  into  context,  by providing  a  discussion  of the 
main principles behind enzyme catalysis and an overview of the previous approaches to 
artificial enzymes.
1.2 Principles of Enzyme Catalysis
Nature has  developed  enzymes  into  sophisticated three-dimensional  structures,  which 
differ from synthetic chemical catalysts in several ways. Firstly, enzymatically catalysed 
reactions occur at reaction rates typically in the range of  106 to  1012 greater than those 
of corresponding  chemically  catalysed  reactions. Secondly,  enzymes  function  under 
very mild reaction conditions -  lower temperatures,  atmospheric pressure and usually 
neutral pH. Thirdly, many of them have a great degree of specificity for their substrate, 
producing  a product  with  a high  degree  of regio-  and  stereoselectivity  and  directing 
reactive intermediates towards only one of several potential products.
The  manner by which  an  enzyme performs  the  above  functions  will  be  discussed  in 
more detail in the following section.
231.2.1  Transition State Theory
Illustrated  below  is  a  simplistic  representation  of the  reaction  pathway  that  occurs 
between an enzyme (E) and a substrate (S) (Equation 1.2.1).2 The substrate binds to the 
enzyme to form an enzyme-substrate complex in the first step. The substrate molecule 
then passes through a series of intermediate  forms of altered geometry and electronic 
distribution before it converts to the final product (P) of the reaction.
E + S  ===  ES  ^   ES*  EP  ^   E + P
Equation 1.2.1 Representation of enzymic reaction pathway.
The free energies of these intermediates forms, especially of those in the most unstable 
transition  states  are  the  major  determinants  of the  reaction  rate.  Hence,  in  order  for 
catalysis to occur, the enzyme must be able to recognise and stabilise the transition state 
of the reaction.3 This theory was originally proposed by Pauling in 1948 and is still the 
most  widely  accepted  view  of enzyme  catalysis.  This  is  illustrated  below  (Figure
1.2.1).
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Figure  1.2.1  Energy  level  diagram  of enzyme-substrate pathway  following  transition  state 
theory, under  conditions.2
The overall activation energy (AGes*) of the system is composed of AGes and AG*kcat- 
AGes represents  the  net  energy  gain  that  results  from  the  formation  of the  enzyme- 
substrate complex, while AGkcat is the amount of energy that must be expended to reach 
the transition  state  of the reaction.  In the  absence of the  enzyme,  the reaction has  to 
overcome a large energy barrier in order to reach the transition state S*. In the presence 
of the enzyme, the reaction first proceeds through the E.S complex, an intermediate that 
is not available during the uncatalysed  reaction. The energy gained from the formation 
of this  complex  can  in part be  used to  form the transition  state  of the reaction E.S*. 
During  the  formation  of  E.S*,  the  molecular  forces  between  the  enzyme  and  the 
substrate (discussed in the next section), have the effect of destabilizing the ground state 
configuration of the bound substrate molecule and energetically favouring the transition 
state complex E.S* which therefore occurs at a lower energy level than S*. The reaction
25then goes through the formation of the E.P complex before final release of the product. 
It can be seen from the diagram that although the initial and final states for catalysed 
and  uncatalysed  reactions  are  energetically  the  same,  the  overall  activation  energy 
barrier has  been  reduced  for the  enzyme  catalysed  reaction.2’3   In  addition  to  this,  in 
order for true catalysis to occur, the system must also exhibit a turnover. The turnover 
number of an enzyme is the number of reaction processes that each active site catalyses 
per unit  time.1   The  enzyme-substrate binding  must be  stronger than  enzyme-product 
binding, i.e.  E.S must be lower in energy than E.P; if the opposite of this is true, then 
product  inhibition  would  be  observed.  The  important  conclusion  to  make  from  this 
picture of enzyme action, is that when designing an enzyme mimic, we must consider 
both  transition  state  stabilisation  and  thermodynamically  favourable  release  of  the 
product.  In  more  complex  cases  of enzyme  catalysis  (e.g.  bimolecular processes  and 
reactions  involving  covalent  enzyme-bound  intermediates),  the  above  model  of 
transition state stabilisation is evidently much less straightforward.
1.2.2  Contribution  of  Intermolecular  Forces  in  Transition  State 
Stabilisation
From  previous  studies,  it  is  clear  that  there  are  many  weak  intermolecular  forces 
involved during the binding of a substrate to the enzyme. In general, the overall binding 
is  due to  hydrogen bonding4,  electrostatic  forces5, hydrophobic  interactions4,  Van der 
Waals forces5 and 7r-stacking.6
Hydrogen  bonding  contributes  significantly  to  the  total  energy  of  the  enzyme  -  
substrate complex. However, since enzymes operate in water, these effects are generally 
disrupted  by  solvation.7  Fersht  and  co-workers  have  quantified  the  contribution  of 
hydrogen  bonding  from  investigation  of  the  coupling  of  tyrosine  to  adenosine 
triphosphate (ATP) to yield tyrosyl-adenosine monophosphate (AMP).8 The reaction is 
catalysed by tyrosyl lRNA synthase. Because the crystal structure of the complex was 
known,  a  series  of point  mutations  were  conducted.  This  determined  which  specific 
hydrogen  bonds  were  important  for  binding.  It  was  found  that  a  neutral  -   neutral 
"hydrogen  bond  contributes  only  0.5  -  1.5  kcal  mol'1   (2.1  -   6.3  kJ  mol'1),  which  is
Q.Q
approximately a 15-fold increase in binding.  ’   However, the contribution of a charged
26hydrogen bond was found to be more significant, approximately 4.7 kcal mol'1  (19.7 kJ 
mol'1), which is about a 3000-fold increase in binding.
Electrostatic interactions usually occur between a charged amino acid side chain and a 
charged  group  on  a  ligand.  An  example  that  demonstrates  the  importance  of 
electrostatic  interactions  comes  from mitochondrial electron transfer cascade.2 During 
this  process,  the  electrons  that  are  transferred  from  the  protein  cytochrome  c  to  the 
enzyme  cytochrome  oxidase  are  used  to  reduce  oxygen  to  water  during  cellular 
respiration. For the electrons to jump from one protein to another, the two must form a 
tight  complex.  The  crystal  structure  of  cytochrome  c  showed  that  the  molecule 
contained  an  unusually  high  number  of  positively  charged  lysine  residues.  The 
corresponding binding site  for cytochrome c  on the cytochrome oxidase consists of a 
high density of aspartic and glutamic acid residues. Consequently, it is believed that the 
formation of the tight complex between the two proteins is assisted by a large number of 
electrostatic  interactions  formed  between  the  charged  amino  acid  residues  (Figure
1.2.2).
O
Lysine  Glutamic acid
(cytochrome c)  (cytochrome oxidase)
Figure 1.2.2 Representation of electrostatic interactions occurring between cytochrome c and 
cytochrome oxidase.
The  work  of Cudd  and  Fridovich  also  highlighted  the  importance  of lysine  residues 
within the active site of superoxide dismutase.10 The enzyme catalyses dismutation of
superoxide O2 ' to O2 and H2O2. It is evident that there is an interaction between O2’ and
positively charged lysine residues within the enzyme active site.  Following removal of 
the  positive  charge  of the  active  site  lysines  by  acetylation,  a  decrease  in  enzyme 
activity  was  observed  indicating  the  significance  of  electrostatic  interactions  for 
catalytic activity.
Hydrophobic  interactions  are  another  major  source  of binding  in  enzyme-substrate 
interactions.  When  non-polar  groups  are  present  in  an  aqueous  environment,  the
27surrounding water molecules are believed to possess an ordered structure.7 When these
non-polar structures come together via formation of a hydrophobic interaction, the cage 
like water structures are broken down, resulting in a net gain of freedom and movement.
hydrophobic  surface  area  from  water,  by binding into  a hydrophobic  region within  a
Although the contribution of hydrophobic effects to  substrate binding is considered to 
be important, it is generally believed that it is a non-specific interaction and that it may 
not  contribute  to  the  specificity  of enzyme-substrate  binding  compared  to  hydrogen 
bonding.  However,  hydrophobic  interactions  can  significantly  stabilise  substrate 
binding. For example Figure 1.2.3 shows two HIV-2 protease inhibitors, both of which 
have similar affinities for the enzyme, despite the fact that the quinoline amide in 1 has 
been replaced by the lipophilic dimethylphenoxy substituent in 2.1 1   X-ray analysis of 1 
revealed  hydrogen  bonds  between  the  quinoline  amide  and  Asp29’  and  Gly48’. 
However,  the  complex  of  2  with  the  enzyme  shows  an  induced  fit  to  the 
dimethylphenoxy group through a shift of 1  A for Asp29’ and 4 A for the side chain of 
Asp30’.  The  similar activities  of 1  and 2  demonstrate that  affinity can be maintained 
through hydrophobic interactions, even at the cost of losing significant hydrogen bonds. 
This  example  also  illustrates  the  very  important  point  that  enzymes  can  undergo 
conformational changes to accommodate substrates (‘induced fit’) in order to optimise 
the favourable binding interactions.
n
This  results  in  increased  entropy  and  favourable  enthalpy  changes.  Removal  of the
receptor  is  worth  approximately  0.68  kcal  mol'1   (2.85  kJ  mol'1)  per  methyl  group.4
NHtBu
R
NHtBu
2
Figure 1.2.3 HIV-2 protease inhibitors.
28Van der Waals  forces  are typically worth about  1   kcal mol'1   in binding stabilisation.2  
Although this  is  a very small  contribution, when conditions permit a large number of 
Van der Waals forces to form, they can collectively provide a significant contribution to 
the  stabilising  energy  to  the  enzyme-substrate  complex.2  However,  they  are  often 
neglected when analysing their contribution to binding equilibria because the Van der 
Waals interactions between the elements of the first and second row of periodic table 
are insensitive to the nature of atoms involved. This means that the forces do not change 
significantly  on  replacing  solvent-substrate  contacts  with  solvent-solvent  or  enzyme- 
substrate contacts.5
7r  -   Stacking  interactions  have  also  been  explored  as  one  of the  driving  forces  in 
molecular recognition.  The cation -   7r interactions  formed between the  side chains of 
phenylalanine,  tyrosine  or  tryptophan  and  the  side  chains  of lysine  or  arginine  have 
received  particular  attention,  because  of  their  important  role  in  the  functioning  of 
potassium  channels.10  Many models have been proposed  for potassium  channels,  and 
suggest that there are numerous aromatic residues found within the channel pore which 
seem  to  be  involved  in  cation  -  7r  interactions.6^2  As  a  result  of this,  it  has  been 
proposed that it is the cation - 7r interactions which are responsible for ion selectivity in 
potassium channels.6
All of the above intermolecular interactions involve binding between a discrete ligand 
and  a  binding  site.  However,  the  changes  in  active  site  interactions  on  going  from 
ground state to transition state are much more difficult to assess. This is mainly because 
these  bonding  interactions  are  dynamic  in  nature,  as  a  result  of  changing  charge 
distribution  due  to  bond  formation  or  cleavage.  This  binding  phenomenon  is  called 
‘dynamic binding’  and it allows us to distinguish between ground state and transition 
state recognition.13 For example, Kirby has illustrated this process in serine proteases, 
where  the  initial  step  of amide  cleavage  involves  an  intermediate  such  as  4  (Figure 
1.2.4).1 3
29Transition state
Figure  1.2.4  a) Initial step of amide bond cleavage by serine protease, b) Representation of 
dyamic binding.
The  transition  state  (5)  for this  reaction  involves  at  least  six  bonds  being broken  or 
formed.  The partially formed covalent bonds at the reaction centre represent  ‘dynamic 
binding’  interactions,  which  have  no  corresponding  ground  state  counterpart.  Hence, 
this partial covalent bonding can distinguish between ground state and transition state 
recognition  and  makes  an  important  contribution  to  binding  and  stabilisation  of the 
transition state in enzyme reactions.
1.2.3  Functional Group Cooperativity
Naturally occurring biomolecules use the cooperativity concept to carry out catalysis or 
substrate  binding  and  recognition.  By  way  of  example,  amide  bond  hydrolysis, 
catalysed  by  chymotrypsin,  illustrates  this  concept.14  The  enzyme  is  involved  in  the 
cleavage  of amides  through  a  mechanism  which  involves  a  catalytic  triad  of serine, 
histidine and aspartic acid (Scheme 1.2.1).14 The hydrolysis sequence is initiated by the 
aspartate-102  side  chain  polarising  the  imidazole  of histidine-57.  This  leads  to  the 
hydroxyl  proton  of  serine-195  being  transferred  to  histidine,  which  results  in  the 
formation  of an  alkoxide.  Serine-195  then  attacks  the  amide,  forming  a  tetrahedral 
intermediate with an oxyanionic centre on the carbonyl carbon. This transition state is 
stabilised by specific hydrogen-bonding interactions between amino acids in the active
30site and the oxyanion centre of the substrate. It is believed that the hydrogen bonds are 
provided  by  the  backbone  nitrogens  of the  nucleophilic  serine  and  a  glycine  residue
‘ J found within the active site.  The reaction proceeds with a histidine residue donating a 
proton  to  the  amino  leaving  group,  which  leads  to  dissociation  of  the  tetrahedral 
intermediate  and  formation  of  the  covalent  acyl-enzyme  intermediate.  Subsequent 
nucleophilic attack by water allows the formation of another tetrahedral transition state, 
followed by the release of hydrolysed product.
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Scheme 1.2.1 Functional group cooperativity in chymotrypsin.
31The  stereochemical  relationship  between  the  groups  on  the  substrate  and the binding 
groups  in  the  enzyme  active  site  is  also  important  for  determining  the  substrate 
specificity of the  enzyme.  In  chymotrypsin,  the  substrate  binding  affinity is  partially 
determined  by  the  hydrogen  bonding  that  forms  between  /3-sheet  structures  of  the 
residues in the  enzyme  active  site and residues of the substrate.  However,  in order to 
actually  distinguish  one  peptide  from  another,  chymotrypsin-like  enzymes  contain  a 
deep cleft into which part of the substrate must fit (Figure 1.2.5).2;15 It is the specific 
amino acid residues within this cleft which influence the nature of the substrate which 
would be able to bind to the active site.  For example,  enzymes within the trypsin-like 
subclass  have  an  aspartate  residue  within  this  cleft,  which  perhaps  explains  their 
selectivity for substrates with arginine or lysine residues.1 5
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Figure 1.2.5 Representation of the active site of chymotrypsin-like enzymes.
Considering  the  short  overview  of  chymotrypsin  given  above  and  the  binding 
interactions  discussed  previously,  the  active  site  of  an  enzyme  needs  to  bind  the 
substrate in an appropriate orientation for catalysis, stabilise the transition state of the 
reaction,  and  also  be  able  to  differentiate  between  potential  substrates.  While  the
32molecular details differ from one enzyme to another, the general interactions illustrated 
above can broadly be applied to most naturally occurring enzymes.
1.3 Previous Approaches to Artificial Enzymes
The most traditional  approach to  enzyme mimics has  involved rational  design, which 
entails  synthesising  a macromolecule with appropriately attached  functional  groups.16 
The functional groups are chosen on the basis of amino acid residues that are found in 
the  natural  enzyme  active  site  and  are  known  to  participate  in  the  catalysis  of  a 
particular  reaction.  Although  the  use  of this  idea  has  been  exemplified  in  catalytic 
cyclodextrins16;1? and cyclophanes18;19 with some impressive results, it can be very time 
consuming, and in a number of cases, an idea that may give promising results in theory 
is not always successful in practice because of a tiny design error. As a result, research 
has  moved  away  from  this  approach to  the  selection  strategy.  The  selection  strategy 
involves simultaneous screening of a wide range of possible catalysts  for enzyme-like 
activity,  thereby reducing the time required  for the  identification of potentially useful 
catalysts.  Furthermore,  the  introduction  of  combinatonal  chemistry  and  improved 
screening techniques has made this approach very attractive.20;21  The earliest examples 
of this approach, use the idea of a transition state analogue (TSA).22 A TSA is a stable 
molecule that  is  able to  mimic  the  geometry and  charge distribution of the transition 
state of a reaction.  A library of molecules is generated and the best molecule selected 
solely on the fact that it has the best binding towards the TSA. Such an approach forms 
the  essence  of generating  catalytic  antibodies.23,24  The  logic  behind  this  is  that  any 
macromolecule that is able to bind the TSA, should also be able to bind and stabilise the 
transition state of that particular reaction. More recently, it was recognised that selection 
based  upon  the  binding  of the  TSA  alone  is  not  enough  to  produce  enzyme  mimics 
which rival the catalytic efficiency of natural enzymes. Hence, using a combination of 
different  approaches  as  for  example  by  incorporating  a  catalytic  group  into  a 
macromolecule,  together  with  the  TSA  host  selection,  has  led  to  some  impressive 
advances in this field.25 Specific examples are discussed in more detail below.
331.3.1 Cyclodextrins as Enzyme Mimics
Cyclodextrins are stable, water-soluble cyclic oligomers of a-D-glucose (Figure 1.3.1). 
The two main features of cyclodextrins are:  (i) they consist of a central cavity capable 
of  binding  hydrophobic  molecules  in  water;  (ii)  they  allow  the  possibility  of  the 
hydroxyl  groups  being  functionalised  around  the  rim  of cyclodextrin.  Both  of these 
characteristics have made cyclodextrins very attractive as potential artificial enzymes.16
6
Figure 1.3.1 a-Cyclodextrin 6 which can be represented in a more simplified manner as 7 or
A  simple  example  that  demonstrates  the  catalytic  activity  of a  cyclodextrin  is  the 
hydrolysis of esters, such as aryl acetates (Scheme 1.3.1).1 6 Initially, the substrate binds 
within the cyclodextrin cavity, via a favourable hydrophobic interaction. Hydrolysis can 
then proceed via nucleophilic attack on the carbonyl of the acetate group by a hydroxyl 
functionality  on  the  cyclodextrin,  resulting  in  the  formation  of alcohol  and  acylated 
cyclodextrin (10).16
9 10
Scheme 1.3.1 Hydrolysis of aryl acetate by cyclodextrin.1 6
34Although significant rate enhancements, up to about 2150-fold were observed with the 
system  described  above,  several  problems  were  revealed.  Firstly,  the  hydrophobic 
phenol product was usually bound so tightly within the cavity, that product inhibition 
was often observed.  Secondly,  the nucleophilic mechanism proceeded via an acylated 
cyclodextrin  intermediate,  where  the  rate  determining  step  of the  reaction  was  the 
hydrolysis of this resultant cyclodextrin intermediate.  In many cases, this intermediate 
was therefore found to be less reactive towards hydrolysis than the original substrate.
To increase the reactivity of cyclodextrins, functionalisation of cyclodextrin rings with 
groups which are more reactive at pH 7 than a hydroxyl has been undertaken.17 Breslow 
and co-workers were inspired by ribonuclease A, to synthesise three different isomers of 
cyclodextrin bis-imidazoles as shown in Figure 1.3.2.  Ribonuclease A is an enzyme 
which  cleaves  ribonucleic  acid  (RNA)  using  two  histidine  residues  found  within  its 
active site, following a general acid-base catalysis mechanism.
AB isomer AC isomer 
12
AD isomer
13
Figure 1.3.2 AB, AC and AD isomers of cyclodextrin bis-imidazoles.
The  mechanism  of the  hydrolysis  of a  cyclic  phosphodiester  is  shown  in  Scheme 
I.3.2.26  The  proposed  mechanism  suggests  that  both  imidazoles  are  involved  in 
hydrolysis.  This  has  been  confirmed  from  a  pH  rate  profile  of  this  reaction. 
Additionally, it was discovered that the AB isomer was the most efficient cyclodextrin 
at carrying out the hydrolysis and further investigations into the mechanism reveal an 
explanation  for this.  By using proton inventory  (a technique that  determines whether 
acid  and  base  groups  act  simultaneously),  it  was  discovered  that  the  transition  state 
involves two protons.  The mechanism proceeds by stabilisation of phosphate oxyanion 
via a hydrogen bond to ImH+ of 14. Water, hydrogen bonded to the remaining Im, then
35attacks the phosphorus atom. As the O-P bond forms, the ImH+ proton transfers along 
with the water proton to produce a phosphorane monoanion. This then proceeds to give 
the product of the reaction.  Hence, the AB  isomer (11) must have the two imidazoles 
placed  in  a  more  favourable  position  for  more  efficient  hydrolysis  to  occur.  This 
example  highlights  the  importance  of  the  geometric  and  electronic  preferences  of 
functional  groups  in  the  artificial  enzyme.  Additionally,  the  functional  groups  have 
displayed cooperativity which is a property observed in many enzyme active sites.
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Scheme  1.3.2  Mechanism  of  hydrolysis  of  cyclic  phosphodiester  by  cyclodextrin  bis 
imidazole.2 6
In order to create artificial enzymes that could bind substrates in aqueous solution, with 
defined  geometry,  cyclodextrin  dimers  have  been  investigated.27  Most  cyclodextrins 
that bind substrates in water have a binding constant of ca.  104 M'1.27 Breslow,27;28 and 
Tabushi,29 conjugated two cyclodextrin rings using  a variety of linkers. These dimers 
demonstrated  improved binding.  For example,  dimer  19  (Figure  1.3.3),  was  found to 
bind its cyclopropene substrate 20, with a binding constant of 108 M'1.27
360 ^ 0
19
Figure 1.3.3 Cyclodextrin dimer and its cyclopropene substrate.2 7
The group used these findings and incorporated a catalytic group within the linker of the 
system. The resulting dimer 21  consisted of a copper (II) complex, which was used to 
investigate  the  hydrolysis  of the  unactivated  benzyl  ester  22  (Figure  1.3.4).30  The 
reaction mechanism was reported to proceed with the ester 22 binding both of its ends 
into the cyclodextrin rings of 21. This is followed by the metal ion delivering a water 
molecule  as  a bound  hydroxide  species,  attacking  the  ester  group.  This  behaviour  is 
similar to that exhibited by many metalloenzymes.30
o,
22
Figure  1.3.4  Cyclodextrin  dimer  with  an  incorporated  copper  (II)  and  its  benzyl  ester 
substrate.3 0
The field of cyclodextrins has also been extended to incorporate trimers and tetramers 
of cyclodextrins, with different transition metals. A famous example is the cytochrome 
P450 mimic which is illustrated in Section 1.3.2.3 1
H  /COO- Na<
t-Bu Bu-t
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371.3.2 Cyclophanes as Enzyme Mimics
Pyruvate  oxidase  is  a  flavin  adenine  dinucleotide  (FAD)  and  thiamine  diphosphate 
(ThDP)  23  dependent  enzyme  found  in  lactobacteria (Figure  1.3.5).32’33  The  enzyme 
catalyses the reaction cascade from pyruvate 26 to acetyl phosphate 29 (Scheme 1.3.3, 
pathway  I).  The  thiazolium  group  of ThDP  forms  an  activated  enol  (27)  which  is 
oxidised by the  flavin co-factor (24)  to  give  an electrophilic  intermediate  28.  This  is 
then  attacked  by  the  inorganic  phosphate  nucleophile  to  give  the  product  29  and 
regenerate the thiazolium ylide (25). In a similar way, aldehydes are oxidised by either 
water or alcohols to  carboxylic  acids or esters respectively by thiazolium  ions  in the 
presence of flavin (Scheme 1.3.3, pathway II).
23 24
Figure 1.3.5 Thiamine diphosphate 23 and flavin 24.
(I) Enzymatic pathway (R = CH3)
II) Pathway in model systems
Flavin (ox)
Flavin (red) (I)0 2
(II) electron acceptor
(I) CH3CO-COOH (26)
(II) R3-CHO
(I) CH3-COOPO32- (29)
(II) R3COOH or 
R3COOCH,
(I) Inorganic phosphate
(II) H2O.CH3OH
28
Scheme 1.3.3 The reaction cascade from pyruvate to acetyl phosphate, catalysed by pyruvate 
oxidase. (I) Enzymatic pathway. (II) Pathway in model systems.
38Pyruvate  oxidase  mimics  have  been  synthesised  by  Diederich,  who  reported  the 
catalytic  use  of cyclophane  30  (Figure  1.3.6).18;19 This  model  of pyruvate  oxidase  is 
advantageous because it combines a binding site  for aromatic  substrates together with 
both the  flavin and thiazolium prosthetic  groups  covalently bound.  The  substrate was 
expected  to  be  bound  within  the  cavity,  hence  the  close  proximity  of the  flavin  and 
thiazolium  moieties  to  the  binding  site  was  expected  to  lead  to  an  improvement  in 
catalysis. The enzyme mimic 30 was found to catalyse the oxidation of 2-napthaldehyde 
31  in the presence of triethylamine, with a & cat of 0.22 s'1  (Scheme  1.3.4). In order for 
the system to exhibit true catalysis, the flavin was reoxidised in situ by regeneration at a 
working  electrode  potential  of  -0.3  V  vs  Ag/AgCl.  Under  these  conditions,  the 
cyclophane had a catalytic turnover of up to 100 cycles.
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Figure 1.3.6 Pyruvate oxidase mimic.
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Scheme  1.3.4  The  transformation  of naphthalene-2-carbaldehyde  to  methyl  naphthalene-2 - 
carboxylate catalysed by pyruvate oxidase mimic.
39Cyclophanes have also been used in other enzyme mimics.  For example, Breslow and 
co-workers  described  the  construction  of a  cytochrome  P-450  mimic  34,  in which  a 
manganese-porphyrin  unit  is  linked  to  4  hydrophobic  cyclophane  binding  groups 
(Figure  1.3.7).34 Catalyst 34 was utilised to  catalyse the hydroxylation  of steroid 33, 
with approximately 70 turnovers. It was observed that 60% of the hydroxylation occurs 
at C-9, while 40% occurs at various other positions.
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Figure 1.3.7 Steroid 33 and cyclophane cytochrome P-450 mimic 34.
40As a comparison, 35 a catalyst similar to 34 (Figure 1.3.8), using cyclodextrins instead 
of cyclophanes  as binding groups was  also prepared  for the  same  steroid  substrate  in 
Figure  I.3.8.34  This  catalyst  displayed  selective  hydroxylation  at  C-9,  with  70
make it  less useful,  but it does provide important information about the behaviour of 
these types of catalysts and their substrates.  The geometry established by substrate 33 
when bound to the cyclophane catalyst 34 is thought to be too flexible. This allows the 
oxidising  Mn=0  moiety  to  reach  more  than  one  site  within  the  substrate  where 
oxidation is possible. This highlights that simple binding of the substrate to the catalyst 
itself is  insufficient  to  achieve  regiospecific  hydroxylation  and just  as  with  natural 
enzymes, a unique geometry is required.
turnovers.34 The poorer selectivity of the cyclophane based catalyst does not necessarily
s
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Figure 1.3.8 Cyclodextrin cytochrome P-450 mimic.
411.3.3 Cyclic Metalloporphyrin Oligomers
Whilst a lot of studies have looked at cyclodextrins as a backbone for artificial enzymes, 
other types of macromolecules have also been explored. One of the problems faced with 
cyclodextrins  is  that  the  hydrophobic  cavity  always  remains  a  fixed  dimension  and 
hence  it  can  only  accommodate  substrates  of  a  certain  size.  Sanders’  group  have 
extensively investigated  cyclic  metalloporphyrins  which possess  hydrophobic  cavities 
that  have  flexibility  (Figure  1.3.9).35'38  The  research  has  focused  on  the  design  of 
metalloporphyrin  catalysts  for  a regiospecific  Diels-Alder reaction between  4-pyridyl 
butadiene (36) and 3-nitroso pyridine (37) to give the oxazine 38 (Scheme 1.3.5).37;38
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Scheme 1.3.5 Regiospecific Diels-Alder reaction between 4-pyridyl butadiene and 3-nitroso
pyridine.
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Figure 1.3.9 Metalloporphyrin oligomers.3 8
Initially,  catalyst 39 was  tested,  and  found to  accelerate the reaction  65-fold (Figure 
1.3.9).  The x-ray structure of the host-product complex 39.38 revealed that when the
42product  was  bound  within  the  cavity,  it  induced  structural  changes  in  39.  The  two 
porphyrin units were pushed apart, increasing the Zn-Zn distance across the acetylene 
linkage  from  10.6 A (39  alone) to  13.5 A (once the 39.38  complex  has  formed).  The 
estimated  distance  of the  transition  state  complex  was  -13.5  A,  which  meant  that 
catalyst 39 was able to distort enough to accommodate the complex.  Much better rate 
acceleration was exhibited by 40 (approximately  1030-fold) where the Zn-Zn distance 
was measured to be  14 A of the catalyst alone. Further studies with catalyst 41, which 
has  a Zn-Zn distance of 16 A (much longer than that  expected  in the transition state 
complex), established that it was less effective than catalyst 40 at accelerating the Diels- 
Alder reaction (only -250-fold). This is perhaps not surprising since the substrates are 
not  spending  enough  time  in  productive  orientations,  making  cycloaddition 
unfavourable.  Additionally,  when  the  reaction  was  attempted  with  catalyst  42,  a 
minimal 2-fold rate acceleration was observed, suggesting that only the cyclic catalysts 
which can hold the reactants at close proximity within the cavity can increase the rate of 
reaction. This example illustrates the importance of flexibility of the enzyme mimic, as 
this allows it to respond to changing geometrical demands of the reactants and transition 
state, which is a key factor in controlling the reaction rate and regioselectivity.
1.3.4  Catalytic Antibodies
Antibodies are proteins belonging to the immunoglobulin family, that are generated by 
the  immune  system  as  a response  to  foreign  species  (antigens)  that  have  entered  the 
bloodstream.1   The first examples of truly catalytic antibodies have been simultaneously 
identified by Lemer23 and Schultz24 in the mid 1980s.
Early work on catalytic  antibodies focused on the TSA approach.  The idea, originally 
described by Jencks proposed that if a molecule carrying chemical information about a 
reaction mechanism  (TSA) was  used to  induce  an immune response,  this would then 
increase  the  probability  of  identifying  antibodies  with  catalytic  properties  for  that 
particular reaction.22  Antibodies that evolve to bind  such  a compound tightly,  should 
also  be  able  to  stabilise  the  transition  state  of that  reaction  and  hence  speed  up  the 
conversion  to  the  product.  This  methodology,  has  now  been  well  established  and 
involves attachment of a TSA to a carrier protein (this complex is then termed a hapten),
43which is then introduced into the bloodstream of a mouse.  Once the immune response 
has occurred,  the desired monoclonal antibody can then be  selected  from the isolated 
polyclonal population on the basis of its binding activity towards the TSA.23
An example of this approach was demonstrated by Lemer through his early work on the 
hydrolysis of ester 43 (Scheme 1.3.6).23 Ester hydrolysis proceeds through a tetrahedral 
intermediate,  which  was  mimicked  by  a  phosphonate  TSA  46  (Figure  1.3.10).  The 
monoclonal  antibody that  was  isolated  in  the  presence  of TSA  46  was  tested  in  the 
hydrolysis reaction. The catalyst showed approximately 960-fold acceleration in the rate 
of hydrolysis.
Catalytic
Antibody
Scheme 1.3.6 Hydrolysis of ester by catalytic antibody.
46
Figure 1.3.10 Phosphonate transition state analogue for ester hydrolysis.
Catalytic  antibodies  have  also  been  utilised  in the  oxy-Cope  rearrangement  (Scheme 
1.3.7).39 The [3, 3] sigmatropic shift occurs via a chair-like transition state,39 hence TSA 
49 was designed to mimic the transition state (Figure  1.3.11).40 Antibody AZ-28 was 
raised against TSA 49 and was found to catalyse the oxy-Cope rearrangement of 47 to 
48.40
44y'
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Scheme 1.3.7 Oxy-Cope rearrangement catalysed by antibody AZ-28.
C0NH(CH2)20(CH 2)2NH,
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Figure 1.3.11 Transition state analogue for oxy-Cope rearrangement.
Using  the  TSA  approach,  a  large  number  of  other  reactions  have  been  catalysed 
including Diels-Alder reactions,41  cyclopropanations,42  elimination reactions,43’44  and 
cationic cyclisations.44
Although this approach has yielded promising results, with rate enhancements in most 
cases, there are a few problems associated with it. During the immune response, it is the 
affinity of the  antibody towards the TSA rather than  catalytic  activity that drives the 
maturation of the immune response.  Therefore although the  antibody may be good  at 
binding  the  TSA,  it  may  not  possess  useful  catalytic  activity.  The  second  major 
drawback is the inaccurate design of the TSA itself. The transition state of a particular 
reaction can  share recognition elements with  ground  state molecules, hence it is very 
difficult to design an accurate TSA with the precise geometry and charge distribution of
45a transition  state.  This  problem  is  illustrated by the  fact that the  transition  state  of a 
reaction is not a discrete entity and in many cases, there are multiple transition states to 
consider.
1.3.4.1  The ‘Bait-and-Switch’ Approach
As  a result  of the  above problems,  chemists have  explored  other  strategies  to  design 
catalytic  antibodies.  The  ‘bait-and-switch’  approach involves designing a TSA with a 
point charge, which mimics a chemical functional group that is expected to transform a 
corresponding  substrate.45  The  charge  on  the  hapten  is  expected  to  induce  a 
complementary charge at the active site of the antibody.  The resulting charged amino 
acid  residues  that  are  recruited  usually  tend  to  catalyse  the  reaction  v/a  a  general 
acid/base or nucleophilic mechanism.  An example of this approach can be seen in the 
phosphodiester hydrolysis reaction (Scheme 1.3.8).45 The TSA 53 (Figure 1.3.12) was 
designed  in  the  hope  that  during  an  immune  response,  a  general  base  will  be 
incorporated within the antibody active site. The base should be in proximity to the 2’ 
hydroxyl group of substrate 50 and should therefore facilitate nucleophilic attack of this 
hydroxyl on the adjacent phosphorus centre. Antibody MATT.F-1 was found to catalyse 
the phosphodiester hydrolysis with a proficiency three orders of magnitude lower than 
that of the naturally occurring enzyme RNAse A for the same substrate 45
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Scheme 1.3.8 Phosphodiester hydrolysis catalysed by antibody MATT.F-1.
46Figure 1.3.12 Transition state analogue for phosphodiester hydrolysis.
1.3.4.2  The Reactive Immunisation Approach
Both  the  TSA  and  the  bait-and-switch  approaches  rely on  chemically  inert  antigens. 
Reactive immunisation is a different approach, pioneered by Lemer and co-workers in 
1995,  which  relies  upon  a highly reactive  antigen to  react  covalently with  a  specific 
functionality within the antibody binding site during immunisation.46 This allows direct 
selection  of active  antibodies  from  a large pool  of inactive  ones.  The  success  of this 
strategy has been exemplified by a number of versatile aldolase catalysts that have been 
created.
The mechanism of natural aldolases is shown in Scheme 1.3.9. A lysine residue in the 
enzyme  active  site  forms  a  covalently bound  intermediate  with  the  substrate,  which 
proceeds  to  form  an  imine,  which  then  tautomerises  to  give  an  enamine  57.  The 
enamine  57  can  then  react  with  another  equivalent  of the  carbonyl  substrate  to  give 
Schiff base 59. After hydrolysis with water the aldol product 61 is generated.25
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Scheme 1.3.9 Mechanism of aldol reaction within active site of natural aldolases.
By creating an immunogenic  1, 3-diketone 62, Lemer reasoned that this should be able 
to trap reactive lysines within the antibody’s active site, via Schiff base formation and 
subsequent rearrangement to a more stable vinylogous amide 63 (Scheme 1.3.10).25 The 
resulting  vinylogous  amide  63  has  a  strong  ultraviolet  (UV)  absorption  at  316  nm, 
which is outside the range of the protein.  Hence, once the library of antibodies raised 
against the diketone has been generated, the most successful candidates can be simply 
identified on the basis of their ability to absorb in that UV region.
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Scheme 1.3.10 Transformation of a 1, 3-diketone to a vinylogous amide.
Antibody  33F12  was  isolated  and  shown  to  have  the  ability  to  catalyse  over  100 
aldehyde-aldehyde,  aldehyde-ketone  and  ketone-ketone  reactions,  with  very  high 
selectivity.25’47 A few of these examples are shown in Scheme 1.3.11.
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Scheme 1.3.11 Examples of aldol reactions catalysed by antibody 33F12.
When compared to their natural enzyme counterparts, these antibodies accept a wider 
range of substrates, with a catalytic turnover approximately within  10 times that of the
9 ^
natural aldolase.  The mechanism of action was shown to be the same as for the natural 
aldolase.  X-ray crystal  structure of the antibody 33F12  revealed that the nucleophilic 
lysine  residue,  which  should  usually be protonated  at  physiological  pH,  is  contained 
within a hydrophobic pocket, which disfavours protonation.25 This suggests that the pKa 
of  the  €-amino  group  of  lysine  is  lowered,  which  may  explain  its  enhanced 
nucleophilicity.25
Although reactive immunisation does not appear to have solved the problem of creating 
an  active  site  with  multiple  catalytic  residues,  it  has  the  advantage  of  selecting 
antibodies  on  the  basis  of their  ability to  initiate  a  chemical  reaction  as  opposed  to 
binding to a TSA.
1.3.4.3  Cofactor Dependent Antibodies
Metal coordinated enzymes are very common in nature, and the metallic species within 
the active site plays an important role in the reaction pathway by enhancing substrate 
selectivity and  accelerating reaction rates.  Nicholas et al.  have modified the antibody
4938C2  by incorporating  a  copper bis-imidazole  cofactor within  its  active  site.48  In the 
absence of the co-factor, antibody 38C2 catalyses an aldol reaction, but after addition of 
the copper complex, the properties of this antibody are altered, resulting in the antibody 
now being able to catalyse ester hydrolysis 48 During the immune response, it was found 
that the lysine residue within the 38C2 active site undergoes covalent bond formation 
with  the  succinic  anhydride  moiety  of  70  (Figure  1.3.13)  (which  was  previously 
precoordinated with CuCh), forming a 38C2-70-CuCl2 complex.  This metalloantibody 
was  then  used  to  catalyse  the  hydrolysis  of  ester  71  (Scheme  1.3.12).  The  study 
demonstrated how the introduction of a metal-coordinated ligand can completely alter 
the nature and the catalytic activity of the parent antibody.
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Figure 1.3.13 Molecule 70 containing the succinic anhydride moiety, which is coordinated to 
CuCl2  prior to forming a complex with antibody 38C2.
Scheme 1.3.12 Ester hydrolysis catalysed by 38C2-70-CuCl2  complex.
1.3.4.4  Summary
As the foregoing discussion has hopefully indicated, catalytic antibody technology can 
be a very powerful approach for creating new catalysts and some impressive advances 
have been made in this  field.  It has been demonstrated that it is possible to carry out 
transformations  with  good  catalytic  rates  and  turnover  numbers,  producing  products 
with high yields with good  selectivity.  Reactions that were difficult to carry out with
50previous  methodologies  have  been  successfully  performed  with  catalytic  antibodies. 
Despite these  advances,  there  are  still many problems remaining with this technology 
and the production of truly efficient enzyme mimics has proven to be very difficult. The 
requirement for the use of mice to generate catalytic antibodies is undesirable and new 
methods such as phage display49 and ribosome display50 that are able to create protein 
libraries, may provide an alternative to the immunisation techniques used thus far. The 
isolation of monoclonal antibodies and screening for the best catalyst can be a very time 
consuming  process,  although  the  advances  in  technology  have  made  the  screening 
protocol  slightly  easier.20’21’51  Finally,  improvements  in  the  design  of transition  state 
analogues may allow the isolation of antibodies whose properties rival those of natural 
enzymes.
1.3.5  Molecularly Imprinted Polymers
Molecular  imprinting  is  a  technique  which  involves  a  cross-linked  polymer  being 
assembled  around  a  template.  If the  template  is  a  TSA,  then  the  resulting  polymer 
should behave as an artificial enzyme for the chosen reaction.52 The general molecular 
imprinting  process  is  outlined  in  Figure  1.3.14.  Firstly,  the  template  is  mixed  with 
monomers  that  contain  functional  groups  which  can  interact  with  it,  to  form  the 
template-monomer  complex.  The  template-monomer  complex  can  be  formed  by 
covalent or non-covalent associations. A mixture of standard monomer and cross-linker 
is then co-polymerised around the template monomer complex forming a macroporous 
polymer.  This  contains  sites  on  which  the  template  molecule  is  bound.  Finally,  the 
template molecule is removed to leave the imprinted polymer with well defined, shape
c'y
specific cavities, which are complementary in shape to the template.
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Figure 1.3.14 The general molecular imprinting process.
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A good example of the use of imprinted polymer sites was demonstrated by Bystrom 
and co-workers.53 Polymer beads were imprinted with a sterol acrylate ester 74 template 
(Scheme 1.3.13). The template was then removed by the reduction of the ester linkage, 
followed  by  reaction  of the  hydroxyl  group  in  the  vacant  sites  with  excess  lithium 
aluminium hydride. The hydride functionality was thus positioned at a specific position 
within the cavity. Polymer 76, containing reducing agents, was then used to selectively 
reduce the ketone of androstan-3, 17-dione 77 at position C-17 only.53
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Scheme 1.3.13  Imprinting a polymer with sterol acrylate and ketone reduction with polymer 
catalyst 76.
Under conventional  conditions,  in the  absence  of the polymer,  there  was  a complete 
regiochemical preference for reduction at the less hindered C-3 carbonyl group, whereas 
in the  geometrically defined  environment of the polymer 76,  only the C-17  ketone  is 
allowed  access  to  the  reducing  agent.  Furthermore,  some  stereochemical  control  was 
also  observed  with  the  final  product  containing  a  mixture  of  17a-0H  and  17/3-OH 
(30:70).
Another elegant use of molecularly imprinted polymers  (MIPs) originates  from Wulff 
and co-workers, who mimicked the activity of carboxypeptidase A.54 The active site of 
carboxypeptidase  A  consists  of two  guanidinium  groups  of arginine  and  a  Zn2+  ion 
bound to His 69, Glu 72 and His 196. During the reaction, the oxyanion generated in the 
rate limiting step involving the breakdown of the tetrahedral transition state is stabilised 
by  Arg  127,  which  is  followed  by  zinc,  which  undertakes  the  catalytic  role  in  the 
hydrolysis  step.55  Substrate  specificity  is  increased  through  the  presence  of  a 
hydrophobic  pocket  in  the  active  site  and  binding  of  the  substrate  to  another 
guanidinium of Arg 145. The system Wulff designed contained an amidinium group, in 
addition to the triamine 79 (Figure 1.3.15) would act as co-ordination site for the Zn2+ 
ion (Scheme  1.3.14).54 The rational was that the amidinium group should stabilise the 
transition state of the reaction as well as polarise the carbonyl moiety of the substrate, 
making it more susceptible to nucleophiles. The TSA 80 (Figure 1.3.15) was used as a 
tetrahedral transition state mimic of carbonate hydrolysis, capable of being stabilised by
53both guanidinium and zinc moieties. Using 80 as an imprint molecule, the activity of the 
resulting MIP was  then investigated in the hydrolysis of diphenylcarbonate (81).  The 
catalyst displayed a 3200-fold rate acceleration and it also exhibited typical Michaelis- 
Menten kinetics.54 The ratio kcJ k unc2X  is used to express the catalytic activity of enzymes 
and  antibodies.  By  using  A :soin  as  & unC at  for the  MIP,  it  was  calculated  that  the  ratio 
kcJ k so\n had the value of 6900.54 This value is remarkably higher than the one which has 
been reported for carbonate hydrolysis by catalytic antibodies (^caAncat= 810).56
81
Figure  1.3.15 Triamine 79, phosphonate transition state analogue 80 and diphenylcarbonate 
81.
54Scheme  1.3.14  Schematic  representation  of a)  the  molecular  imprinting  with  TSA  80  and 
monomer 79 in the presence of Zn2+; b) removal of the template; c) and d) catalysis step.54
The  utilisation  of  molecular  imprinting  has  also  been  reported  for  Diels-Alder 
reactons,57  ester  hydrolysis58,59  and  isomerisation  reactions60as  well  as  in  protecting 
group strategies.6 1 MIPs are generally stable to harsh conditions such as extreme pH and 
temperature  and  although  these  characteristics  can  be  used  to  advantage,  their  scope 
remains  limited.  This  may  partially  be  due  to  the  problems  associated  with  the 
formation  of the template-monomer complex.  As  previously mentioned,  covalent  and 
non-covalent  interactions  are  involved  in  the  formation  of  the  template-monomer 
complex. In the non-covalent case, the combination of weak intermolecular forces leads 
to  the  pre-organisation  step  being  a  dynamic  equilibrium,  with  the  free  and  complex 
forms in a constant exchange. As a result, the molecular recognition sites formed within 
the  polymer  become  heterogeneous,  which  can  lead  to  problems  in  the  catalytic 
applications of these polymers. One of the most important factors in enzyme catalysis is 
that an enzyme can change its conformation in order to accommodate the substrate into
55its  active  site.  MIPs  often  have  very rigid  structures,  which  means  that  they  cannot 
undergo conformational changes.
1.3.6  Synthetic Polymers as Artificial Enzymes
The  use  of  synthetic  polymers  as  enzyme  mimics  has  always  been  an  attractive 
approach,  due  to  their  compatibility  with  organic  solvents  and  stability  to  higher 
temperatures. Synthetic polymers can form a backbone to the artificial enzyme allowing 
the attachment of various binding or catalytic groups which can aid the recognition of 
substrates and even perform catalysis. As early as the 1960s, it was noticed that flexible, 
water soluble polymers with suitable side chains, such as poly(4-vinylpyridine) (82) and 
poly(A-vinylimidazole)  (83)  (Figure  1.3.16),  displayed  different  affinities  towards 
small  molecules  and  were  able  to  catalyse  the  hydrolysis  of ortho  nitrophenyl  esters 
84.62
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Figure  1.3.16  Poly(4-vinylpyridine) (82), poly(A-vinylimidazole) (83) and nitrophenyl ester 
(84).
The behaviour of these polymers had intrigued Klotz and co-workers and since then, the 
group have conducted a number of detailed studies using water soluble polymers such
f \ “ K
as  polyethyleneimine  (PEI)  (Figure  1.3.17).  PEI  is  usually  prepared  as  a  highly 
branched  macromolecule,  with  a  very  compact,  locally  concentrated  conformation.
56This  is  believed  to  help  with  its  increased  binding  ability  towards  small  molecules, 
compared with the much more extended and open conformation of linear polymers. The 
compact conformation of PEI has been compared to that of serum albumin, which has 
an incredibly strong affinity for small molecules of widely different structures.63
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Figure 1.3.17 Polyethyleneimine.
The  fact that  such  a polymer with strong  ligand binding was  so  readily available led 
Klotz to graft functional groups onto the polymer matrix. A notable discovery was that 
alkylation of PEI  with  10% dodecyl  groups  and  15% with  imidazole gave a polymer 
which  was  able  to  hydrolyse para  nitrophenyl  esters  86  (Scheme  1.3.15)  in  a  truly 
catalytic manner.64
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Scheme 1.3.15 Ester hydrolysis by polyethyleneimine.
Table  1.3.1,  shows  a  comparison  between  the  effectiveness  of  different  catalysts 
towards  the  hydrolysis  of a  nitrophenyl  ester  86.  PEI  derivative  is  270  times  more 
effective than free imidazole, however it does not match the activity of a-chymotrypsin, 
even with activated unnatural ester substrates.64,65
57Catalyst Catalytic Constant k 
(m-1 min'1)
Imidazole 10
a-Chymotrypsin 10000
PEI, 10% dodecyl gp, 15% imidazole 2700
Table  1.3.1  Comparison  of  catalytic  efficiencies  of  imidazole,  a-chymotrypsin  and 
polyethyleneimine.
Branched insoluble polymers have more rigid backbones and more hydrophobic pockets 
than branched soluble polymers such as PEI, which may be more advantageous in some 
catalysts. This encouraged Suh to synthesise an effective polymer catalyst with protease 
activity.66  Imidazoles  were  randomly  attached  to  poly(chloromethylstyrene-co- 
divinylbenzene)  (PCD),  to  give  catalyst  89  (Scheme  1.3.16),  which  was  able  to 
hydrolyse albumin, with the optimum activity between pH 7 -  9. Catalyst 89 contained 
22  mol%  of imidazoles  and  when this  is  lowered  to  5  mol%,  a marked  reduction  in
2  1   3  1 proteolytic activity was observed (k0 decreased from 3.13 x  10'  m'  to 0.13 x  10'  m' ). 
It  is  believed  that  the  mechanism  of action  involves  two  imidazoles  as  depicted  in 
Scheme 1.3.16. 66
PCD PCD PCD
89 90 91
Scheme 1.3.16 Hydrolysis of albumin by catalyst 89.
58Many enzymes contain two or more metal ions within their active site and examples of
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these  include  methionine  aminopeptidases,  metallo-(3-lactamases,  and  proline 
dipeptidases.69  Suh  constructed  an  artificial  multinuclear  metalloprotease  93  through 
transfer  of  three  moieties  of  tris(2-aminoethyl)amine  (tren)  from  the  trinuclear 
macrocyclic complex 92 to PCD (Figure 1.3.18).70;71
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Figure 1.3.18 Trinuclear macrocyclic complex 92, multinuclear metalloprotease 93 and amide 
substrates.
The catalytic activity of 93 was investigated using amides 94 -  97. It was found that the 
catalyst only hydrolysed amides 95 - 97 which contained carboxyl groups. To account 
for this selectivity, the mechanism in Figure 1.3.19 was proposed. The first copper (II) 
ion  complexes  to  the  carboxyl  group  and  the  second  copper  (II)  coordinates  to  the 
oxygen of the amide. This leaves the third copper (II) with the attached hydroxyl group 
to position itself in the correct geometry for nucleophilic attack. The estimated kcat for 
the amide hydrolysis was 0.1 h 1  at pH 8.5 and 50 °C.70 This is compatible with a & catof
0.18 h 1  for hydrolysis of an amide substrate at pH 9 and 25 °C observed with a catalytic 
antibody.7 1
5998
Figure 1.3.19 Hydrolysis of amides by metalloprotease 93.
Another  PCD  based  artificial  metalloenzyme  has  been  used  in  phosphodiester
hydrolysis. Deoxyribonucleic acid (DNA) is very stable to hydrolysis, the half-life for
1  1   71 ) 
spontaneous hydrolysis is estimated at about  10  years at pH 7 and 25 °C.  However,
DNA can be hydrolysed using a Co(III) complex of cyclen and Co(III)Cyc 99, is one of
1 ^
the most effective catalysts for the hydrolysis of DNA.  The mechanism illustrated in 
Figure 1.3.20 has been proposed for the catalytic action of Co(III)Cyc.
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Figure 1.3.20 Co(III)Cyc complex 99 and proposed mechanism of DNA hydrolysis.
A  PCD  derivative  incorporating  Co(III)Cyc  was  prepared  (101,  Figure  1.3.21)  and 
assessed for hydrolytic activity.74 101 was shown to be a very efficient catalyst, with the 
DNA hydrolysis half life measured to be  30 min at  25  °C.  A comparison of the rate 
constants  for  Co(III)Cyc  alone  and  PCD-based  Co(III)Cyc  complex  showed  that 
attachment  to  PCD  increased  the  activity of the  catalyst by  200  times.74  It has been
60estimated  that  only  a  small  number  of Co(III)Cyc  moieties  are  exposed  to  the  resin 
surface and hence only a small fraction of these would function as the catalytic groups. 
Consequently,  the  co-operation  between  two  or  more  metal  centres  is  unlikely  and 
instead, it has been proposed that the increased activity of the PCD -  based catalyst may 
possibly be due to the gel-like microenvironment of PCD exerting favourable effects on 
the reactivity of Co(III)Cyc complex.74
1 0 1
Figure 1.3.21 PCD derivative incorporating Co(III)Cyc complex.
1.3.7 Combinatorial Polymers as Enzyme Mimics
During the mid nineties, Menger and co-workers introduced a highly creative approach 
towards  artificial  enzymes  by  generating  a  large  library  of randomly  functionalised 
polymers.75'77  In  an  attempt  to  create  a  reducing  agent,  mixtures  of  three  or  four 
carboxylic acids (102 -  109), selected from Scheme 1.3.17, were randomly attached to 
polyallylamine  110.  This  allowed  the  group  to  create  a  large  and  diverse  polymer 
library.77 Furthermore, each polymer contained 5 -  10% of dihydropyridine in addition 
to metals such as zinc (II), magnesium (II) and iron (II). Dihydropyridines are known to
•  78
convert ketones to alcohols in nicotinamide adenine dinucleotide (NADH) models.
61R2 R3
111
Scheme  1.3.17  Synthesis of a polymer library consisting of polyallyalamine and carboxylic 
acids.
Each of 8198  combinatorially generated polymers with and without the presence of a 
metal ion were then screened for catalytic activity towards benzoylformic acid (Scheme 
1.3.18).  92%  of these  yielded  less  than  10%  of product  and  were  hence  considered 
inactive.  The polymers  that were  found to be most  active had  a number of things  in 
common which are believed to have contributed to catalysis: a metal ion, a hydrophobic 
chain and the presence of an imidazole or guanidine moiety.77 The half-life of one of the
no
better reductions was 2 hours, which was faster relative to many other NADH models.
62Combinatorial
polymer
Scheme 1.3.18 Reduction of benzoylformic acid using combinatorial polymers.
Combinatorial  polymers  have  also  been  used  to  catalyse  the  dehydration  of  (3-
7  f\
hydroxyketone  116  (Scheme  1.3.19).  The  general  design  of  these  polymers  was 
essentially  the  same  as  described  above,  however  in  this  instance,  poly(acrylic 
anhydride)  114  was  used,  and  amines  were  attached  to  the  polymer  instead  of 
carboxylic  acids.  The best polymer screened displayed rate  acceleration  of 920 times 
above the background reaction.
114
F^NH,, R,NH2
r3nh2>
H20 , pH12, sonicate
R,HN  'O   R,HN  O  R,HN  O  R4HN  O  R,HN  O  R,HN  O  R,HN  'O
115
O
Polymer 115
0 2N
117
Scheme 1.3.19 Combinatorial polymer 115 and dehydration of /3-hydroxyketone catalysed by
115.
Although  this  combinatorial  approach  has  generated  some  promising  results,  the 
polymeric mixtures generated are complex systems, which are impossible to separate, 
thus  making  it  difficult  to  determine  their  structure,  and  perhaps  even  more 
frustratingly, making meaningful mechanistic conclusions all but impossible.
631.3.8 Directed Evolution of Enzymes
Many  enzymes  are  commercially  available  today  and  work  well  in  catalysing 
enentioselective transformations of a number of unnatural compounds. However, their 
great  degree  of  specificity  means  that  they  cannot  be  used  on  a  wider  range  of 
substrates. In an attempt to deal with such problems, directed evolution strategies have
7Q
been  employed  (Figure  1.3.22).  The  starting  point  of  this  technique  involves 
obtaining a wild-type enzyme which catalyses a particular reaction of interest, but not 
with  an  acceptable  level  of enantioselectivity.  The  gene  that  encodes  the  wild-type 
enzyme  is  then  subjected  to  random  mutagenesis  methods,  such  as  the  error-prone
on  o 1
polymerase  chain  reaction  or DNA  shuffling.  The  library of mutant  genes  is  then 
inserted into a microorganism and mutant enzymes are expressed. The enzymes are then 
screened  for catalytic  activity (using techniques  such as  infrared thermography  )  and 
enantioselectivity in  the  reaction of interest.  The mutant  gene of the  optimal  enzyme 
variant  is  then  subjected  once  more  through  the  whole  process  of  mutagenesis, 
expression and screening. This process can be repeated as many times as required and it 
creates a type of ‘Darwinistic evolution’, leading to the formation of a superior enzyme, 
every time it is performed.
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Figure 1.3.22 General representation of directed evolution process.
To  demonstrate  this  approach,  Reetz  et al  selected  a  hydrolytic  kinetic  resolution  of 
ester  118,  catalysed  by  a  bacterial  lipase  from  Pseudomonas  aeruginosa  (Scheme 
1.3.20).83 The wild-type lipase showed an ee of only 2% for the (S)-acid 119. The first 
round  of mutagenesis,  expressed  about  1000  lipase mutants,  which  were  isolated  and 
screened on the basis of released /?-nitrophenol product, which has an absorption at 410 
nm.  The candidates which  favoured the hydrolysis of the (S)  enantiomer of ester  118 
were then isolated and exposed to further mutagenesis. After four generations, the group 
obtained an artificial enzyme which catalysed the hydrolysis reaction with an ee of 81% 
for (.S^-acid 119.83
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Scheme  1.3.20  Hydrolytic  kinetic  resolution  of  ester  118  catalysed  by  Pseudomonas 
Aeruginosa lipase.
The process  of random  mutagenesis  identifies  sensitive  positions  (‘hot  spots’)  in  the 
enzyme which are responsible for enantioselectivity. An x-ray crystal structure of wild- 
type lipase from P. aeruginosa unexpectedly revealed that the ‘hot spots’ are not really 
close to the active site. This contrasts all the previous studies that attempted to improve 
selectivity,  by  applying  site-directed  mutagenesis  close  to  the  active  site,  keeping  in 
mind  the  principles  of  ‘induced  fit’  theory.84'86  Molecular  modelling  studies  in  this 
particular  case  suggested  that  specific  amino  acids  found  at  remote  positions  of the 
enzyme, may cause it to slightly change its shape, leading to higher enantioselectivity.83
Another example of directed evolution has also been employed in the Baeyer-Villiger
87 reaction  (Scheme  1.3.21).  Flavin-dependent  enzymes  such  as  cyclohexanone 
monooxygenase  (CHMO)  can be  used  as  a  catalyst  for  this  reaction.88’89  During  the 
enzymatic process, dioxygen reacts with the enzyme-bound flavin adenine dinucleotide 
(FAD)  to  form  an  intermediate  hydroperoxide,  which  initiates  the  Baeyer-Villiger 
reaction by transferring one oxygen atom from O2 to the substrate (ketone). As a model 
reaction, the rearrangement of 4-hydroxycyclohexanone 121 was chosen, using CHMO 
from Acinetobacter sp. NCIMB 9871. The Baeyer-Villiger reaction of ketone 121 leads 
to  lactone  ((R)  or  (6)),  which  can  then  rearrange  to  122  or  123,  with  retention  of 
stereochemistry (Scheme 1.3.21).87 Using the wild-type enzyme, the reaction pathway 
favours  (R)-122  with  an  ee  of 9%.  After  performing  mutagenesis,  the  best  selected 
enzyme, 2-D19-E6, was shown to catalyse the reaction with an ee of 90% in favour of 
(R)-122.
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Scheme 1.3.21 Baeyer-Villiger reaction catalysed by CHMO enzyme.
It is believed that one factor influencing the enantioselectivity during the rearrangement 
is  that  the  hydroxy  group  of the  substrate  is  acting  as  a  potential  hydrogen  donor, 
placing the substrate in two different protein environments, depending on whether the 
favoured  product  is  (R)  or  (S).  This  hypothesis  led  the  group  to  use  4- 
methoxycyclohexanone  as  a  substrate  to  provide  them  with  further  information.  The 
enzyme 2-D19-E6, shown to have high selectivity in the reaction of hydroxy ketone 121 
for (/?)-122  (90  %  ee),  only showed  25%  ee  in  favour of (K)-125  in  the  reaction  of
R7 methoxy ketone 124 (Scheme 1.3.22).  However, the enzyme 1-K2-F5 that showed the 
most  5-enantiomer  selectivity  in  reaction  of  121,  showed  nearly  complete 
enantioselectivity  (98.6%  ee  in  favour  of (S)-126)  when  catalysing  the  reaction  of 
methoxy  ketone  124.  Since  the  methoxy  functionality  is  a  hydrogen  acceptor,  this 
suggests that enzyme  1-K2-F5 had undergone an amino acid substitution in order to be 
able to  form  an  additional hydrogen bond to the methoxy group  during the transition 
state of the reaction. Characterisation of 1-K2-F5 confirmed that this was the case, with
on
serine replacing phenylalanine at position 432.
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Scheme 1.3.22 Baeyer-Villiger reaction catalysed by CHMO enzyme.
The group also demonstrated that enzymes generated by direct evolution can be used on
87
a wider range of substrates.  Reactions of other 4-substitued cyclohexanone derivatives 
such as methyl, ethyl, chloro, bromo and iodo were also catalysed with selectivities of 
95 -  99% ee.
1.4 Summary
As  illustrated  from  the  above  discussion,  there  have  been  many  approaches  taken 
towards  developing  artificial  enzymes.  We  have  seen  the  use  of  more  traditional, 
rational design approach, where a molecule is designed by incorporating a group that is 
known  to  be  catalytic  within  the  active  site  of a  natural  enzyme.  Although  much 
information has been learned about different aspects of enzyme catalysis and functional 
group  cooperativity,  this  approach  can  be  very  time  consuming  and  even  the  most 
careful  planning  of  the  design  can  lead  to  unproductive  results.  More  successful 
outcomes  have  been  seen  with  approaches  which  have  employed  a  selection  event, 
allowing one to choose the most efficient catalyst from a large library of molecules. The 
catalyst can be selected on the basis of its binding towards an appropriate TSA and this 
approach  has  been  successful  in  several  cases  as  illustrated  by  catalytic  antibodies. 
However,  problems  associated  with  designing  a  TSA  which  has  the  electronic  and 
geometric  features  that  closely  resemble  the  transition  state  of  the  reaction  has 
prevented  this  approach  from  generating  catalytic  molecules  that  rival  enzymes. 
Alternatively,  incorporating  a  catalytically  active  group  within  the  active  site  in 
combination  with  TSA binding  as  exemplified  by reactive  immunisation  in  catalytic 
antibodies has led to more significant results. In general, the problems associated with 
all  selection  events  are  the  large number of possible  combinations  generated  and the
68necessity for screening techniques in order to detect catalytic activity. The development 
of new  technology,  such  as UV/Vis  spectroscopy,  IR thermography82  and  automated 
mass  spectrometry  has  allowed  for  the  use  of  improved  and  new  screening 
methods.20,21,51  However,  despite this,  screening techniques remain a crucial  area that 
needs  developing  in  order  for  greater  success  to  be  achieved.  Developments  in 
combinatorial chemistry have also facilitated progress in this area, however difficulties 
in isolating and characterising the selected host have been identified. Finally, advances 
in  molecular biology techniques  have  allowed  for the  development  of more  efficient 
artificial  enzyme  systems.  However,  these  artificial  enzymes,  together  with  catalytic 
antibodies still share the same undesirable properties as natural enzymes, such as lack of 
thermal stability and pH sensitivity.
Despite the fact that there have been a number of impressive advances in this field, the 
development  of an  artificial  enzyme,  which  has  the  efficiency,  stereoselectivity  and 
turnover of a natural  enzyme still remains to be seen.  Clearly,  there are many factors 
involved in  enzyme catalysis,  and for us, the one thing that remains  is to continue to 
learn from Nature’s principles. Combining this knowledge, together with technological 
advances, will hopefully allow us to eventually create more efficient and sophisticated 
artificial enzymes.
69CHAPTER 2
RESULTS AND DISCUSSION
STUDIES RELATED TO THE DEVELOPMENT OF 
ARTIFICIAL ESTERASES
702.1  Introduction
A novel  approach  towards the construction of an  artificial  esterase was  taken by our 
own research group and first described in 2001.90;91  Thus a protocol was developed for 
the modular assembly of artificial enzymes, which combined the positive elements of 
both  the  design  and  selection  approaches.  The  basic  principle  was  to  consider  an 
enzyme at its most simplistic level -  as a molecule that can both “hold” and “bite”, and 
also possess the flexibility to achieve the operation of bringing the “hands” (recognition 
and substrate binding) to the mouth (catalytically active group). The resultant artificial 
enzyme (Figure 2.1.1) therefore consisted of a flexible polymer backbone, inspired by 
the work of Menger76;77 and Klotz,64 with two differing threads attached to it, one whose 
function was to facilitate the reaction through substrate recognition and transition state 
binding, whilst the second was to contain a necessary functional group for catalysis. The 
binding group was a specifically designed and selected unit, which could act, to stabilise 
the transition  state of the reaction.  This binding group would  also hopefully hold the 
ester substrate in the correct orientation for effective hydrolysis by the catalytic group, 
thus resulting in an increase in the catalytic activity of the polymer. Although the exact 
tertiary  structure  of  the  polymer  was  unknown,  it  was  thought  that  the  random 
attachment of such groups and the overall flexibility of the system would increase the 
possibility  of the  “esterase”  developing  effective  regions  for  catalysis  to  occur.  The 
modular assembly of an artificial esterase in this way was also envisaged to permit rapid 
variation of both the binding site and/or the catalytically active group,  and this would 
allow the assessment of a range of factors which are essential for enzyme catalysis.
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Figure 2.1.1  A diagrammatic representation of an artificial “millipede” enzyme,  a) Binding, 
catalytic and hydrophilic/hydrophobic groups are randomly grafted onto a polymeric backbone, 
b) Aerial view -  each receptor site is surrounded by a number of catalytic groups, and once a 
substrate is bound, any one of these may be in correct position to attack the substrate and act as 
catalyst.9 1
722.1.1  The protocol for selection of a binding group (receptor site)
In order to select an  appropriate binding unit, our group  initially chose an  unactivated 
ester  substrate  127  (Figure  2.1.2)  which  contained  potential  binding  groups 
(highlighted in red) and was also UV active thus allowing the hydrolysis reaction to be 
monitored.
o  o
127
Figure 2.1.2 Ester substrate used for hydrolysis studies.9(>yi
The  next step was to consider a suitable transition  state analogue for the hydrolysis of 
ester  127  and  in  this  respect,  the  choice  was  essentially  based  on  the  principles
9 T *94
developed  by  Lerner and  Schultz  in  their pioneering work  on  catalytic  antibodies.  ’ 
Thus in order to explain how this decision was reached, let us first analyse the pathway 
followed  during  ester  hydrolysis  (Scheme  2.1.1).  This  reaction  can  be  catalysed  by 
either acid or base, and proceeds via nucleophilic attack on the carbonyl group, resulting 
in a change of hybridisation from sp2  to sp1  when the tetrahedral intermediate is formed.
•  09 This then breaks down in the rate determining step to liberate the acid and the alcohol.
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Scheme 2.1.1 General ester hydrolysis, a) Base catalysed hydrolysis, b) Acid catalysed
hydrolysis.
Since the transition state of the reaction involves a tetrahedral  intermediate, any stable 
analogue  which  mimics  the  geometry  and  charge  distribution  of  this  tetrahedral 
intermediate should, in theory,  function as a good TSA.  Phosphonates have often been 
used as inhibitors of natural esterases because of their tetrahedral geometry around the 
phosphorus  centre.  Hence,  they  were  considered  to  be  good  mimics  of  the  ester 
hydrolysis transition  state.93  Phosphonate  128 was therefore  synthesised  as  a TSA  for 
the  hydrolysis  reaction  of ester  127  (Scheme  2.1.2).  Thus  the  requisite  phosphonate 
contained both a carboxylic acid and a phosphonate moiety which can form salts with 
basic  groups  and  amide  linkages  which  can  form  hydrogen  bonds  with  other  polar
91 groups.
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Scheme 2.1.2 Hydrolysis of ester 127 via a tetrahedral intermediate, which is mimicked by
transition state analogue  128.
Dipeptides  were  chosen  as  potentially  suitable  binding  units  because  they are  rich  in 
acidic,  basic  and  hydrogen  bond  donor/acceptor  functionalities.  Nine  commercially 
available dipeptides were selected (Table 2.1.1) and analysed  for their binding affinity 
towards  the  TSA  128  using  Pulsed  Field  Gradient  (PFG)  NMR  techniques.94"96  This 
technique  employs  the  use  of  the  translational  diffusion  coefficient  (D),  which  is 
molecular  mass  dependent:  small  molecules  diffuse  faster  than  larger  molecules  in 
solution.  When two molecules form a complex  in solution, the overall  molecular mass 
changes and this can be observed as a slowing or decrease in the translational diffusion 
coefficient.  Although  this  technique  is  normally  employed  to  study  the  binding  of a 
small  molecule  with  a  high  molecular  weight  receptor,  our  own  group  were  able  to 
detect  binding  of the  dipeptide  to  the  TSA  in  an  aqueous  environment  through  the 
simple  expedient  of  using  Le  Chatelier’s  principle.  The  translational  diffusion 
coefficients of the dipeptides were measured in D2O at pD 7 and the results obtained are 
shown  in  Table  2.1.1.91:96  From  these  studies,  it was  found  that the dipeptide  H-Arg- 
Arg-OH  and  TSA  complex  displayed  the  greatest change  in  the  diffusion  coefficient,
i.e. this dipeptide displayed the best binding potential towards the TSA. This is perhaps 
not  surprising,  since  the  interaction  between  the  guanidine  of  arginine  and  thecarboxylic  acid  of the  TSA  128  is  well  documented  (Figure  2.1.3),  and  was  also 
confirmed  by  molecular  modelling  studies.90  Although  the  Arg-Arg  dipeptide  was 
selected as the strongest binder for incorporation into the artificial esterase, it does not 
necessarily mean that it will be the most effective unit for catalysis. However, the ability 
to rank the binding  affinities of the TSA with a simple  selection  of readily available 
dipeptides makes this NMR procedure extremely useful.
Entry Dipeptide 1010 x D [mV1] 10_1° x D’ [m V ] Rd [%]a
1 H-Arg-Arg-OH 4.10 ±0.04 3.40 ± 0.04 17 ± 2
2 H-Ala-Arg-OH 4.76 ± 0.05 4.18 ±0.08 12 ± 2
3 H-/3Ala-Lys-OH 4.91 ±0.03 4.39 ± 0.04 11 ± 1
4 H-/3Ala-His-OH 5.18 ±0.03 4.71 ±0.05 9 ± 1
5 H-Ser-His-OH 4.89 ± 0.03 4.46 ± 0.05 9 ± 1
6 H-Gly-Tyr-OH 4.97 ± 0.04 4.64 ± 0.07 7 ± 1
7 H-/3Ala-Leu-OH 4.97 ± 0.04 4.62 ± 0.09 7 ± 1
8 H-Gly-Thr-OH 5.54 ±0.04 5.19 ±0.04 6 ± 1
9 H-Ala-Gly-OH 6.08 ± 0.05 5.72 ±0.08 6 ± 1
Table  2.1.1  NMR  binding  studies  of potential  dipeptide  binding  sites.  D  is  the  observed 
diffusion  coefficient  for  3  mM  solution  of dipeptide  in  D20  at  298  K.  D’  is  the  observed 
diffusion coefficient for mixtures containing dipeptide (3 mM) and TSA 128 (30 mM) in D20 at 
298 K.aRd is the relative change in diffusion coefficient (100(D-D’)/D).9 6
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Figure 2.1.3 Representation of the interaction between a guanidine and a carboxylic acid.
2.1.2  Selection of the catalytic functional group
With a suitable binding unit in hand, the next stage was to choose an effective catalytic 
group.  The  catalytic  group  was  selected  on  the  basis  of amino  acids  functionalities
76which were well known to participate in catalysis during ester hydrolysis within natural 
enzymes.  Therefore  cysteine,  histidine  and  serine  were  all  considered.97  However, 
histidine was chosen, because it can function as a general acid/base pair as observed in 
ribonucleases  (Scheme  2.1.3).97  It  was  anticipated  that  it  might  perform  a  similar 
function within this system.
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Scheme 2.1.3 General acid/base catalysis in ribonucleases.9 7
2.1.3 Constructing an artificial esterase
Polyallylamine  110  (Figure  2.1.4)  was  chosen  as  a  polymer  support,  since  it  is  a 
flexible  polymer  and  also  possesses  free  amino  groups  thereby  providing  an  easy 
method  for  the  attachment  of the  binding  and  catalytic  units  using  standard  peptide 
coupling techniques.
110
Figure 2.1.4 Polyallylamine
77In addition, since it was considered to be essential for the Arg-Arg binding group to be 
conformationally mobile when attached to the polymer,  a spacer unit (6-aminocaproic 
acid) was attached to the binding unit. The resulting binding unit, which consisted of the 
protected tripeptide 6-(Fmoc-Arg(Pbf)-Arg(Pbf)-)amido caproic acid 131 (Figure 2.1.5) 
was prepared by solid phase synthesis.9 1
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Figure 2.1.5 The tripeptide 131 binding group.
The  artificial  esterase  132  (Figure  2.1.6)  was  then  assembled  by  simultaneous 
attachment of the binding unit  131  and the histidine catalytic  group,  and this process 
was then followed by the attachment of a lysine residue which could be considered to 
act  as  a  hydrophilic  group.  It  was  envisaged  that,  by  introducing  the  binding  and 
catalytic groups at the same time, they would influence the positioning of each other on 
the polymer backbone. Removal of the protecting groups, then gave the desired polymer 
132 (Figure 2.1.6). Other polymers were also prepared, one containing only lysine and 
the binding unit  134  (2:1  ratio),  another with lysine  and the  catalytic  group  133  (2:1 
ratio) and finally a “blank” polymer 135, containing lysine residues only (Figure 2.1.7). 
In  this  way,  it  was  possible  to  explore  the  relative  importance  of the  units  and  the 
possible  synergistic  effects  which  contributed  to  those  polymers  possessing  the  best 
catalytic activities.
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Figure 2.1.6 a) Graphical representation of artificial esterase, b) Chemical representation of
artificial esterase.
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Figure 2.1.7 Examples of further artificial esterases prepared.
79The fully deprotected polymers 132 - 135 were then investigated to determine whether 
they catalysed hydrolysis  of ester  127.  The hydrolysis  reaction  in  aqueous phosphate 
buffer  at  pH  7  was  followed  by the  formation  of the  acid  product  and  the  resultant 
decrease  in  the  concentration  of starting  material  both  of which  were  monitored  by 
analytical  HPLC.  It  should  be  noted  that  the  formation  of the  alcohol  could  not  be 
monitored  because  of  its  relatively  poor  UV  absorbance.  The  blank  polymer  135, 
consisting of lysine only, did not hydrolyse the ester. For all the other polymers 132-134 
hydrolysis was observed. The initial relative rates for product formation were calculated 
to be  890:90:1  for polymers  132:134:133  respectively.9 1  The hydrolysis  observed  for 
polymer  133  was considered to be due to the presence of the imidazole group which 
could  function  as  a nucleophilic  catalyst.  The  initially  surprising  activity of polymer 
134,  was  attributed  to  the  fact  that  the  guanidine  groups  of arginine  residues  were 
protonated,  thus giving a higher local concentration of hydroxide ions in the vicinity, 
which were then able to hydrolyse the ester. It was clear however, that when the binding 
and  catalytic  residues  were  present  together  as  in  polymer  132,  the  most  efficient 
catalyst was produced.91  Within this approach, it was also possible to demonstrate the 
enzymic  phenomenon  of  competitive  inhibition.  Thus,  exposure  of  an  equimolar 
mixture of the phosphate TSA and the ester substrate led to a drastic decrease in the rate 
of ester hydrolysis.
Despite  the  fact  that  the  detailed  mechanism  of  the  catalysis  was  unknown,  this 
preliminary  study  demonstrated  the  possibilities  of a  valuable  new  approach  for  the 
creation  of  artificial  enzymes  and  provided  detailed  information  about  the  relative 
importance and cooperativity of the groups within the active site.
2.2  Objectives of the current research programme
In  light  of the  results  from  the  preliminary  exploratory  study  discussed  above,  our 
intention  was  to  extend  our  knowledge  of  the  above  system,  and  by  using  the 
information acquired, to further explore these types of polymer systems. Consequently, 
the main objectives of the present study, using the same design concept were:
a)  To further investigate the activity of artificial esterases by modifying the binding 
groups within the polymer.
80b) To analyse the effect of changing pH, solvent and substrate concentration on artificial 
esterase activity.
c) To evaluate ester substrate specificity.
d) To extend this design concept to the synthesis of other classes of artificial enzymes.
2.3  Development of artificial esterases
Since it was our intention to synthesise several different analogues of artificial esterases, 
containing different binding sites, the first step was to synthesise the protected peptides. 
Using the previously conducted NMR binding  studies  as  a guide96  (Table 2.1.1),  we 
wished to incorporate the moderate binding H-Ala-Arg-OH motif and the poor binding 
H-Ala-Gly-OH dipeptide within our enzyme mimic.  It was our desire to correlate the 
NMR binding strength to the effectiveness of artificial esterase. Since the dipeptides H- 
Ala-Arg-OH  and  H-Ala-Gly-OH  are  comprised  of two  different  amino  acid residues, 
these motifs  also  allow  us  to  vary the relative positions  of the two  amino  acids with 
respect  to  the polymer backbone.  Hence,  the protected  forms  of both  H-Ala-Arg-OH 
and the reverse, H-Arg-Ala-OH would have to be synthesised. The fact that the amino 
acids are placed in different positions in relation to the polymer backbone, may affect 
the behaviour of the polymer during ester hydrolysis. The same argument applies to H- 
Ala-Gly-OH, hence H-Gly-Ala-OH was also selected for incorporation. Additionally, it 
was reasoned that the synthesis of the polymer containing the previously used H-Arg- 
Arg-OH  binding  unit  should  be  repeated  for  comparison  purposes  and  this  would 
hopefully give us a more complete picture of the behaviour of these types of polymer 
systems.  Hence,  in  summary,  the  initial  aim  was  to  synthesise  the  five  artificial 
esterases illustrated in Figure 2.3.1.
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Figure 2.3.1 Initial artificial esterases targeted.
2.3.1  Preparation of binding groups
The binding motifs (Arg-Arg, Arg-Ala, Ala-Arg,  Gly-Ala and Ala-Gly) were selected 
on  the  basis  of binding  the  TSA  as  assessed  by  NMR  spectroscopy  (Table  2.1.1, 
Section 2.1.1).96 The binding units were prepared manually on solid phase, utilizing 2- 
chlorotrityl resin  144  (Scheme 2.3.2),  following the procedure described previously.9 1  
Initially,  the  binding  unit  131  consisting  of  a  6-aminocaproic  acid  linker  and  the 
arginine dipeptide which was protected with 9-fluorenylmethoxycarbonyl  (Fmoc)  and 
2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl  (Pbf)  groups  was  synthesised 
(Scheme  2.3.2).  The  route  commenced  with  the  Fmoc  protection  of 6-aminocaproic 
acid  140  using  9-fluorenylmethyl  chloroformate  (Fmoc-Cl)  141  and  10%  aqueous 
sodium  carbonate  in  dioxane  to  afford  Fmoc  protected  6-amino  caproic  acid  142 
(Scheme 2.3.1).
= -Arg-Arg
= -Arg-Ala  „
= -Ala-Arg  CA = 6 -amino caproic
= -Ala-Gly  ?c,d (spacer)
= -Gly-Ala
82140
+
10% aq. Na2C 03,
dioxane, 0°C to r.t., 
4 h,  77%
Scheme 2.3.1 Synthesis of Fmoc 6-aminocaproic acid 142.
The acid 142 was then coupled to 2-chlorotrityl resin 144 using diisopropylethylamine 
(DIPEA) (Scheme 2.3.2). At this point and for all the further coupling steps, a test for 
the  level  of Fmoc  substitution  was  performed,  in  order  to  give  an  indication  of the 
efficiency of reaction.  The substitution was measured by treating a known quantity of 
resin  with  piperidine/DMF  (2:8)  solution  in  a silica UV  cell.  Piperidine  cleaves  the 
Fmoc protecting group to form dibenzofulvene, which reacts with piperidine to form the 
fulvene-piperidine by-product 143 (Figure 2.3.2). The by-product 143 has a strong UV 
absorption at 290 nm.98
Figure 2.3.2 Fulvene-piperidine adduct.
The  level  of Fmoc  substitution  can  then  be  determined  in  mmol/g  from  Equation
2.3.1.
98
Substitution = ( Absorbance/ mg of sample x 1.75)
Equation 2.3.1
83Fmoc  protected  caproic  acid  in  piperidine/DMF  (2:8)  solution  afforded  resin  145 
(Scheme  2.3.2),  Attachment  of the  first  Pbf protected  arginine  residue  to  145,  was 
achieved  using  DIPEA,  (lH-benzotriazol-l-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate (PyBOP) and  1  -hydroxybenzotriazole (HOBt) in DMF.  This was 
followed by Fmoc deprotection and coupling of the second arginine unit.
.  _ iri_ A   lo u   1. FmocArg(Pbf)-OH, PyBOP
1.  DIPEA, DCM, r.t, 3 h  HOBt, DIPEA, DMF, r.t., 4 h
Fmoc-CA-OH  +  2-CI-Trt-0    ►   H2N -C A -0-#
2.  Piperidine/DMF (2:8),  2. Piperidine/DMF (2:8),
142  144  r.t., 3 h  145  r.t., 3 h
H2N-Arg(Pbf)-CA- o-# 
146
1. FmocArg(Pbf)-0H, PyBOP 
HOBt, DIPEA, DMF, r.t., 4 h
2. AcOH/trifluoroethanol/DCM 
(2:2:6), r.t., 3 h
moc
131, Fmoc-Arg-Arg(Pbf)-CA-OH, Overall Yield = 19% 
4 b   = 2-chlorotrityl resin
CA = 6-aminocaproic acid
Scheme 2.3.2 Solid phase synthesis of tripeptide binding group 131.
Cleavage  of  the  tripeptide  from  the  resin,  using  a  mixture  of  acetic 
acid/trifluoroethanol/DCM  gave  the  desired binding  group  131  in  19%  overall  yield. 
The  same  synthetic  sequence  shown  in  Scheme  2.3.2,  was  repeated  in  an  analogous 
manner for the generation of the further peptides shown in Figure 2.3.3.
84Fmoc-Ala-Arg(Pbf)-CA-OH
O
Fmoc\
147, Overall yield = 21%
Pbf  N 
H
)<=NH
Fmoc-Arg(Pbf)-Ala-CA-OH
Fmoc''''
148, Overall yield = 33%
Pbf—N 
H
)*=NH
Fmocv
'(TT
F moc-Gly-Ala-CA-OH Fmoc-Ala-Gly-CA-OH
O
Fm oc\
149, Overall yield = 46% 150, Overall yield = 32%
Figure 2.3.3 Additional tripeptide binding groups prepared.
2.3.2  Synthesis  of  artificial  esterases  containing  a  polyallylamine 
backbone
All  of the polymers were  synthesised using the  same procedure  as  shown in Scheme 
2.3.3. Polyallylamine hydrochloride 151  (n = 752), was converted to its free base using 
potassium hydroxide in methanol." It was important that both the peptide binding sites 
and histidine catalytic unit were incorporated into the polymer at the same time, as it 
was hoped that this would allow them to influence the positioning of each other on the 
polymer backbone. Hence, the peptide binding groups (131, 147-150) and the histidine 
catalytic  residue  were  coupled  to  the  polymer,  simultaneously,  using  N- 
hydroxysuccinimide and DIC to give 152-156 (Scheme 2.3.3).
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MeOH, r.t.,  H  N 
16 h
151 110
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+
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Fmoc R
152 R = -Arg(Pbf)Arg(Pbf)-Fmoc
153 R = -Arg(Pbf)Ala-Fmoc
154 R = -Ala-Arg(Pbf)-Fmoc
155 R = -Ala-Gly-Fmoc
156 R = -Gly-Ala-Fmoc
HN
A . .
TFA/TIPS/H20 (95:2.5:2.5), 
r.t., 5 h
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I
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157 R = -Arg(Pbf)Arg(Pbf)-Fmoc
158 R = -Arg(Pbf)Ala-Fmoc 
159R = -Ala-Arg(Pbf)-Fmoc
160 R = -Ala-Gly-Fmoc
161 R = -Gly-Ala-Fmoc
J n-m-l  L  j   J m
HN'  HN"
O^^^LystFmocjO  (j)A
I   R'
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HN
A His
I
Fmoc
Piperidine/DMF (2:8), 
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HN HN
'¥ *
R"
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162 R’ = -Arg-Arg-Fmoc
163 R’ = -Arg-Ala-Fmoc
164 R' = -Ala-Arg-Fmoc
165 R' = -Ala-Gly-Fmoc
166 R' = -Gly-Ala-Fmoc
132 R" = -Arg-Arg-NH2
136 R" = -Arg-Ala-NH2
137 R" = -Ala-Arg-NH2
138 R" = -Ala-Gly-NH2
139 R" = -Gly-Ala-NH2
n = 752
CA = 6-aminocaproic acid
Scheme 2.3.3 Synthesis of artificial esterases 132 and 136- 139.
The next step was to couple the lysine residue and this was achieved by attaching Fmoc 
protected  lysine  to  form  polymers  157  -   161.  The  resulting  polymers  (157  -   161) 
consisted of the peptide binding group, a histidine catalytic unit and a hydrophilic lysine 
group in approximately 1:1:1  ratio (based upon  equivalents of amino  acids used).  The 
deprotection  of  the  acid  labile  protecting  groups  (Pbf  and  Trt)  was  achieved  by 
sonication  of the polymers  in a mixture of TFA/triisopropylsilane(TIPS)/water.  Some
86problems were encountered during the purification of polymers 162 -  166. Purification 
by washing the polymer with TFA and water at the end of the reaction,  as previously 
reported, was only suitable for polymers  162 and 164.90 For all of the other polymers, 
(163,  165 and 166), purification could not be conducted due to their solubility in TFA. 
Instead,  these polymers  were precipitated by addition  of water,  followed by washing 
with a suitable organic solvent such as methanol or DCM. The concluding step involved 
the  cleavage  of  the  base  labile  Fmoc  protecting  groups  using  a  mixture  of 
piperidine/DMF to give the initial set of artificial esterases (132,  136 -  139) (Scheme
2.3.3).
The  final  artificial  esterase (168) to  be  synthesised consisted  of the  Arg-Arg binding 
unit and the histidine catalytic residue as before.  However, we decided to exclude the 
lysine moiety leaving a third of the amine sites on the polymer unoccupied. The rational 
in this instance was to make the polymer more soluble in an aqueous environment. The 
synthesis was carried out in an analogous manner to that previously described (Scheme
2.3.4).
Pbf-Arg(Fmoc)-Arg(Fmoc)-CA-OH 131
FmocHis(Trt)OH
H,N 2 '
110
DIC, NHS,
CHCI3, r.t., 4 h
r.t., 24 h
m n-m-l
HN HN H2N
His(Trt) O ' CA
Arg(Pbf) Fmoc
167  Arg(Pbf) 
Fmoc
1. TFA/TIPS/H20  (95:2.5:2.5) 
r.t., 3.5 h_______________
2. Piperidine/DMF (2:8) 
r.t., 4.5 h
m n-m-l
HN HN
His
Arg
168
Arg
CA = 6-amino caproic acid 
n =752
Scheme 2.3.4 Synthesis of artificial esterase 168 (no lys).
872.3.3  Characterisation of polymers
Several  problems  were  encountered  when  characterising  the  polymers  due  to  their 
solubility in organic/aqueous solvents and the limited range of analytical techniques that 
could  be  utilized.  For  the  polymers  that  were  partially  soluble  in  organic  solvents, 
solution phase NMR spectroscopy was used. However, several polymers had solubility 
problems in organic  solvents, especially after the protecting groups were cleaved.  For 
these  polymers,  solution  NMR  was  not  possible  and  characterisation  was  attempted 
using solid state carbon NMR. For cases where no proton or carbon NMR spectra could 
be obtained, structure assignment was made only on the basis of infra-red (IR) data. For 
polymer 137, no NMR characterisation was possible due to  formation of an insoluble 
gum.  The  gum  could not be packed  appropriately into  the NMR rotor,  and hence  an 
acceptable  solid  state  carbon  NMR  could  not  be  obtained.  Hence,  the  proposed 
structural  assignment  was  based  on  the  previous  compound  (164)  in  that  synthetic 
sequence (Scheme 2.3.3). See Appendix for selected examples of NMR spectra.
2.4  Synthesis of initial ester substrates
At the outset, we were interested in making two differing ester substrates for studies of 
hydrolysis  reactions  including the phenethyl  ester  127,  (Figure  2.4.1)  which was  the 
original ester tested previously,91  and secondly the cinnamyl ester 169 (Figure 2.4.1). 
As mentioned earlier, during the hydrolysis of 127, the formation of alcohol could not 
be monitored due to its poor UV absorbance.90 It was hoped that the ester 169 would 
circumvent  this  problem,  with  the  cinnamyl  alcohol  having  a  much  better  UV 
absorbance.  It  was  also  desirable  to  monitor  the  alcohol  formation  as  well  as  acid 
formation  after hydrolysis because the  acid product is  structurally very similar to the 
ester and hence could stay bound to the artificial esterase, after the hydrolysis reaction 
has occurred, thus giving an inaccurate indication of the quantity of product that is truly 
being formed.
88Figure 2.4.1 Initial ester substrates targeted.
2.4.1  Preparation of cinnamyl ester substrate
The synthesis of cinnamyl ester 169 was initially attempted, following the methodology 
previously used to generate the phenethyl ester 127 (Scheme 2.4.1).90,91
H„N
OH  TFAA, Na2C03, MeCN,  O
r  A
°   H 20,0°C to r.t., 1  h, 49%  F3C  N
OH
(COCI)2, DMF, 
DCM, r.t., 4 h
170 171
F,C
172
C l Cinnamyl alcohol, Et3N,
DCM, r.t.,  15 h, 58% A n
3  H 173
NaBH., MeOH, r.t.
  X   -
16 h
174
Scheme 2.4.1 Attempted route to cinnamyl ester 169.
Commercially  available  p-aminophenylacetic  acid  170  was  protected  using 
trifluoroacetic anhydride to afford carboxylic acid 171. Acid 171 was then converted to 
the  acid  chloride  using  oxalyl  chloride  to  give  172.  Attempts  to  isolate  172  were 
unsuccessful  due to  degradation of the product.  Therefore,  the  synthesis of ester  173 
was attempted by generating the acid chloride in situ and then trapping it with cinnamylalcohol.  This  successfully  provided  ester  173  in  58%  yield.  Deprotection  of  the 
trifluoroacetamide  moiety proved  problematic.  Sodium  borohydride  in  methanol  was 
initially  attempted,  however  only  the  hydrolysed  product  175  (Figure  2.4.2)  was 
detected  suggesting  that  either the conditions  were  too  basic  or the  ester was highly 
labile.
175
Figure 2.4.2 By-product 175 detected during sodium borohydride deprotection of 173.
Subsequently, a number of different reaction conditions were investigated to isolate the 
deprotected  amine  174  (Table  2.4.1).  Initially  a  shorter  reaction  time  was  attempted 
(entry 1). However, t.l.c. and NMR spectra analysis indicated that the hydrolysis of the 
ester 173 commences upon addition of NaBH4. The addition of NaBH4 in methanol at 0 
°C was also attempted (entry 2), because it was thought that NaBH4 was too reactive at 
room temperature. However this too resulted in ester hydrolysis. The use of potassium 
carbonate  in  water  and  methanol  is  another  common  method  of  removing  the 
trifluoroacetamide  group  (entry  3) ,100  however  hydrolysis  of  the  ester  was  also 
observed.
Entry Reagent Used Solvent Temperature
(°C)
Reaction 
Time (hours)
1 NaBH4 MeOH 20 2
2 NaBH4 MeOH 0, then 20 6
3 K2C0 3 MeOH, H20 20 2
Table 2.4.1 Different conditions attempted for trifluoroacetamide deprotection of 173.
Due to difficulties encountered with the trifluoroacetamide group, it was decided that a 
different protecting group should be utilized. The Boc group was used as an alternative
90and  the  synthesis  of a  Boc  protected  cinnamyl  ester  derivative  177  was  attempted 
(Scheme 2.4.2). Boc protected amine 176 was prepared using di-terf-butyl dicarbonate 
and  triethylamine  to  give  the  acid  176  in  94%  yield.  The  carboxylic  acid  176  was 
subsequently  converted  to  the  ester  177  using  dicyclohexylcarbodiimide  (DCC). 
Initially an attempt to deprotect the amine 177 using a mixture of  TFA/DCM (1:1) was 
unsuccessful,  due  to  hydrolysis  of  the  ester  moiety.  Several  different  ratios  were 
investigated for deprotection, and the optimal conditions used a 4% v/v solution of TFA 
in  DCM.  This  generated  the  free  amine  in  an  acceptable  yield  of 54%.  Subsequent 
coupling of amine 178 with glutaric anhydride then afforded the desired cinnamyl ester
169.
OH
Di-terf-butyl dicarbonate, 
170
Et,N, dioxane,  H20, r.t.,  18 h, 
94%
H
176
Cinnamyl alcohol,  DCC, 
DMAP,  Et3N,
DCM/THF (1:1), r.t., 40 h, 
57% H 177
TFA, DCM,
r.t., 5 h, 54%
178
Glutaric anhydride,Et3N,
DCM, reflux,  19 h, 53%
HO
169
Scheme 2.4.2 Synthesis of cinnamyl ester substrate 169.
912.4.2 Synthesis of phenethyl ester substrate
Due to the problems associated with the trifluoroacetamido protecting group during the 
synthesis of cinnamyl ester 169, we decided not to follow this route. Instead, we elected 
to  synthesise  phenethyl  ester  127  following  the  route  already  established  for  the 
cinnamyl  ester  169  (Scheme  2.4.2).  Thus,  the  acid  176  was  coupled  to  phenethyl 
alcohol using DCC, giving ester 179 in 54% yield (Scheme 2.4.3). Deprotection of the 
Boc group using TFA/DCM, and subsequent reaction with glutaric anhydride furnished 
the desired phenethyl ester substrate 127.
^  nu   2 -phenyl ethanol,
> l  x   X T Y   D C C ,D M A P '—
Et3N, THF/DCM (1:1), 
H  1 ? 6   r.t., 22 h, 54%
> L 1
O  ~   1. TFA/DCM (1:1), r.t., 2.5. h,  100%
2. Glutaric anhydride,  Et3N, DCM, 
H  1 7 9   reflux,  17 h, 48%
Scheme 2.4.3 Synthesis of phenethyl ester substrate 127.
2.5  Activity of artificial esterases
With the polymer catalysts  and  substrate esters now in hand,  we turned  our attention 
towards  an investigation of the potential  activity of artificial  esterases.  Before testing 
the polymers as catalysts for the hydrolysis of ester substrates,  a control reaction was 
carried out in order to assess hydrolysis in the absence of the polymers.  A solution of 
each of the esters 127 and 169 was prepared in phosphate buffer at pH 7 and stirred for
9224 hours. The reactions were monitored by HPLC and this confirmed that no hydrolysis 
had occurred.
2.5.1  Hydrolysis of phenethyl ester 127
The polymers were first of all tested for their ability to hydrolyse ester  127 (Scheme
2.5.1).  Although  it  is  difficult  to  quantify  the  number  of binding  sites  and  catalytic 
groups within our esterase polymers, we estimated that the amount of polymer used in 
all of all these reactions was approximately 5 mol % at a 0.5 mM ester concentration. 
The reactions were initially monitored by observing  a decrease in ester concentration 
and/or an increase in acid production.
Artificial esterase (132, 136-139,168)
H
129  130
Scheme 2.5.1 Hydrolysis of phenethyl ester 127.
The first polymer to be tested was 132 and contained the Arg-Arg motif which on the 
basis of binding to the phosphonate transition state analogue, was expected to display 
good activity. The first observation made was that the isolation technique used for the 
polymer had an effect on its activity. More specifically, in the final step of the synthesis 
of 132, which involved washing the polymer with water, however, it was observed that 
the polymer changed  from  a white  solid to  a gum.  This polymer batch  (132)  (Table
2.5.1,  entry 1) had no hydrolytic activity, whereas another batch of polymer 132, which 
had no  aqueous  wash,  was  active  (Table  2.5.1,  entry 2).  In  order to  investigate  this
93further,  the  two  batches  of  polymer  132  were  examined  using  scanning  electron 
microscopy (SEM) (Figure 2.5.1).
Entry Polymer containing 
binding site R
Solvent Hydrolysis
observed?
Conversion 
to product
(%)a
1. 132, R = Arg-Arg (aqueous 
wash)
Phosphate 
buffer pH 7
No -
2. 132, R = Arg-Arg (no 
aqueous wash)
Phosphate 
buffer pH 7
Yes 20
Table 2.5.1  Effect  of aqueous  wash  on  polymer  (132)  activity.  In  a  typical  experiment,  the 
polymer (10 mg) was added to  a  stirred solution  of ester in  aqueous buffer (0.5  mM,  1   ml)  at 
room temperature.  The reaction  was monitored by HPLC.a The %  conversions  shown are the 
best results obtained after testing several different batches of  the same polymer after 24 h.
a)  b)
Figure 2.5.1  Scanning electron micrograph showing a) Polymer 132 before aqueous wash and
b) Polymer 132 after aqueous wash.
The scanning electron micrograph (a) (Figure 2.5.1) indicates that before the aqueous 
wash,  the polymer has  an  obvious tertiary structure.  Conversely the  same polymer is 
shown in picture (b) (Figure 2.5.1) after an aqueous wash,  indicating that the tertiary 
structure is completely destroyed and hence a loss of activity is observed.
94After establishing,  as expected, that polymer 132  could hydrolyse ester 127, our next 
goal was to  follow the consumption of ester 127  and formation of acid  129 over unit 
time (Figure 2.5.2 and 2.5.3).
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Figure 2.5.2 A plot of ester (127) concentration against time for polymer 132 over the first 225 
min of the reaction. In a typical experiment, the polymer (10 mg) was added to a stirred solution 
of ester in  aqueous buffer (0.5  mM,  1   ml)  at room temperature  for 24 h.  The reaction was 
monitored by HPLC.
The  hydrolysis  reaction  was  monitored  closely  over  225  minutes  and  an  additional 
measurement was recorded at 24 hours.  The single measurement taken after 24 hours 
(not shown in Figure 2.5.3) had indicated that there was some further increase in acid 
concentration overnight.  This  indicates  that it is possible that the  acid  formation was 
monitored  at  the  wrong  time  frame  and  that  perhaps,  the  ‘real’  catalysis  may  be 
occurring after a period of 225 minutes rather than at the beginning of the reaction as 
initially anticipated.  It should be noted that when several different batches of polymer 
132 were prepared and tested, they all exhibited some hydrolysis, however not with the 
same efficiency. Hence, the different batches all give different amounts of acid product, 
with the best polymer showing 20% conversion to the product,  after 24 hours. This is 
comparable with the results obtained previously with this same polymer, under the same
95conditions.91  It should be highlighted however, that performing the hydrolysis reactions 
with the same batch of polymer, similar results were obtained. Clearly, polymers of this 
type, as implied by the scanning electron micrograph study, are extremely sensitive to 
the exact nature of the  surrounding environment and may undergo  drastic changes  in 
tertiary structure.
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Figure 2.5.3 A plot of acid (129) concentration against time for polymer 132 over the first 225 
min of the reaction. In a typical experiment, the polymer (10 mg) was added to a stirred solution 
of ester (127) in aqueous buffer (0.5 mM, 1  ml) at room temperature for 24 h. The reaction was 
monitored by HPLC.
962.5.2  The  activity  of artificial  esterases  containing  different  binding 
sites
The  next  stage  of our  investigation  was  to  determine  how  changes  in  the  peptide 
binding  site  within  the  polymer  would  influence  activity.  The  results  of  the  five 
different polymers in the hydrolysis of ester 127 (Scheme 2.5.1) are presented in Table 
2.5.2.
Entry Polymer 
containing 
binding group R
Solvent Hydrolysis
observed?
Conversion 
to product
(%)a
NMR 
binding 
studies, Rd
( % ) 91
1 132,
R = CA-Arg-Arg
Phosphate 
buffer pH 7
Yes 2 0 17 ± 2
2 136,
R = CA-Arg-Ala
Phosphate 
buffer pH 7
No 0 Not
determined
3 137,
R = CA-Ala-Arg
Phosphate 
buffer pH7
Yes 15 12 ± 2
4 138,
R = CA-Ala-Gly
Phosphate 
buffer pH7
No 0 6 ±  1
5 139,
R = CA-Gly-Ala
Phosphate 
buffer pH7
No 0 6 ±  1
6 168,
R = CA-Arg-Arg 
(no lys)
Phosphate 
buffer pH7
Yes 10 17 ± 2
Table  2.5.2  The  influence of changing the binding group  on polymer activity.  In a typical 
experiment, the polymer (10 mg) was added to a stirred solution of ester 127 in aqueous buffer 
(0.5  mM,  1   ml)  at  room  temperature.  The  reaction  was  monitored  by  HPLC.  a  The  % 
conversions shown are the best results obtained after testing several different batches of  the 
same polymer after 24 h.
If we compare how the activity of the polymers correlates with the ranking obtained for 
the  binding  groups  using  NMR  binding  studies,  we  see  only  three  of the  polymers 
displayed hydrolytic activity (Table 2.5.2, entries  1, 3  and  6 respectively and see also 
Figure  2.5.4).  Polymer  132  (entry  1),  containing  the  CA-Arg-Arg  binding  site, 
exhibited the highest activity, with a 20% conversion to the product. Polymer 137 (entry 
3), still showed some activity, but possessing weaker binding ability, it displayed  15% 
conversion  to  the  product.  The  polymer  136  (entry  2),  containing  the  CA-Arg-Ala 
dipeptide gave none of the desired hydrolysis products when tested. These results imply
97that  the  majority  of the  binding  to  the  transition  state  is  performed  by  the  arginine 
residue which  is furthest away from the polymer backbone.  The inactivity of polymer 
136 could be explained by the fact that the arginine residue is more hindered and hence 
is unable to participate in effective binding of the transition state for the reaction.
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Figure 2.5.4  A  plot  of acid (129) concentration  against time  for polymers  132,  137 and  168 
over the first 400 min of the reaction.  In a typical experiment, the polymer (10 mg) was added 
to a stirred solution of ester (127) in aqueous buffer (0.5  mM,  1   ml) at room temperature for 24 
h. The reaction was monitored by HPLC.
The  other  polymers,  containing  the  weakest  binding  group,  Ala-Gly  (Table  2.5.2, 
entries 4 and  5)  demonstrated  no  activity at all.  Finally, polymer  168 (entry 6)  which 
contained  no  lysine  residues  also  exhibited  some  hydrolysis  (10% product formation, 
Table 2.5.2).  However,  unlike all  of the other polymers, this polymer was completely 
soluble in phosphate buffer. We questioned whether the solubility of the polymer might 
aid  catalysis,  but  this  does  not  seem  to  be  the  case,  when  compared  to  its  analogue,
98polymer  132.  One  characteristic  which  all  three  polymers  in  Figure  2.5.4  have  in 
common is the fact that they seem to have the ability to catalyse ester hydrolysis at a 
very fast initial rate at the beginning of the reaction (within the first 60 min, see Figure
2.5.5)  and these rates then slow down as illustrated by the curves displaying a type of 
saturation kinetics.  This indicates that product inhibition may be occurring, which is to 
be expected as the diacid product 129 is produced in the close proximity to the bidentate 
Arg-Arg.  It should be noted again that the same observations apply to these polymers as 
mentioned previously regarding polymer 132, the single measurement taken after 24 h, 
indicates that more hydrolysis was occurring after the period of saturation kinetics.
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Figure 2.5.5 The graph in Figure 2.5.4, expanded to show the first 60 min of the reaction for 
clarity. In a typical experiment, the polymer (10 mg) was added to a stirred solution of ester 127 
in aqueous buffer (0.5 mM, 1   ml) at room temperature for 24 h. The reaction was monitored by 
HPLC.
One  thing  that  is  clear,  is  that  all  the  polymers  are  showing  a  decrease  in  ester 
concentration regardless of whether they have the ability to hydrolyse the ester (Figure
992.5.6).  This  is  perhaps not surprising,  since  all  the polymers contain  a binding group, 
which should be able to bind the ester substrate to some extent.
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Figure 2.5.6 A plot of ester (127) concentration against time for polymers  132 and  136 - 139 
over the first 300 min of the reaction.  In a typical experiment,  the polymer (10  mg) was added 
to a stirred solution of ester in aqueous buffer (0.5 mM,  1   ml) at room temperature for 24 h. The 
reaction was monitored by HPLC.
2.5.3  Initial velocities of reactions with active polymers
In  conventional  enzymatic  systems,  from a plot of product concentration  against time 
(Figure 2.5.7) one can calculate the initial velocity, u.2   If the very early portion of the 
plot  is  considered,  we  can  see  that  the  initial  product  formation  occurs  in  an 
approximately linear fashion with time.  For this limited time period, the initial velocity 
can be approximated as the gradient of the linear plot (Equation 2.5.1),2
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Figure 2.5.7 Representation of product formation for a typical enzyme catalysed reaction.2
t) = A[P]/At 
Equation 2.5.1
Using  this  technique,  we  attempted  to  calculate  the  initial  velocities  from  the  plots 
shown in Figure 2.5.4. This was problematic in the instance of polymer 132, since the 
points are very scattered. Hence the initial velocity was calculated on the basis of a best 
fit  line,  between  the  first  few  points  of the  graph.  For  the  other  two  polymers,  the 
method described above was used and the results are presented in Table 2.5.3.
101Entry Polymer 
containing 
binding site 
R
Hf4 x v (mM 
min1)3
Vreia t; (sec_1)b i>reib Conversion 
to product 
after 24 h 
(%)
1 132 (R = Arg- 
Arg)
9.71 ±0.39 1 0.06 ± 
0 .0 0 2
1 2 0
2 136 (R = Arg- 
Ala)
100 ±4.00 13.8 0.47 ± 
0.018
7.8 15
3 168 (R = Arg- 
Arg), no lys
12 ±0.48 1.7 0.072
±0.003
1.2 10
Table 2.5.3  Initial velocities of reactions with active polymers.a Calculated using Equation 
2.5.1. b Calculated using Equation 2.5.2. urei describes initial relative velocities for comparison 
purposes.
The calculated initial rates should be interpreted with caution as they are approximated. 
For  example  polymer  132  (Table  2.5.3,  entry  1),  which  displayed  the  best  binding 
ability towards the transition state has a very slow initial velocity.  However this same 
polymer  (132)  gave  the  highest  conversion  to  hydrolysis  products  after  24  h.  It  is 
difficult to conclude what is happening within the micromolecular environment of the 
polymer from these results.  Nevertheless,  it is tempting to  speculate that the Arg-Arg 
binding  unit  in polymer  132  is,  in  effect,  too  efficient  at  both  substrate  and  product 
binding whereas the Arg-Ala unit (polymer  136)  can release the product more  easily 
hence contribute to enhanced turnover.
There  is  another  way  of calculating  initial  velocities  and  this  is  from  using  the  UV 
absorptions  monitored  during  our reaction.  Having  established  a  single  specific  time 
point within the linear time period, the initial velocity is determined from the difference 
in UV absorbance at that time point and at the initiation of the reaction divided by the 
time (Equation 2.5.2):2
1)  AH  At  I{  fo/feading 
Equation 2.5.2
102The intensity of the signal being measured at time t and time zero is given by It and /o , 
respectively  and  treading  is  the  time  interval  between  initiation  of  the  reaction  and 
measurement of the UV response. Using this method, essentially gives similar relative 
initial velocities compared to the first method.
2.5.4  Hydrolysis of cinnamyl ester 169
The next stage was to test the ability of the polymers to hydrolyse the cinnamyl ester 
substrate  169  (Scheme  2.5.2).  As  previously  mentioned,  we  believed  that  the  acid 
product remained bound to the polymer after hydrolysis (as demonstrated by saturation 
curves shown in Figure 2.5.4).  This meant that the concentration of acid product 129 
produced  was  potentially  inaccurately  monitored.  Hence,  monitoring  the  release  of 
alcohol would be more suitable, as it cannot form ionic salts.  Since efforts to monitor 
the  release  of  the  alcohol  during  the  hydrolysis  of  the  phenethyl  ester  127  were 
unsuccessful because of its poor UV absorbance, we felt that the introduction of a more 
UV active alcohol would help solve this problem.
o
o
HO N
H
169
Artificial esterase (132,136-139, 168)
H
129  180
Scheme 2.5.2 Hydrolysis of cinnamyl ester 169.
In the event, to our dismay, it was observed that the cinnamyl ester 169, was completely 
insoluble  in  phosphate  buffer  at  pH  7.  However,  since  the  ester  was  soluble  in 
acetonitrile,  the  hydrolysis  reaction  was  first  attempted  in  a  mixture  of phosphate
103buffer/acetonitrile (1:1) (entry 1, Table 2.5.4). At this stage, no reduction in ester or any 
formation  of  the  products  (acid  129  or  alcohol  180)  was  observed.  Fortunately, 
however,  a  combination  of buffer/acetonitrile  in  a  99:1  ratio  has  been  employed  in 
comparable  artificial  systems101  and by using  this  solvent  combination,  polymer  132 
exhibited catalysis (entry 2, Table 2.5.4 and Figures 2.5.8,  2.5.9 ).  The more soluble 
analogue, polymer  168  also  demonstrated hydrolysis of the ester  169  (entry 3, Table 
2.5.4  and  Figures  2.5.8,  2.5.9),  but  gave  a  smaller  conversion  to  product  when 
compared to 132. Due to the ester being very labile (as we experienced during the TFA 
deprotection,  see  Section  2.4.1),  we  tested  whether  the  ester  would  spontaneously 
hydrolyse,  in the  absence  of polymer,  however this was not the  case  (entry 4,  Table 
2.5.4).
Entry Polymer Solvent
Hydrolysis
observed?
lO"4 x v (mM 
min'1)1
Vrel
Conversion 
to product 
after 24 h
(%>b
1.
132,
R = CA- 
Arg-Arg
Buffer/
MeCN
(1:1)
No
- -
0
2.
132,
R = CA- 
Arg-Arg
Buffer/
MeCN
(99:1)
Yes 15 ±0.60 1.8 8 6
3.
168,
R = CA- 
Arg-Arg, 
no lys
Buffer/
MeCN
(99:1)
Yes 8.5 ± 0.34 1 49
4.
No
polymer
Buffer/
MeCN
(99:1)
No - - 0
Table 2.5.4 Hydrolysis of cinnamyl ester 169. In a typical experiment, the polymer (10 mg) 
was added to a stirred solution of ester in aqueous buffer/acetonitrile (99:1) (0.5 mM,  1  ml) at 
room temperature. The reaction was monitored by HPLC.a Calculated  using Equation 2.5.1.b  
The % conversions shown are the best results obtained after testing several different batches of 
the same polymer after 24 h, as monitored by HPLC. urei describes initial relative velocities for 
comparison purposes.
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Figure 2.5.8 A plot of acid (129) concentration against time for polymers 132 and 168 over the 
first 300  min  of the  reaction.  In  a  typical  experiment,  the  polymer (10  mg)  was  added  to  a 
stirred  solution  of ester  (169)  in  aqueous  buffer/acetonitrile  (99:1)  (0.5  mM,  1   ml)  at  room 
temperature for 24 h. The reaction was monitored by HPLC.
As predicted, the formation of both acid  129 (Figure 2.5.8) and cinnamyl alcohol  180 
(Figure 2.5.9)  was  observed.  However, a further problem  was encountered  here.  The 
acid and the alcohol should be formed in equimolar amounts (assuming that neither one 
is binding to the polymer), but this did not seem to be the case. According to the results, 
the acid was forming in a much larger quantity when compared with the alcohol.  In the 
event, we discovered that the reason for this behaviour was that the alcohol is insoluble 
in  the  buffer/acetonitrile  (99:1)  mixture.  It  is  therefore  very  likely  that  it  was 
precipitating out during the hydrolysis reaction and hence giving unreliable readings.  It 
is nevertheless encouraging that alcohol formation can be followed by UV detection.
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Figure 2.5.9 A plot of alcohol (180) concentration against time for polymers 132 and 168 over 
the  first 300 min of the  reaction.  In a  typical  experiment,  the polymer (10  mg) was added to a 
stirred  solution  of ester  (169)  in  aqueous  buffer/acetonitrile  (99:1)  (0.5  mM,  1   ml)  at  room 
temperature for 24 h. The reaction was monitored by HPLC.
*
2.5.5  The activity of artificial esterases at different pH
Natural enzymes are very sensitive to the pH  of their environment.  The pH  can affect 
the binding of substrate, catalytic activity and the tertiary structure of the enzyme.1   The 
pH rate profile for a natural esterase enzyme such as chymotrypsin is shown  in Figure 
2.5.10  and  exhibits  a  classic  bell  shaped  curve.2   The  traditional  explanation  for  this 
behaviour  is  that the  centre (optimum  pH)  and  breadth  of the  curve depend  upon  the 
acid  dissociation  constant of the  relevant  amino  acid  residues  within  the  enzyme.  As 
previously  mentioned  in  the  Introduction  (Section  1.2.3),  chymotrypsin  consists  of a 
catalytic triad composed of Asp  102, His 57 and Ser 195. The ability of chymotrypsin to 
hydrolyse  its  peptidic  substrate  depends  on  hydrogen  bonding  and  proton  transfer 
among  the  residues  of  the  catalytic  triad,  which  will  certainly  be  affected  by  the 
different degrees of ionisation of these residues as the pH is varied.  As the diagram in
106Figure 2.5.10 illustrates that there is typically a narrow range of pH values over which 
enzyme catalytic efficiency is maximised. Very extreme pH environments, usually lead 
to irreversible denaturation of the enzyme, which results in loss of activity.1
max
4  5  6  7  8  9  10
pH
Figure 2.5.10 The effect of pH on the velocity of a typical enzymatic reaction.2
Accordingly,  it  was  of considerable  interest to  explore the behaviour of our artificial 
esterase at different pH. For these experiments, it was decided to use the polymer that 
displayed  the  most  encouraging  results,  132  (R  =  CA-Arg-Arg).  The  polymer  was 
accordingly  stirred  in  a  solution  of citrate  buffer  at  pH  6  and  borate  buffer  at pH  8 
together with phenethyl  ester 127, under the same conditions  as previously employed. 
The results are shown in Figure 2.5.11  and Table 2.5.5, together with the results at pH 
7  for  comparison  purposes.  When  comparing  the  relative  initial  velocities  to  the 
hydrolysis at pH 6, higher initial velocities are observed for reactions at pH 7 (entry 2) 
and pH 8 (entry 3). The corresponding percentage conversions to the product also show 
the same trend, with the highest conversion being at pH  8. This indicates that polymer 
132, is more efficient at the beginning of the reaction at pH 7 and pH 8, possibly due to 
subtle conformational changes within the polymer, which may allow more access to the 
catalytic residues. The low levels of hydrolysis detected at pH 6 (entry 1), are probably 
due  to  most  of the  free  amine  sites  on  the  polymer being  protonated.  As  discussed 
previously, the protonated polymer will be less able to participate in binding both the 
substrate  and  the transition  state  for the  reaction.  However,  in borate buffer at pH  8, 
when there should be no protonated amines on the residues or backbone, polymer 132 
demonstrated significantly higher conversion (entry 3). At pH  8, the acid product  129
107can probably be liberated more easily as its salt, thus freeing the binding site for further 
reaction.
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Figure 2.5.11  A plot of acid (129) concentration against time  for polymer 132, at pH  6, pH  7 
and pH  8  over the  first  180  min  of the  reaction.  In  a  typical  experiment,  the  polymer (10  mg) 
was  added  to  a  stirred  solution  of  ester  (127)  in  aqueous  buffer  (0.5  mM,  1   ml)  at  room 
temperature for  180 min. The reaction was monitored by HPLC.
Entry pH 10 4 xi)(mM 
min'1)3
Drel Conversion 
to product 
after 180 
min (%)
1 6 6.87 ±0.27 1 6
2 7 9.71  ±0.39 1.4 20
3 8 48.0 ±  1.9 6.9 42
Table  2.5.5  Initial  velocities  of  reactions  with  polymer  132,  at  pH  6,  pH  7  and  pH  8.  a 
Calculated  using  Equation  2.5.1.  i)rei  describes  initial  relative  velocities  for  comparison 
purposes.
108A  similar  type  of behaviour  was  also  observed  with  the  more  soluble  polymer  168 
(Figure 2.5.12  and Table  2.5.6).  However,  the  percentage  conversions to  the product 
do not follow the same pattern as the  initial velocities.  For example, although  at pH  8 
the  polymer  has  the  lowest  initial  velocity,  at  this  pH,  it  also  shows  the  highest 
conversion  to the product.  Extrapolating the efficiency of the esterase  from  the  initial 
velocity  alone  is  risky,  as  demonstrated  here,  although  polymer  168  has  the  lowest 
initial  velocity  at  pH  8,  the  conversion  to  product  is  ultimately  higher.  Polymer 
efficiency should therefore be seen as an overall evaluation of both  initial velocity and 
conversion to product.
Control  experiments were  carried  out at both  pH  6  and  pH  8  and  some hydrolysis of 
phenethyl ester 127 was detected in the absence of the polymer. We have taken this into 
account and the results shown are the corrected values.
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Figure 2.5.12 A plot of acid (129) concentration against time for polymer 168, at pH  6, pH 7 
and pH  8 over the  first  180  min of the  reaction.  In  a typical  experiment,  the  polymer (10  mg) 
was  added  to  a  stirred  solution  of  ester  (127)  in  aqueous  buffer  (0.5  mM,  1   ml)  at  room 
temperature for 24 h. The reaction was monitored by HPLC.
109Entry pH HT4 x v (mM 
min1)3
Vrel Conversion 
to product 
after 300 
min (%)
1 6 7.11 ±0.28 4.9 0 .8
2 7 9.78 ±0.39 6.7 2 .6
3 8 1.45 ±0.05 1 7.8
Table  2.5.6  Initial  velocities  of reactions  with polymer  168,  at pH  6,  pH  7  and  pH  8.  a 
Calculated  using  Equation  2.5.1.  ur e i  describes  initial  relative  velocities  for  comparison 
purposes.
2.5.6  The activity of artificial esterases at different ester concentrations
The activity of polymer 132  (R = CA-Arg-Arg) was tested at four different phenethyl 
ester 127 concentrations, in phosphate buffer at pH 7 (Figure 2.5.13 and Table 2.5.7). 
Polymer 132 demonstrated the ‘best’ activity at 0.5 mM ester concentration, in terms of 
initial velocity and conversion to product. As the concentration increases from 0.5 mM, 
the  activity  of  the  esterase  diminishes.  Additionally,  as  the  concentration  of  ester 
decreases from 0.5 mM to 0.2 mM, the activity of the polymer again diminishes.  It is 
not very clear why this particular trend occurs.  There has  been  some  evidence  from 
previous studies that at concentrations higher than 0.5 mM, significant self-association 
effects are observed for the ester 127 and this could possibly prevent productive binding 
to the polymer at higher concentrations.91  If this  is the case, perhaps the binding and 
catalytic  units  on  the  polymer  find  it  more  difficult  to  access  the  ester  substrate, 
resulting in less product formation.
110Activity of polym er 132 at different concentrations of phenethyl  ester 127
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Figure  2.5.13  A  plot  of acid (129) concentration  against  time  for  polymer  132,  at  different 
concentrations of phenethyl ester 127, over  180 min of the reaction.  In a typical experiment, the 
polymer (10  mg) was added to a stirred solution of ester (127) in aqueous buffer (0.2  mM,  0.5 
mM,  1   mM  or 2  mM,  1   ml) at room temperature  for  180  min.  The  reaction  was  monitored by 
HPLC.
Entry Ester
conc.
(mM)
10 4 x o (mM 
min'1)8
Orel Conversion 
to product 
after 180 
min (%)
1 0.2 4.72 ± 0.19 2 5
2 0.5 9.71  ±0.39 4.2 20
3 1 12.0 ±0.48 5 7
4 2 2.33 ±0.09 1 5
Table 2.5.7  Initial  velocities  of reactions  with  polymer  132, at different ester concentrations. 
“Calculated  using  Equation  2.5.1.  urei  describes  initial  relative  velocities  for  comparison 
purposes.
Ill2.6  Preparation of a histidine catalytic unit with an additional caproic 
acid spacer
The  idea  of  inserting  the  6 -aminocaproic  acid  (CA)  spacer  between  the  polymer 
backbone and the binding group has already been discussed previously. Accordingly, it 
was  also  of interest  to  insert  a  spacer  group  between  the  polymer  and  the  catalytic 
histidine residues  for the  same reason of conformational  flexibility.  Our rational was 
that if both the binding and catalytic groups were more conformationally mobile, then 
this might aid catalysis, and hence would lead to a more efficient artificial esterase. In 
addition to polymers in Schemes 2.3.3 and 2.3.4, our sixth target artificial esterase was 
the  one  depicted  in  Figure  2.6.1a.  Consequently,  the  synthesis  of  a  dipeptide, 
containing  appropriate  protecting  groups,  had  to  be  undertaken  (for  example  Figure 
2.6.1b). The free acid moiety would provide a point of attachment to the resin.
a)
m n-m-l
HN HN HN
CA I
Arg
Lys
His
181  Arg
CA =  6 -amino caproic acid
b)
,N—p
'"N
H
OH
P = Protecting group
Figure  2.6.1  a)  Artificial  esterase containing a spacer between both the binding group and 
histidine  catalytic  unit,  b)  An  example  of a  potential  dipeptide  to  be  synthesised  with  the 
appropriate protecting groups before incorporation into polyallylamine.
112Initially,  the  route  commenced  with  the  use  of the  commercially  available  protected 
histidine derivative 182. This was converted to the corresponding activated ester, using 
TV-hydroxysuccinimide and A,A-diisopropylcarbodiimide (DIC), to yield 183 (Scheme
2.6.1). Although the ester 183 was obtained successfully, NMR analysis confirmed that 
there was  excess  of DIC  and  its  corresponding  urea by-product present.  Attempts  to 
purify ester  183  by either recrystallisation (ethyl  acetate/petroleum  spirit) or by flash 
chromatography did not meet with success.  Since DIC forms a urea by-product that is 
soluble in most organic solvents, it was thought that it would be preferable to use N, N ’- 
dicyclohexylcarbodiimide  (DCC)  instead,  since  its  urea  is  much  less  soluble.102  The 
reaction  was  repeated  using  DCC  instead  and  the  resulting  A, A'-dicyclohexylurea 
(DCU), which appeared as a white precipitate, was filtered off. However, traces of DCU 
remained after purification.
Ph
Ph
Ph
N ^\  ^ Ph
Ph DIC, A/-hydroxysuccinimide, 
CHCU, r.t., 3 h
183
Scheme 2.6.1 Attempted synthesis of histidine ester 183.
Consequently, the use of DIC was reconsidered due to the more efficient generation of 
the activated ester. However, the isolation of ester was not attempted and instead, in situ 
conversion  to  the  desired  amide  was  undertaken  (Scheme  2.6.2).  Although  the 
formation  of the  desired  product  184  was  confirmed  by  NMR  analysis,  a  complex 
mixture of impurities was  also present.  Furthermore,  attempts to purify the dipeptide 
184 were unsuccessful, and hence this approach was abandoned.
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Scheme 2.6.2 Attempted synthesis of dipeptide 184.
The  next  strategy  attempted  was  to  protect  the  free  carboxylic  acid  of caproic  acid, 
hopefully preventing the  formation of any undesired products.  The benzyl  protecting 
group was selected, since it can be deprotected under mild hydrogenation conditions.103 
However there was reported  evidence that the trityl  group  may be  labile under these 
conditions.104  Therefore another suitably protected histidine derivative would have to 
be selected to be compatible with the linker. In view of the fact that the de-benzylation 
step would involve hydrogenation, Boc protected histidine seemed a good choice since 
its removal is completely orthogonal with respect to the benzyl group.  6-Aminocaproic 
acid 140 was protected using benzyl alcohol in the presence of /7-toluene sulfonic acid 
to  give  the  benzyl  protected  caproic  acid  salt  185  (Scheme  2.6.3).  Quantitative 
conversion  to  the  free base  (186) was  achieved  using  dichloromethane  and  saturated 
sodium carbonate.105
H,N
140
Benzyl alcohol, p-TsOH, 
toluene, 120°C, 5 h, 81%
C7H 7S 0 3  h3N
185
sat. aq. NaHC03 
DCM, r.t., 30 min, 100%
186
Scheme 2.6.3 Synthesis of benzyl protected 6-aminocaproic acid 186.
114Boc protected histidine  188  (Scheme 2.6.4) was then  formed in  50%  yield, using di- 
tert-butyl dicarbonate and triethylamine.
NH
COOH
187
i-ferf-butyl dicarbonate,
N=^\  .0
JLJC^
O N   COOH 
H
188
Scheme 2.6.4 Synthesis of Boc protected histidine 188.
The peptide coupling with benzyl protected caproic acid 186 was then attempted via the 
formation  of the  activated  A-hydroxysuccinimide  ester,  (Scheme  2.6.5,  Table  2.6.1, 
entry  1).  The  best  conditions  involved  the  use  of DCC  as  a  coupling  reagent  and 
compound  189 was isolated in 33% yield.  However, NMR analysis indicated that the 
product  once  again  contained  the  urea  by-product  and  attempts  to  purify  by  flash 
chromatography and recrystallisation were similarly unsuccessful in this case.
1. See Table 2.6.1 for conditions
N  COOH
Scheme 2.6.5 Synthesis of dipeptide 189.
Entry Reaction Conditions Yield of 189
1. DCC, A-hydroxysuccinimide, CHCI3, r.t., 5 h 33% together 
with DCU
2 . DIC, A-hydroxysuccinimide, CHCI3, r.t., 6 h 1 0%
3. EDCI.HC1, A-hydroxysuccinimide, Et3N, CHCI3, r.t, 5 h 0%
4. PyBOP, Et3N, MeCN, r.t., 5 h 0%
5. Ethyl chloroformate, Et3N, DCM, r.t., 5 h 0%
6 . HATU, Et2NCH(CH3)2, DMF, r.t., 5 h 7%
7. Isobutyl chloroformate, A-methylmorpholine, DCM, 
-15°C, 20 min
19%
Table 2.6.1 Attempted reaction conditions for the synthesis of dipeptide 189.
115DIC  was next  attempted  (Table 2.6.1,  entry 2),  because  as mentioned previously,  its 
urea by-product is soluble in organic solvents, and it was reasoned that this could aid its 
removal  by recrystallisation.  Unfortunately  189  was  obtained  in  low  yield  (ca.10%). 
Due  to  the  problems  encountered  with  the  carbodiimides  mentioned  above,  it  was 
decided that the use of l-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride 
(EDCI) (Table 2.6.1, entry 3), which forms a water soluble urea, which can be easily 
removed in work-up might be more suitable.106 However, the desired product was not 
isolated and the NMR analysis confirmed that the peptide coupling had not occurred. 
Although PyBOP has often been used for sluggish peptide coupling reactions107 (Table
2.6.1,  entry 4), in this case, no product was detected. The use of ethyl chloroformate to 
form  a  mixed  anhydride  was  also  unsuccessful  (Table  2.6.1,  entry  5).  The  final 
coupling  reagent  considered  was  0-(7-azabenzotriazol-l-yl)-Ar ,A,A',A- 
tetramethyluronium hexafluorophosphate (HATU) (Table 2.6.1, entry  6).  The reaction
1  A fi
gave  a complex  mixture  of products,  with  189 being  isolated  in  only 7%  yield.  A 
slight  improvement  in  yield  of the  reaction  was  found  when  it  was  performed  with 
isobutyl  chloroformate  in  the  presence  of A-methyl  morpholine,  giving  189  in  19% 
yield (Scheme 2.6.6) .109 Although the yield was modest, the purity of the desired amide 
was  excellent  and  hence,  we proceeded  to  the  next  step.  Deprotection  of the benzyl 
group was achieved by catalytic transfer hydrogenation, using 1,4-cyclohexadiene in the 
presence of palladium on carbon and the desired acid 190 was isolated in an excellent 
90% yield (Scheme 2.6.6) .110
o o
1.  Isobutyl chloroformate. 
A/-methyl morpholine, C
N  COOH
A/-methyl morpholine, DCM, -15 °C, 20 min
H
188 O 189
O
Pd/C, EtOH, r.t.,  19 h, 90%
1 ,4-cyclohexadiene,
O
190
Scheme 2.6.6 Synthesis of dipeptide 190.
116The synthesis of polymer 181, containing a histidine unit attached to the caproic  acid 
spacer  is  shown  in  (Scheme  2.6.7)  and  was  carried  out  in  a  manner  analogous  to 
previous polymers.
h2n
110
P bf-Arg( P bf  )-Arg( P bf)-C  A-0 H  131
Boc-His(Boc)-CA-OH 190
DIC, NHS, 
CHCI3, r.t., 4 h
r.t. 2  h
n-m-l
HN
CA
Arg(Pbf)
191 Arg(Pbf)
HN
X O '  CA I
His(Boc)
Boc
Fmoc
F moc-Lys(Fmoc)-0 H,
DIC, NHS, 
CHCI3, r.t., 5 h
n-m-l
HN HN
r.t.,  2 2  h
Lys(Fmoc)0 CA
Arg(Pbf) Fmoc
HN
X
Arg(Pbf)
Fmoc
His(Boc)
Boc
192
1. TFA/TIPS/H20  (95:2.5:2.5) 
r.t., 4 h
2. Piperidine/DMF (2:8) 
r.t., 4 h
n-m-l
HN HN
CA Lys
Arg
HN
X O '  'CA  I
His
Arg
181
CA =  6 -amino caproic acid 
n = 752
Scheme 2.6.7 Synthesis of artificial esterase 181.
1172.6.1  The  activity  of  the  artificial  esterase  containing  an  extended 
histidine catalytic unit with the caproic acid spacer
To our enormous  surprise, when activity of polymer 181  (Figure 2.6.2) was tested in 
phosphate buffer at pH  7, HPLC  analysis confirmed that the esterase was completely 
inactive. Possible explanations for the lack of activity could be the lack of solubility of 
the polymer in buffer, the formal increase in the distance between the histidine residue 
and  the binding  group  or the  fact  that  too  many  lipophilic  methylene  units  are  now 
concentrated  in the “active  site” region.  This  example nevertheless  demonstrates  that 
relatively minor alterations can drastically affect the polymer’s ability to hydrolyse the 
ester.
CA =  6 -aminocaproic acid
Figure 2.6.2 Artificial esterase 181.
2.7  Synthesis of artificial esterase containing a tentagel resin backbone
Since  all  artificial  esterases  examined  thus  far  were  based  on  a  polyallylamine 
backbone, it was of interest to ascertain how the activity of the artificial esterase would 
be influenced by using a different polymeric support for the threads. Tentagel resin, for 
example, unlike polyallylamine, is much more compatible with organic solvents and has 
very  good  swelling  properties,  especially  in  DCM.111;112  We  therefore  decided  to 
incorporate a tentagel based resin within our system, and to retain the same binding unit 
Arg-Arg, histidine nucleophile, and lysine spacer which had shown superior activity in 
our  earlier  studies.  The  synthesis  was  carried  out  using  a  similar  method  to  that 
previously described in Section 2.3.2, and using the Arg-Arg binding unit, histidine and 
lysine in an approximate 1:1:1 ratio (Scheme 2.7.1).
118FmocArg(Pbf)Arg(Pbf)CA-OH 131
-NH,
193
FmocLys(Fmoc)0 H
DIC, HOBt,
DMF, r.t.,  10 min
r.t., 24 h
FmocHis(Trt)OH
DIC,  HOBt,
DMF, r.t.,  10 min
r.t., 3 h
NH I
CA I
Arg(Pbf)
Fmoc  1 9 5
NH  NH
I.  I
His(Trt)  Lys(Fmoc)
Arg(Pbf)  pmoc  Fmoc
NH  NH  NH,
i  I   2
CA  His(Trt)
| r 8 (pbf>   Fmoc 
Arg(Pbf)  , 9 4
Fmoc
1. TFA/TIPS/H20  (95:2.5:2.5) 
r.t.,  6  h
2.  Piperidine/DMF (2:8), 
r.t,  6  h
NH I
CA I
Arg
Arg
NH I
His
196
NH I
Lys
Tentagel resin,
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Scheme 2.7.1 Synthesis of artificial esterase 196, containing a tentagel resin backbone.
The esterase 196 was tested in phosphate buffer pH 7, but no hydrolysis was observed. 
Since  the  resin  has  better  swelling  properties  in  organic  solvents,  the  hydrolysis 
reactions  were  also  attempted  in  a  mixture  of  THF/phosphate  buffer  (1:1)  and 
acetonitrile/phosphate buffer (1:1).  However, in all of these cases, disappointingly, no 
hydrolysis was observed.
1192.8 Hydrolysis of other ester substrates
At  this  stage,  we  also  wished  to  investigate  the  substrate  specificity of our  artificial 
esterases.  The  hydrolysis  of commercially available  ethyl  phenylacetate  197  (Figure
2.8.1)  was selected for study because in contrast compared to esters 127 and 169, it does 
not contain the additional amide and acid binding groups for recognition. Polymers 132 
and  137,  for which  ester hydrolysis had previously been observed,  did not  show  any 
product formation with ethyl phenylacetate 197. In both cases, however, a reduction in 
ester concentration was observed.
Frustratingly, an additional series of esters 199 (Scheme 2.8.1), 200 (Scheme 2.8.2) and 
202  (Scheme  2.8.3) which were  also prepared in order to  assess  substrate behaviour, 
proved  to  have  problems  of solvent  incompatibility and  hence  could  not be  studied. 
Nevertheless, in a more encouraging vein, the fact that the esterases 132,  137 and 168 
hydrolysed  their  designed  substrate  and  did  not  hydrolyse  ethyl  phenylacetate 
demonstrated that our artificial enzymes could indeed, as with many naturally occurring 
enzymes, be considered as substrate specific.
197
Figure 2.8.1 Ethyl phenylacetate
2-phenyl ethanol, DCC, DMAP,
Et3N, DCM/THF (1:1), 
r.t.,  18 h, 30%
Ph
198 199
Scheme 2.8.1 Synthesis of ester 199.
120Ethylene glycol phenyl, DCC, 
DMAP, Et3N
DCM/THF (1:1), r.t.,  18 h, 73%
Scheme 2.8.2 Synthesis of ester 200.
1. KOH,  H20, ethanol, 
r.t., 3 days, 91%
2. 2-Phenyl ethanol, DCC, 
DMAP,  Et3N,  r.t.,  18 h, 
52%
Scheme 2.8.3 Synthesis of ester 202.2.9 Conclusions from the esterase studies
This  section  has  described  further  developments  in  our  novel  strategy  for  the 
preparation  of artificial  enzymes.  Our  objective  was  to  use  this  approach  to  further 
investigate  some  different  factors  which  are  responsible  for  catalysis  and  hence  to 
subsequently find the most efficient artificial esterase.
The dipeptides which displayed quantifiable binding affinity towards the phosphonate 
transition  state  analogue  128  as  established  by  the  previous  NMR  studies96  were 
accordingly incorporated  into  a polymer backbone,  together with  a histidine catalytic 
group. As a result, a number of different variants of artificial esterases were prepared. 
We  found that  only three of the  esterases  showed  activity,  polyallylamine containing 
Arg-Arg  and  Ala-Arg binding  groups  and the  soluble polymer with  a missing  lysine 
residue.  Out of these three,  it was  found that the esterase  132  containing the peptide 
which showed the best binding towards the transition state analogue, Arg-Arg, was the 
most efficient in terms of overall conversion.  We have verified the importance of the 
amino acid sequence within the binding group in relation to the polymer backbone. This 
was  illustrated  by  the  example  of the  unreactive  polymer  136  containing  Arg-Ala 
binding  group,  with  the  arginine  directly  attached  to  the backbone.  Furthermore,  we 
established that the most efficient hydrolysis occurs at pH 8 with the designed substrate. 
We  have  also  demonstrated  that  changing  the  polymer  backbone,  gives  the  catalyst 
completely  different  properties  and  although  we  had  the  same  groups  attached  to 
tentagel, the polymer was still inactive.
We have exploited the most significant advantage of this approach, by demonstrating 
that  through  simple  variation  of  the  groups  attached  to  the  polymer  backbone,  a 
systematic exploration of catalyst activity could be achieved. This information can now 
be used in principle to generate new catalysts with even better efficiency. Nevertheless, 
despite the fact that we have managed to gather a lot of information on cooperativity 
between binding and catalytic  groups,  as well as the activity of these polymers under 
different  conditions  and  their  substrate  specificity,  the  methodology  of  effectively 
random  coupling  of the  two  functional  units  to  a polymer backbone  needs  some re­
thinking.  As  we  observed,  by  synthesising  several  different  batches  of  the  same
122polymer,  they have  a tendency to  exhibit different efficiencies.  Although in all cases 
ester hydrolysis was observed, they performed to different extents, leading us to believe 
that each polymeric thread that is produced by random attachment of functional groups, 
forms a distinct molecular entity and ultimately this is undesirable.  The  sensitivity of 
the tertiary structure to minor work up modifications is also of some concern.
The method by which the formation of the acid product was monitored needs  further 
improvements  and  hence  the  measurements  presented  in  this  chapter  should  only be 
considered as preliminary.  It is possible that the acid  formation was monitored at the 
wrong time frame and that perhaps, the ‘real’ catalysis may be occurring after a period 
of 300 minutes rather than at the beginning of the reaction as initially anticipated. The 
fact that substantially more product formation was observed after a period of 24 hours 
also indicates that this may be the case. Therefore the polymers could be undergoing an 
initial  period  of ‘recognition’  of the  substrate,  before  catalysing the  reaction.  In  this 
case,  a  continuous  assay  should  be  designed  in  order  to  monitor product  formation, 
which could be more useful in determining the time period when the polymers  are at 
their most active state.
2.10 Future Outlook
In overall terms, we were nevertheless satisfied with the additional results achieved for 
these artificial esterases especially in an aqueous buffered medium.  However, there is 
still plenty of scope for further studies in the area of artificial esterases.
Investigations into different types of catalytic groups, such as serine or cysteine, which 
are  also  found  within  natural  enzymes  could  certainly be  carried  out.  Although  our 
studies  were  limited  to  the  small  number  of binding  groups  identified  by the  NMR 
technique,  clearly,  these may not be optimal.  Finding a more  efficient binding group 
would require  research  into  new binding  assays  and  exploitation  of other techniques 
such as UV or fluorescence in combination with NMR binding studies. Most certainly, 
this would also involve investigations into more accurate design and understanding of 
transition state analogues.
123Further  studies  on  different  polymer  backbones,  ranging  from  more  or  less  soluble 
polymers  as  desired  could  also  be  done  to  see  how  the  microenvironment  of the 
polymer affects catalysis.
It  would  also  be  of interest  to  complete  the  competition  studies  that  were  initiated, 
providing  that  a  suitable  ester  substrate  which  is  soluble  in phosphate buffer  can be 
found.
Finally, this approach could be extended to involve kinetic resolution of ester substrates 
since  binding  groups  on  the  polymeric  backbone  could  be  selected  for  a  single 
enantiomer.
124CHAPTER 3 
RESULTS AND DISCUSSION 
ARTIFICIAL ALDOL CATALYSTS
1253.1  Introduction
Using the design concept previously developed for artificial esterases, it was of interest 
to  explore  this  approach  in  terms  of an  artificial  aldolases.  As  discussed  previously 
(Section  1.3.4.2, Scheme  1.3.9), in natural aldolases, a lysine residue performs the key 
catalytic step,  forming a reactive  imine/ enamine intermediate for the aldol reaction to 
proceed.25
source  residue
= Proton  O   ~ Lysine
Figure 3.1.1  Representation of artificial aldolase catalyst.
Accordingly,  we  envisaged  that  an  artificial  aldolase  would  consist  of  a  polymer 
backbone with two different functional groups attached to it (Figure 3.1.1).  In the first 
instance, as a gross simplification of the design we had for esterases, it was decided to 
select lysine as the first group and a carboxylic acid as the second group. Our hope that 
this  system  would  have  some  characteristics  of the  natural  enzyme  is  expressed  in 
Figure 3.1.2, wherein a nucleophilic enamine is formed using the lysine residue and the 
carboxylic  acid  functions  as  a  proton  source  to  enhance  the  electrophilicity  of the 
aldehydic carbonyl group.
+  (  NHLys-Polymer
r ./^ H   204
203
Figure 3.1.2 Enamine attack on aldehyde during an aldol reaction.
1263.2  Preliminary studies with artificial aldolases
When  selecting  the  polymer  backbone  for  our  initial  investigations  into  artificial 
aldolases,  the  obvious  choice  was  to  utilise  polylysine  since  the  lysine  residues  are 
already present and hence only the carboxylic acid units would need to be incorporated. 
As  a  carboxylic  acid  source,  we  elected  to  use  1,5-pentadioic  acid,  which  after 
incorporation onto the polylysine backbone should confer conformational mobility on 
this  important  functionality.  The  initial  aldol  catalyst  207  was  therefore  formed  via 
reaction  of the  free  base  of polylysine  hydrobromide  with  glutaric  anhydride  (0.5 
equivalent)  to  give  a  polymer  containing  carboxylic  acids  and  free  amines  in 
approximately  1:1  ratio  (Scheme 3.2.1).113  We were of course aware that ammonium 
salts could be formed in equilibrium with the free form of the “amino acid” shown, but 
reasoned that even a small concentration of the latter could be effective in promoting the 
desired reaction.
For  our  preliminary  aldol  reactions,  we  decided  to  study  the  reaction  between 
acetophenone  and benzaldehyde  (Scheme  3.2.2).  There were  several  reasons  for this 
choice  including  the  expectation  that  enamine  regiospecific  formation  between 
acetophenone and  lysine should be readily achieved;  the fact that both of the starting 
materials  and the known product  can be readily detected by UV, hence  allowing the 
reaction to be easily followed. In the event however, our initial attempts to perform an 
aldol  reaction  between  acetophenone  and  benzaldehyde,  catalysed  by  polymer  207, 
were uniformly unsuccessful.  The polymer 207 was tested in a number of solvents as
1.  2,6-lutidine,  DMF, r.t., 
5 min
2.  Glutaric anhydride (0.5 eqv.) 
DMF, 0°C to r.t., 24 h
OH O
Scheme 3.2.1 Synthesis of aldolase catalyst 207.
127shown  in  Scheme  3.2.2  and  Table  3.2.1.  After  24  hours  no  aldol  product  209  was 
detected under any of the conditions specified in Table 3.2.1.
1.) Polymer 207 (5% w/w)
0   solvent (see Table 3.2.1),  qH  q
pA   " 8hX  -  A ,
2.) Benzaldehyde, r.t., 24 h
208  209
Scheme 3.2.2 Attempted aldol reaction between acetophenone and benzaldehyde, using
polymer catalyst 207.
Entry Solvent Product detected?
1. Ethanol No
2. THF No
3. DCM No
4. Acetonitrile No
5. DMF No
Table 3.2.1 Aldol reaction (Scheme 3.2.2) monitored by UV and NMR.
As a result of the failure of our catalyst to generate any product, we questioned whether 
the lysine residues in polymer 207 were hindered by the morphology of the polymer, 
which  therefore  may  have  inhibited  enamine  formation  in  the  reaction.  Hence,  we 
decided to synthesise an alternative catalyst based on a polyallylamine backbone, onto 
which we  incorporated glutaric  anhydride (0.5  equivalent)  and Fmoc protected lysine 
(0.5  equivalent).  Again,  we  envisaged  that  the  lysine  and  pentadioic  acid  would  be 
incorporated in 1:1  ratio. The synthesis of this polymeric catalyst 211 is outlined below 
(Scheme 3.2.3).
128FmocLys(Fmoc)OH (0.5 eqv.)
n
Nl-L
DIC,  NHS
CHCI3,  r.t.,
5 h
110
n = 752
Glutaric anhydride (0.5 eqv.), 
CHCI3, r.t., 24 h
n-m
NH NH
NHFmoc
OH
HN
210  Fmoc
Piperidine/DMF (2 : 8), 
r.t., 20 h
n-m
NH NH
NH.
OH
H2N
211
Scheme 3.2.3 Synthesis of aldol catalyst 211.
The resulting polymer 211  was  tested under the  same  reaction conditions previously 
attempted with the polylysine derived polymer (Scheme 3.2.4 and Table 3.2.2).
Ph
o
A
208
1. Polymer 211 (5% w/w)
solvent (see Table 3.2.2),  OH  O
2. Benzaldehyde, r.t.,
24 h  209
Scheme 3.2.4 Attempted aldol reaction between benzophenone and benzaldehyde, using 
polymer 211 as a catalyst.
129Entry Solvent and conditions Products detected?
1. Ethanol, r.t. No
2. THF, r.t. No
3. DCM, r.t. No
4. MeCN, r.t. No
5. DMF, r.t. No
6. Ethanol, 60 °C No
7. THF, 60 °C No
Table 3.2.2 Aldol reaction (Scheme 3.2.4) monitored by UV and NMR.
However,  under the conditions stated in entries  1 - 7   (Table 3.2.2), no aldol adducts 
were observed in any of the different solvents that were investigated.
Since  neither  polymer  207  or  polymer  211  were  able  to  catalyse  the  aldol  reaction 
outlined  in  Scheme  3.2.4,  we  considered  whether  an  alternative  polymer  backbone 
might be desirable. Since both polylysine and polyallylamine are more compatible with 
aqueous media,90;113  and due to the fact that we were attempting the aldol reaction in 
organic  solvents,  a  polymer  support  more  compatible  with  organic  solvents  would 
potentially be of more use.  Tentagel resin has been reported to possess good swelling 
properties in organic medium11 1  and we therefore decided to incorporate this within our 
system.  Tentagel resin was reacted with glutaric anhydride (0.5  equivalents) (Scheme 
212), resulting in polymer 212 consisting of a free amine and a carboxylic acid in an 
approximately 1:1  ratio. In the first instance, we decided not to attach lysine to tentagel 
resin, as we felt that the free primary amino group of tentagel  resin should be sufficient 
to perform the enamine formation.
* - nh2
193
Substitution 
= 0.4 mmol/g
Glutaric anhydride (0.5 eqv.), 
DCM, r.t., 24 h
NH-
212
Scheme 3.2.5 Synthesis of aldol catalyst 212.
130This time, we  decided  to  use tolualdehyde as a substrate,  instead  of benzaldehyde,  since
we thought  the  formation  of the aldol product would be monitored more  easily by the
chemical  shift  of the  methyl  group  by  *H  NMR  spectroscopy.  However,  under  the 
conditions tested,  the desired aldol  adduct (213) was not detected (Scheme 3.2.6 and 
Table 3.2.3).
1. Polymer 212 (12 mol%)
O  solvent (see Table 3.2.3),
II  r.t., 3 h
x
2. p-tolualdehyde, r.t., 24 h
208
Scheme 3.2.6 Attempted aldol reaction between benzophenone and p-tolualdehyde, using
polymer 212 as a catalyst.
Entry Solvent and conditions Products detected?
1. Ethanol, r.t. No
2. THF, r.t. No
3. DCM, r.t. No
4. MeCN, r.t. No
Table 3.2.3 Aldol reaction (Scheme 3.2.6) monitored by UV and NMR.
As a result of the fact that none of the aldol catalysts (207, 211  and 212) containing a 
primary amino group had proved successful, we questioned whether the primary amine 
had  the  ability  to  evolve  from  the  derived  imine  to  an  enamino  species,  under  the 
reaction conditions investigated.  Secondary amines can of course allow easier enamine 
formation, and we therefore reasoned that incorporation of proline (a secondary amine) 
into our polymer system might be more suitable. Before discussing this aspect further, it 
is appropriate to provide a short overview of the recent literature, on organic catalysts 
where proline derivatives have been widely used as catalysts in aldol reactions.
3.3  Organocatalysts in aldol reactions
In 1974, Hajos and Parrish reported the use of L-proline as a catalyst in the asymmetric 
intramolecular aldol cyclization of the triketone 214 (Scheme 3.3.1).114
131L-proline (3 mol %)
acetonitrile
215 214
Scheme 3.3.1 Proline catalysed intramolecular aldol reaction.
Subsequently,  List and co-workers described the first proline-catalysed intermolecular 
asymmetric  aldol  reaction  (Scheme  3.3.2).115  These  proline  catalysed  reactions  had 
several key advantages: (1) proline was inexpensive, non-toxic and readily available in 
both enantiomeric forms; (2) The reaction did not require inert conditions and could be 
run at room temperature; (3) The reaction did not require the pre-generation of enolate 
equivalents or the presence of a metallic species; (4) The catalyst was water soluble and 
could be removed in an aqueous work-up.
A
54
H
NO.
216
L-proline (30 mol %) 
DMSO,  6 8 %
OH
N0 2
116, 76% ee
Scheme 3.3.2 Proline catalysed intermolecular aldol reaction.
The  proline  catalysed  reaction  has  been  proposed  to  proceed  through  an  enamine 
mechanism, analogous to natural aldolases (Scheme 3.3.3).25 The proline functions as a 
nucleophile  and  an  acid/base  co-catalyst  in  the  form  of  the  carboxylate.115  The 
enantioselectivity can be explained with a metal free version of the Zimmerman-Traxler 
type  transition  state,116  where the tricyclic  hydrogen bonded network  favours  the re­
facial attack.
132imine
RCHO
enamine re-facial attack
Scheme 3.3.3 Proposed mechanism of the proline catalysed aldol reaction.
As  a  result  of finding  such  an  efficient  catalyst,  there  have  been  some  remarkable 
advances made in this field. Thus, proline has been used in aldehyde-aldehyde reactions 
as illustrated by MacMillan and coworkers (Scheme 3.3.4).117
o L-proline (10 mol %) 
DMF, 4 °C, 80%
O  OH
217 218, 4:1  anti.syn, 
99% ee
Scheme 3.3.4 Proline catalysed aldol reaction.
Many  derivatives  of proline  have  also  been  synthesised  in  the  attempt  to  improve
selectivity of the reactions. For example, the proline based dipeptide 223 developed by 
118 Wu et al.  demonstrated better selectivity over proline (Scheme 3.3.5, (a)), whereas a 
sulfonamide derivative 224 generated by the Ley group119 offered improved solubility 
in organic solvents (Scheme 3.3.5, (b)).
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Scheme 3.3.5 Aldol reactions catalysed by proline derivatives.
Proline and its derivatives have also been used as catalysts in nitro-Michael additions 
(Scheme 3.3.6)119 and asymmetric Mannich-type reactions (Scheme 3.3.7).119,120
o
221
Ph^A /N °2
Catalyst 226 (15 mol %), 
MeOH, 50 °C
-n  f y
H  N -N  
H
Catalyst 226
225,  1:15 anti.syn, 
53% ee
Scheme 3.3.6 Proline derivative catalysed nitro-Michael addition.
134OMe
CHO NH.
A
54
O
+
L-Proline 
(35 mol%)
DMSO
NO. OMe NO.
227
228
216
Scheme 3.3.7 Proline catalysed Mannich reaction.
3.4  Synthesis of aldol catalysts containing proline
3.4.1  Tentagel based aldol catalyst
In  the  light  of the  foregoing  discussion,  we  felt  that  it  may be  more  appropriate  to 
replace  our  lysine  catalytic  residue  with  proline.  Before  incorporating  it  into  the 
polymer, proline was first protected with a Boc group to give Boc proline 230 (Scheme
3.4.1).
The next step was to synthesise our aldol catalyst, using tentagel resin as the polymeric 
backbone  due  to  its  compatibility  with  organic  solvents.  Our  intention  was  to 
incorporate the proline and pentadioic acid moieties in an approximately 1:1 ratio onto 
the polymer. Initially, a synthetic route was undertaken whereby Boc protected proline 
and Fmoc glycine were attached to tentagel resin (Scheme 3.4.2). The function of the 
Fmoc protected glycine spacer was to allow us to monitor the substitution of the glycine 
residue on the resin, using the Fmoc substitution test outlined in Section 2.3.1. Use of 
this  methodology  permits  us  to  approximate  the  number  of proline  catalytic  groups
'COOH dioxane/water (2 :1 ), 
r.t., 24 h, 44%
'COOH
Scheme 3.4.1 Synthesis of Boc proline 230.
135attached to  the  resin.  This  should  in turn  allow  us  to  estimate  the  percentage  of the 
catalyst  used  in  our  aldol  reactions.  Polymer  231  was  then  deprotected 
(piperidine/DMF)  and  treated  with  glutaric  anhydride.  Boc  deprotection  gave  our 
desired catalyst as a trifluoroacetate salt (233). However, using this synthetic sequence, 
Fmoc  substitution measurements revealed that the acid and catalytic proline were not 
attached in a 1:1 ratio.
BocProOH (5 eqv.), FmocGlyOH (5 eqv.), 
HATU, DIPEA, DMF, r.t., 24 h 
-NH,  --------------------------------------------------    NH
1. Piperidine/DMF (2:8), r.t., 2 h
193
Subst. of amines = 0.4 mmol/g
TFA/DCM (1:1), r.t.,
2 h
NH
I   2. Glutaric anhydride (2 eqv.), 
I [r0  DCM, r.t.,  19 h
Fmoc  Boc 
231
<piy
Fmoc subst. = 0.24 mmol/g
NH HN.
,NH NH,  CFoCOO'
233
OH
NH  NH I   I
Gly  Pro
Boc
232
Approx. ratio of proline 
to carboxylic acid = 2:3
Scheme 3.4.2 Synthesis of tentagel based aldol catalyst 233.
A more controlled synthesis was hence carried out, following the procedure of Ladlow 
and  coworkers,121  where  FmocGlyOH  and  BocGlyOH  were  initially  attached  to  the 
resin  in  excess  (Scheme  3.4.3).  It was  reported  that  both  glycine  derivatives  should 
attach to the resin in approximately  1:1  ratio.12 1   However, Fmoc  substitution analysis 
revealed  that  the  two  glycine  residues  were  attached  in  approximately  2:3  ratio  in 
compound 234.  The rest of the synthesis was completed using standard procedures to 
obtain the final aldol catalyst 238. Although the incorporation was not achieved in the 
desired  1:1  ratio,  this  procedure  was  more  reproducible  (giving  constant  Fmoc 
substitution values) than the previous synthetic route outlined above (Scheme 3.4.2).
136-NH,
FmocGlyOH (5 eqv.), 
BocGlyOH (5 eqv.), HOBt,
DIC, DMF, r.t., 23 h
193
Subst. of free amines 
= 0.5 mmol/g
1. Pyridine/DCM (2:8) 
wash
2. Glutaric anhydride 
CHCI3, r.t., 2 days
1. BocProOH, HOBt, 
DIC, DMF, r.t.,  18 h
2. TFA/DCM (1:1), r.t., 
6  h
NH I
Gly
I
Fmoc
NH I
Gly
Boc
TFA/DCM (1:1), r.t.
24 h
234
Fmoc subst. = 0.18 mmol/g
Piperidine/DMF (2:8),
CF,COO
Fmoc
r.t., 4 h
NH
Gly
I
Fmoc  , ' " ,2 
235
NH I
Gly
NH,
NH I
Gly
NH,
237
238  HO
Ratio of proline to carboxylic acid = 2:3
Scheme 3.4.3 An improved synthesis of tentagel based aldol catalyst 238.
Initial testing of polymer 238 was carried out using acetophenone and p-tolualdehyde 
and  the  polymer  was  assessed  for  its  activity  in  organic  solvents  (Table  3.4.1). 
However, no product was again detected under these conditions (Table 3.4.1, entries 1- 
3). It was therefore subsequently tested in a monophasic aqueous system of acetonitrile 
and buffer at different pH values (Table 3.4.1,  entries 4 -6). Unfortunately, however, 
under either acidic (entry 4) or basic conditions (entry 6) no aldol adducts was formed.
o
pA
208
1. Aldolase 238 (20 mol%)
solvent (see Table 3.4.1),
r.t., 3 h 
----------------- x---------------- ►
2. p-tolualdehyde, r.t., 24 h
Scheme 3.4.4 Attempted aldol reaction between acetophenone and p-tolualdehyde, using
polymer catalyst 238.
137Entry Solvent and conditions Product detected?
1. DCM No
2. THF No
3. MeCN No
4. MeCN/Citrate buffer pH6 (1:1) No
5. MeCN/Phosphate buffer pH7 (1:1) No
6. MeCN/Borate buffer pH8 (1:1) No
Table 3.4.1 Aldol reaction (Scheme 3.4.4) monitored by UV and NMR.
3.4.2  Polyallylamine based aldol catalyst
As a result of the failure of the tentagel based catalyst, our next step was to conjugate 
the proline and pentadioic acid moieties to a polyallylamine backbone. Polyallylamine 
based resins are more compatible with aqueous systems and it was anticipated that this 
could  be  exploited  within  our  system.  The  synthesis  of the  required  catalyst  240  is 
outlined below in Scheme 3.4.5.
n
NH,
110
Glutaric anhydride (0.5 eqv.) 
CHCI3, r.t.,  6  h
BocProOH (0.5 eqv.), DIC, 
A/-hydroxysuccinimide, CHCI3, 
r.t.,  18h
n-m
NH NH
N(Boc)
OH
239
TFA/DCM (1:1), r.t., 
2.5 h
n-m
NH NH
NH,+  CFoCOO’
240
OH
Scheme 3.4.5 Synthesis of polyallylamine based aldolase catalyst 240.
138The catalytic properties of polymer 240 were then assessed for the reaction in Scheme 
3.4.6, under the conditions outlined in Table 3.4.2. However, under aqueous conditions 
(entries 2-4) no reaction was detected. This was somewhat disappointing as it had been 
hoped  that  the  favourable  swelling  properties  of  polyallylamine  would  make  the 
catalytic proline residues more accessible to the ketone.
1. Polymer 240 (20 mol%)
solvent (see table 3.4.2), 
r.t., 3h
2. p-tolualdehyde, r.t., 24 h
Scheme 3.4.6 Attempted aldol reaction between acetophenone and /7-tolualdehyde, using
polymer catalyst 240.
Entry Solvent and conditions Product detected?
1. MeCN, r.t. No
2. MeCN/Citrate buffer pH6 (1:1), r.t. No
3. MeCN/Phosphate buffer pH7 (1:1), r.t. No
4. MeCN/Borate buffer pH8 (1:1), r.t. No
5. DMF, r.t. No
6. DCM, r.t. No
7. THF, r.t. No
8. Diethyl Ether, r.t. No
9. Ethanol, 75 °C No
Table 3.4.2 Aldol reaction (Scheme 3.4.6) monitored by UV and NMR.
For completeness, a range of organic solvents was also examined (Table 3.4.2, entries 5 
-9), but as before, no reaction was observed.
1393.4.3  Aldol reaction using proline and its derivatives as catalysts
Following  the  problems  encountered  with  our  catalysts,  we  decided  to  establish 
appropriate  reaction  conditions  with proline  on  its  own,  with  the  aid  of information 
already available in the literature.  Once this had been determined, we then planned to 
use  our  catalyst  under  the  corresponding  conditions.  Following  the  procedure  of
117
MacMillan,  who  had  carried  out  aldol  reactions  between  two  aldehydes,  we 
attempted  to  use  the  same  reaction  conditions  on  our  substrates,  with  proline  as  a 
catalyst (Scheme 3.4.7).
p-tolualdehyde, 
L-proline (10 mol%),
------------x----------------
Ph
DMF, - 4°C
208
Scheme 3.4.7 Attempted aldol reaction, using L-proline as a catalyst.
However,  these  conditions  were  unsuccessful  for  our  substrates.  Therefore,  we 
attempted to reproduce exactly the same results stated in the paper (Scheme 3.4.8).117 
However,  in our hands,  we were unable to repeat the reaction between benzaldehyde 
and  propionaldehyde  and  the  self coupling  of propionaldehyde.  In  both  cases,  we 
isolated a complex mixture of materials, with no evidence of the desired aldol products 
241 and 218 by NMR spectroscopy.
O  Propionaldehyde,  0
L-proline (10 mol %),
Ph  H  DMF, -4°C,  18 h  Ph
208  241
O  L-proline (10 mol %),  0   OH
DMF, -4°C,  18 h
H   X  H'
217  218
Scheme 3.4.8 Attempted aldol reactions, using L-proline as a catalyst.
1403.4.3.1  Aldol reactions using proline derivative 242
Our next  strategy was  to  investigate  the  catalytic  dipeptide  242  used  by  Li  and  co­
workers  in the  aldol reaction between nitrobenzaldehyde  and  acetone  (where  acetone 
was used as a solvent) (Scheme 3.4.9).122
O  CH2Ph
COOH
H  242
/V-methylmorpholine,
242 (20 mol %),  0   OH
acetone/DMSO (1:4),
r.t., 16 h  I I
^^^N 02  
116
Scheme 3.4.9 Aldol reaction performed by Li et al.n2, using dipeptide 242 as a catalyst.
The first step was to synthesise the dipeptide catalyst 242, used in their studies, which is 
described below.
Our  initial  route  to  dipeptide  242  involved  coupling  CBz  protected  proline  to 
phenylalanine methyl ester (Scheme 3.4.10). The peptide coupling was first attempted 
via  activated  succinimide  ester  formation  using  EDCI  and  7V-hydroxysuccinimide. 
However,  low  yields  of  dipeptide  244  were  isolated.  The  coupling  was  more 
successfully achieved by formation of the mixed anhydride using ethyl chloroformate 
and in situ reaction with protected phenylalanine (Scheme 3.4.10).123
141^V^COOH
0=<
o
c
Ph
243
1. Ethyl chloroformate, Et3N, THF 
-10°C, 40 min.________________
2. Phenylalanine methyl ester 
hydrochloride,  Et3N, THF/DCM 
(1:1), -10°C to r.t.,  17 h, 61%
O
OMe
o=<(  O 
O
(
Ph
Ph
244
Aq. NaOH (4 M),
N dioxane/water (1 :1 ), r.t.,  /  n
2.5 h, 82%   0 = \   O
O  Ph
^Ph  245
OH
Pd/C, H2, ethanol, r.t.,  18 h
------------------x--------------------
O
242
OH
Ph
Scheme 3.4.10 Attempted synthesis of dipeptide 242.
The subsequent step  involved cleavage of the methyl ester 244.  This was first carried 
out  using  aqueous  sodium  hydroxide  in  methanol,  however,  in  this  case,  starting 
material was also recovered.124 Hydrolysis was then attempted using sodium hydroxide
125 in dioxane, which cleanly gave the desired acid 245 in 82% yield (Scheme 3.4.10). 
The  last  step  involved  deprotection  of  the  Cbz  group  by  hydrogenation.  Initially, 
transfer hydrogenation  conditions  using palladium  on  carbon  in  the  presence  of 1,4- 
cyclohexadiene  resulted  in  recovery  of starting  material  and  a  complex  mixture  of 
unknown by-products.110 Heating the reaction to 50 °C did not facilitate deprotection, 
and once again, the NMR spectra revealed a mixture of products. The final attempt was 
to  use  hydrogen  gas  instead  of  1,4-cyclohexadiene,  and  although  the  NMR  spectra 
showed a small amount of desired product 242, our efforts to purify the compound were 
unsuccessful (Scheme 3.4.10).
We therefore turned our attention to the use of an alternative protecting group on the 
proline residue. Boc protected proline was coupled to phenylalanine methyl ester using 
the mixed anhydride method to yield 246  (Scheme 3.4.11).  Hydrolysis of the methyl
142ester  and  deprotection  of the  Boc  group  proceeded  smoothly,  leading  to  the  desired 
catalytic dipeptide 242 being isolated in 43% yield.
/  \  1. Ethyl chloroformate, THF, Et3N,  j—\  H   9
>   COOH  -------10 °C, 40 min----------------------
° = <   2. Phenylalanine methyl ester  0 = ^   O  V.
,0   hydrochloride, THF/DCM (2:1),  o   Ph
EUN, -10 °C to r.t., 17 h, 94%  — /
230  / \   246
A < |N a 0 H (4 M )'  T F A /D C M (1 :1 )V   QVV^OH
dioxane/water (1:1),  0 = ^   O  ^   r.t., 3.5 h, 43%  O  L
r.t., 2 h, 79%  Ph  Ph
247
242
Scheme 3.4.11 Synthesis of dipeptide 242.
3.4.3.2 Testing the dipeptide 242 as a catalyst in aldol reaction
The  dipeptide  242  was  then  investigated  in  the  aldol  reaction  between  4- 
nitrobenzaldehyde and acetone,  in the presence of TV-methylmorpholine as outlined in 
Scheme  3.4.9,  under  the  same  conditions  described  by  Li.122  The  aldol  adduct  was 
successfully obtained in  87%  yield.  With the  successful  aldol conditions in hand,  we 
next  applied this to  the  same  aldol reaction using our polymer catalyst 238  (Scheme
3.4.12). This resulted in a product conversion of 72% by NMR spectroscopy, which was 
very  encouraging.  The  precise  role  of A-methylmorpholine  in  this  reaction  was  not 
obvious.  However,  Li  et al.  used  it to  adjust their reaction mixture to  pH  8.122  As  a 
result, they observed the reaction time was shortened from 192 to 96 hours.  In our case, 
when  the  reaction  was  performed  in  the  absence  of A-methylmorpholine  (Scheme
3.4.12), no product was  detected.  In this instance,  in addition to  adjusting the pH, its 
role could be the desalting of the TFA salt of the proline on resin 238. The presence of 
the  TFA  salt  would  most  likely prevent the  enamine  formation between proline  and 
benzaldehyde.  Additionally,  it  should  also  be  noted  that  when  the  reaction  was 
performed with A-methylmorpholine in the absence of polymer catalyst 238, no product 
formation was detected.
143NH I
Gly
NH
0 = <
CFXOO H z O
NH I
Gly
HN.
polymer 238  HO
Aldolase 238 (20 mol %)
/V-methylmorpholine, 
acetone/DMSO (1:4), 
r.t., 16 h
216 116
Scheme 3.4.12 Aldol reaction catalysed by polymer 238.
3.4.4  Re-investigation of catalytic activity of tentagel catalyst 238
3.4.4.1  Optimising reaction conditions for an aldol reaction
Encouraged  by  the  fact  that  polymer  238  exhibited  some  activity,  we  selected  the 
reaction between 4-nitrobenzaldehyde with acetone as a model, in order to optimise the 
reaction conditions (Scheme 3.4.13 and Table 3.4.3).
H
NO.
216
Aldolase 238 (2 mol %), 
/V-methylmorpholine, r.t.
See Table 3.4.3 for reaction 
conditions
116
Scheme 3.4.13 Aldol reaction catalysed by polymer 238.
Using 2 mol % of our tentagel catalyst 238, the aldol reaction was tested in a variety of 
organic solvents, which all gave similar NMR conversion yields (entries 2 -  6), albeit 
over longer reaction times.  Addition of water to the reaction enhances the percentage 
conversion to aldol product (entry 7). As highlighted by Houk, the most energetically
144demanding step in the aldol reaction sequence is the breakdown of the carbinolamine 
which  is  formed  on  hydrolysis  of the  iminium  cation,  and  as  suggested  by  these
theoretical  studies,  an increased concentration of water in the reaction could shift the
•  •  1   equilibrium towards the product.  Increasing the reaction duration, gave an impressive
80% conversion to the product (entry 8). Interestingly, doubling the water content of the
reaction  gave only a trace of product presumably due to  premature hydrolysis of the
enamine intermediate (entry 9). This may also be partially due to the fact that the resin
does not have very good swelling properties in water111 and hence ‘shrinks’, making the
catalytic  site  less  accessible  to  the  substrate.  The  solvent  system  that  gave  the  best
results  was  a  mixture  of acetone/water  (entry  11),  which  resulted  in  a  quantitative
conversion by NMR analysis.
Entry Solvent Reaction 
time (h)
Ratio of 
aldehyde to 
producta
1. Acetone/DMSO (1:4) 16 3.5:1
2. Acetone 40 5:1
3. Acetone/Acetonitrile (1:4) 40 10:1
4. Acetone/DCM (1:4) 40 5:1
5. Acetone/Dioxane (1:4) 40 4:1
6. Acetone/DMF (1:4) 40 8:1
7. Acetone/DMSO/Water (1:3.5:0.5) 18 1.6:1
8. Acetone/DMSO/Water (1:3.5:0.5) 40 1:4
9. Acetone/DMSO/W  ater (1:3.5:1) 18 32:1
10. Acetone/DMSO/Water (1:3.5:0.25) 40 5:1
11. Acetone/Water (4.5:0.5) 40 0:1
Table 3.4.3 Optimising reaction conditions for aldol reaction in Scheme 3.4.13. “Molar ratio 
determined by NMR analysis of crude isolated material.
3.4.4.2  Aldol substrate specificity studies (Part 1)
Following the optimisation of the aldol reaction using polymer 238, the most favourable 
solvent conditions  employing acetone/water (9:1)  (Table 3.4.3) were applied in aldol 
reactions, where the aldehyde substrate was varied (Scheme 3.4.14). The reaction was 
stopped after a period of 18 hours.
145Aldolase 238 (2 mol %),
/V-methylmorpholine,
Aldehyde  ----------------------------------------------►  Product
(see Table 3.4.4)  acetone/water (9:1), r.t.,  18 h  (see Table 3.4.4)
Scheme 3.4.14
From  examination  of the  results  in  Table  3.4.4  it  can be  concluded  that  only those 
aldehydes which contain electron withdrawing groups attached to the benzene ring can 
undergo  an aldol reaction (entries 2,6,8,  11-15) under our conditions.  This is perhaps 
not  surprising,  since  the  electron  withdrawing  groups  make  the  carbon  atom  of the 
aldehyde more electron deficient and thus more susceptible to nucleophilic attack by the 
enamine.  Although  the  NMR  analysis  of  the  crude  mixtures  for  some  reactions 
indicated no  remaining  aldehyde was present,  the  corresponding isolated  yields were 
much lower than expected (entries 6, 8, 11  and 12). This probably arises due to some of 
the  product  remaining  trapped  on  the  resin,  even  though  the  resin  was  thoroughly 
washed after the reaction. The aldol reaction was also attempted with recovered catalyst, 
and although the  catalyst can be re-used, the products were obtained in lower yields. 
Thus for example, for the aldol reaction shown in entry 11, the product was isolated in 
30% yield, however when the same reaction was attempted with the recovered catalyst, 
the product was isolated in only 17% yield.
146Entry Aldehyde Expected
product
Ratio of 
aldehyde to 
product3
Isolated yield
(%)b
1. j O t cho P hC H 2 0 ^ ^
2 4 8
O H   0 
P hC H 2 0^^^  2 4 9 1:0 -
2. X T 2 5 0
O H   0 
Br'Xi^  2 5 1 1:1 19
3.
1   »
Q H   0 
2 5 3 1:0 -
4.
p r "
O H
2 5 4
O H   0
I   2 5 5   O H
1:0 -
5.
0   r V C H 0
a nX J
H 2 5 6
O H   0
J X ^ H
1:0 -
6. X T
2 1 9
O H   0
C ] X ^   2 2 0 0:1 18
7.
.C H O
0
2 5 8 S—   2 5 9 3:1
7
8.
iT Y C H 0
'V U  0  2 6 0 0
0:1 30
9.
o   ,r V C H 0 A0 XJ
2 6 2
O H   0
X  jGi 2 6 3 1:0 -
10. j a C H 0
2 6 4 1:1 21
11. jC T
o 2n ^ ^
2 1 6
O H   0 
o 2n ^ ^   H«
0:1 30
12. prC H 0
n o 2
2 6 6
O H   0 
I   2 6 7
n o 2
0:1 43
13. C T ^%o2
2 6 8
O H   0 
^ ^ N 0 2   269 1:4 25
14714 j C T
270
on  0
NCX J   27. 1:2.6 32
15. F i 7 C H O
272
OH  0  
273 0:1 -
16.
/C H O
U . J
H
274
OH  O
O t Y '
H
1:0 -
17.
276 a 1? -
1:0 -
18.
Ph
" ^ C H O
278
P h
279  OH  0
1:0 -
Table  3.4.4  Activity  of aldol  catalyst  238  with  varying  aldehyde  substrates.  a Molar ratio 
determined by NMR analysis of crude isolated material after  18 h. b Isolated yield of product 
after column chromatography.
When the polymers were tested on hetero-aromatic systems, the reaction of thiophene- 
3-carboxaldehyde  (entry  7)  proceeded  in  modest  yield,  but,  as  expected,  the  more 
electron  rich  indole  congener  (entry  16)  proved  unsuccessful.  Attempted  cross  aldol 
reactions  with  either  an  alicyclic  (entry  17)  or  acyclic  (entry  18)  aldehyde  did  not 
furnish any detectable product.
1483.4.4.3  Enantioselectivity of aldol reaction
Our  next  goal  was  to  ascertain  whether  the  aldolase  238  exhibited  any  degree  of 
enantioselectivity for the successful aldol reactions. When analysing the aldol adducts 
of eight reactions (Table 3.4.5), chiral induction was observed for five of the substrates. 
The  R product  was  favoured  for  entries  2,  7,  and  8.  Curiously,  whilst the  use  of 4- 
bromobenzaldehyde  gave  no  enantiomeric  excess  (entry  1),  the  adduct  from  the  4- 
chloro derivative was formed with 19% ee. The para nitro and cyano analogues (entries 
7 and 8) displayed moderate chiral enrichment (both 48%), however, the methyl ester 
derivative was generated as a racemate (entry 4). Interestingly, a substantial difference 
was observed amongst the ortho, meta and para nitro benzaldehyde derivatives (entries 
5  -7).  Thus,  the  meta  analogue  indicated  no  enantiomeric  enhancement,  whilst,  the 
ortho derivative (entry 6) exhibited some selectivity. However, since the latter is not a 
literature  compound  and  the  enantiomers  could  not  be  separated  on  a  chiral  HPLC 
column, the favoured enantiomer could not be determined. It should be noted that when 
the aldol reactions were attempted with L-proline on its own, under the same conditions 
stated in Scheme 3.4.14, no selectivity was observed. This could be due to the fact that 
A-methylmorpholine can deprotonate the carboxylic acid and the resultant proline salt 
cannot  adopt  the  Zimmerman-Traxler  type  transition  state116  with  the  ketone  as 
illustrated in Scheme 3.3.3.
As mentioned previously, the low isolated yields of the aldol products imply that some 
of the products may be trapped on the polymer. This has raised some concern regarding 
the observed ee values in Table 3.4.5. If some of the product remains on the polymer, it 
may  be  possible  that  one  enantiomer  may  be  retained  in  preference  to  the  other. 
However,  after  taking  into  consideration  the  initial  loading  of the  polymer,  together 
with the fact that only 2 mol % of the polymer is used, we have calculated that only the 
maximum of 7% of any potential aldol products formed could in theory stay bound on 
the polymer. This indicates that even if one enantiomer was favourably trapped, the ee 
values that we measured are unlikely to be significantly affected.
149Entry Aldol product 
favoured ee (%)
[a]Dof
enantiomeric
mixture
1.
OH  0
0a 0°
2.
9H   ft 
C , X j   2 2 0
19b + 13.5°
3.
QH  0  
S   2 5 9
69a,c -6.8°
4.
0
oa 0°
5.
OH  0  
2 6 7
n o 2
oa 0°
6.
OH  0  
2 6 9
N 02
n.d.c,d -13.8°
7.
9H   ft 
O zN J ^   1 1 6
48a,b +23.7°
8.
9H   9 
2 7 1
48a,b +40.8°
Table 3.4.5  Selectivity of aldol catalyst 238.a Determined by chiral-phase HPLC analysis. b  
Determined by optical rotation and corresponding literature values.c  Not a literature compound, 
hence  the  favoured  enantiomer  unknown.  d  ee  not  determined,  enantiomers  could  not  be 
separated on chiral-phase HPLC.
We  note  parenthetically  that  in  order  to  carry  out  analysis  by  chiral  HPLC,  the 
corresponding  racemates  of  the  above  products  had  to  be  synthesised.  This  was 
performed following the procedure of Schultz et al., by treating the aldehyde in acetone 
as  a  solvent,  with  dropwise  addition  of aqueous  sodium  hydroxide  at  0  °C  (Scheme 
3.4.15).'27
150H  R
Aq. NaOH, acetone
AA
O  OH
0 °C,  15 min R
R = 219 p-PhCI 
258 Thiophene
R =  2 2 0  p-PhCI (69%)
259 Thiophene (53%)
260 PhC02Me 
216 p-PhN02  
266 m-PhN02 
268 o-PhN02  
250 p-PhBr 
270 p-PhCN
261 PhC02Me (28%) 
116 p-PhNOz (46%) 
267 /7?-PhN02 (21%) 
269 o-PhN02 (60%) 
251 p-PhBr (26%) 
271 p-PhCN (14%)
Scheme 3.4.15 Synthesis of racemic aldol product.
3.4.4.4  Aldol substrate specificity studies (Part 2)
A  small  number  of  screening  reactions  with  ketones  other  than  acetone  were  also 
investigated  using  catalyst  238  (Scheme  3.4.16  and  Table  3.4.6).  Our  intention was 
only to observe whether the aldol reaction would proceed with these ketones and hence 
products were not isolated by purification.  Thus, use of cyclopentanone (Table 3.4.6, 
entry  1)  revealed  encouraging  results,  whilst  the  corresponding  reaction  with 
cyclohexanone  (Table  3.4.6,  entry 2)  was  unsuccessful,  with only a trace of desired 
product  222  and  dehydrated  product  281  detectable  by  NMR  analysis.  Using 
cyclobutanone  as  a  ketone  gave  only  15%  of the  desired  product  by NMR  analysis 
(entry 3), whereas 2-methyl cyclopentanone gave no product at all (entry 4).
Ketone
See Table 3.4.6
Product
216
Scheme 3.4.16 Reaction of 4-nitrobenzaldehyde with different ketones.
151Entry Ketone Conditions Product
Ratio of 
aldehyde to 
product3
1.
o
6
66
Polymer 238 (4 mol%), 
jV-methylmorpholine, 
DCM, r.t., 18 h
O  OH 
280
42
2.
O
6
221
Polymer 238 (4 mol%), 
A-methylmorpholine, 
DCM, r.t., 18 h
Q  OH
222  2 
+
(Vcl, 
281  2
Trace of 
mixed 
products 
observed
3.
282
Polymer 238 (4 mol%), 
A-methylmorpholine, 
DCM, r.t., 24 h
0   OH 
283
15
4.
0
(V
284
Polymer 238 (4 mol%),
TV-methylmorpholine, 
DCM, r.t., 18 h
Table 3.4.6 Reaction of 4-nitrobenzaldehyde with different ketones.a Molar ratio determined 
by NMR analysis of crude isolated material after 18 h.
These preliminary results  imply,  that  in principle,  the  activity of polymer 238  is not 
restricted to acetone. This presents the possibility that more elaborate systems could be 
investigated in future.
3.4.5  Development of alternative tentagel based catalysts
Since the reaction protocol adopted required the use of A-methylmorpholine, it was not 
clear whether the presence of carboxylic acid in polymer 238 had any beneficial effect 
on  the  aldol  reaction  itself.  Accordingly,  the  polymer  containing  only  the  proline 
residue was prepared (Scheme 3.4.17). Comparison of the activity of polymer 286 with 
polymer 238 in an aldol reaction (Scheme 3.4.18), revealed that there was no difference 
in terms of either conversion or enantiomeric excess. This indicates that the carboxylic 
acid  attached  to  polymer  238  does  not  play  a  significant  role  within  this  particular 
system, in terms of activating the aldehyde as we had initially thought.
152BocProOH,  HOBt,  NH  TFA/DCM(1:1)  NH
-NH2        0 = <         0 = <
193
DIC, DMF, r.t.,  17 h  V   r.t„  3 h
/   NBoc  /   NH
Substitution A  .  Z o3  Z o O
= 0.4 mmol/g
Scheme 3.4.17 Synthesis of aldol catalyst 286.
H
NO.
216
Polymer 286 (2 mol %), 
/V-methylmorpholine,
acetone/water (9:1)
Yield = 50% 
ee = 49%
Scheme 3.4.18 Aldol reaction catalysed by polymer 286.
For  comparison  purposes,  the  resin  containing  only  the  carboxylic  acid  was  also 
prepared (Scheme 3.4.19) and tested in the aldol reaction shown in Scheme 3.4.19. As 
expected, it was inactive and no product was isolated.
T
NH
Glutaric anhydride,  0 = \
• - n h 2  ---------------------------  >
CHCI3, r.t., 24 h  /
193  \
0=\
Substitution  OH
= 0.4 mmol/g
287
Scheme 3.4.19 Synthesis of polymer 287.
The third type of catalyst which we decided to  examine was one which contained an 
internal base.  As the use of A-methylmorpholine was required for all of our reactions, 
we  wanted  to  see  whether  the  introduction  of an  A-methylmorpholine  analogue  (to
153mimic the base) as one strand of our polymer, would allow us to avoid the use of this 
base in solution.
288
Ethyl bromoacetate, Water, reflux,  18 h, 74%
benzene, reflux,  1  h,
26%  M
OH 
0  290
Scheme 3.4.20 Synthesis of 290.
Ethyl bromoacetate was reacted with 7V-methyl piperazine, followed by hydrolysis with 
water to give 290 in 74% yield (Scheme 3.4.20). The acid 290 was then incorporated 
into the resin, using our previously established procedure to give the desired polymer 
293 (Scheme 3.4.21).
m -m 2
193
Substitution 
= 0.4 mmol/g
1. 290, HOBt, DIC, DMF 
r.t.,  19 h__________
2. TFA/DCM (1:1), r.t.,
4 h
FmocGlyOH, BocGlyOH
HOBt, DIC, DMF, r.t.,
23 h
NH NH I
Gly Gly
Fmoc  Boc 
234
Fmoc Substitution 
= 0.18 mmol/g
Piperidine/DMF (2:8), 
r.t., 4 h
l  •   i
NH  NH I   i
< p iy
NH
Gly
NH,
292
o
1. Pyridine/DCM wash
2. BocProOH, HOBt, DIC 
DMF, r.t., 24 h
3. TFA/DCM (1:1), r.t., 6 h
NH I
Gly
NH
NH I
Gly
NH,
NH I
(piy
Boc
291
NH I
Gly
HN^O
h2 n+ ^
xCFjCOO"
293
Approximate ratio of 
proline to base 
=   1.2:1
Scheme 3.4.21 Synthesis of aldol catalyst 293 with incorporated internal base.
154Initial  testing  of  the  aldolase  293  (Scheme  3.4.22),  in  the  absence  of  N- 
methylmorpholine gave only recovered starting materials.  Once again, the presence of 
the TFA salt of proline and of the A-methyl piperazine unit was probably undesirable, 
and hence the polymer was washed with a solution of triethylamine/DCM (2:8) in order 
to  liberate  the  free  amino  groups.  This  was  followed  by  extensive  washings  of the 
polymer  with  DCM  and  methanol,  in  order  to  remove  any  traces  of triethylamine. 
Gratifyingly,  the  use  of the  free  base  polymer  293  as  a  catalyst  resulted  in  a  100% 
conversion to product, determined by NMR analysis.
Aldolase 293 (2 mol %),  O  QH
H
N 0 2
216
acetone/water (9:1), r.t., 
18 h
116
Scheme 3.4.22 Aldol reaction catalysed by polymer 293.
The ability of the tertiary amine unit to mediate proton transfer is clearly a significant 
observation. It may be involved at several steps of the sequence, either as its free base or 
in its protonated form, to aid enamine formation or to deliver a proton to the initial aldol 
adduct.
3.4.6  Re-investigation of catalytic activity of polyallylamine catalyst 
240
In light of the results obtained with the tentagel based aldol catalysts, it was appropriate 
to revisit the polyallyamine based polymer 240, synthesised previously (Section 3.4.2). 
Polymer 240 was tested on our model system  (Scheme 3.4.23), under the conditions 
outlined in Table 3.4.7. From the Table, it can be seen that a mixture of acetone/water 
(entries 2  and 4)  was  shown to be the best solvent for the reaction.  In contrast to the 
tentagel based resin an increase in the water content of the reaction (Table 3.4.7, entry 
4) did not appear to have any adverse affect on conversion, possibly as a consequence of 
the better compatibility of polyallylamine with aqueous systems.
155n-m
NH NH
NH,+  CFXOO"
240
OH
216
Aldolase 240 (2 mol %) 
/V-methylmorpholine, r.t.,  18 h,
for solvent conditions, see 
Table 3.4.7
O  OH
116
Scheme 3.4.23 Aldol reaction catalysed by polyallylamine based polymer 240.
Entry Solvent Ratio of aldehyde to 
product3
Isolated yield 
(%)b
1. Acetone/ DMSO (1:4) No product observed -
2. Acetone/Water (4.5 : 0.5) 0:1 29
3. Acetone/DMSO/Water 
(1  : 3.5 : 0.5)
2:1 -
4. Acetone/Water (1  :  1) 0:1 -
Table 3.4.7 Reaction conditions attempted for the aldol reaction catalysed by polymer 240.a  
Molar ratio determined by NMR analysis of crude isolated material after 18 h. b Isolated yield of 
product after column chromatography.
3.4.7  Development of a Merrifield resin based aldol catalyst
As previously mentioned (Section 3.4.3.1) the dipeptide 242 (Figure 3.4.1) was shown
1  97
to catalyse aldol reactions by Li et al..  We therefore questioned whether the catalytic 
properties of this dipeptide would change if we attached it to a solid support. Since the 
dipeptide does not contain any functional groups which would provide a suitable link  to 
the resin, we decided to select the hydroxyproline version of the dipeptide (294, Figure 
3.4.1)  with  the  hydroxyl  group  of  294  providing  a  suitable  point  for  attachment. 
Merrifield resin was chosen as our polymer backbone, since it has a chloro group which
156can be easily displaced by a nucleophile. It should be noted that peptide 294 was also
investigated  by  Li  and  co-workers  in  their  aldol  studies  and  they  found  it  to  have
•   122 comparable catalytic properties to the proline derivative, peptide 242 (Figure 3.4.1).
QH2Ph  o   CH2Ph
N  COOH  HO""</N ^ ^ N >^COOH
u  —N   H
H  H
242  294
Figure 3.4.1 Aldol catalysts 242 and 294, used by Li and co-workers in their studies.
Before attachment to the resin, a suitably protected version of dipeptide 294 had to be 
synthesised  (Scheme  3.4.24).  Addition of Boc  anhydride  in the presence  of aqueous 
sodium  carbonate,  gave  compound  296  in  only  20%  yield.  Attempting  the  same 
reaction, over 2 days, did not improve the yield.
HO^  HO
Boc20 ,  10% aq. Na2C 0 3
.OH  -------------------------------------- ►   ,  OH
N  "TT  Dioxane/THF (10:1)  .N
O  r.t.,  17 h, 20%  0 = \   0
,0
295  — A   296
Scheme 3.4.24 Synthesis of Boc protected hydroxy proline 296.
In  order to  improve  the  yield,  the  reaction was  repeated  using NaOH  in THF/water, 
however the product was still isolated in a disappointing 20% yield.
One  of the  major problems  encountered  for the  Boc  protection was the  solubility of 
hydroxyproline. We felt that if the methyl ester was prepared, this would be much more 
soluble  and  would  allow  Boc  protection  to  proceed  more  easily.  Reaction  of 
hydroxyproline with thionyl chloride in methanol proceeded smoothly to generate ester 
297  in  80%  yield  (Scheme  3.4.25).  Subsequent  Boc  protection  gave  298  in  58% 
yield.128  Protection  of the  hydroxyl  group  with  tert-butyl  dimethyl  silyl  (TBDMS) 
chloride,129 followed by cleavage of the ester with sodium hydroxide130 gave the desired 
acid 300, which was suitable for peptide coupling.
157HO
1.  SOCI2, MeOH,  HO
0° to r.t, 1h  )  \  Boc20, Et3N
'0H        /   \   ,0Me M   V   / V   . U M B
H  fl  2. Reflux, 63 h, 80%  N  DCM, 0°C, 30 min,
O  H  II  then r.t., 17 h, 58%
295  297
H 0  TBDMSO
Aq. NaOH, MeOH OMe
o=<
298
OMe
0=<
299
H,0, 45°C, 1  h, 36%
TBDMSO
OH
300
Scheme 3.4.25 Synthesis of protected hydroxyproline 300.
The  next  step  was  to  couple  a  protected  version  of phenylalanine  to  the  protected 
hydroxyproline  unit 300.  A requirement  for the phenylalanine component was that it 
should  also  possess  a  UV  active  alcohol  attached  to  it,  since  this  would  allow  us 
eventually to measure the substitution of the dipeptide on the resin by simple cleavage 
of  the  alcohol  in  a  manner  similar  to  the  procedure  previously  used  for  Fmoc 
substitution  measurements  (see  Section  2.3.1).  We  felt  that  cinnamyl  alcohol  was  a 
suitable choice, since it has good UV absorption. Phenylalanine was therefore protected 
with  a  Boc  anhydride  to  form  302  (Scheme  3.4.26),  followed  by  the  coupling  of 
cinnamyl alcohol using DCC.  Some product was isolated in this case, however, it was 
very difficult to separate it from the urea by-product and hence alternative routes were 
explored.
158r
Ph
H2N  COOH
301
Boc20 ,  10% aq. Na2C 03, 
dioxane,  r.t.,  18 h, 90%
i  o  r Ph
—  r \  m
DCC, Et3N, DMAP, 
DCM/THF (1:1)
O  N  COOH  .  .  .  .  ,  '
H  cinnamyl alcohol, r.t.,  18 h
302
i   0   rP h
^ O ^ N - 1Y 0' - ^ Ph
o
303
Scheme 3.4.26 Synthesis of protected phenylalanine ester 303.
The use of EDCI,  was next considered,  since its urea by-product is  soluble in water. 
However,  in this reaction,  only a trace of product was recovered.  Ester formation via 
Mitsunobu  conditions  (PPI13,  DEAD)  gave  no  desired  product.1 3 1   Using  the  mixed 
anhydride method in the presence of ethyl chloroformate led to a mixture of the desired 
product  303  and  the  ethyl  ester  304  (Scheme  3.4.27).123  Unfortunately,  these  esters 
were inseparable by flash chromatography.
302
1. ethyl chloroformate, Et3N, THF, 
OH  -10°C, 40min.
2. cinnamyl alcohol, Et3N, THF, 
-10°C to r.t.,  18 h
i  o  r Ph
303
i   0   rP h
304
Scheme 3.4.27 Synthesis of protected phenylalanine ester 303.
The  final  attempt  was  to  couple  the  alcohol  via  in  situ  formation  of  the  N  - 
carboxyanhydride  305,  however  no  product  was  isolated  in  this  case  (Scheme 
3.4.28).132
159r
Triphosgene,
H2N  COOH  THF, 50°C, 3h
301
Ph
H2N
O
306
Ph
HN^.0
T
o
305
Cinnamyl alcohol
------------x ---------►
THF, 50°C,  17h
Scheme 3.4.28 Attempted synthesis of phenylalanine ester 306.
Alternatively, prior isolation of the A-carboxyanhydride (Scheme 3.4.29), followed by a 
subsequent  reaction  with  the  alcohol,  in  the  presence  of  either  sodium  hydride  or 
triethylamine as a base also failed to yield the desired product (Scheme 3.4.29).
r -—ph  ^   /P
I  Triphosgene,  y — ( /
H2N  COOH  THF, 50°C, 3h  H N ^^O  
301  O  305
1 •  NaH- THF- 0 °C to r.t.,  1  h 
HO  Ph  ---------
r—Ph
—x---------------- ►  H2N "^ Y ^ °'V ^ ^ ::/Ph
, 0 °C to r.t.,  18 h  2  II 307  2. 305, THF, v,    ^  3Q6
HO— ^ P h   1 : Et3N’TH%0 : C.!O -.rt -.1. l  H  N
307  2.305, THF, r.t., 72 h  2  H   m
Scheme 3.4.29 Attempted synthesis of phenylalanine ester 306.
Due to the surprising lack of success in preparing the cinnamyl ester of phenylalanine, 
we decided to use the methyl ester as the protecting group instead, even though in this 
case we would not be  able to  estimate  the  substitution of dipeptide  on the resin.  An 
estimate of the approximate amount of dipeptide once it is attached to Merrifield resin 
was  therefore  used.  Coupling  of commercially  available  phenylalanine  methyl  ester 
hydrochloride with protected proline 300, using EDCI, gave the dipeptide 309 (Scheme
1603.4.30).  Deprotection of the silyl protecting group with tetrabutyl ammonium fluoride 
(TBAF) yielded dipeptide 310, together with an ammonium impurity, which could not 
be separated from 309.
TBDMSO
.Ph
OH
o=<
300
+   hci.h2n
O  EDCI,  HOBt,
O  DCM/H20  (1:1),
0 °C to r.t., 44 h, 55%
308
TBDMSO  HO
XX  TBAF, THF,  0  °C,  1  h  I XjL X
‘N'  " If  OMe    ►   OMe
0 = <   o   i  then r.t.,  2  h  o = <   q   L
.0   Ph  O  Ph
309  —yC  310
Scheme 3.4.30 Attempted synthesis of protected phenylalanine ester 310.
Nonetheless, attachment of crude dipeptide 310 to Merrifield resin was attempted, using 
caesium  carbonate  (Scheme 3.4.31),  followed by the hydrolysis of the ester moieties 
with  lithium  hydroxide.133  At this point,  the Malachite  green test  for the presence of 
carboxylic  acids  gave a negative result.  This indicated either that the peptide had not 
coupled to the resin or that the hydrolysis step was not successful. Nevertheless, a small 
amount of the resin was carried through to the next step, which involved cleavage of the 
Boc groups using TFA/DCM solution to give 312. The chloranil test for the presence of 
secondary amines indicated that proline was not coupled to the resin. This suggests that 
the initial attachment of hydroxyproline to the resin was unsuccessful. Nonetheless, we 
attempted  to  use  the  resin 312  as  a catalyst  in  our model  aldol reaction,  in case the 
qualitative  tests  were  giving us  false  negative  results.  Resin 312  did not  exhibit any 
catalytic activity, thereby further implying that the peptide was not coupled in the first 
place.
161HO
O
O
,N  Merrifield resin, aq.  Cs2C 03,
N  7T  ' T   OMe  ----------------------x-
°= <   O  ^
O  Ph
water, dioxane, r.t., 5 min o=<
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N OMe
O
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O  Ph
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1.  LiOH,  MeOH/Water, reflux, 66 h
------------------ X --------------------- !
2. TFA/DCM, r.t., 6 h
O
312
O
OH
'Ph
Scheme 3.4.31  Attempted synthesis of polymer catalyst 312.
3.4.8  Designing an aldol catalyst with improved selectivity
Even at this most simplistic first generation level, we have observed some encouraging 
results  using  the  tentagel  based  aldolase  238,  with  selectivities  comparable  to  those 
previously  reported.122  Accordingly,  we  were  interested  in  developing  this  catalyst 
further, especially in terms of its stereoselectivity.  In order to achieve this, the inclusion 
of both a chiral recognition group in conjunction with the catalytic proline group on the 
polymer backbone would be desirable (Figure 3.4.2).
I   = Chiral  O   = Catalytic
binding group  group
for aldol transition 
state
Figure 3.4.2 Representation of aldol catalyst with incorporated chiral binding group.
162In  order to  find  the  most  appropriate binding  group,  we therefore  adapted the NMR 
protocol  developed  within  our  own  group96  for  determining  the  binding  energies  of 
suitable transition state analogues for the aldol reaction.
3.4.8.1  Development of transition state analogues
In terms  of preparing a suitable transition state  analogue, we were influenced by the 
work of Lemer et a/.134 who had used the /3-diketo-sulfone 313 (Figure 3.4.3) as their 
transition state analogue for generation of a library of catalytic aldolase antibodies. The 
tetrahedral geometry of sulfone moiety in 313 was considered to mimic the tetrahedral 
transition state in the carbon-carbon bond forming step of the aldol reaction.
Figure 3.4.3 /3-diketo-sulfone TSA.
More recently however, Domingo and co-workers conducted a number of comparative 
computational  studies  between  the  /3-ketosulfoxide  314  (Figure  3.4.4)  and  the  /3- 
diketosulfone  313  (Figure  3.4.3).135  They concluded  that  the  pyramidal  arrangement 
around the  chiral  sulfur atom  of the /3-ketosulfoxide  314 would  act  as a much better 
mimic of a product like tetrahedral transition state for the aldol reaction. Bearing this in 
mind, we decided that one of our potential TSAs would be a /3-ketosulfoxide such as 
314 (Figure 3.4.4).  This has the advantage of being chiral and hence should facilitate 
enantioselectivity, once an appropriate binding group has been found. We also decided 
to  synthesise  a  second  TSA  315  (Figure  3.4.4).  In this  instance,  we hoped  that the 
presence of the E olefin bond would enable better control of the enamine geometry. The 
carbons in the transition state of the aldol reaction are sp  hybridised,  and this planar 
TSA may be more representative of the aldol transition state.
163Transition State
Figure 3.4.4 Sulfoxide TSAs (314 and 315) and representation of the aldol transition
state.
3.4.8.2  Synthesis of sulfoxide transition state analogues
The transition state analogues we aimed to prepare are shown in Figure 3.4.5. Although 
our  aldehyde  substrates  had  different  substituents  attached  to  the  benzene  ring,  our 
decision  to  use  the /?< 2ra-toluene  sulfoxide  TSA  was  due  to  the  fact  that  they  are 
available using established methodology by Solladie.136;137
316  317
Figure 3.4.5 Target sulfoxide transition state analogues.
Starting from /7-toluene sulfinic acid, chirality was introduced into the molecule using 
menthol  to  give  319  in  a  modest  conversion  of 31%  (Scheme  3.4.32).  Addition  of 
dimethylmethanephosphonate  led  to  inversion  of configuration  to  afford  320  in  situ, 
followed by a Wittig reaction to obtain the desired a, /3-unsaturated sulfoxide 317 as the
138 trans isomer.
164o  Na
2. (-)Menthol,  pyridine, 
ether, 0 °C to r.t., 3 h, 
31%
1. SOCI2, benzene, 
0 °C to r.t.,  1  h
THF, 0 °C, 4 h, 27%
CH3Mgl,  Et20 ,
0
318 319 321
Dimethyl
methanephosphonate, "BuLi, 
THF, -78°C to -20 °C,  1  h
1. LDA, THF,
-78 °C to 0 °C,  1  h
2.  EtOAc, 0 °C, 4 h, 
33%
O   O =  +   I I  
S .  .P .
316
1.  nBuLi, THF, -78°C, 2 h
2.  Acetaldehyde, THF, 
-78 °C to r.t., 3 h,  14%
9
j y
317
Scheme 3.4.32 Synthesis of sulfoxide TSAs 316 and 317.
The second route to the formation of the /3-ketosulfoxide 316 involved treatment of 319 
with methyl magnesium iodide to give 321 in 27% yield. Compound 321 was converted 
to the /3-ketosulfoxide 316 using lithium diisopropylamine (LDA) and ethyl acetate in 
33% yield.
3.4.8.3  Selecting a binding group for the transition state analogues
With the sulfoxide (316 and 317) TSAs in hand, we next turned our attention towards 
the  selection  of appropriate binding  groups.  A review  of the  literature  indicated that 
carboxylic  acids  and  hydroxyl  groups  have  favourable  binding  interactions  with 
sulfoxides.139'141  This influenced us to select a small set of amino acid based potential 
binders, that contained a carboxylic acid functionality and were also chiral. We focused 
on the binding of the carboxylic acid moiety to the sulfoxides and therefore we had to 
cap the amino group. A number of Boc protected amino acids were selected as potential 
binders and these are shown in Table 3.4.8. Tryptophan and phenylalanine were chosen 
on the basis that they contained aromatic rings, which we were hoping would favour 7 r - 
7 r stacking with the  aromatic  ring of the  sulfoxides,  in addition to the binding of the 
sulfoxide  moiety with  the  carboxylic  acid.  Cysteine  and  serine  were  selected  on the
165basis  of their  hydroxyl  and  thiol  group  side  chains  which  could  potentially  act  as 
hydrogen bond donors.  Finally,  alanine was chosen as a control, since it is devoid of 
further functionality, allowing the potential binding contribution of the carboxylic acid 
group to binding to be estimated.
The  PFG  NMR  binding  studies  were  conducted  using  the  previously  established 
protocol.91,96  The  studies  were  performed  in  chloroform  solution  with  a  3  mM 
concentration of Boc protected  amino  acid and a 30 mM  concentration of TSA.  The 
results are presented in Table 3.4.8, which shows the change in diffusion coefficient as 
a percentage value.
Entry Amino
Acid
D
(x 10'10 
m2/s)
D’(xlO'10
m2/s)
Rd
with
TSA
316
(%)
D”
(x 10'10 
m2/s)
Rd with 
TSA 317 
(%)
1 BocSerOH 11.69 9.51 19 9.06 22
2 BocCysOH 11.85 10.42 12 9.56 22
3 BocAlaOH 12.02 11.43 5 11.10 8
4 BocPheOH 10.01 9.85 2 9.98 0
5 BocTrpOH 8.27 8.09 2 Not
determined
Not
determined
Table 3.4.8 Results of NMR binding studies between Boc protected amino acids and sulfoxide 
TSAs 316  and 317.  D  is the diffusion coefficient for 3  mM  solution of Boc amino acid in 
CDC13. D’ is the diffusion coefficient for mixtures containing Boc amino acid (3 mM) and TSA 
316 (30 mM). D” is the diffusion coefficient for mixtures containing Boc amino acid (3 mM) 
and  TSA  317  (30  mM).  R <i  is  the  relative  change  in  diffusion  coefficient (100(D-D’)/D  or 
100(D-D”)/D).
Serine and cysteine exhibited the most favourable binding towards both TSAs (biggest 
change  in  diffusion  coefficient).  Alanine  demonstrated  modest binding,  however the 
aromatic  amino  acids phenylalanine  and tryptophan had poor interactions with either 
sulfoxide  TSA,  possibly due to  unfavourable  steric  constraints.  Following the results 
outlined  above,  we  decided  to  incorporate  serine  within  our polymeric  system  as  it 
demonstrated the best binding. Serine was chosen instead of cysteine due to the fact that 
cysteine can potentially form unfavourable disulfide bonds.
1663.4.8.4  Synthesis of aldol catalyst containing a serine binding group
It was decided that the serine residue should be attached to the polymer via a suitable 
spacer. A polymeric system based upon tentagel resin was again used, to enable a more 
accurate comparison with catalyst 238. Preparation of the spacer unit involved reacting 
TBDMS protected serine methyl ester142 with glutaric  anhydride to  afford the desired 
serine unit 323 in 73% yield (Scheme 3.4.33).
The  serine  derivative  323  was  incorporated onto  the tentagel resin,  together with the 
catalytic  proline  unit  (Scheme  3.4.34).  Following  previously  established  procedures, 
Boc protected and Fmoc protected glycine were attached to tentagel to give 234. Boc 
deprotection,  followed by attachment of the serine derivative 323 gave resin 324. The 
proline  catalytic  unit  was  incorporated  by  Fmoc  deprotection  of 324,  followed  by 
treatment with Boc protected proline. Deprotection of both the Boc and TBDMS groups 
was  achieved using TFA/DCM.143  It was  anticipated that the  serine methyl  ester 325 
could  moderate  the  aldol  reaction,  therefore  a  quantity  was  retained  for  testing. 
Hydrolysis of 325 with sodium hydroxide gave aldolase catalyst 326.
322
Glutaric anhydride,
Et3N, DCM, reflux, 
18 h, 73%
OH
Scheme 3.4.33 Synthesis of serine derivative 323.
167FmocGlyOH (5 eqv.), 
BocGlyOH (5 eqv.),
HOBt, DIC, DMF, 23 h
193
Subst. of amines 
= 0.4 mmol/g
NH  NH I   I
Gly  Gly
Fmoc  Boc
234
1. TFA/DCM, r.t., 24 h
2. 323, HOBt, DIC, DMF, 
r.t., 2 days
Fmoc subst. = 0.23 mmol/g
NH I
Gly
Fmoc
324
MeO,C
HN
J^^OTBDMS
1. Piperidine/DMF (2:8), r.t., 18 h
2. BocProOH, HOBt, DIC 
DMF, r.t., 20 h
3. TFA/DCM, r.t., 5 h
NH NH
Aq. NaOH (1  M)/Dioxane (1:3),
0°C, 1 h NH HN
O :
NH
325 HN
OH
NH  NH I   I
<fiy  G iy
NH  HN
O
NH
326 HN
OH
HO,C
Approx. ratio of 
proline:serine = 1.4:1
Scheme 3.4.34 Synthesis of aldolase catalyst 326 with incorporated serine binding group.
3.4.8.5  Activity of aldol catalyst 326 containing serine binding group
The  serine  based  polymer  326  was  examined  for  activity  on  three  previously tested 
aldehydes.  Additionally,  the  activity of the  serine methyl  ester catalyst 325  was  also 
investigated.  This  was  conducted  in  order  to  assess  the  contribution  of  the  free 
carboxylic acid on selectivity and yield of conversion. The results are shown in Table 
3.4.9,  together with  the  results  of the  original  polymer 238  (see  Section  3.4.4.3)  for 
comparison purposes.
The first reaction to be investigated was the model reaction, with 4-nitrobenzaldehyde 
(Table 3.4.9, entry  1).  In this case, both the methyl ester 325 and the acid 326 had no 
effect  on  either  the  conversion  or the  enantiomeric  excess.  The  second  aldehyde,  4- 
carboxymethyl  benzaldehyde  (Table  3.4.9,  entry  2),  for  which  polymer  238  had 
previously displayed no enantioselection, also yielded racemic product with the methyl 
ester 325. In sharp contrast however, use of the acid 326, led to a preference for the R-
168enantiomer  (ee  =  33%).  The  aldol  reaction  with  4-chlorobenzaldehyde  proceeded  in 
moderate yield and gave an almost identical stereo-selectivity for both polymer 238 and 
serine methyl ester polymer 325 (Table 3.4.9, entry 3).  Interestingly, the acid catalyst 
326, displayed a preference for the opposite enantiomer. It is difficult to speculate as to 
why different steroselectivities were observed, and additional substrates would need to 
be  studied  in  order  to  give  us  more  insight  into  the  behaviour  of the  catalyst.  The 
differences between the catalysts containing the serine methyl ester unit (325) and the 
acid (326) (Table 3.4.9, entries 2 and 3), suggest that hydrogen bonding may play some 
role  in  altering the  selectivity of the catalyst.  In this  case,  the presence  of particular 
groups  on  the  benzene  ring  of the  substrate  aldehyde,  such  as  the  hydrogen  bond 
acceptor in entry 2, may lead to a particularly favourable interaction with serine,  and 
hence favour attack from proline from one side more than the other. Alternatively, the 
interactions of the substrates with the polymer may also be dependent on the size and 
shape of the substrate and this may affect how the substrate fits into the cavities of the 
polymer, once again leading to different selectivities.
169Aldolase 238, 325 or 326 (2 mol %),  V ?  9 H 
/V-methylmorpholine,
acetone/water (9:1), r.t., 18 h  (I
R = 116 N0 2  
26lC02Me 
2 2 0  Cl
Entry Aldehyde Favoured 
product with 
catalyst 238
Favoured 
product with 
catalyst 325
Favoured 
product with 
catalyst 326
1. £ T
216
? H   ft
0 2n^ ^   U 6
ee =  48% 
Yield = 30%
OH  O
02N
ee = 48% 
Yield = 28%
OH  O
ee = 48% 
Yield = 33%
2.
O  260
0   261
ee =  0% 
Yield = 30%
OH  O
0  261
ee =  0% 
Yield =  31%
OH  O
O
ee =  33% 
Yield =   16%
3. x r
219
9H   9 
2 2 0
ee =   19% 
Yield =  30%
9H   9 
2 2 0
ee =  22% 
Yield =  23%
OH  O 
2 2 0
ee =  8% 
Yield =  21%
Table 3.4.9 Selectivity of the aldol catalyst 238, 325 and 326.
Finally,  we  attempted  to  use  aldolase  326  containing  the  serine  moiety  to  examine 
whether  we  can  encourage  one  of  the  previously  unsuccessful  aldol  reactions  to 
proceed. However, aldehyde 252 (Scheme 3.4.35) was once again unreactive.
170o Aldolase 326 (2 mol %) 
/V-methylmorpholine, r.t.,  18 h,
H --------------------x-------
Acetone/water (9:1)
O  OH
252 253
Scheme 3.4.35 Attempted aldol reaction using aldol catalyst 326.
3.5  Exploring artificial aldolases through supramolecular assembly
3.5.1  Introduction
The approach thus far described towards the construction of artificial enzymes is based 
on  the  facts  that  an  enzyme  can  be  considered  to  possess  a  binding  region,  a 
catalytically active  functional  group  and the  flexibility to  achieve  stereoelectronically 
favoured reaction pathways for attack on the bound substrate by the catalytic group. As 
we  have  seen,  this  strategy  has  provided  evidence  for  the  cooperativity  between  a 
binding site selected to recognise a designed transition state mimic and a catalytically 
active  group  in  a  flexible  environment.  However,  as  discussed  in  Section  2.9,  each 
polymeric  thread  that  has  been  produced  by  a  random  attachment  of catalytic  and 
binding  groups  forms  a  distinct  molecular  entity  and  this  aspect  is  inherently 
undesirable.  In  order  to  address  this  problem,  and  in  tandem  with  our  studies  on 
artificial  aldolases we therefore conducted some very preliminary studies towards the 
formation  of  molecular  assemblies,  which  could  hopefully  generate  more  defined 
molecular structures.
Our plan was to explore simple systems, based on triple hydrogen bond interactions as 
illustrated  in  Figure  3.5.1.  This  strategy  involved  the  synthesis  of  complementary 
monomer units,  which combine,  to  form  a polymer consisting of a hydrogen bonded 
network, which should possess a more uniform structure. This approach should enable a 
rapid variation of the binding site and/or catalytic group if required.
171= monomer unit containing the receptor site
R1
= monmer unit containing a catalytically active group
R2
::::::  = hydrogen bonded network
Figure 3.5.1 Representation of hydrogen bonded monomer units.
Recently,  significant  advances  have  been  made  in  the  formation  of supramolecular 
polymers  via  complementary  hydrogen  bonding  networks  of  two  different 
monomers.144 147  These  systems  have  been  explored  extensively  by  Lehn  and  some 
examples are illustrated in Figure 3.5.2.146;147
R1
O
329
Figure 3.5.2 Hydrogen bonded dimers.
Initially,  we  wished  to  investigate  a  basic  system  consisting  of a  dimeric  unit  332, 
comprising of a 2,6-diaminopyridine 330  and  a functionalised uracil counterpart 331.
172These  units  can  form  a  triple  hydrogen  bonded  interaction  (Figure  3.5.3).  Systems 
containing  derivatives  of  diaminopyridine  and  uracil  have  been  explored  in  the
1  48
literature.  Our desire was to attach both catalytic and binding groups to the monomers 
and generate a supramolecular catalyst designed specifically for the aldol reaction.
Figure 3.5.3 Target dimer unit.
Hence, one monomer would have proline attached, whilst the other would contain the 
carboxylic  acid  (Figure  3.5.4).  Although  we  have  previously  established  that  the 
presence of a carboxylic acid was not necessary for the aldol reaction catalysed by our 
own  polymeric  system  (Section  3.4.5),  we  decided  to  incorporate  one  within  this 
system, due to the fact that the primary literature indicated its importance.115; 126
Figure 3.5.4 Target dimer unit consisting of proline catalytic group and carboxylic acid proton 
donor.
3.5.2  Synthesis of monomer units
The  synthesis  of the  diaminopyridine  unit  333,  generated  from  2,6-diaminopyridine, 
using Boc protected proline, in the presence of DCC (Scheme 3.5.1) gave 337 in 38%
173yield. Deprotection was achieved using TFA/DCM mixture, and the desired product 333 
isolated in 64% yield.
BocProOH,  DCC
H2N  N  nh 2 
336
TFA/DCM (1:1), 
r.t.,  6  h, 64%
V  fl  o  °Y°
N  J l ,   Y   A   N
DMF, r.t., 3 days, 38%  (   |j  N  N
337
CF3COOH
H   ft 
O   H   N   B
CFXOOH
333
Scheme 3.5.1 Synthesis of diaminopyridine derivative 333.
Our attention then  focused upon preparation of the uracil monomer 334.  Reaction of 
uracil  with  glutaric  anhydride  was  initially  attempted  using  DMAP  in  chloroform 
(Scheme  3.5.2).  However,  after  heating  for  17  h,  no  product  was  observed.  The 
coupling was repeated using a mixture of acetonitrile/pyridine to help aid solubilisation 
of uracil,  but  no  acylated  derivatives  were  isolated.  Uracil  was  hence  dissolved  in 
DMSO and then treated with glutaric  anhydride at 50 °C  for  17 h, but once again no 
product formation was observed.
HN'
O ^N -
H
338
Glutaric anhydride
-----------x--------------
solvent
Scheme 3.5.2 Attempted synthesis of uracil derivative 334.
Attempts  to  introduce  pentadioic  acid  were  therefore  put  on  hold  and  our  attention 
turned to incorporation of acetic  acid.  Following previously established methodology, 
uracil  was  alkylated  with  chloroacatic  acid  to  afford  339  in  67%  yield  (Scheme
1743.5.3).149 Since our aim was to include any carboxylic acid within our system, we did 
not feel that this slight modification would significantly impact on our design rational 
(Figure 3.5.4).
O  O
HN'^ij  Chloroacetic acid, KOH,  HN'
water, reflux, 2.5 h, 67%  O ^ ^ N '
a   ‘
338  |  339
OH
Scheme 3.5.3 Synthesis of uracil derivative 339.
Before starting investigations into whether the two monomer units are able to  form a 
dimer by hydrogen bonding, we first wished to assess whether the prolinylpyridine 333 
could act as a catalyst for the aldol reaction. Indeed, we found that using 20 mol% of the 
diaminopyridine derivative 333  gave the  aldol product  116 with  100% conversion by 
NMR  analysis.  The  behaviour  of the  prolinyl  pyridine  derivative  333  as  an  organic 
catalyst is certainly a useful observation and worthy of further study in its own right.
216
333 (20 mol %), 
/V-methylmorpholine,
O  OH
Acetone/Water (9:1), r.t.,  18 h
116
Scheme 3.5.4 Aldol reaction using diaminopyridine derivative 333 as a catalyst.
The next step was to investigate if the two monomers could form a hydrogen bonded 
complex (Figure 3.5.5). Our intention was to study the formation of the dimer by NMR 
spectroscopy. Hydrogen bonding is ideally studied in chloroform solution,150 however, 
the  diaminopyridine  derivative  333  was  only  soluble  in  methanol  whereas the uracil 
derivative 339 was soluble in DMSO. This precluded us from studying this further, due 
to the insolubility of both monomer units in a chloroform solution.
175339
333
Figure 3.5.5 Example of a possible hydrogen bonded complex between 333 and 339.
In an attempt to make both units more soluble in chloroform, we wanted to attach them 
to  long  alkyl  chains.  Starting  from  2,6-diaminopyridine,  lauryl  chloride  was 
successfully coupled using triethylamine in THF (Scheme 3.5.5).1 5 1
H„N  N  NH
■21  ’     2
336
CH3(CH2)1 0COCI,
Et3N, THF, 0 °C to 
r.t., 24 h, 43%
340
O   H  "
341
h  ft  r '  n  o
( 7   h  'N'  'H
342
Scheme 3.5.5 Towards the synthesis of diaminopyridine derivative 342.
Attachment of Boc proline and removal of the Boc protecting group could have been 
attempted to give the diaminopyridine derivative 342, however, due to time constraints, 
the synthesis was not carried out.
In the case of the other monomer, we decided to utilise orotic acid 344 as an alternative 
to uracil,  since it contained a suitable point of attachment for other functional groups.
176Orotic acid 344 was attached to the methyl ester of caproic acid 343 to give 345 in a low 
yield of 8% (Scheme 3.5.6).152 However, once again time constraints prevented further 
work.  It  should  be  noted  however,  that  345  was  not  soluble  in  chloroform,  which 
suggests  that  attachment  of these  particular  alkyl  chains  would  not necessarily have 
aided solubility of 346 or 342 in chloroform in this instance.
Thionyl chloride, MeOH, 
0 °C to r.t., 3.5. h, 63%
140 343
HN
OH
344
345, N-methyl morpholine,  EEDQ,
DMF, 55 °C,  18 h, 8%
345
HN
H
N
OH
O
346
Scheme 3.5.6 Towards the synthesis of orotic acid derivative 346.
3.6  Conclusions and Perspectives from the aldolase studies
Several  aldol  reactions  have  been  successfully  performed  using  tentagel  resin 
containing  proline  and  carboxylic  acid,  notably  with  polymer  238.  The  activity 
demonstrated  by  polymer  286  implied  that  within  our  system,  the  presence  of  a 
carboxylic  acid  is  not  necessary  for  the  reaction  to  proceed,  under  the  specified 
conditions.  Aromatic  aldehydes  that  contain  an  electron withdrawing  group  were the 
substrates  that  were  most  likely  to  undergo  an  aldol  reaction.  Some  selectivity was 
observed  and  we  have  demonstrated  that  by  introducing  a  chiral  binding  group,  the 
selectivity  of the  catalyst  can  be  altered,  although  this  was  shown  to  be  substrate 
dependent. We have also demonstrated that other polymers such as polyallylamine can 
also  be  successfully  employed  in  our  catalytic  system.  The  advantages  of using  a 
polymer as a catalyst are that it can readily be removed at the end of reaction and that 
one can effortlessly incorporate any binding group into the polymer in order to modify
177the selectivity of the catalyst. However, the disadvantage is the fact that isolated yields 
are low, possibly due to a lot of product remaining on the polymer after the reaction.
There are still a number of things that could be done with aldolases.  More substrates 
could  be  studied,  especially,  aliphatic  ones.  A  larger  range  of substrates  should  be 
studied with the aldolase containing serine, to obtain a better picture of its  selectivity 
capabilities.  Other binding groups could also be incorporated and alternative catalytic 
groups,  such  as  various  proline  derivatives  can  be  studied.  The  behaviour  of  the 
aldolases should be monitored as product formation against time as well as at different 
substrate  concentrations  to  establish  the  kinetic  behaviour  of the  aldolase  catalysts. 
Other varieties of polymers should also be incorporated to see how the selectivity and 
kinetic behaviour of these may vary.
Although, we were not faced with problems of reproducibility with the aldolase system, 
possibly due to slightly more controlled attachment of functional groups to the resin, as 
discussed in the esterase section, synthesising artificial enzymes with a more precisely 
located  binding  and  catalytic  groups  on  a  more  defined  polymeric  strand  would be 
desirable.  Hence,  the work  initiated on  supramolecular chemistry should be explored 
further. As demonstrated by our preliminary results, the diaminopyridine derivative 333 
containing proline,  has  the  ability to  catalyse the  aldol  reaction.  Once,  the  solubility 
problems of both diaminopyridine and uracil derivatives are resolved, the self assembly 
of the two monomer units, could provide us with a more efficient aldolase catalyst as 
well as initiating an interesting study to see whether extensive polymeric structures are 
really  required  for  catalytic  activity.  In  general,  the  synthesis  of artificial  enzymes 
through self-assembly, could incorporate all the essential features of our earlier models 
and as well as being more elegant, it provides potential for more rapid variation of both 
the catalytic  and binding group.  Through this  systematic variation, one can hope that 
this  approach  might  provide  us  with  a  better  understanding  of cooperativity  effects 
between functional groups which are found in natural enzymes, as well as the synthesis 
of catalysts for a wide range of chemical transformations.
1783.7 Final Remarks
The  foregoing  study has  hopefully  indicated  that  the  simplistic  concept  of attaching 
different  functionalised  threads  to  a  polymer  backbone  provides  a  simple  and 
experimentally convenient method for exploring cooperativity and hence for generating 
catalysts  which  can  be  considered  to  function,  at  least  to  some  degree,  as  artificial 
enzymes.  The contribution of the PFG NMR method using transition state mimics to 
estimate  selective  binding  efficiencies  in  “receptor  sites”  and  the  knowledge  of 
commonly used catalytically active functional groups employed in enzymes can serve 
as the basis for the selection of two differing threads as in the esterase studies. By way 
of contrast, the aldol reaction, requiring both transition state recognition and controlled 
proton movement is a much more complex reaction and in this respect our studies using 
the most  favourable  electron  deficient  aldehydes  as the carbonyl  component must be 
regarded as a prelude to more advanced systems. The reversal of selectivity observed on 
the introduction of the binding unit using one enantiomer of the chiral sulfoxide serves 
to emphasise the subtlety of the overall process. As we have demonstrated throughout, 
the nature of the polymeric backbone is of course of crucial relevance in these studies, 
particularly in terms of solvents used.
In terms of future perspectives, a great body of work remains to be done, especially in 
terms of developing a general method which will ensure that each polymeric thread is 
identical.  In this respect, the very preliminary results on the attempted construction of 
supramolecular threads (or even dimeric assemblies) may provide a way forward.
179CHAPTER 4 
EXPERIMENTAL
1804.1  General Experimental
All chemicals were purchased from  Sigma Aldrich,  Avocado,  Lancaster, BDH, Nova 
Biochem  and Bachem  and unless  stated these were used without  further purification 
unless otherwise stated.
!H NMR spectra were recorded at 300 MHz on a Bruker AMX300 spectrometer, 400 
MHz on a Bruker AMX400  specrometer,  or 500 MHz on a Bruker Avance DRX500 
spectrometer. The chemical shift (8 ) of each peak is given relative to tetramethylsilane 
(TMS),  where  8   TMS  =  0  ppm.  Chemical  shifts  are  quoted  using  following 
abbreviations:  s,  singlet;  d,  doublet;  t,  triplet;  q,  quartet;  dd,  doublet of doublets;  m, 
multiplet; br, broad.
13C NMR spectra were recorded at 75  MHz on a Bruker AMX300 spectrometer,  100 
MHz on  a Bruker AMX400  specrometer,  or  125  MHz on a Bruker Avance DRX500 
spectrometer.  The  chemical  shift  (8)  of each  peak  is  given  relative  to  the  residual 
solvent  peak.  Solid  state  13C  NMR  spectra  were  recorded  at  75  MHz  on  a  Bruker 
MSL300 spectrometer.
IR spectra were  obtained  from  a Shimadzu FTIR-8700 machine.  Absorption maxima 
are  reported  in wavenumbers  (cm'1 ),  using the  following  abbreviations:  w, weak;  m, 
medium;  s,  strong;  br, broad.  Only selected  absorbencies  are reported.  Solid state IR 
was  performed  using  Perkin  Elmer  Spectrum  One  machine.  UV-vis  spectra  were 
recorded using Shamadzu UV-2401PC spectrophotometer.
Mass spectra were obtained using VG ZAB SE instrument.
Melting points were measured on a Reichert Hotstage apparatus,  for all solids, where 
possible and are quoted to the nearest °C and are uncorrected.
Optical rotations were recorded using a POLAAR2000 photo polarimeter.
Analytical HPLC was carried out on Perkin Elmer Series 2000 lc pump, using Gilson 
231  XL  sampling  injector,  Gilson 401  C  dilutor and Waters  486  tunable  absorbance 
detector.  The  column used was  Waters  Symmetry Ci8 5pm reverse phase  (3.9 x  150
181mm).  Enantiomeric  excess  determination was  carried  out  using  a HPLC  with Perkin 
Elmer Series 2000 lc pump, Gilson 231  XL sampling injector, Gilson 402 dilutor and 
Waters  486  tunable  absorbance  detector.  The  columns  used  were  Chiralcel  OD, 
Chiralpak AD  or Chiralcel OB  (Daicel Chemical Industries).  All the HPLC  data was 
monitored using Atlas Lab Systems 2000 software.
Scanning electron micrographs were obtained using a Hitachi s-570 machine.
Analytical thin layer chromatography (t.l.c.) was carried out on pre-coated, aluminium 
backed (Merck 60  F254  silica) plates.  T.l.c.  visualising systems used were ultraviolet 
light (254 nm), potassium permanganate solution  {KMn0 4  (1.25  g) and Na2C0 3  (6.25 
g)  in  water  (250  ml)},  acidic  vanillin  {vanillin  (15  g)  and  conc.  H2SO4  (2.5  ml)  in 
ethanol (250 ml)}, acidic anisaldehyde solution  {anisaldehyde (15 g) and conc. H2SO4 
(2.5  ml)  in ethanol  (250 ml)}, or bromocresol green solution  (bromocresol green (40 
mg) and NaOH solution (0.1 M) in ethanol (100 ml)}.
The qualitative tests133 used to test the presence of certain functional groups on resins 
are:
Kaiser test  {ninhydrin (5 g), phenol (80 g) and aqueous KCN solution (0.001  M, 2 ml) 
in ethanol ( 1 2 0  ml)} -  the resin beads turn blue in the presence of primary amines. 
Chloranil test  {p-chloranil (2 g) in DMF (100 ml) and acetaldehyde (2 g) in DMF (100 
ml}- the resin beads turn blue/green in the presence of secondary amines.
Malachite green test  {malachite green oxalate (0.25 g) in ethanol (100 ml)} -  the resin 
beads turn green in the presence of carboxylic acid groups.
Anhydrous  tetrahydrofuran  was  distilled  from  sodium  and  benzophenone  under 
nitrogen.  Anhydrous  dichloromethane  was  distilled  from  calcium  hydride  under 
nitrogen.  Anhydrous  methanol was distilled from  a solution of methanol,  magnesium 
turnings and iodine. Triethylamine and diisopropylamine were refluxed with potassium 
hydroxide,  distilled  and  stored  over  potassium  hydroxide  pellets  under  nitrogen. 
Dimethylformamide  was  dried with MgSCU  and then distilled  and  stored over Linde 
Type  4 A molecular  sieves  under nitrogen.  Brine refers to  saturated  sodium chloride 
solution.
182The term in vacuo refers to the removal of solvents by means of evaporation at reduced 
pressure, provided by a water or air pump, using a Btichi rotary evaporator.
For all air and moisture sensitive reactions, glassware was dried at  120 °C and cooled 
under a flow of nitrogen.
The following assignement system will be used for mono substituted benzene rings:
0 \ ^ P
m
where o denotes ortho, m denotes meta and p denotes para.
1834.2 Artificial Esterases
4.2.1  Synthesis of Ester Substrates
(4-Trifluoroacetylamido phenyl)-acetic acid (171)153
4-Aminophenylacetic acid (3.00 g, 20.0 mmol) was dissolved in acetonitrile (30 ml) and 
water (3.0 ml) and cooled to 0 °C.  Sodium carbonate (4.21  g, 40.0 mmol) was added, 
followed by dropwise addition of trifluoroacetic anhydride (8.42 ml, 60.0 mmol). The 
reaction was allowed to warm to room temperature and stirred vigorously for 1   h. The 
volatiles were removed in vacuo and the resulting residue was partitioned between ethyl 
acetate  (30  ml)  and  water  (30  ml).  The pH  of the  solution  was  adjusted to  2  using 
concentrated aqueous HC1 solution and the layers were separated.  The organic extract 
was washed with aqueous HC1  ( 2 M,  2 x 20 ml), brine (20 ml), dried over MgSC>4 and 
the mixture concentrated until a brown precipitate appeared. The solid was collected by 
filtration to  afford the product as a brown solid (2.41  g,  49%).  m.p.  200 °C (lit.  175 
°C153);  Rf = 0.65  (Si02;  ethyl  acetate)  'H NMR (300 MHz,  CD3OD) 5H /ppm 3.56 (s, 
2H, AXCH2CO2H), 7.26 (d, J = 8.5, 2H, H(3) and H(5)), 7.55 (d, J = 8.5, 2H, H(2) and 
H(6 )); 13C NMR (75 MHz, CD3OD) 5c/ppm 41.7 (ArCH2C0 2H),  117.9 (q, Jcf = 285.9, 
CF3-),  122.7 (C(2) and C(6 )),  131.5 (C(3) and C(5)),  134.2 and  136.8 (C(l) and C(4)),
157.0  (q, CF3C(0)NH-),  175.8 (-C02H); W F NMR (282 MHz, CD3OD) Sf/ppm  -77.4 
(CF3-); vm,%  (nujol/cm'1) 1377 (s, C-F), 1703 (m, C=0), 2924 (s, C-H), 3250 (w, N-H); 
m/z (FAB) 248 (75%, [M + H]+).
184(4-Trifluoroacetylaminophenyl)-acetic acid (2/s,4E,6Z)-4-vinyl octa-2,4,6-trienyI
ester (173)
To  a  stirred  suspension  of carboxylic  acid  (171)  (1.00  g,  4.05  mmol)  in  anhydrous 
dichloromethane  (30  ml),  under  nitrogen,  was  added  oxalyl  chloride  (0.47  ml,  5.40 
mmol) and a few drops of dimethylformamide (ca.  100 pi). The suspension was strirred 
for  4  h  at  room  temperature,  after  which  time,  it  became  homogenous.  Cinnamyl 
alcohol (0.81  g, 6.07 mmol) and triethylamine (1.69 ml,  12.00 mmol) were added and 
stirring was  continued  for  15  hours.  Solvent was removed  in  vacuo to  give a yellow 
residue, which was dissolved in ethyl acetate ( 2 0 0  ml) and the mixture was washed with 
aqueous HC1 (0.5 M, 2 x 100 ml), saturated aqueous NaHCCh (2 x 100 ml), brine (100 
ml), and dried over MgSC>4. The solvent was removed in vacuo to yield an orange oil, 
which was purified by flash chromatography (Si0 2 ; petroleum spirit/ethyl acetate;  2 :1) 
to give  173  as  a white solid (0.85  g, 58%).  m.p.  143  °C;  Rf = 0.50 (Si0 2 ; petroleum 
spirit/ethyl acaetate; 2:1). *H NMR (300 MHz, CDCI3) 5n/ppm 3.58 (s, 2H, ArCFhCCV 
), 4.68 (d, J = 5.2, 2H, ArCH2C0 2CH2-), 6.18 (m,  1H, -CH=CHAr), 6.53 (d, J= 15.9, 
1H, -CH=CHAr), 7.16 -  7.43 (m, 9H, ArH), 8.0 (s, br, 1H, -NH-); 13C NMR (75 MHz, 
CDCI3) 5c/ppm 41.1 (ArCH2C02-), 66.0 (ArCH2C0 2CH2-), 118.1 (F3CC(0 )NH-),  1 2 1 .1  
(C(3),  C(5)),  123.2  (-CH=CHAr),  126.5  (para ArC),  128.6  and  128.8 (2 x ortho ArC 
and  2  x  meta  ArC),  130.6  and  130.7  (C(2),  C(6 )),  132.4  (quaternary  ArC),  134.7(- 
CH=CHAr),  134.9  and  136.9  (C(l),  C(4)  and),  155.2  (F3CC(0 )NH-),  1 7 1 .6  
(ArCH2C02-);  19F  NMR  (282  MHz,  CDC13)  6f/ppm  -76.1  (CF3C(0)NH-);  vmax 
(DCM/cm'1)  1346  (m,  C-F),  1601  (m,  Ar),  1703  (s,  C=0  (amide)),  1730  (s,  C=0 
(ester)),  2900 (w,  C-H),  3311  (w, N-H);  m/z (FAB) 363  ( 27%,  [M]+); HRMS found 
363.1077,  [M]+  (Ci9H 160 3NF3)  requires  363.1082;  Anal.  (C19H16O3NF3)  found  C, 
62.89; H, 4.54; N, 3.88%; requires C, 62.81; H, 4.44; N, 3.85%.
1854-terf-Butoxycarbonylamino phenyl acetic acid (176)154
OH
>k
To 4-aminophenylacetic acid (1.00 g, 6.62 mmol) in dioxane (20 ml) and water (10 ml) 
was  added triethylamine  (1.38  ml,  9.93  mmol),  followed by di-terJ-butyl dicarbonate 
(2.17  g,  9.93  mmol)  and the  resulting mixture  stirred  at  room  temperature  for  18  h. 
Aqueous sodium hydroxide (1  M, 50 ml) and ethyl acetate (50 ml) were added and the 
layers separated.  The  aqueous layer was  acidified to pH 4 with concentrated aqueous 
HC1, and a brown precipitate formed. The product was extracted into ethyl acetate (3 x 
50 ml), which was washed with brine (100 ml) and water (100 ml). The organic extracts 
were dried  over MgSC>4  and  concentrated  in  vacuo to  afford the product as  a brown
solid  (1.54  g,  94%).  m.p.  158  °C  (lit.  141.5  -   142.5  °C154);  'H  NMR  (300  MHz, 
CD3OD) SH /ppm  1.50 (s, 9H, -C(CH3)3),  3.46 (s, 2H, ArCHjCC^H), 7.15  (d, J = 8.5, 
2H, H(3) and H(5)), 7.31 (d, J = 8.5,2H, H(2) and H(6 )); 13C NMR (75 MHz, CD3OD) 
5c/ppm  29.1  (-C(CH3)3),  41.7  (AiCH2C02H),  81.3  (-C(CH3)3),  120.4  (AiC),  130.5 
(AiC),  155.8 (ArNHC02-),  176.2 (ArCH2C02H); i»m ax (nujol/cm'1) 1377 (m, C-(CH3)3), 
1593 (m, Ar),  1701  (s, C=0), 3383 (m, NH);  m/z (FAB) 252 (12%,  [M + H]+), 251 
(29%, [M]+), 196 (82%, [M -  tBu + H]+), 152 (8%, [M - Boc]+).
186(4-terf-Butoxycarbonylamino phenyl) acetic acid (E)-3-phenyl allyl ester (177)
O
O
o
N 3
Carboxylic acid 176 (0.60 g, 2.39 mmol) was dissolved in anhydrous dichloromethane 
(10  ml)  and  tetrahydrofuran  (10  ml).  Cinnamyl  alcohol  (0.32  g,  2.39  mmol), 
dicyclohexylcarbodiimide  (0.54  g,  2.63  mmol),  4,4-dimethylaminopyridine  (0.01  g, 
0.05  mmol)  and triethylamine  (0.66  ml,  4.78  mmol) were  added to the mixture.  The 
reaction  was  stirred  for  40  h  at  room  temperature.  The  urea  by-product  was  then 
removed by filtration and the solvents removed in vacuo. The residue was dissolved in 
dichloromethane  ( 2 0   ml)  and  the  mixture  was  then  washed  with  saturated  aqueous 
NaHCCb solution (20 ml), aqueous HC1 (1 M, 20 ml), brine (20 ml) and water (20 ml). 
The  organic  solution  was  dried  over  MgS0 4 ,  filtered  and  concentrated  in  vacuo  to 
afford the crude product  as  a brown oil.  Purification by flash chromatography (Si02; 
petroleum spirit/ethyl acetate; 2:1) gave the product as a white solid (0.50 g, 57%). m.p. 
108  °C;  Rf =  0.76  (Si02;  petroleum  spirit/ethyl  acetate;  1:1);  NMR  (300  MHz, 
CDC13) SH /ppm 1.66 (s, 9H, -C(CH3)3), 3.89 (s, 2H, ArCI^CC^R), 4.88 (d, J= 5.0, 2H, 
-C0 2CH2CH=CH-), 6.40 (m,  1H, -CH=CHAr),  6 .6 8  (m, J=  15.0,  1H, -CH=CHAr)
7.44  (m,  9H,  ArH);  13C  NMR  (75  MHz,  CDC13)  Sc/ppm  28.5  (-C(CH3)3),  40.9 
(ArCH2C02-), 65.5 (-C02CH2CH=CH-), 80.6 (-C(CH3)3), 118.9 (C(3) and C(5)), 123.2 
(-CH=CHAr),  126.8 (ArC)),  128.1  and  128.6 (2 x ArC and 2 x ArC),  128.7 (C(2) and 
C(6 )),  130.0  (1  x  quaternary  ArC),  134.3  (-CH=CHAr),  136.4  and  137.6  (C(l)  and 
C(4)),  152.9  (ArNHC02-),  171.5  (ArCH2C02-);  vmax  (nujol/cm'1)  1377  (s,  C-(CH3)3), 
1693  (s,  C=0  (amide)),  1732  (s,  C=0  (ester)),  2928  (s,  C-H),  3369  (m, NH);  m/z 
(FAB)  368  (5%,  [M + H]+),  367  (11%,  [M]+), 267 (3%,  [M -  Boc]+); HRMS found 
390.1686,  [M + Na]+ (C22H25N0 4Na) requires 390.1681; Anal. (C22H25N04) found C, 
71.92; H, 7.31; N, 3.82%; requires C, 71.91; H, 6 .8 6 ; N, 3.81%.
187(4-Ammonium phenyl)-acetic acid (£)-3-phenyl-allyl ester trifluoroacetate (178)
cf3 coo'  +H3N
Ester 177 (2.06 g, 3.00 mmol) was stirred in trifluoroacetic acid (4 % v/v in anhydrous 
dichloromethane)  at  room  temperature  for  5  h  under  nitrogen.  The  mixture  was 
concentrated in vacuo to give a brown oil, which was purified by flash chromatography 
(SiC>2;  petroleum  spirit/ethyl  acetate;  2 :1)  to  give  the  desired product  as  a brown oil 
(0.81  g,  54%).  Rf =  0.33  (Si0 2 ;  petroleum  spirit/ethyl  acetate,  2:1);  1H  NMR  (300 
MHz, CDCI3) 5H /ppm 3.30 (s, br, 3H, ArNH3+), 3.56 (s,  2 H, ArCH2C0 2-), 4.74 (d, J = 
6.0, 2H, ArCH2C0 2CH2-), 6.27 (m, 1H, -CH=CHAr), 6.60 (d,J  = 12, 1H, -CH=CHAr), 
6.69 (m, 2H, H(2) and H(6 )), 7.11  (m, 2H, H(3) and H(5)), 7.25 -  7.39 (m, 5H, ArH); 
13C NMR (75 MHz, CDCI3) Sc/ppm 39.6 (ArCH2C02-), 64.2 (ArCH2C02CH2-),  114.3 
(C(3) and C(5)),  122.3  (-CH=CHAr),  122.9 (C(l)),  125.6 (ArC),  127.0 and  127.6 (4 x 
ArC), 128.0 (C(2) and C(6 )), 133.0 (-CH=CHAr), 135.3 (quaternary ArC), 144.4 (C(4)),
170.9  (ArCH2C02-); vmax (film/cm'1 ) 1150 (s, C-OR), 1740 (s, C=0), 3370 (s, NH); m/z 
(FAB) 382 (35%,  [M + H]+), 267 (100%, [M -  TFA]+).
4-[4-((2^,4£,6Z)-4-Vinylocta-2,4,6-trienyloxycarbonylmethyl) phenylcarbamoyl] 
butyric acid (169)
O  O  2
H
Glutaric anhydride (0.13 g, 1.17 mmol) was added to a stirred solution of triethylamine 
(0.28  ml,  2.04  mmol)  and  amine  salt  178  (0.37  g,  0.97  mmol)  in  anhydrous 
dichloromethane (12  ml),  under nitrogen.  The  solution was heated at reflux  for  19 h.
188After cooling,  dichloromethane (30 ml) was added and the solution was washed with 
aqueous  HC1  (2  M,  50  ml)  and  brine  (50  ml).  The  organic  extract  was  dried  over 
MgSC>4  and  concentrated  in  vacuo.  Purification  by  recrystallisation  from 
water/acetonitrile yielded the product as a brown solid (0.36 g, 53%). m.p. 145 °C; Rf = 
0.80 (Si02; methanol/ethyl acetate, 9:1); 'H NMR (300 MHz, CD3OD) 6 H /ppm 2.03 (m, 
2 H, HO2CCH2CH2-), 2.46 (m, 4H, HO2CCH2CH2CH2-), 3.71 (s, 2 H, A1CH2CO2-), 4.78 
(d,  2H,  ArCH2C0 2CH2-),  6.34  (m,  1H,  -CH=CHAr),  6.63  (d,  J  =  16.0,  1H,  - 
CH=CHAr),  7.27  -   7.81  (m,  9H,  ArH);  13C  NMR  (75  MHz,  CD3OD)  8c/ppm  22.1 
(HO2CCH2CH2), 34.1  (H02C(CH2)2CH2-), 36.9 (HO2CCH2-), 41.5 (ArCH2C02-), 66.3 
(ArCH2C0 2CH2-),  121.3 (C(2) andC(6 )),  124.2 (-CH=CHAr), 127.6 (para ArC),  129.0 
and  129.6  (ortho ArC  and  meta  ArC),  130.8  (C(3)  and  C(5)),  131.3  (1  x  quaternary 
ArC), 134.9 (-CH=CHAr), 137.7 and 138.9 (C(l) andC(4)),  173.3 (ArCH2C02-), 173.7 
(ArNHC(0)-),  176.8 (H0 2C-);  rm ax (nujol/cm'1 )  1529 (s, C=0 (amide)),  1728 (s, C O  
(ester)),  2920  (s,  C-H),  3279  (m, N-H);  m/z (CI+) 382  (80%,  [M + H]+),  381  (16%, 
[M]+), 266 (7%, [M -  alcohol + H]+); HRMS found 382.1649, [M + H]+ (C22H24N05) 
requires 382.1654; Anal. (C22H23NO5) found C, 69.61; H, 6.42; N, 3.65%; requires C, 
69.28; H, 6.08; N, 3.67%.
(4-terf-Butoxycarbonylamino phenyl) acetate-2-phenethyl ester (179)
I   O
(4-ter/-Butoxycarbonylamino-phenyl)  acetic  acid  176  (3.00  g,  12.0  mmol)  was 
dissolved in anhydrous tetrahydrofuran/dichloromethane (1:1, 40 ml), under nitrogen. 2 - 
Phenyl  ethanol (1.43  ml,  12.0 mmol), dicyclohexylcarbodiimide (2.71  g,  13.0 mmol), 
4,4-dimethylaminopyridine (0.03 g, 0.24 mmol) and triethylamine (3.32 ml, 23.0 mmol) 
were  added  and  the  solution was  stirred  at room temperature  for 22  h.  The urea by­
product was filtered off and the resulting filtrate was concentrated in vacuo. The residue 
was dissolved in dichloromethane (50 ml) and washed with aqueous saturated NaHCCb 
(50 ml), aqueous HC1 (1 M, 50 ml), water (50 ml) and brine (50 ml) and then dried over 
MgSd*.  The  solvents were removed in  vacuo,  which  afforded the crude product as a
189brown oil. Purification by flash chromatography (Si0 2 ; gradient; petroleum spirit/ethyl 
acetate,  (7:3)  to petroleum  spirit/ethyl  acetate (1:2))  gave the title product as  a white 
solid (4.24, 54%). m.p. 60 °C; Rf = 0.73 (Si0 2 ; petroleum spirit/ethyl acetate;  1:1); 
NMR  (300  MHz,  CDC13)  5H /ppm  1.53  (s,  9H,  C(CH3)3),  2.91  (t,  J =  7.0,  2H,  - 
CH2CH2Ar), 3.54 (s, 2H, ArOHhCOr), 4.30 (t, J = 7.0, 2H, -CH2CH2Ar), 7.14 -  7.33 
(m, 9H, ArH); 13C NMR (75 MHz, CDC13) 5c/ppm 28.4 (C(CH3)3), 35.1  (-CH2CH2Ph),
40.8  (ArCH2C02-),  65.3  (-CH2CH2Ar),  80.5  (C(CH3)3),  118.7  (C(3)  and C(5)),  126.6 
(para ArC),  128.5 and 128.6 (2 x ortho ArC and 2 x meta ArC), 128.9 (C(2) and C(6 )),
129.9  (1 x quaternary ArC), 137.5 and 137.7 (C(l) and C(4)), 152.8 (-CONH-), 171.6 (- 
CH2CO2-); vmzx (nujol/cm'1 ) 1370 (m,C-(CH3)3), 1593 (m, Ar),  1716 (s, C=0), 2921  (s, 
CH),  3356  (s,  NH);  m/z  (FAB)  355  (48%,  [M]+),  255  (22%,  [M -  Boc]+);  HRMS 
found  355.1790,  [M]+  (C21H25NO4)  requires  355.1784;  Anal.  (C21H25NO4)  found  C, 
71.09; H, 7.58; N, 4.07%; requires C, 70.96; H, 7.09; N, 3.94%.
(4-Ammonium-phenyl)-acetate-2-phenethyl ester trifluoroacetate (347)
CF3COO- H3N
(4-ter/-Butoxycarbonylamino-phenyl)  acetate phenethyl ester 179 (0.30 g, 0.80 mmol) 
was  dissolved  in  anhydrous  dichloromethane  (4  ml),  under  nitrogen.  Trifluoroacetic 
acid (4 ml) was added and the mixture was stirred for 2.5 h at room temperature. The 
volatiles were removed under reduced pressure and the desired product was isolated as a 
brown  oil  (0.31  g,  100%).  Rf =  0.23  (Si0 2 ;  petroleum  spirit/ethyl  acetate;  1:1);  *H 
NMR  (300  MHz,  CDC13)  SH /ppm  2.99  (t,  J =  7.0  2H,  -CHzCHzAr),  3.62  (s,  2H, 
ArCFhCCV), 4.33  (t, J = 6.9, 2H, -CFhCHzAr), 7.14 -  7.26 (m, 9H, ArH); 13C NMR 
(75  MHz,  CDC13)  6c/ppm  34.8  (-CH2CH2Ar),  40.4  (ArCH2C02-),  66.2 (-CH2CH2Ar),
115.3  (q, CF3C02-),  123.1  (para ArC),  126.7  ( 2 x meta ArC),  128.6,  128.9  ( 2 x ortho 
ArC, C(2), C(6 )),  131.0 (C(3), C(5)), 135.2, 137.3 (C(4), 1 x quaternary ArC and C(l)),
160.9  (q, Jcf = 39.5, CF3C02-,), 172.5 (-CH2C02-); JW  (neat/cm’1) 1142 (s, C-F), 1720 
(s,  C=0),  2951  (s,  C-H),  3425  (m, NH);  m/z (FAB) 256  (6 %,  [M + H - TFA]+,  255 
(17%,  [M -  TFA]+);  HRMS  found 256.1334,  [M + H - TFA]+ (Ci6Hi8N02) requires
190256.1338.
4-(4-Phenethyloxycarbonylmethyl phenylcarbamoyl) butyric acid (127)90
O
HO N
H
6
(4-Ammonium  phenyl)  acetate-2-phenethyl  ester  trifluoroacetate  347  (2.51  g,  6.80 
mmol)  was  dissolved  in anhydrous dichloromethane  (40 ml) under nitrogen.  Glutaric 
anhydride (0.93 g, 8.16 mmol) and triethylamine (1.18 ml, 8.50 mmol) were added and 
the mixture was  heated  at reflux  for  17  h.  After cooling,  the  solvents were removed 
under reduced pressure. The crude product was dissolved in ethyl acetate (100 ml) and 
then washed with aqueous HC1 (2 M,  100 ml), water (100 ml) and brine (100 ml) and 
dried over MgSC>4.  The solvents were removed in vacuo  and the desired product was 
isolated as a yellow solid (1.20 g). m.p. = 106 °C (lit.  105 -  107 “C90); ‘H NMR (300 
MHz,  CD3CN)  SH /ppm  1.95  (m,  2H,  -CH2CH2CH2-),  2.36  (m,  4H,  -
CH2CH2CH2C(0 )N-), 2.88 (t, J = 6.7, 2H, -CHjCHjAr), 3.53 (s, 2H, ArCH2C02-), 4.26 
(t, J= 6.7, 2H, -CH2CH2Ar), 7.12 -  7.30 (m, 7H, ArH), 7.47 (d, J = 8.4, 2H, ArH), 8.40 
(s,  1H, -C(O)NH-);  13C  NMR (75  MHz,  CD3CN) Sc/ppm  21.6  (-CH2CH2CH2-), 33.6 
(CO2CH2CH2CH2-),  35.7  (-CH2CH2Ar),  36.7  (-CH2CH2CH2NH-), 41.2  (ArCH2C02-),
66.1  (-CH2CH2Ar),  120.7,  127.4,  129.5,  130.0  and  130.7  (9  x  ArC)  130.8  (1  x 
quaternary ArC), 138.8 and 139.4 (C(l) and C(4)), 172.3 (ArCH2C02-), 172.5 (-CONH- 
), 175.2 (-CO2H); fmax (nujol/cm1) 1526 (m, Ar), 1652 (s, C=0 (amide)), 1730 (s, C=0 
(acid  and  ester)),  2923  (s,  CH),  3312  (w,  NH);  m/z  (FAB)  370  (48%,  [M  +  H]+); 
HRMS found 370.1661, [M + H]+ (C21H24NO5) requires 370.1655.
191Phenyl-acetate-2-phenyI ester (199)155
Phenylacetic  acid  (1.50  g,  11.0  mmol)  was  dissolved  in  anhydrous 
tetrahydrofuran/dichloromethane (1:1, 20 ml) under nitrogen. 2-Phenylethanol (1.32 ml,
11.0  mmol), dicyclohexylcarbodiimide (2.50 g, 12.0 mmol), 4 ,4 -dimethylaminopyridine 
(27.0  mg,  0.22  mmol)  and  triethylamine  (3.07  ml,  22.0  mmol)  were  added  and  the 
reaction  stirred  at  room  temperature  for  18  h.  The  urea by-product was  removed by 
filtration  and  the  filtrate  was  concentrated.  The  crude  product  was  dissolved  in 
dichloromethane (70 ml) and washed with saturated aqueous Na2CC>3 (50 ml), aqueous 
HC1 (1 M, 50 ml), water (50 ml) and brine (50 ml), dried over MgSCU and concentrated. 
Purification  by  flash  chromatography  (Si0 2 ;  gradient;  ethyl  acetate/petroleum  spirit 
(3:7) to ethyl acetate/petroleum spirit (1:1)) gave the desired product as a colourless oil 
(0.80  g,  30%).  Rf =  0.63  (SiC>2;  petroleum  spirit/ethyl  acetate;  1:1);  NMR  (300 
MHz, CDC13) 5H /ppm 2.96 (t, J= 7.0, 2H, -CHzCKbAr), 3.64 (s, 2H, ArCt^CC^-), 4.35 
(t, J = 7.0, 2H, -CH2CH2AJ), 7.18 -  7.36 (m,  10H, ArH); 13C NMR (75 MHz, CDCI3) 
6c/ppm 35.0 (-CH2CH2Ar), 41.5 (ArCH2C02-), 65.4 (-CH2CH2Ar), 126.6, 126.8, 127.1, 
128.5, 128.6,  129.0 and 129.4 (10 x ArC), 134.0 and 137.8 (2 x quaternary ArC), 171.5 
(A1CH2CO2-); JViax (neat/cm'1)  1584 and  1604 (m, Ar),  1732 (s, C=0), 2854 and 2931 
(s,  CH);  m/z  (FAB)  263  (100%,  [M  +  Na]+),  241  (3%,  [M  +  H]+);  HRMS  found 
241.1224, [M + H]+ (Ci6H 170 2) requires 241.1229.
192Phenyl-acetic acid 2-phenoxy-ethyl ester (200)
Ethylene glycol phenyl ether (1.38 ml,  11.0 mmol) and phenyl acetic acid (1.50 g, 11.0 
mmol) were dissolved in a mixture of anhydrous dichloromethane/tetrahydrofiiran (1:1, 
30 ml) under nitrogen. Dicyclohexylcarbodiimide (2.50 g, 12.0 mmol) followed by 4,4- 
dimethylaminopyridine (27.0 mg, 0.20 mmol) and triethylamine (3.07 ml, 22.0 mmol) 
were then added and the reaction was stirred for 18 h. The urea by-product was filtered 
off and solvents removed under reduced pressure. The crude material was dissolved in 
dichloromethane (50 ml) and washed with saturated aqueous NaHCC>3 (50 ml), aqueous 
HC1 (1  M, 50 ml), brine (50 ml) and water (50 ml) and dried over MgSC>4 and solvent 
removed under reduced pressure. Purification by flash chromatography (SiC>2; gradient; 
petroleum spirit/ethyl acetate (4:1) to petroleum spirit/ethyl acetate (2:1)) afforded the 
desired  product  as  a  yellow  liquid  (2.06  g,  73%).  Rf  =  0.76  (Si0 2 ;  ethyl 
acetate/petroleum  spirit;  1:1);  *H  NMR  (300  MHz,  CDCI3)  Sn/ppm  3.67  (s,  2H, 
ArCH2C0 2-), 4.14 (m, 2H, -C^OAr), 4.46 (m, 2H, -CH2CH2OAr), 7.03 (m, 3H, ArH),
7.30  (m,  7H,  ArH);  13C  NMR  (75  MHz,  CDC13)  5c/ppm 41.2  (ArCH2C02-),  63.3  (- 
CH2CH2OAr),  65.8  (-CH2CH2OAr),  114.7,  121.3,  127.1,  128.6,  129.3,  129.6  (ArC),
133.9  (C(l)),  158.6 (C(7)),  171.6 (-CH2C02-); vm stx (DCM/cnT1 )  1088 (m, C-O),  1593 
(w, Ar),  1740 (m, C=0), 2924 (s, C-H); m/z (FAB) 257 (33%,  [M + H]+), 256 (17%, 
[M]+); HRMS found 257.1181, [M + H]+(Ci6Hi70 3) requires 257.1178.
193(1-Methyl-lH-pyrrol-2-yl) acetic acid (348)156
O
5  X   v   ' 0 H
A solution of potassium hydroxide (3.89 g, 70.0 mmol) in water (40 ml) was added to a 
stirred  solution  of methyl  l-methyl-2-pyrroleacetate  (5.00  ml,  35.0 mmol)  in ethanol 
(80 ml). The resulting solution was stirred at room temperature for 3 days. Ethanol was 
removed under reduced pressure and the resulting aqueous  solution was washed with 
diethyl ether (50 ml). The aqueous layer was then acidified to approximately pH 2 using 
concentrated  aqueous  HC1  and  a brown precipitate  formed,  which was  extracted into 
ethyl acetate (3 x 50 ml). The combined organic extracts were washed with brine (200 
ml), dried over MgSC>4 and concentrated in vacuo.  The desired product was isolated as 
a beige solid (4.40 g, 91%).  m.p.  126 °C (lit.  135 °C156); *H NMR (300 MHz, CDC13) 
SH /ppm 3.58 (s, 3H, -CH3), 3.67 (s, 2H, -CH2CO2H), 6.10 (m, 2H, H(3), H(4)), 6.61 (m, 
1H, H(5)); 13C NMR (75 MHz, CDC13) 5c/ppm 32.6 (-CH2C0 2H), 34.2 (-NCH3), 107.5 
(C(3)),  109.4 (C(4)),  123.1  (C(5)),  124.3 (C(2)),  177.4 (-C02H); vm A X  (nujol/crn1) 1645 
(m, C O ), 2937 (s, C-H); m/z (Cf) 137 (100%, [M-2H]+).
(1-Methyl-1 H-pyrrol-2-yl) acetic acid phenethyl ester (202)
(1-Methyl-l//-pyrrol-2-yl)-acetic  acid  348  (3.00  g,  20.0  mmol)  was  dissolved  in 
anhydrous  dichloromethane  (35  ml)  and  anhydrous  tetrahydrofuran  (35  ml)  under 
nitrogen.  2-Phenyl  ethanol  (2.58  ml,  10.0  mmol),  dicyclohexylcarbodiimide  (4.89  g,
24.0  mmol),  4,4-dimethylaminopyridine  (0.05  g,  0.43  mmol)  and triethylamine  (6.00 
ml, 43.0 mmol) were added and the resulting solution was stirred at room temperature 
for  18  h.  The  urea  by-product  was  then  removed  by  filtration  and  the  filtrate  was
194concentrated  in  vacuo.  The  residue  was  dissolved  in  dichloromethane  (100  ml)  and 
washed with saturated aqueous NaHCC>3 (100 ml), aqueous HC1 (1  M,  100 ml), brine 
(100  ml)  and  water  (100  ml).  The  chlorinated  layer  was  dried  over  MgSC>4  and 
concentrated  in  vacuo.  Purification  by  flash  chromatography  (Si02;  petroleum 
spirit/ethyl acetate; 3:1) afforded the desired product as a brown oil (2.70 g, 52%). m.p. 
8 6 °C; Rf = 0.33 (Si02; petroleum spirit/ethyl acetate; 1:1) 'H NMR (300 MHz, CDCI3) 
SH /ppm 3.01 (m, 2H, -CHzCHjAr), 3.52 (s, 3H, -CH3), 3.67 (s, 2H, -CH2CO2-), 4.40 (m, 
2H, -CH2CH2Ar ), 6.14 (m, 2H, H(3), H(4)), 6.65  (m,  1H, H(5)), 7.23 -  7.31  (m, 5H, 
ArH); 13C NMR (75 MHz, CDCI3) 6c/ppm 32.7, 33.9 and 35.0 (-C(2)CH2-, -NCH3 and 
-CH 2Ar),  65.5  (-CH2CH2Ar),  107.1  and  108.9  (C(3)  and  C(4)),  122.6  (C(5)),  124.9 
(C(2)),  127.2,  128.6  and  129.1  (5 x ArC),  137.9 (1  x quaternary ArC),  170.6 (-C02-); 
Vn*x  (DCM/cm1)  1678  (s,  C=0),  2922  (w,  C-H)  m/z  (CI+)  244  (3%,  [M+H]+),  243 
(10%,  [M]+); HRMS found 244.1341, [M + H]+ (Ci5Hi8N02) requires 244.1338.
1954.2.2 Synthesis of Binding Units
Synthesis of FmocArg(Pbf)Arg(Pbf)-CA-OH Binding Unit 131
i-Mnr:A  _   20% Piperidine/DMF  _
Fmoc-CA-OH  +   2-CI-Trt-®   DIPEA, DCI^  F m oc-C A -O -#--------------------------- ►   H2 N-CA-0-
142  144  349 145
FmocArg(Pbf)-OH, PyBOP,  20%  Piperidine/DMF
----------------------------- ►  F moc-Arg( Pbf  )-CA-0    ►   H2 N-Arg(Pbf)-CA-0-
HOBt,  DIPEA, DMF
350  146
FmocArg(Pbf)-OH,  PyBOP,  2:2:6
------------------------------------►   FmocArg(Pbf)-Arg(Pbf)-CA-0-A    ►
HOBt,  DIPEA,  DMF  AcOH:MeOH:DCM
351
FmocArg(Pbf)-Arg(Pbf)-CA-OH
131
0   =  2 -chlorotrityl resin 
CA =  -HN(CH2 )5C 02H
6-(9H-Fluoren-9-ylmethoxycarbonylamino)-hexanoic acid (142)
A stirred solution of 6 -aminocaproic acid (3.00 g, 23.0 mmol) in 10% aqueous sodium 
carbonate solution (6.09 g in 60 ml of water, 57.0 mmol) was cooled to 0 °C, whereupon 
9-fluorenylmethyl  chloroformate  (5.92  g,  23.0 mmol)  in dioxane  (30 ml) was  added. 
The solution was stirred for  10 min, after which time a white precipitate had formed. 
The solution was allowed to warm to room temperature and stirred for 4 h. The mixture 
was diluted with water (500 ml)  and washed with ether (2 x  100 ml).  The pH of the 
aqueous  layer  was  adjusted  to  pH  1   (using  concentrated  aqueous  HC1)  and  a white
196precipitate  formed.  The  mixture was  extracted  with  ethyl  acetate  (3  x  200 ml).  The 
combined organic extracts were dried over MgSC>4 and concentrated in vacuo to afford 
a white solid,  which was purified by flash chromatography (Si0 2 ;  ethyl acetate).  The 
desired product was isolated as a white solid (6.23 g, 77%). m.p. 109 °C (lit.  116 °C157); 
Rf =  0.57  (Si02;  ethyl  acetate);  NMR  (300  MHz,  CDC13)  5H /ppm  1.37  (m,  2H, 
HO2CH2CH2CH2-)  1.53  (m,  2 H,  -CH2CH2NHC(0 )-),  1.64  (m,  2 H,  HO2CCH2CH2-), 
2.35 (t, J=  7.2, 2H, HO2CCH2-), 3.19 (br, m, -CH2NHC(0 )-), 4.21  (m, 1H, H(l)), 4.41 
(d,  J =  6.0,  2H,  H(1)CH2-),  4.76  (br,  s,  1H,  CH2NHC(0)),  7.31  (m,  2H,  H(4)  and 
H(ll)), 7.40 (m, 2H, H(5) and H(10)), 7.58 (d, J= 7.3, 2H, H(3) and H(12)), 7.76 (d, J 
= 7.4, 2H, H(6 )  and H(9));  13C NMR (75  MHz, CDCI3)  6c/ppm 24.3, 26.2, 29.7 (3 x 
CH2,  HO2CH2CH2CH2CH2-),  33.8  (-CH2NHC(0)-),  40.9  (H02CCH2-),  47.4  (C(l)),
6 6 .6   (C(1)HCH2-),  120.0,  125.0,  127.1,  127.7  (C(3),  C(4),  C(5),  C(6 ),  C(9),  C(10), 
C(ll) and C(12)),  141.4 (C (2) and C(13)),  144.1  (C(7) and C(8 )),  156.6 (-NHC(O)-),
178.6 (HO2C-); rm ax (nujol/cm'1 ) 1686 (s, C=0 (carbamate)), 2928 (s, C-H), 3342 (s, N- 
H); m/z (FAB) 376 (4%,  [M + Na]+), 354 (33%,  [M + H]+).
Resin 349
#-2CI-Trt-CA(Fm oc)
Diisopropylethylamine (1.97 ml, 11.3 mmol) was added to a stirred solution of Fmoc-6 - 
aminocaproic  acid  142  (1.00  g,  2.83  mmol)  in  anhydrous  dichloromethane  (20  ml) 
under nitrogen. The mixture was stirred for an additional 10 min. The resulting solution 
was  added  to  2-chlorotrityl  resin  (1.69  g,  1.40  mmol/g)  and the mixture  agitated by 
sonication at room temperature for 3 h. The resin was filtered and washed sequentially 
with methanol (3 x 40 ml), methanol/dichloromethane /diisopropylethylamine (2:17:1, 3 
x  40  ml),  dichloromethane  (3  x  40  ml),  dimethylformamide  (3  x  40  ml)  and 
dichloromethane (3 x 40 ml). The resin was dried under vacuum overnight to afford the 
desired product (2.75 g). Fmoc substitution = 0.95 mmol/g.
197Resin 145
#-2CI-Trt-CA-NH2
The resin 349  (2.75  g) was suspended in piperidine/dimethylformamide solution (2:8, 
20 ml) and sonicated at room temperature for 3  h. The resin was filtered and washed 
with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml). The resin was 
dried under vacuum to give the deprotected resin 145 (1.90 g).
Resin 350
2CI-T  rt-CA-Arg(Pbf)Fmoc
Fmoc-Arg(Pbf)-OH (3.49 g, 5.38 mmol), PyBOP (2.80 g, 5.38 mmol) and HOBt (0.73 
g, 5.38 mmol) were dissolved in anhydrous dimethylformamide (30 ml) under nitrogen. 
Diisopropylethylamine (1.04 ml, 5.96 mmol) was added and the resulting solution was 
immediately added to the resin 145 (1.90 g, 0.95 mmol/g). The resulting suspension was 
agitated  by  sonication  at  room  temperature  for  4  h.  The  Kaiser  test  indicated  the 
reaction  was  completed.  The  resin  was  then  filtered  and  washed  sequentially  with 
dimethylformamide (4 x 50 ml), dichloromethane (3 x 50 ml), dimethylformamide (2 x 
25 ml) and dichloromethane (2 x 50 ml). The resin was dried under vacuum to afford 
350 (3.04 g). Fmoc substitution = 0.47 mmol/g.
198Resin 146
#-2CI-Trt-CA-Arg(Pbf)-NH2
The resin 350 (3.04 g) was suspended in piperidine/dimethylformamide (2:8, 30 ml) and 
the  mixture  was  sonicated  at  room  temperature  for  3  h.  The  resin  was  filtered  and 
washed with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml) and dried 
under vacuum to give the product 146 (2.58 g).
Resin 351
# — 2CI-Trt-CA-Arg(Pbf)-Arg(Pbf)Fmoc
Fmoc-Arg(Pbf)-OH (3.02 g, 4.66 mmol), PyBOP (2.42 g, 4.66 mmol) and HOBt (0.63 
g, 4.66 mmol) were dissolved in anhydrous dimethylformamide (30 ml) under nitrogen. 
Diisopropylethylamine  (0.67  ml,  3.85  mmol)  was  added  and  the  mixture  added 
immediately to  the resin  146  (2.58  g,  0.47  mmol/g).  The  suspension was  agitated by 
sonication  at  room  temperature  for  4  h.  The  Kaiser  test  indicated  the  reaction  was 
completed.  The  resin  was  then  filtered  and  washed  sequentially  with 
dimethylformamide (4 x 50 ml), dichloromethane (3 x 50 ml), dimethylformamide (2 x 
25 ml) and dichloromethane (2 x 50 ml). The resin was then dried under vacuum to give 
the  product  351  (3.74  g).  Fmoc  substitution  =  0.29  mmol/g.
199FmocArg(Pbf)Arg(Pbf)CA-OH (131)90
NH
HO
II  / / ^ n
NH  M  °
The  resin  351  (3.74  g,  0.29  mmol/g)  in  a  solution  of  acetic
acid/trifluoroethanol/dichloromethane (2 :2 :6 , 2 0  ml) was sonicated at room temperature 
for  3  h.  The  resin  was  subsequently  filtered  and  washed  with  acetic 
acid/trifluoroethanol/dichloromethane  (2:2:6,  40  ml),  dichloromethane  (40  ml), 
methanol (20 ml) and dichloromethane (40 ml). The filtrate was concentrated in vacuo 
to  afford  a  brown  coloured  oil.  Purification  by  flash  chromatography  (SiC>2; 
methanol/ethyl  acetate;  2:8),  gave the product as a white  solid (0.64  g,  19% over six 
steps). m.p.  134 °C (lit.  135 -  137 °C90); Rf = 0.58 (SiCh; methanol/ethyl acetate;  2 :8);
NMR (300  MHz,  CD3OD)  5H /ppm  1.25  -   1.60  (m,  14H, HO2CCH2CH2CH2CH2- 
and 2 x (-CH2CH2CH2NHC(NH)NH-),  1.44 (s,  12H, 2 x  (-CH2C(CH3)20 ),  1.96 (s, 
6 H,  2   x  C(e)CH3),  2.21  (m,  2H,  HO2CCH2-),  2.52  (s,  3H,  C(f)CH3),  2.54  (s,  3H, 
C(f)CH3), 2.59 (s, 3H, C(b)CH3), 2.61  (s, 3H, CQOCIfc), 2.97 (s, 2H, -CH2C(CH3)20 -), 
2.98 (s, 2H, -CH2C(CH3)20 -), 3.22 (m,  6H, -CH2NHC(0 )-and 2 x (-CH2NHC(NH)NH- 
), 3.75 (m,  1H, H(h)), 4.13 (m,  1H, H(l)), 4.21  (m,  1H, H(g)), 4.42 (m, 2H, H(1)CH2-),
7.31  (m, 2H, (H(4) and H(ll)), 7.39 (m, 2H, H(5) and H(10)), 7.65 (m, 2H, H(3) and 
H(12)),  7.79  (d, J = 7.4,  2H, H(6 )  and H(9));  13C  NMR (100 MHz,  CD3OD,  320 K)
2005c/ppm  13.2  (C(e)CH3),  19.0,  20.2  (C(b)CH3  and  C(f)CH3),  26.4,  27.5,  28.1 
(H02CCH2CH2CH2CH2-),  29.3  (2  x  -CH2C(CH3)20-),  30.5,  31.1  (2  x  -  
CH2CH2CH2NH(=NH)-),  35.8  (H02CCH2-),  40.9,  42.1  (2  x  -CH2NH(C=NH)  and  - 
CH2NHC(0)CH(g)-), 44.6 (2 x -CH2C(CH3)20-), 49.1  (C(l»,  5 5 .0  (C(g)), 57.0 (C(h)),
68.7  (C(1)HCH2-), 88.3 (2 x -CH 2C(CH3)20-), 119.1 (2 x C(e)), 121.6 (C(6) and C(9)),
126.8  (C(3)  and  C(12)),  128.8  (C(4) and C(11)),  129.4 (C(5)  and C(10)),  134.2  (2 x 
C(b) and 2 x  C(£)),  135.1  (2  x C(a)),  140.0 (C(7) and C(8 )),  143.2 (C(2) and C(13)),
145.9 (2 x C(c)),  158.7 (2 x C(d)),  160.5 (-NHC(O)O-) and 2 x -NH(C=NH)-),  174.2,
178.4  (2 x -C(0)NH- and -C02H);  (nujol/cm1)  1377 (s, -S02-N),  1535  (w, C=0 
(amide)),  1636 (w, C=0 (acid)), 2853 (s, C-H), 3333 (w, N-H); m/z (FAB) 1170 (44%, 
[M + H]+); |a]D  + 9.0 0 (c 0.20, MeOH).
Synthesis of FmocAla-Arg(Pbf)-CA-OH Binding Unit 147
runcA  _  20% Piperidine/DMF  A
Fmoc-CA-OH  +  2-CI-Trt-^  P.LPEA, PCM  Fmoc-CA-O-#-----------------------    H2N-CA-0-#
142  144  3 4 9   145
FmocArg(Pbf)-OH, PyBOP,
Fmoc-Arg(Pbf)-CA-0-^
350
20% Piperidine/DMF
H2N-Arg(Pbf)-CA-0-#
146
HOBt, DIPEA, DMF
Fmoc-Ala-OH, PyBOP
FmocAla-Arg(Pbf)-CA- < y-m  
352
2:2:6
HOBt, DIPEA, DMF AcOH:MeOH:DCM
FmocAla-Arg(Pbf)-CA-OH
147
^  = 2-chlorotrityl resin 
CA =  -HN(CH2)5C02H
201Resin 349
#-2CI-Trt-CA(Fmoc)
Diisopropylethylamine (1.97 ml, 11.3 mmol) was added to a stirred solution of Fmoc-6 - 
aminocaproic  acid  142  (1.00  g,  2.83  mmol)  in  anhydrous  dichloromethane  (20  ml) 
under nitrogen. The mixture was stirred for an additional 10 min. The resulting solution 
was  added  to  2-chlorotrityl  resin  (1.69  g,  1.40  mmol/g)  and the mixture  agitated by 
sonication at room temperature for 3 h. The resin was filtered and washed sequentially 
with methanol (3 x 40 ml), methanol/dichloromethane /diisopropylethylamine (2:17:1, 3 
x  40  ml),  dichloromethane  (3  x  40  ml),  dimethylformamide  (3  x  40  ml)  and 
dichloromethane (3 x 40 ml). The resin was dried under vacuum overnight to afford the 
desired product (2.41 g). Fmoc substitution = 1.26 mmol/g.
Resin 145
#-2CI-Trt-CA-NH2
The resin 349  (2.41  g) was suspended in piperidine/dimethylformamide solution (2:8, 
20 ml) and sonicated at room temperature for 3  h.  The resin was filtered and washed 
with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml). The resin was 
dried under vacuum to give the deprotected resin 145 (1.90 g).
202Resin 350
#-2CI-Trt-CA-Arg(Pbf)Fmoc
Fmoc-Arg(Pbf)-OH (4.64 g, 7.14 mmol), PyBOP (3.71  g, 7.14 mmol) and HOBt (0.96 
g, 7.14 mmol) were dissolved in anhydrous dimethylformamide (30 ml) under nitrogen. 
Diisopropylethylamine (2.48 ml,  14.3 mmol) was added and the resulting solution was 
immediately added to the resin 145 (1.89 g, 1.26 mmol/g). The resulting suspension was 
agitated  by  sonication  at  room  temperature  for  4  h.  The  Kaiser  test  indicated  the 
reaction  was  completed.  The  resin  was  then  filtered  and  washed  sequentially  with 
dimethylformamide (4 x 50 ml), dichloromethane (3 x 50 ml), dimethylformamide (2 x 
25 ml) and dichloromethane (2 x 50 ml). The resin was dried under vacuum to afford 
350 (3.22 g). Fmoc substitution = 0.77 mmol/g.
Resin 146
#-2CI-Trt-CA-Arg(Pbf)-NH2
The resin 350 (3.22 g) was suspended in piperidine/dimethylformamide (2:8, 30 ml) and 
the  mixture  was  sonicated  at  room  temperature  for  3  h.  The  resin  was  filtered  and 
washed with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml) and dried 
under vacuum to give the product 146 (2.58 g).
Resin 352
®-2CI-T  rt-CA-Arg(Pbf)-Ala-Fmoc
Diisopropylethylamine (2.20 ml,  12.6 mmol) was added to a stirred solution of Fmoc- 
alanine  (1.97  g,  6.33  mmol),  PyBOP  (3.29  g,  6.33  mmol)  and  HOBt  (0.85  g,  6.33 
mmol) in anhydrous dimethylformamide (30 ml), under nitrogen. The resulting mixture 
was added immediately to the resin 146 (2.74 g, 0.77 mmol/g) and the suspension was 
agitated  by  sonication  at  room  temperature  for  4  h.  The  Kaiser  test  indicated  the
203reaction  was  completed.  The  resin  was  filtered  and  washed  sequentially  with 
dimethylformamide (4 x 50 ml), dichloromethane (3 x 50 ml), dimethylformamide (2 x 
25 ml) and dichloromethane (2 x 50 ml). The resin was dried under vacuum to give the 
product 352 (3.16 g). Fmoc substitution = 0.49 mmol/g.
FmocAla-Arg(Pbf)-CA-OH (147)
A  suspension  of  the  resin  352  (3.16  g,  0.49  mmol/g)  in  a  solution  of  acetic 
acid/trifluoroethanol/dichloromethane (2 :2 :6 , 2 0  ml) was sonicated at room temperature 
for  3  h.  The  resin  was  filtered  and  washed  sequentially  with  acetic 
acid/trifluoroethanol/dichloromethane  (2:2:6,  40  ml),  dichloromethane  (40  ml), 
methanol (20 ml) and dichloromethane (40 ml). The filtrate was concentrated in vacuo 
to  afford  a  brown  coloured  oil.  Purification  by  flash  chromatography  (SiCb; 
methanol/ethyl  acetate;  2:8)  gave the product  as  a white  solid (0.50  g,  21%  over six 
steps). m.p.  135 °C; Rf = 0.51 (SiC>2; methanol/ethyl acetate; 2/8);  NMR (500 MHz, 
CD3OD)  5H /ppm  1.31  (m,  6 H,  -CH2CH2CH2NHC(NH)NH-  and HO2CCH2CH2CH2-), 
1.39  (s,  6 H,  -CH2C(CH3)20 -),  1.46  -   1.57  (m,  7H,  HO2CCH2CH2CH2CH2-  and  - 
HNC(0)CHC(CH3)-),  2.03  (s,  3H,  C(e)CH3),  2.24  (m,  2 H,  HO2CCH2-), 2.48  (s,  3H, 
C(f)CH3),  2.55  (s,  3H,  C(b)CH3),  2.92  (s,  2H,  -CH2C(CH3)20 -),  3.12  (m,  4H,  -
204ClfcNHCCO)-  and  -CH2NHC(NH)NH-),  4.09  (m,  1H,  -HNC(0)CH(CH3)-),  4.17  (m, 
1H, H(l)), 4.32 (m, 3H, -HNC(0)CHNHC(0)- and H(1)CH2-), 7.28 (m, 2H, H(4) and 
H(ll)), 7.34 (m, 2H, H(5) and H(10)), 7.63 (m, 2H, H(3) and H(12)), 7.75 (d, J= 6.9, 
2H,  H(6 )  and  H(9));  13C  NMR  (125  MHz,  CD3OD)  6c/ppm  12.5  (C(e)CH3),  18.0 
(C(b)CH3), 18.4 (C(f)CH3), 19.6 (-C(0)CH(CH3)NH-), 25.7 (HO2CCH2CH2CH2-), 27.4 
(HO2CCH2CH2-),  28.7  (-CH2C(CH3)2-0-), 29.9, 30.3,  33.0 (-CH2CH2NHC(0)- and  - 
CH2CH2NHC(NH)NH-),  34.9  (HO2CCH2-),  40.2  (-CH2NHC(0)-),  43.9  (-
CH2NHC(NH)NH-),  52.3  (-C(0)NHCH(CH3)C(0)-),  54.2  (-C(0)CHNHC(0)-),  68.0 
(C(1)CH2-),  87.6 (-CH2C(CH3)2-0-),  118.4 (C(e»,  120.9 (C(6 ) and C(9)),  126.2 (C(3) 
and C(12)),  128.2 (C(4) and C(11)), 128.8 (C(5) and C(10)), 133.5 (C(c)), 134.3 (C(b)),
139.4 (C(7) and C(8)),  142.5 (C(2 ) and C(13)), 145.1 (C(a)), 145.3 (C(f)), 158.1 (C(d)),
158.5  (C(1)CH2C02-),  159.8  (-HNC(NH)NH-),  173.7,  175.7,  177.6  (H02C-,  - 
NHC(0)CHNH- and -NHC(0)CH(CH3)NH-);  vm„ (nujol/cm'1 ) 1377 (s, S0 2-N),  1542 
(br, C=0 (amide)),  1708 (w, C=0 (acid)), 2922 (s, C-H), 3376 (w, N-H);  m/z (FAB) 
833  (69%,  (M]+);  HRMS  found  833.3870,  [M]+  (C43H56N60 9S)  requires  833.3908; 
[a]D  + 3.1 °(c 0.26, MeOH).
205Synthesis of FmocArg(Pbf)-Ala-CA-OH Binding Unit 148
_  20%  Piperidine/DMF
Fmoc-CA-OH  +   2-C I-T rt-0  DIPEA,  DCI^  F m oc-C A -O -#--------------------------- ►   H2N-CA-0-
142  144  349  145
Fmoc-Ala-OH,  PyBOP,  20% Piperidine/DMF  A
-----------------------------►   Fm oc-A la-C A -O -#        H2N -A la-C A -0-#
HOBt,  DIPEA, DMF
353  354
FmocArg(Pbf)-OH, PyBOP,  2:2:6
FmocArg(Pbf)-Ala-CA-0— ^
HOBt,  DIPEA,  DMF  w   AcOH:MeOH:DCM
355
FmocArg(Pbf)-Ala-CA-OH
148
9   = 2-chlorotrityl resin 
CA =  -HN(CH2)5C 0 2H
Resin 349
#-2CI-Trt-CA(Fmoc)
Diisopropylethylamine (1.38 ml, 7.93 mmol) was added to a stirred solution of Fmoc-6 - 
aminocaproic  acid  142  (0.70  g,  1.98  mmol)  in  anhydrous  dichloromethane  (20  ml) 
under nitrogen. The mixture was stirred for an additional 10 min. The resulting solution 
was  added  to  2-chlorotrityl  resin  (1.18  g,  1.40  mmol/g)  and  the  mixture  agitated by 
sonication at room temperature for 3 h. The resin was filtered and washed sequentially 
with methanol (3 x 40 ml), methanol/dichloromethane /diisopropylethylamine (2:17:1, 3 
x  40  ml),  dichloromethane  (3  x  40  ml),  dimethylformamide  (3  x  40  ml)  and 
dichloromethane (3 x 40 ml). The resin was dried under vacuum overnight to afford the 
desired product (1.70 g). Fmoc substitution = 0.97 mmol/g.
206Resin 145
# — 2CI-Trt-CA-NH2
The resin 349  (1.70 g) was suspended in piperidine/dimethylformamide solution (2:8, 
20 ml)  and sonicated at room temperature for 3 h.  The resin was filtered and washed 
with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml). The resin was 
dried under vacuum to give the deprotected resin 145 (1.16 g).
Resin 353
®-2CI-T  rt-CA-Ala-Fmoc
Diisopropylethylamine (1.17 ml, 6.75 mmol) was added to a stirred solution of Fmoc- 
alanine  (1.05  g,  3.38  mmol),  PyBOP  (1.76  g,  3.38  mmol)  and  HOBt  (0.46  g,  3.38 
mmol) in anhydrous dimethylformamide (15 ml), under nitrogen. The resulting mixture 
was added immediately to the resin 145 (1.16 g, 0.97 mmol/g) and the suspension was 
agitated  by  sonication  at  room  temperature  for  4  h.  The  Kaiser  test  indicated  the 
reaction was completed. The resin was filtered and washed with dimethylformamide (4 
x  50  ml),  dichloromethane  (3  x  50  ml),  dimethylformamide  (2  x  25  ml)  and 
dichloromethane (2x50 ml). The resin was dried under vacuum to give the product 353 
(1.38 g). Fmoc substitution = 0.57 mmol/g.
Resin 354
# — 2CI-Trt-CA-Ala-NH2
A suspension of the resin 353 (1.38 g) in piperidine/dimethylformamide solution (2:8, 
20 ml) was sonicated at room temperature for 3  h. The resin was filtered and washed 
with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml) and dried under 
vacuum to give 354 (1.13 g).
207Resin 355
#-2CI-Trt-CA-Ala-Arg(Pbf)Fmoc
Diisopropylethylamine (0.67 ml, 3.86 mmol) was added to a stirred solution of Fmoc- 
Arg(Pbf)-OH (1.25 g, 1.93 mmol), PyBOP (1.00 g,  1.93 mmol) and HOBt (0.26 g, 1.93 
mmol) in anhydrous dimethylformamide (20 ml) under nitrogen. The resulting mixture 
was immediately added to the resin 354 (1.13 g, 0.57 mmol/g) and the suspension was 
agitated  by  sonication  at  room  temperature  for  4  h.  The  Kaiser  test  indicated  the 
reaction was completed. The resin was filtered and washed with dimethylformamide (4 
x  50  ml),  dichloromethane  (3  x  50  ml),  dimethylformamide  (2  x  25  ml)  and 
dichloromethane (2 x 50 ml). The resin was dried under vacuum to give 354 (1.75 g). 
Fmoc substitution = 0.38 mmol/g.
FmocArg(Pbf)-Ala-CA-OH 148
10
HN
Resin  355  (1.75  g,  0.38  mmol/g)  in a  solution  of  acetic
acid/trifluoroethanol/dichloromethane (2 :2 :6 ,  15 ml) was sonicated at room temperature 
for  3  h.  The  resin  was  filtered  and  washed  with  acetic
acid/trifluoroethanol/dichloromethane  (2:2:6,  40  ml),  dichloromethane  (40  ml),
208methanol (20 ml) and dichloromethane (40 ml). The filtrate was concentrated in vacuo 
to  afford  a  brown  oil.  Purification  by  flash  chromatography  (SiCb;  methanol/ethyl 
acetate; 20:80) gave the product as a white solid (0.55 g, 33% over six steps). m.p. 150 
°C; Rf = 0.45  (Si02; MeOH/EtOAc; 2:8);  'H NMR (500 MHz, CD3OD) 5H /ppm  1.30 
(m,  4H,  HO2CCH2CH2CH2-,  -CH2CH2CH2NHC(NH)NH-),  1.40  (s,  6H,  -
CH2C(CH3)2C(0 )-),  1.46 -   1.57  (m, 9H, HO2CCH2CH2CH2CH2-, -HNC(0)CH(CH3)- 
and -CH2CH2NHC(NH)NH-), 2.04 (s, 3H, CCeJCHj), 2.20 (m, 2H, HO2CCH2-), 2.50 (s, 
3H,  C(f)CH3), 2.57  (s,  3H,  C ^ Q t) ,  2.93  (s,  2H,  -CH2C(CH3)2-0 -), 3.15  (m, 4H,  - 
CH2NHC(0 )CH(CH3)-  and  -CH2NHC(NH)NH-),  4.05  (m,  1H,  -HNC(0)CH(CH3)), 
4.19 (m,  1H, H(l)), 4.29 -  4.41  (m, 3H, -NHC(0)CHNHC02- and H(1)CH2-), 7.25 (m, 
2H, H(4) and H(11)), 7.26 (m, 2H, H(5) and H(10)), 7.62 (m, 2H, H(3) and H(12)), 7.75 
(d, J = 7.6, 2H, H(6 ) and H(9)); !3C NMR (125 MHz, CD3OD) 6 c/ppm  12.5 (C(e)CH3),
18.2  (C(b)CH3), 18.4 (C(f)CH3), 19.6 (-C(0)CH(CH3)NH-), 26.3 (HO2CCH2CH2CH2-),
27.5  (HO2CCH2CH2-),  28.7  (-CH2C(CH3)2-0-),  30.0,  30.2,  30.7  (-CH2CH2NHC(0)- 
and  -CH2CH2NHC(NH)NH-),  36.6  (HO2CCH2-),  40.2  (-CH2NHC(0)-),  43.9  (- 
CH2NHC(NH)NH-)  48.5  (C(l)),  48.8  (-CH2C(CH3)2-0-),  50.5  (-C(0)CH(CH3)NH-),
56.1  (-C(O)CHNHC(O)-),  67.9  (C(1)HCH2-),  87.6  (-CH2C(CH3)2-0 -),  118.4  (C(e)),
120.9  (C(6 ) and C(9)), 126.2 (C(3) and C(12», 128.2 (C(4) and C(ll)), 128.8 (C(5) and 
C(10)), 133.5 (C(c)), 134.4 (C(b)), 139.4 (C(7) and C(8)), 142.6 (C(2) and C(13)), 145.1 
(C(a)),  145.3  (C(f»,  158.2  (C(d)),  158.6  (C(l)CH2OC(0)-),  159.8  (-NHC(NH)NH-), 
174.4,  174.7,  180.3  (HO2C-,  -NHC(0)C(CH3)NHC(0)-);  I'm,,  (nujol/cm1)  1377  (s, 
SO2-N),  1552 (br, C=0 (amide)), 1645 (br, C O  (amide)), 1708 (w, O O  (acid)), 2854, 
2923  (s, C-H),  3322 (w, N-H);  m/z (FAB) 834 (35%,  [M + H]+),  833 (65%,  [M]+); 
HRMS found 833.3964, [M]+ (C43H56N6 0 9S) requires 833.3908.
209Synthesis of FmocGly-Ala-CA-OH Binding Unit 149
n in r .  _   20% Piperidine/DMF  ^
Fmoc-CA-OH  +   2-C I-T rt-^  D.IP.|A ,  PCM  F m o c-C A -O -#----------------------------►   H2N-CA-0“#
142  144  349  145
Fmoc-Ala-OH,  PyBOP,  20% Piperidine/DMF  A
-----------------------------     Fm oc-A la-C A -O -#        H2N -A la-C A -Q -#
HOBt,  DIPEA,  DMF
353 354
Fmoc-Gly-OH,  PyBOP 
HOBt,  DIPEA,  DMF
Fmoc-Gly-Ala-CA-O—^  
356
2:2:6
AcOH:MeOH:DCM
Fmoc-Gly-Ala-CA-OH
149
2-chlorotrityl resin 
CA= -HN(CH2)5C 0 2H
Resin 349
#-2CI-Trt-CA(Fmoc)
Diisopropylethylamine (1.38 ml, 7.93 mmol) was added to a stirred solution of Fmoc-6 - 
aminocaproic  acid  142  (0.70  g,  1.98  mmol)  in  anhydrous  dichloromethane  (20  ml) 
under nitrogen. The mixture was stirred for an additional 10 min. The resulting solution 
was  added  to  2-chlorotrityl  resin  (1.18  g,  1.40  mmol/g)  and the  mixture  agitated by 
sonication at room temperature for 3 h. The resin was filtered and washed sequentially 
with methanol (3 x 40 ml), methanol/dichloromethane /diisopropylethylamine (2:17:1, 3 
x  40  ml),  dichloromethane  (3  x  40  ml),  dimethylformamide  (3  x  40  ml)  and 
dichloromethane (3 x 40 ml). The resin was dried under vacuum overnight to afford the 
desired product (2.48 g). Fmoc substitution = 0.91 mmol/g.
210Resin 145
#-2CI-Trt-CA-NH2
The resin 349  (2.48  g) was suspended in piperidine/dimethylformamide solution (2:8, 
20 ml) and sonicated at room temperature for 3  h.  The resin was filtered and washed 
with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml). The resin was 
dried under vacuum to give the deprotected resin 145 (1.94 g).
Resin 353
^~2CI-T  rt-CA-Ala-Fmoc
Diisopropylethylamine (1.84 ml,  10.6 mmol) was added to a stirred solution of Fmoc- 
alanine  (1.65  g,  5.30  mmol),  PyBOP  (2.75  g,  5.30  mmol)  and  HOBt  (0.71  g,  5.30 
mmol) in anhydrous dimethylformamide (15 ml), under nitrogen. The resulting mixture 
was added immediately to the resin 145 (1.94 g, 0.91  mmol/g) and the suspension was 
agitated  by  sonication  at  room  temperature  for  4  h.  The  Kaiser  test  indicated  the 
reaction was completed. The resin was filtered and washed with dimethylformamide (4 
x  50  ml),  dichloromethane  (3  x  50  ml),  dimethylformamide  (2  x  25  ml)  and 
dichloromethane (2 x 50 ml). The resin was dried under vacuum to give the product 353 
(2.64 g). Fmoc substitution = 0.76 mmol/g.
Resin 354
# — 2CI-Trt-CA-Ala-NH2
A suspension of the resin 353 (2.64 g) in piperidine/dimethylformamide solution (2:8, 
20 ml) was sonicated at room temperature for 3  h.  The resin was filtered and washed 
with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml) and dried under 
vacuum to give 354 (2.01 g).
211Resin 356
2CI-T  rt-CA-Ala-Gly-Fmoc
Diisopropylethylamine (1.59 ml, 9.17 mmol) was added to a stirred mixture of Fmoc- 
glycine  (1.36  g,  4.58  mmol),  PyBOP  (2.38  g,  4.58  mmol)  and  HOBt  (0.62  g,  4.58 
mmol) in anhydrous dimethylformamide (20 ml), under nitrogen. The resulting mixture 
was then added immediately to the resin 354 (2.01  g, 0.76 mmol/g) and the suspension 
was agitated by sonication at room temperature for 4 h.  The Kaiser test indicated the 
reaction was completed. The resin was filtered and washed with dimethylformamide (4 
x  50  ml),  dichlorormethane  (3  x  50  ml),  dimethylformamide  (2  x  25  ml)  and 
dichloromethane (2 x 50 ml). The resin was dried under vacuum to give 356 (2.62 g). 
Fmoc substitution = 0.40 mmol/g.
FmocGly-Ala-CA-OH (149)
.OH
O
The  resin  356  (2.62  g,  0.40  mmol)  was  sonicated  in  a  solution  of  acetic 
acid/trifluoroethanol/dichloromethane (2:2:6, 20 ml) at room temperature for 3 h. The 
resin was filtered and washed with acetic acid/trifluoroethanol/dichloromethane (2 :2 :6 , 
40 ml), dichloromethane (40 ml), methanol (20 ml) and dichloromethane (40 ml). The 
filtrate  was  concentrated  in  vacuo  to  afford  a  brown  oil.  Purification  by  flash 
chromatography (Si0 2 ;  methanol/ethyl  acetate;  2 :8)  gave the desired the product as a 
beige solid (0.62 g, 46% over six steps). m.p.  1 1 0 °C; Rf = 0.48 (SiCb; methanol/ethyl 
acetate; 2:8);  'H NMR (500 MHz, CD3OD) SH /ppm  1.33  (m, 5H, H02CCH2CH2CH2- 
and -HNC(0)C(CH3)-),  1.48 (m, 2H, -CH2CH2NHC(0 )-),  1.57 (m, 2 H, HO2CCH2CH2- 
), 2.24 (t, J=  7.4, 2H, HO2CCH2-), 3.14 (m, 2H, -CH2CH2NHCXO)-), 3.74, 3.79 (AB q,
212J= 16.7, 2H, -HNC(0 )CH2NH-), 4.20 (m, 1H, H(l)), 4.32 -  4.38 (m, 3H, H(1)CH2- and 
-NHC(0)CH(CH3)-), 7.28 (m, 2H, H(4) and H(ll)), 7.36 (m, 2H, H(5) and H(10)), 7.61 
(d, J = 7.4, 2H, H(3) and H(12)), 7.75 (d, J=  7.5, 2H, H(6 ) and H(9)); UC NMR (125 
MHz,  CD3OD)  Vppm  18.3  (-HNC(0)CH(CH3)-),  25.7  (HO2CCH2CH2CH2-),  27.4 
(HO2CCH2CH2-),  30.0  (-CH2CH2NHC(0)-),  35.1  (H02CCH2-),  40.4  (-
CH2CH2NHC(0)-),  45.2  (-HNC(0)CH2NH-),  48.9  (C(l)),  50.4  (-
HNC(0)CH(CH3)), 68.3 (C(1)HCH2-),  120.9 (C(6 ) and C(9)),  126.1  (C(3) and C(1 2)), 
128.1 (C(4) and C(11)), 128.8 (C(S) and C(10)), 142.6 (C(7) and C(8 )), 145.3 (C(2) and 
C(13)),  171.7,  174.6,  177.8  (H02CCH2-, -HNC(0)CH(CH3)-  and  -HNC(0)CH2NH-); 
C m ax  (KBr/cm'1 )  1538  (br,  C=0  (amide)),  1645  (br,  C=0  (amide)),  1708  (br,  C=0 
(acid)),  2936  (s,  C-H),  3069 (s,  C-H),  3308 (s, N-H);  m/z (FAB) 482 (100%,  [M + 
H]+);  HRMS  found  504.2117,  [M  + N af  (C26H3iN30 6Na)  requires  504.2110;  Anal. 
(C26H31N3O6.H2O)  found C,  61.66; H, 6.69; N,  8.31%; requires C, 62.51; H,  6 .6 6 ; N, 
8.41%.
Synthesis of FmocAla-Gly-CA-OH Binding Unit 150
Fmoc-CA-OH  +   2-C I-T rt-^  DlpEA, DCM  pmoc-CA-O- 
142  144  349
20% Piperidine/DMF
h2n-c a-o -
145
Fmoc-Gly-OH,  PyBOP 
HOBt,  DIPEA,  DMF
Fmoc-Gly-CA-O— ^  
357
20% Piperidine/DMF
H2N-Gly-CA-Q -#
358
Fmoc-Ala-OH,  PyBOP 
HOBt,  DIPEA,  DMF
FmocAla-Gly-CA-O—®
2:2:6
359
AcOH:MeOH:DCM
Fmoc-Ala-Gly-CA-OH
150
^   = 2-chlorotrityl resin 
CA =  -HN(CH2)5C 0 2H
213Resin 349
#-2CI-Trt-CA(Fmoc)
Diisopropylethylamine (1.97 ml, 11.3 mmol) was added to a stirred solution of Fmoc-6 - 
aminocaproic  acid  142  (1.00  g,  2.83  mmol)  in  anhydrous  dichloromethane  (20  ml) 
under nitrogen. The mixture was stirred for an additional 10 min. The resulting solution 
was  added  to  2-chlorotrityl  resin  (1.69  g,  1.40  mmol/g)  and the mixture  agitated by 
sonication at room temperature for 3 h. The resin was filtered and washed sequentially 
with methanol (3 x 40 ml), methanol/dichloromethane /diisopropylethylamine (2:17:1, 3 
x  40  ml),  dichloromethane  (3  x  40  ml),  dimethylformamide  (3  x  40  ml)  and 
dichloromethane (3 x 40 ml). The resin was dried under vacuum overnight to afford the 
desired product (2.40 g). Fmoc substitution = 0.97 mmol/g.
Resin 145 
#-2CI-Trt-CA-NH2
The resin 349  (2.40 g) was suspended in piperidine/dimethylformamide solution (2:8, 
20 ml) and sonicated at room temperature for 3 h.  The resin was filtered and washed 
with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml). The resin was 
dried under vacuum to give the deprotected resin 145 (1.84 g).
Resin 357 
2CI-T  rt-CA-Gly-Fmoc
To a stirred solution of Fmoc-Glycine (1.59 g, 5.35 mmol), PyBOP (2.78 g, 5.35 mmol) 
and  HOBt  (0.72  g,  5.35  mmol)  in  anhydrous  dimethylformamide  (20  ml), 
diisopropylethylamine  (1.86  ml,  10.7  mmol)  was  added.  The  resulting  solution  was 
immediately added to the resin 145 (1.84 g, 0.97 mmol/g). The suspension was agitated 
by sonication at room temperature for 4 h.  The Kaiser test indicated the reaction was
214completed. The resin was filtered and washed sequentially with dimethylformamide (4 
x  50  ml),  dichloromethane  (3  x  50  ml),  dimethylformamide  (2  x  25  ml)  and 
dichloromethane  (2 x  50 ml).  The resin was dried under vacuum to give product 357 
(2.40 g). Fmoc substitution = 0.82 mmol/g.
Resin 358 
#-2CI-Trt-CA-Gly-NH2
The resin 357  (2.40  g) was suspended in piperidine/dimethylformamide solution (2:8, 
20 ml)  and sonicated at room temperature for 3  h. The resin was filtered and washed 
with dimethylformamide (5 x 30 ml) and dichloromethane (5 x 25 ml), and dried under 
vacuum to give product 358 (1.87 g).
Resin 359
2CI-T  rt-CA-Gly-Ala-Fmoc
To a stirred solution of Fmoc-Alanine (1.43 g, 4.60 mmol), PyBOP (2.39 g, 4.60 mmol) 
and  HOBt  (0.62  g,  4.60  mmol)  in  anhydrous  dimethylformamide  (20  ml), 
diisopropylethylamine (1.60 ml,  9.20 mmol) was added.  The solution was then added 
immediately to  the resin 358  (1.87  g,  0.82 mmol/g).  The  suspension was  agitated by 
sonication  at  room  temperature  for  4  h.  The  Kaiser  test  indicated  the  reaction  was 
completed. The resin was filtered and washed sequentially with dimethylformamide (4 
x  50  ml),  dichloromethane  (3  x  50  ml),  dimethylformamide  (2  x  25  ml)  and 
dichloromethane (2 x 50 ml). The resin was dried under vacuum to give the product 359 
(2.56 g). Fmoc substitution = 0.58 mmol/g.
215FmocAla-Gly-CA-OH 150
A  suspension  of  resin  359  (2.56  g,  0.58  mmol/g)  in  acetic
acid/trifluoroethanol/dichloromethane (2 :2 :6 , 2 0  ml) was sonicated at room temperature 
for  3  h.  The  resin  was  then  filtered  and  washed  sequentially  with  acetic 
acid/trifluoroethanol/dichloromethane  (2:2:6,  40  ml),  dichloromethane  (40  ml), 
methanol (20 ml) and dichloromethane (40 ml). The filtrate was concentrated in vacuo 
to  afford  a  brown  coloured  oil.  Purification  by  flash  chromatography  (Si02; 
methanol/ethyl acetate; 2:8) gave the product as a white solid (0.44 g, 32% yield over 
six steps).  m.p.  104 °C; Rf = 0.52 (Si0 2 ; chloroform/methanol/acetic acid;  80:20:0.1);
NMR (500 MHz, CD3OD) 5H /ppm 1.26 (m, 2H, H0 2CCH2CH2CHr), 1.33 (m, 3H, - 
NHC(0)CH(CH3)NH-),  1.46 (m, 2H, CH2CH2NHC(0 )-),  1.53 (m, 2H, HO2CCH2CH2- 
),  2.17  (m,  2H,  HO2CCH2-),  3.12  (m, 2H,  -CH2CH2NHC(0 )-),  3.74,  3.85  (AB q, J = 
16.9,  2H,  -HNC(0)CH2NH-),  4.04  (m,  1H,  -HNC(0)CH(CH3)HN-),  4.21  (m,  1H, 
H(1)CH2-), 4.38 (m, 2H, H(1)CH2-), 7.29 (m, 2H, H(4) and H(ll)), 7.37 (m, 2H, H(5) 
and H(10)), 7.64 (m, 2H, H(3) and H(12)), 7.76 (d,  J=  7.4, 2H, H(9) and H(6 ));  13C 
NMR  (125  MHz,  CD3OD)  5c/ppm  17.4  (-HNC(0)CH(CH3)NH-),  26.1  (-
HO2CCH2CH2CH2-), 27.5 (HO2CCH2CH2), 29.9 (-CH2CH2NHCO-), 36.2 (H02CCH2-),
40.3  (-CH2CH2NHC(0)-),  43.6  (-HNC(0)CH2NHC(0)-),  48.7  (C(l)),  52.6  (- 
C(0)CH(CH3)NHC(0)-),  6 8 .0   (C(1)CH2-),  121.0  (C(6 )  and  C(9)),  126.2  (C(3)  and 
C(12)),  128.2 (C(4) and C(ll)),  128.8  (C(5) and C(10)),  142.6 (C(7) and C(8)),  145.2 
(C(2)  and  C(13),),  158.7  (C(1)CH2C0 2NH-),  171.4,  176.3,  179.7  (H02CCH2CH2,  - 
CH2NHC(0)CH2. and -HNC(0)CH(CH3)-);  vmax (nujol/cm'1)  1560 (br, C=0 (amide)), 
1647 (br, C=0 (amide)), 1694 (br, C=0 (acid)), 2853 (s, C-H), 3295 (N-H);  m/z (FAB) 
504  (49%,  [M  +  Na]+),  482  (29%,  [M  +  H]+);  HRMS  found  482.2285,  [M  +  H]+ 
(C26H32N30 6) requires 482.2291; Anal. (C26H3iN30 6.H20) found C, 61.94; H, 6.36; N,
2168.45%; requires C, 62.51; H, 6 .6 6 ; N, 8.41%; [a]D  + 1.8 ° (c 0.34, MeOH).
Synthesis of BocHis(Boc)-CA-OH Catalytic Unit 190
5-(2-tert Butoxycarbonylamino-2-carboxy ethyl) imidazole-1-carboxylic
acid tert butyl ester (188)158
OH O
L-Histidine (0.30 g,  1.94 mmol) was dissolved in methanol (7.5 ml) and triethylamine 
(0.25  ml, 4.26 mmol)  followed by di-ter£-butyl dicarbonate (0.93  g,  1.76 mmol) were 
added  and  the  reaction was  stirred  at room temperature  for 23  h.  The  solvents were 
removed in vacuo and the resulting residue was partitioned between water ( 2 0 ml) and 
diethyl  ether  (30  ml).  The  layers  were  separated  and  the  aqueous  layer  was  then 
acidified to pH 4 with aqueous HC1 (1 M) and subsequently extracted with ethyl acetate 
(3  x  2 0   ml).  The  combined  ethyl  acetate  layers  were  dried  over  MgSC>4  and 
concentrated in vacuo,  which provided a sticky white solid. The solid was dissolved in 
methanol/dichloromethane  (1:1)  and then precipitated by the addition of hexane.  The 
desired product was isolated as a white solid (0.34 g, 50%). m.p. 109 °C;  NMR (300 
MHz, CDC13) SH /ppm 1.41  (s, 9H, -C(CH3)3),  1.58 (s, 9H, -C(CH3)3), 3.16 (brm, 2H, - 
CH2-), 4.48 (br m, 1H, -NHCHC02H), 5.44 (br s, 1H, -C(O)NH-), 7.14 (s, 1H, -C=CH), 
8.13  (s,  1H,  N=CHN-);  13C  NMR  (75  MHz,  CDC13)  5c/ppm  27.8  and  28.4  (2  x  -  
C(CH3)3), 29.7  (-CH2-),  52.8  (-NHCHC02H),  79.6 and 86.4 (2 x -C(CH3)3),  115.6 (- 
C=CH-), 136.5 (-C=CH-), 137.0 (-N=CHN), 146.3 (Im-NC(O)O-), 155.2 (-NHC(O)O-),
173.0  (-C02H);  vm ax (DCM/cnf1)  1366 (s,  -C(CH3)3),  1707,  1763  (s, C=0), 2476 (w, 
O N ), 2970 (m, C-H), 3447 (w, N-H); m/z (CI+) 356 (48%,  [M + H]+).
2176-Ammonium-hexanoic acid benzyl ester/i-toluene sulfonate (185)159
O
O
6 -Aminocaproic acid (2.00 g, 15.0 mmol), benzyl alcohol (16 ml, 150 mmol) and para- 
toluene sulfonic acid (3.19 g,  17.0 mmol) were dissolved in toluene and heated at 120 
°C (Dean-Stark conditions) for 5 h. After cooling, diethyl ether (70 ml) was added and 
the mixture cooled (ca.  4 °C), the resulting white solid was isolated by filtration. The 
filter cake was washed with diethyl ether and dried under vacuum to yield the desired 
product  as  a  white  solid  (5.10  g,  81%).  m.p.  110  °C;  Rf  =  0.41  (Si0 2 ;  ethyl 
acetate/methanol;  4:1);  *H  NMR  (300  MHz,  CDC13)  SH /ppm  1.23  (m,  2H, 
H3NCH2CH2CH2-),  1.46 (m, 4H, -H3NCH2CH2CH2-), 2.19 (m,  2 H, H3NCH2-), 2.30 (s, 
3H, CHjAr-), 2.73 (s, 2H, -CH2CO2-), 5.07 (s, 2H, -CI^Ar), 7.14 (d, 2H, J= 7.8, tosyl 
ArH), 7.33 (m, 5H, ArH), 7.66 (br s, 3H, -NH3), 7.72 (d, J = 8.0, 2H, -tosyl ArH); 13C 
NMR  (75  MHz,  CDCI3)  5c/ppm  21.3  (CH3Ar),  24.2,  25.8  and  27.0
(H3NCH2CH2CH2CH2-),  33.8  (H3NCH2-),  39.7  (-CH2CO2),  6 6 .2   (-C0 2CH2Ar),  125.9, 
128.2, 128.6 and 129.1 (9 x ArC), 136.0, 140.9 and 141.1 (3 x quaternary ArC), 173.2 (- 
CO2CH2-); Pmax (nujol/cm-1) 1621 (w, Ar), 1725 (s, C=0), 2855 (s, CH); m/z (FAB) 222 
(67%,  [M  +  H+  -  [MeArS03]'),  244  (36%,  [M  +  Na+  -  MeArS03*);  HRMS  found 
244.1315, [M + Na+ - MeArSCy (Ci3Hi9N0 2 Na) requires 244.1313.
2185-[2-(5-Benzyloxycarbonyl-pentylcarbamoyl)-2-ferr-butoxycarbonylamino-ethyl]- 
imidazole-1-carboxylic acid tert-butyl ester (189)
O
O
A  solution  of BocHis(Boc)OH  188  (9.50  g,  27.0  mmol)  and  anhydrous  A-methyl 
morpholine (6.44 ml, 59.0 mmol) in anhydrous dichloromethane (150 ml) was cooled to 
-15 °C under nitrogen. Isobutyl chloroformate (4.07 ml, 31.0 mol) was added dropwise 
and the solution was stirred at -15 °C for 20 min..  6 -Ammonium-hexanoic acid benzyl 
ester /^-toluene  sulfonate  186  (11.0  g,  27.0  mmol)  was  added  and  the  mixture  was 
allowed to warm to room temperature and stirring was continued for 20 h. The solvent 
was removed in vacuo and the residue was partitioned between ethyl acetate (80 ml) and 
water  (80  ml).  The  layers  were  separated  and  the  organic  layer  was  washed  with 
aqueous KHSO4 ( 1 0% v/v,  1 0 0 ml), brine  ( 1 0 0  ml), aqueous NaHC03  (1 0% v/v,  1 0 0  
ml),  brine  (100  ml),  dried  over  MgSC>4  and  solvents  removed.  Purification by  flash 
chromatography  (Si0 2 ;  gradient;  petroleum  spirit/ethyl  acetate  (3:1)  to  petroleum 
spirit/ethyl  acetate  (1:3))  gave  the  product  as  a brown  oil  (2.97  g,  19%).  Rf =  0.27 
(Si02;  ethyl  acetate/petroleum spirit;  3:1);  NMR (400 MHz, CDCI3) 5n/ppm 0.93 
(m,  3H,  -CH2CH(H)CH2C0 2-),  1.38  (m,  1 0H,  -C(CH3 )3  and  -CH2CH(H)CH2C02-), 
1.58 (m,  1 1H, -C(CH3) 3 and-CH 2(CH2)3C0 2-), 2.32 (m, 2 H, -CfkCOr), 2.91 (m,  1H, - 
NHC(0)CHCH(H)-), 3.10 (m,  1H, NHC(0)CHCH(H)-), 3.15 (m, 2H, -CH2(CH2)4C02- 
), 4.38 (br m,  1H, -NHC(O)CH-), 5.09 (s, 2H, -CH^At), 6.07 (br m, 1H, NHC02-), 6.69 
(br m, 1H, NHC(O)CH-), 7.29 (m, 6 H, ArH and -CH=C-), 7.98 (s, 1H, -N=CH-N-); 13C 
NMR (75  MHz, CDC13) 5c/ppm 24.3  (-CH2CH2CH2C02-), 26.0 (-CH2CH2C02-), 27.6 
and  27.9  (-C(CH3)3),  28.9  (-CH2(CH2)3C02-),  30.9,  33.8  (-CH2C02-  and  -  
NHC(0)CHCH2-),  38.9  (-C(0)NCH2-),  54.0 (-NHC(O)CH-),  65.8  (-CH2Ar), 79.2 and
85.2  (2  x  -C(CH3)3),  114.5  (-CH=C-),  126.7,  128.1,  128.3  (ArC),  136.0  (quaternary
219ArC),  136.5  (-CH=C-),  139.3  (-N=CHN-),  146.7  (Im-NC(O)O-),  155.5  (-
NHC02C(CH3)3),  171.4 (-NHC(O)CH-), 173.0 (-C02CH2Ar); m/z (CI+) 559 (23%,  [M 
+  H]+);  HRMS  found  559.31383,  [M  +  H]+  (C29H43N4 0 7 )  requires  559.31316;  [a]D 
+16.3 °(c 0.40, MeOH).
5-[2-tert Butoxycarbonylamino-2-(5-carboxy pentylcarbamoyl) ethyl] imidazole-1
carboxylic acid tert-butyl ester (190)
To a stirred solution of 189 (0.50 g, 0.87 mmol) in ethanol (10 ml) was added palladium 
on carbon (10%, 0.50 g) and 1, 4-cyclohexadiene (0.83 ml, 8.70 mmol) under nitrogen. 
The mixture was stirred at room temperature for 19 h. The mixture was filtered through 
a plug of Celite and the filter cake was washed with ethanol (3x10 ml). The filtrate was 
concentrated  in  vacuo  and  the  crude  product  was  triturated  with 
dichloromethane/hexane which gave the product as a white solid (0.38 g, 90%). m.p. 72 
°C; Rf = 0.10 (Si02; ethyl  acetate/petroleum spirit;  1:1); *11 NMR (300 MHz, CDC13) 
5H /ppm 1.25 (m, 13H, -Q C H ^ and-CTkC^CHzCCV), 1.48 (m, 11H, -C(CH3)3 and- 
CH2(CH2)3C 02-),  2.18  (m,  2H,  -CHjC0 2-),  2.71  (m,  1H,  -NHC(0)CHCH(H)-),  2.78 
(m,  1H,  NHC(0)CHCH(H)-),  3.09  (m,  2H,  -CH2(CH2)4C02-),  4.33  (br  m,  1H,  - 
NHC(O)CH-), 5.83  (br m,  1H, NHC02-), 7.08 ( m,  1H, NHC(O)CH-), 7.18 (m,  1H, -  
CH=C-),  7.94  (s,  1H,  -NCH-N-);  13C  NMR  (75  MHz,  CDC13)  5c/ppm  22.5  (- 
CH2CH2CH2C02-), 26.0 (-CH2CH2C02-), 27.8, 28.2 (-C(CH3)3), 28.8 (-CH2(CH2)3C02- 
),  31.2  (-NHC(0)CHCH2-),  34.0  (-CH2C02-),  39.0  (-CH2(CH2)4C02-),  54.3  (- 
NHC(O)CH-),  79.7,  85.7  (2  x  -C(CH3)3),  114.8  (-CH=C-),  136.6  (-CH=C-),  139.1  (- 
N=CH-N-),  146.6  (Im-NC(O)O-),  155.6  (-NHC02C(CH3)3),  171.3  (-NHC(O)CH-),
OH
O
220177.0  (-C02H);  IV,,* (DCM/cm'1)  1390 (s, C(CH3)3),  1664 (s, C=0 (amide)),  1710 (s, 
C=0 (acid and Boc)), 2924 (s, C-H), 3437 (s, N-H); m/z (Cf) 469 (8 %,  [M + Hf), 369 
(75%,  [M + H -  Boc]+); HRMS found 469.26474,  [M + H]+  (C22H37N4O7) requires 
469.26621; Anal. (CisHasNjCVAHjO) found C, 55.47; H, 7.74; N,  11.57%; requires C, 
55.33; H, 7.81; N, 11.73%; [a]D  +10.4° (c 0.28, MeOH).
2214.2.3 Synthesis of Artficial Esterases
Synthesis of Artificial Esterases containing Arg-Arg Binding Unit
Polymer 167
m n-m-l
HN HN
His(Trt)
Fmoc
CA
Arg(Pbf)
Arg(Pbf)
Fmoc
Polyallylamine  hydrochloride  (100  mg,  1.08  mmol)  was  treated  with  potassium 
hydroxide (35.0 mg, 0.62 mmol) in methanol (10 ml) at room temperature for 16 h. The 
solvent  was  removed  under  reduced  pressure  and  ethanol  (15  ml)  was  added  to  the 
residue.  The resulting white precipitate was removed by filtration and the filtrate was 
concentrated in vacuo to leave approximately 1 0 ml of solvent.
FmocArg(Pbf)Arg(Pbf)-CA-OH  (131)  (360  mg,  0.30  mmol),  FmocHis(Trt)OH  (200 
mg,  0.30  mmol),  A^Af’-diisopropylcarbodiimide  (0.12  ml,  0.74  mmol)  and  N- 
hydroxysuccinimide  ( 1 0 0  mg,  0 .8 6  mmol) were  dissolved in chloroform  ( 2 0 ml)  and 
stirred  at  room  temperature  for  3  h.  This  solution  was  added  to  the  solution  of 
polyallylamine  in  ethanol  (above)  and the resulting mixture was then stirred at room 
temperature  for 24 h.  The reaction mixture was  concentrated to  approximately 20 ml 
and the crude product was precipitated by the addition of methanol. The precipitate was 
purified by trituration from methanol and the resulting solid was dried under vacuum. 
The  desired  polymer  was  isolated  as  a beige  solid  (280  mg).  NMR  (300  MHz, 
CDCI3)  6 H /ppm  1.13  -   1.63  (br,  CH?  of polyallylamine  and  amino  acids),  2.01  (br, 
ArCHj  of  Pbf),  2.45  (br,  CH  of  polyallylamine,  -CH?N-  of  amino  acids  and 
polyallylamine), 3.88 -  4.20 (br, oH of amino acids and -NHCO7CH7- of Fmoc group),
2226.90 -  7.76 (br, ArH of Fmoc, Trityl and histidine groups).
Polymer 360
m n-m-l
HN HN
His CA
Fmoc Arg
Arg
Fmoc
.xCF3C02H
A suspension of polymer (167) (252 mg) in trifluoroacetic acid/ triisopropylsilane/water 
(95:2.5:2.5, 20 ml) was sonicated at room temperature for 3 h. Water (5 ml) was added 
to the mixture which formed a cream coloured gum, which was isolated by filtration. 
The gum was washed with dichloromethane (3  x 30 ml), then dried under vacuum to 
yield  the  product  as  a  cream  coloured  gum  gum  (233  mg).  1H  NMR  (500  MHz, 
CD3OD)  6 H /ppm  1.17 -   1.96 (br,  CH? of polyallylamine and amino acids), 2.45, 3.15 
and 3.36 (br, CH of polyallylamine, -CH?N- of amino acids and polyallylamine), 4.06 -  
4.32 (br, oH of amino acids and -NHCCbCH?- of Fmoc group), 7.25 -  7.72 (br, H of 
Fmoc groups and histidine).
223Polymer 168
m n-m-l
HN HN
His CA
Arg
Arg
A suspension of polymer 360 (205 mg) in piperidine/anhydrous dimethylformamide (15 
ml, 2:8) was sonicated at room temperature for 3.5 h. The mixture was filtered and the 
resulting solid washed with dimethylformamide (5  x 20 ml), dichloromethane (5 x 20 
ml)  and dried under vacuum.  The desired product was  isolated as  a white solid (154 
mg).  'H  NMR (300  MHz,  D20) < 5 H /ppm  1.25 -   1.83  (br,  CH2  of polyallylamine and 
amino  acids),  2.27  -   3.39  (br,  CH  of polyallylamine,  -CH?N-  of amino  acids  and 
polyallylamine, -CH2- of histidine), 3.68 -  4.30 (br, oH of amino acids), 6.96 and 7.70 
(br, -CH=C- and N=CH-N of histidine).
Polymer 157
m n-m-l
HN HN HN
His(Trt) Lys(Fmoc)0 CA
Fmoc Fmoc
Arg(Pbf)
Fmoc
Polyallylamine  hydrochloride  (50.0  mg,  0.54  mmol)  was  treated  with  potassium 
hydroxide (35.0 mg, 0.62 mmol) in methanol (10 ml) at room temperature for 16 h. The 
solvent  was  removed  under  reduced pressure  and  ethanol  (15  ml)  was  added  to  the 
residue.  The resulting white precipitate was removed by filtration and the filtrate was
224concentrated in vacuo to leave approximately 10 ml of solvent.
FmocArg(Pbf)Arg(Pbf)-CA-OH  (131)  (180  mg,  0.15  mmol),  FmocHis(Trt)OH  (100 
mg,  0.15  mmol),  A^AT-diisopropylcarbodiimide  (0.05  ml,  0.32  mmol)  and  N- 
hydroxysuccinimide  (50.0 mg,  0.43  mmol) were dissolved in chloroform (20 ml) and 
stirred  at  room  temperature  for  3  h.  This  solution  was  added  to  the  solution  of 
polyallylamine  in  ethanol  (above)  and the resulting mixture was  then stirred at room 
temperature  for  2  h.  Concurrently,  FmocLys(Fmoc)-OH  (0.16  g,  0.27  mmol),  N,N’- 
diisopropylcarbodiimide (0.05  g, 0.32 mmol) and A-hydroxysuccinimide (0.04 g, 0.38 
mmol) were dissolved in chloroform  ( 2 0  ml) and stirred at room temperature for 2 h. 
This solution was then added to the solution containing polyallylamine and stirring was 
continued for 24 h. The reaction mixture was concentrated to approximately 20 ml and 
the  crude  product was precipitated by the  addition  of methanol.  The precipitate was 
purified by trituration from chloroform/methanol and the resulting solid was dried under 
vacuum.  The desired polymer was isolated as a white gum.  (100 mg).  NMR (300 
MHz,  CDCI3)  6 n/ppm  1.23 -   1.50 (br, CH?  of polyallylamine and amino acids), 2.00 
(br,  ArCHj  of  Pbf),  2.52  (br,  CH  of polyallylamine,  -CH?N-  of  amino  acids  and 
polyallylamine), 3.69 -  4.40 (br, oH of amino acids and -NHCO7CH7- of Fmoc group), 
7.12 -  7.75 (br, ArH of Fmoc, Trityl and histidine groups).
225Polymer 162
m n-m -l
HN HN HN
His Lys(Fmoc)0 CA
Fmoc Arg Fmoc
Arg
Fmoc
.xCF3C02H
A  suspension  of  polymer  (157)  (91.0  mg)  in  trifluoroacetic  acid/
triisopropylsilane/water (95:2.5:2.5,  10 ml) was sonicated at room temperature for 3 h. 
Water (5 ml) was added to the mixture which formed a white gum, which was isolated 
by filtration. The gum was washed with water (2 x 30 ml), trifluoroacetic acid (40 ml) 
and water (40 ml), then dried under vacuum to yield the product as a yellow gum (87 
mg).  NMR (300 MHz, CD3OD) 5H /ppm 1.16 -  1.79 (br, CH? of polyallylamine and 
amino  acids),  2.52  and  3.12  (br,  CH  of polyallylamine,  -CH?N-  of amino  acids  and 
polyallylamine), 4.09 -  4.30 (br, aH of amino acids and -NHCOoCH?- of Fmoc group), 
7.23 -  7.67 (br, H of Fmoc groups and histidine).
226Polymer 132
m n-m-l
HN HN HN
His CA Lys
Arg
Arg
A  suspension  of polymer  162  (54.0  mg)  in piperidine/anhydrous  dimethylformamide 
(15 ml, 2:8) was sonicated at room temperature for 3.5 h. The mixture was filtered and 
the resulting solid washed with dimethylformamide (5 x 20 ml), dichloromethane (5 x 
20 ml) and dried under vacuum. The desired product was isolated as a white solid (31.0 
mg).  NMR (300 MHz,  D2O)  dn/ppm  1.37 -  2.16  (br,  CH?  of polyallylamine and 
amino  acids),  2.31  -   3.52  (br,  CH  of polyallylamine,  -CH?N-  of amino  acids  and 
polyallylamine, -CH2- of histidine), 3.89 -  4.34 (br, oH of amino acids), 6.97 and 7.74 
(br, -CH=C- and N=CH-N of histidine);  vmax (solid state/cm'1 )  1559 (s, C=0 (amide), 
2175 (m, C=N), 3228 (w, N-H).
227Polymer 192
m n-m-l
HN HN HN
CA
I
His(Boc)
Lys(Fmoc) O CA
Arg(Pbf) Fmoc
Boc
Arg(Pbf)
Fmoc
Polyallylamine  hydrochloride  (100  mg,  1.08  mmol)  was  treated  with  potassium 
hydroxide (70.0 mg,  1.24 mmol) in methanol (15 ml) at room temperature for 16 h. The 
solvent  was  removed  under reduced  pressure  and  ethanol  (25  ml)  was  added to  the 
residue.  The resulting white precipitate was removed by filtration and the filtrate was 
concentrated in vacuo to leave approximately 1 0 ml of solvent.
FmocArg(Pbf)Arg(Pbf)-CA-OH  131  (350 mg,  0.30 mmol),  BocHis(Boc)-CA-OH  190 
(150  mg,  0.31  mmol),  A^Af’-diisopropylcarbodiimide  (0.12  ml,  0.74  mmol)  and  N- 
hydroxysuccinimide  ( 1 0 0  mg,  0 .8 6  mmol) were dissolved in chloroform  ( 2 0  ml)  and 
stirred  at  room  temperature  for  4  h.  This  solution  was  added  to  the  solution  of 
polyallylamine  in  ethanol  (above)  and  the  resulting  mixture  was  stirred  at  room 
temperature for 2 h.  Concurrently, FmocLys(Fmoc)-OH (320 mg, 0.54 mmol),  N,N- 
diisopropylcarbodiimide  (0.10  ml,  0.64  mmol)  and  TV-hydroxysuccinimide  (80.0  mg, 
0.70 mmol) were dissolved in chloroform (10 ml) and stirred at room temperature for 5 
h. This solution was then added to the solution containing polyallylamine and stirring 
was  continued  for  22  h.  The  solvent  was  removed  in  vacuo  and  the  residue  was 
dissolved in chloroform (10 ml) with the aid of sonication. Methanol (ca.  30 ml) was 
added, until a white precipitate formed.  The precipitate was isolated and then washed 
with methanol (3 x 20 ml) and dried under vacuum. The desired polymer was isolated 
as a white solid (50.0 mg) vmax (solid state/cm'1)  1062 (s, C-O (Pbf groups)),  1331  (m, 
SO2 (Pbf groups)),  1496  (s, Ar (Pbf groups)),  1675  (m, C=0 (amides, Boc and Fmoc 
groups)),  2891  (m,  C-H),  3043  (m,  [-NH3]+),  3347  (N-H  (amides)),  3492  (N-H 
(amines)).
228Polymer 361
m n-m-l
HN HN HN
CA
I
His
Lys(Fmoc)  O CA
Arg Fmoc
Arg
Fmoc
.xCF3C02H
A  suspension  of polymer  192  (50  mg)  in  trifluoroacetic  acid/triisopropylsilane/water 
(95:2.5:2.5,  10  ml)  was  sonicated  at  room  temperature  for  4  h.  The  polymer  was 
isolated by filtration and washed with chloroform (2 x 50 ml), then dried under vacuum 
to yield a waxy solid (55 mg). 13C NMR (75 MHz, solid state) 5c/ppm 17.9 -  68.7 (br, 
CH2 of polyallylamine and amino acids),  115.4,  118.6 and 128.2 (br, ArC of imidazole 
and Fmoc groups), 141.8 (br, ArC of Fmoc groups) 158.4 (br, -NHC(NH)NH-), 162.3 (- 
NHC(0)2- of Fmoc groups), 175.0 (br, -C(O)NH-).
229Polymer 181
m n-m-l
HN HN HN
CA
I
His
CA Lys
Arg
Arg
A  suspension  of polymer 361  (79.0  mg)  in piperidine/anhydrous  dimethylformamide 
(2:8,  15  ml)  was  shaken  at room temperature  for 4 h.  The polymer was  filtered  and 
washed sequentially with dimethylformamide (3 x 30 ml), dichloromethane (3 x 30 ml), 
dimethylformamide  (2  x  10  ml)  and  dichloromethane  (3  x  30 ml).  The polymer was 
dried under vacuum to yield the desired product as a brown solid (52.0 mg). 13C NMR 
(75 MHz, solid state) 5c/ppm 15.0 -  55.6 (br, CH2 of polyallylamine and CH and CH2 of 
amino  acids),  109.8,  127.4,  137.1  (br,  ArC  of  imidazole),  158.5  and  163.9  (br,  - 
NHC(NH)NH-), 175.6 (br, -C(O)NH-).
Resin 195
1 ------- 1 ------- 1
NH  NH  NH
I  I  I
CA  Lys(Fmoc)  His(Trt)
Arg(Pbf)  pm0c  Fmoc
Arg(Pbf)
Fmoc
Tentagel resin  (3.00  g,  0.40 mmol/g) was  swelled in dimethylformamide for 30 min. 
and then filtered.
HOBt  (0.10  g,  0.72  mmol)  was  added  to  a  solution  of tripeptide  131  (0.42  g,  0.36 
mmol),  FmocHis(Trt)OH  (0.22  g,  0.36  mmol)  and diisopropylcarbodiimide  (0.16 ml,
2301.00  mmol)  in dimethylformamide  (20 ml).  The  solution was  stirred for  10 min.  and 
then added to tentagel resin (above) and subsequently shaken for 3 h.
To a solution of FmocLys(Fmoc)OH (0.35 g, 0.60 mmol) and diisopropylcarbodiimide 
(0.13 ml, 0.84 mmol) in dimethylformamide (20 ml), HOBt (81.0 mg, 0.60 mmol) was 
added.  The  solution was  stirred  for  10 min.  and then  added to the  above  solution of 
resin and the mixture shaken for further 24 h. The resin was filtered and washed with 
dimethylformamide  ( 2 0 0  ml), dichloromethane  ( 2 0 0  ml), dimethylformamide ( 1 0 0  ml) 
and  dichloromethane  ( 1 0 0   ml)  and  dried under vacuum  to  yield  the  desired product 
(3.65 g).
Resin 362
NH  NH  NH
I  I  I
CA  Lys(Fmoc)  His(Trt)
Ara  ^ I  y  Fmoc  Fmoc
Arg
Fmoc  xCF3C02H
A solution of trifluoroacetic acid/triisopropylsilane/water (95:2.5:2.5, 50 ml) was added 
to the resin 195 (3.59 g) and the mixture shaken at room temperature for 6 h. The resin 
was then filtered and washed with dichloromethane (4 x 50 ml) and dried under vacuum 
to give 362 (5.73 g).
231Resin 196
NH  NH  NH
I   I   I
CA  Lys  His
Arg
Arg
A solution of piperidine/dimethylformamide (2:8, 30 ml) was added to resin 362 (5.69 
g)  and  the  mixture  shaken  at  room  temperature  for  6  h.  The  resin  was  filtered  and 
washed  sequentially  with  dimethylformamide  ( 2 0 0   ml),  dichloromethane  ( 2 0 0   ml), 
dimethylformamide (100 ml) and dichloromethane (100 ml). The resin was dried under 
vacuum to give 196 (2.79 g).
Synthesis of Artificial Esterases containing Ala-Arg Binding Unit
Polymer 159
J m n-m-l
HN HN HN
His(Trt)
Fmoc
Lys(Fmoc)0 CA
Ala Fmoc
Arg(Pbf)
I
Fmoc
Polyallylamine  hydrochloride  (100  mg,  1.08  mmol)  was  treated  with  potassium 
hydroxide (70.0 mg, 1.24 mmol) in methanol (15 ml), at room temperature for 16 h. The 
mixture was concentrated under reduced pressure, and ethanol (25 ml) was added to the
232residue. The resulting white precipitate was removed by filtration, and the filtrate was 
then concentrated in vacuo, to leave approximately 1 0 ml of solvent.
FmocArg(Pbf)Ala-CA-OH 148 (270 mg, 0.32 mmol), FmocHis(Trt)OH (200 mg, 0.32 
mmol),  A,A’-diisopropylcarbodiimide  (0.23  ml,  1.45  mmol)  and 
A-hydroxysuccinimide (100 mg, 0.88 mmol) were dissolved in chloroform (40 ml), and 
stirred  at  room  temperature  for  4  h.  This  solution  was  added  to  the  solution  of 
polyallylamine in ethanol (above), and the resulting mixture stirred at room temperature 
for  2  h.  Concurrently,  FmocLys(Fmoc)-OH  (320  mg,  0.54  mmol), 
A.A’-diisopropylcarbodiimide  (110 mg,  0.70  mmol)  and A-hydroxysuccinimide  (90.0 
mg, 0.75 mmol) were dissolved in chloroform (35 ml), and stirred at room temperature 
for 2 h. This solution was then added to the solution containing polyallylamine (above). 
The resulting mixture was stirred for 24 h. The reaction mixture was concentrated to a 
volume of 20 ml. The crude product was precipitated by the addition of methanol. The 
resulting  solid was washed with chloroform  (50 ml)  and methanol  (50 ml),  and then 
dried under vacuum to  afford  a yellow gum (270 mg).  !H  NMR (400 MHz,  CDCI3) 
Sn/ppm  1.27 -   1.70 (br,  CH?  of polyallylamine and amino acids), 2.00 (br, ArCH3 of 
Pbf), 2.54 (br, CH of polyallylamine, -CH?N- of amino acids and polyallylamine), 3.83 
-   4.60  (br,  gH  of amino  acids),  6.99  -   7.63  (br,  ArH  of Fmoc,  Trityl  groups  and 
histidine).
233Polymer 164
m n-m-l
HN HN HN
His Lys(Fmoc)0 CA
Fmoc Ala Fmoc
Arg
Fmoc
xCF3 C02H
A suspension of polymer 159  (270 mg) in trifluoroacetic  acid/triisopropylsilane/water 
(95:2.5:2.5,  10 ml) was sonicated at room temperature for 3 h. Water (5 ml) was added 
to the mixture to  form a yellow gum.  The gum was isolated by filtration and washed 
with water (2 x  30 ml),  trifluoroacetic  acid (1  x 40 ml), water (1  x 40 ml) and dried 
under vacuum to yield the desired product as a yellow gum (180 mg).  NMR (400 
MHz,  CDCI3)  Sn/ppm  1.19 -   1.78  (br,  CH?  of polyallylamine and amino  acids), 2.92 
(br, CH of polyallylamine, -CH?N- of amino acids and polyallylamine), 4.08 and 4.29 
(br, oH of amino acids), 7.54 -  7.68 (br, ArH of Fmoc group and histidine).
Polymer 137
m n-m-l
HN HN HN
His CA Lys
Ala
Arg
A suspension of polymer 164 (180 mg) in piperidine/anhydrous DMF solution (2:8,  15 
ml) was sonicated at room temperature for 3 h, under nitrogen. The mixture was filtered
234and the resulting solid washed with dimethylformamide (3 x 30 ml), water (2 x 40 ml) 
and dichloromethane (2 x 40 ml). The polymer was dried under vacuum to yield an off 
white  gum  (100  mg).  pmax  (solid  state/cm'1 )  1670  (s,  C=0  (amide)),  2938  (m,  C-H), 
3426 (m, N-H).
Polymer 158
m n-m-l
HN HN HN
His(Trt) Lys(Fmoc) O CA
Fmoc Arg(Pbf) Fmoc
Ala
Fmoc
Polyallylamine  hydrochloride  (100  mg,  1.08  mmol)  was  treated  with  potassium 
hydroxide (70.0 mg, 1.24 mmol) in methanol (15 ml) at room temperature for 16 h. The 
solvent  was  removed  under reduced  pressure  and  ethanol  (25  ml)  was  added  to  the 
residue.  The resulting white precipitate was removed by filtration and the filtrate was 
concentrated in vacuo to leave approximately 1 0 ml of solvent.
FmocAla-Arg(Pbf)-CA-OH 147 (270 mg, 0.32 mmol), FmocHis(Trt)OH (200 mg, 0.32 
mmol), A, A ’-diisopropylcarbodiimide (0.23 ml,  1.45 mmol) and A-hydroxysuccinimide 
(100  mg,  0.88  mmol)  were  dissolved  in  chloroform  (30  ml)  and  stirred  at  room 
temperature for 4 h. This solution was added to the solution of polyallylamine in ethanol 
(above)  and  the  resulting mixture  stirred  at  room temperature  for 2  h.  Concurrently, 
FmocLys(Fmoc)-OH  (320  mg,  0.54  mmol),  A, A-diisopropylcarbodiimide  (110  mg, 
0.70  mmol)  and  A-hydroxysuccinimide  (90  mg,  0.75  mmol)  were  dissolved  in 
chloroform (35 ml) and stirred at room temperature for 2 h. The resulting mixture was 
then added to the solution containing polyallylamine and stirring was continued for 24 
h. The reaction mixture was concentrated to approximately 20 ml and the crude product
235was precipitated by the addition of methanol. The precipitate was purified by trituration 
from chloroform/methanol and the resulting solid was dried under vacuum. The desired 
polymer was isolated as a beige solid (276 mg).  NMR (300 MHz, CDC13) 5H /ppm 
1.12-1.50 (br, CH? of polyallylamine and amino acids), 2.00 (br, ArCHb of Pbf group), 
2.54 (br, CH of polyallylamine and -CH?N- of amino acids and polyallylamine), 3.86 -  
4.60 (br, gH of amino acids and -NHCO?CH?- of Fmoc group), 7.25 -  7.57 (br, ArH of 
Fmoc and Trityl groups and histidine).
Polymer 163
.   m n-m-l
HN HN HN
His Lys(Fmoc)0 CA
Fmoc Arg Fmoc
Ala
Fmoc
.xCF3C02H
A suspension of polymer 158  (269 mg) in trifluoroacetic  acid/triisopropylsilane/water 
(95:2.5:2.5,  10 ml) was sonicated at room temperature for 6 h. Water (5 ml) was added 
to the mixture which formed a yellow gum. The gum was purified by trituration from a 
mixture of chloroform and water. The resulting solid was then washed with chloroform 
(2 x 50 ml) and then dried under vacuum. The desired polymer was isolated as a cream 
coloured gum (160 mg).  'H NMR (300 MHz, CD3OD) SH /ppm 1.26 -  1.71 (br, CH2 of 
polyallylamine  and  amino  acids),  3.11  (br,  CH  of polyallylamine,  -CH?N-  of amino 
acids and polyallylamine), 4.07 and 4.30 (br, oH of amino acids and -NHCO2CH2- of 
Fmoc group), 7.16 -  7.70 (br, ArH of Fmoc groups and histidine).
236Polymer 136
m n-m-l
HN HN HN
His CA Lys
Arg
Ala
A  suspension  of polymer  163  (149  mg)  in  piperdine/anhydrous  dimethylformamide 
(1:1, 20 ml) was shaken at room temperature for 4.5 h. A precipitate was formed by the 
addition  of petroleum  spirit/ethyl  acetate  (1 :1),  which  was  filtered  and  dried  under 
vacuum.  The  desired  product  was  isolated  as  a  white  solid  (113  mg).  vm ax  (solid 
state/cm ') 1558 (m, C=0), 1709 (C=0), 2136 (w, C=N), 2920 (m, C-H), 3384 (s, N-H).
Synthesis of Artificial Esterases containing Ala-GIy Binding Unit
Polymer 160
m n-m-l
HN HN HN
His(Trt) Lys(Fmoc)0 CA
Fmoc Ala Fmoc
Gly
Fmoc
Polyallylamine  hydrochloride  (100  mg,  1.08  mmol)  was  treated  with  potassium 
hydroxide (70.0 mg, 1.24 mmol) in methanol (15 ml) at room temperature for 16 h. The 
solvent  was  removed  under  reduced  pressure  and  ethanol  (25  ml)  was  added  to  the 
residue.  The resulting white precipitate was removed by filtration and the filtrate was 
then concentrated in vacuo to leave approximately 1 0 ml of solvent.
237FmocGly-Ala-CA-OH  149  (150  mg,  0.32  mmol),  FmocHis(Trt)OH  (190  mg,  0.31 
mmol), A, A-diisopropylcarbodiimide (0.23 ml, 1.45 mmol) and  A-
hydroxysuccinimide (190 mg, 1.69 mmol) were all dissolved in chloroform (40 ml) and 
stirred  at  room  temperature  for  4  h.  This  solution  was  added  to  the  solution  of 
polyallylamine  in ethanol (above)  and the resulting mixture was then stirred at room 
temperature  for  2  h.  Concurrently,  FmocLys(Fmoc)-OH  (320  mg,  0.54  mmol), 
A, A'-diisopropylcarbodiimide  (110 mg,  0.70  mmol)  and A-hydroxysuccinimide  (90.0 
mg, 0.81  mmol) were dissolved in chloroform (35 ml) and stirred at room temperature 
for 2  h.  This  solution was  then  added  to  the  solution  containing polyallylamine  and 
stirring was continued for 24 h. The reaction mixture was concentrated to a volume of 
20  mL  and  the  crude  product  was  precipitated  by  the  addition  of methanol.  The 
precipitate was purified by trituration from chloroform/methanol and the resulting solid 
was dried under vacuum. The desired polymer was isolated as a white solid (123 mg).
NMR (300 MHz, CDC13) 5H /ppm 1.10-1.50 (br, CFh of polyallylamine and amino 
acids),  2.51  -  3.10  (br,  CH  of  polyallylamine,  -CH?N-  of  amino  acids  and 
polyallylamine), 3.41  - 4.41  (br, oH of amino acids and -NHCCbCH?- of Fmoc group),
7.09  -  7.70 (br, ArH of Fmoc and Trityl groups and histidine);
Polymer 165
m n-m -l
HN HN HN
His Lys(Fmoc)0 CA
Fmoc Ala Fmoc
Gly
i
Fmoc
.xCF3C02H
A suspension of polymer 160  (119 mg) in trifluoroacetic  acid/triisopropylsilane/water 
(95:2.5:2.5,  10 ml) was sonicated at room temperature for 3 h. Water (5 ml) was added
238to the mixture which formed a white precipitate, which was isolated by filtration and 
washed with water (2  x  30 ml).  The resulting crude  solid was then triturated  from  a 
mixture  of chloroform  and  water,  which  afforded  a  white  gum.  The  gum  was  then 
washed with chloroform (5 x 30 ml) and dried under vacuum, which gave the product as 
a white gum (102 mg).  'H NMR (300 MHz, CD3OD) SH /ppm  1.13 -  1.42 (br, CH2 of 
polyallylamine  and  amino  acids),  2.42  -  3.06  (br,  CH  of polyallylamine,  -CH2N-  of 
amino acids and polyallylamine), 3.77 - 4.21  (br, aH of amino acids and -NHCCbCH? 
of Fmoc group), 7.23 -  7.65 (br, ArH of Fmoc groups and histidine).
Polymer 138
m n-m-l
HN HN HN
His CA Lys
Ala
Gly
A  suspension  of polymer  165  (95.0  mg)  in piperidine/anhydrous  dimethylformamide 
solution (2:8,  15 ml) was sonicated at room temperature for 3 h under nitrogen. Water 
was  then  added  until  a  precipitate  formed,  which  was  isolated  by  filtration.  The 
resulting solid was washed with dimethylformamide (5 x 30 ml), dichloromethane (5 x 
30ml)  and dried under vacuum to yield a beige solid (50.0 mg).  13C NMR (75 MHz, 
solid state) < 5 c/ppm 36.6 (br, CH and CH2 of polyallylamine and amino acids), 125.2 (br, 
carbons of imidazole), 160.5, 174.2 (br, carbons of amides); vmax (solid state/cm"1 ) 1543 
(s, -C(O)NH), 2135 (w, C=N), 2921 (m, CH), 3214 (m, C(O)NH), 3348 (m, NH).
239Polymer 161
n-m-l m
HN HN HN
His(Trt) Lys(Fmoc) O CA
Fmoc Gly Fmoc
Ala
I
Fmoc
Polyallylamine  hydrochloride  (100  mg,  1.08  mmol)  was  treated  with  potassium 
hydroxide (70.0 mg, 1.24 mmol) in methanol (15 ml) at room temperature for 16 h. The 
solvent  was  removed  under  reduced  pressure  and  ethanol  (25  ml)  was  added  to  the 
residue.  The resulting white precipitate was removed by filtration and the filtrate was 
concentrated in vacuo to leave approximately 1 0 ml of solvent.
FmocAla-Gly-CA-OH  150  (150  mg,  0.31  mmol),  FmocHis(Trt)OH
(190  mg,  0.31  mmol),  A,A’-diisopropylcarbodiimide  (0.23  ml,  1.45  mmol)  and 
A-hydroxysuccinimide (190 mg,  1.69 mmol) were dissolved in chloroform (25 ml) and 
stirred  at  room  temperature  for  4  h.  This  solution  was  added  to  the  solution  of 
polyallylamine in ethanol (above) and the resulting mixture stirred at room temperature 
for  2  h.  Concurrently,  FmocLys(Fmoc)-OH  (320  mg,  0.54  mmol), 
A,A-diisopropylcarbodiimide  (110  mg,  0.70 mmol)  and A-hydroxysuccinimide  (90.0 
mg, 0.80 mmol) were dissolved in chloroform (25 ml) and stirred at room temperature 
for 2  h.  This  solution  was  then  added to  the  solution  containing polyallylamine  and 
stirring was continued for 24 h. The reaction mixture was concentrated to approximately 
20  ml  and  the  crude  product  was  precipitated  by  the  addition  of  methanol.  The 
precipitate was purified by trituration from chloroform/methanol and the resulting solid 
was dried under vacuum. The desired polymer was isolated as a white gum (119 mg). 
'H NMR (400 MHz, CDC13) 5H /ppm 1.10-1.52 (br, CH2 of polyallylamine and amino 
acids),  2.51,  3.05  and  3.19  (br,  CH  of polyallylamine,  -CH?N-  of amino  acids  and 
polyallylamine), 3.43, 3.81, 4.14 and 4.34 (br, oH of amino acids), 7.10 -  7.55 (br, ArH 
of Fmoc and Trityl groups and histidine);
240Polymer 166
n-m-l m
HN HN HN
His Lys(Fmoc)0 CA
Fmoc Gly Fmoc
Ala
Fmoc
.xCF3C02H
A suspension of polymer 161  (113  mg) in trifluoroacetic  acid/triisopropylsilane/water 
(95:2.5:2.5,  10 ml) was sonicated at room temperature for 3 h. Water (5 ml) was added 
to the mixture which formed a yellow gum. The gum was isolated by filtration and then 
washed with water (2  x  30 ml).  The resulting crude  solid was then triturated from  a 
mixture of chloroform  and water and then washed with chloroform (5  x  30 ml).  The 
desired polymer was isolated as a yellow gum (105 mg). fH NMR (500 MHz, CD3OD) 
Sn/ppm 1.05-1.31  (br, CH? of polyallylamine and amino acids), 2.43 and 3.09 (br, CH 
of polyallylamine,  -CH?N-  of amino  acids  and polyallylamine),  3.56,  3.77,  4.04  and
4.29  (br, oH of amino acids), 7.08 -  7.68 (br, ArH of Fmoc groups and histidine).
241Polymer 139
n-m-l m
HN HN HN
His CA Lys
Gly
Ala
A  suspension  of polymer  166  (99.0  mg)  in piperidine/anhydrous  dimethylformamide 
(2:8,  20 ml) was  sonicated  at room temperature  for 7 h.  The volatiles were removed 
under  reduced  pressure  and  the  residue  was  washed  sequentially  with 
dimethylformamide (50 ml),  water (50 ml),  dichloromethane (50 ml), chloroform (50 
ml),  methanol  (50  ml)  and  chloroform  (50  ml).  The  resulting  solid  was  dried  under 
vacuum,  which  gave  the  desired product  as  a beige  solid  (62.0  mg).  NMR (500 
MHz, CD3OD) 5H /ppm 1.33 -  1.69 (br, CH? of polyallylamine and amino acids), 2.49 -
3.17  (br, CH of polyallylamine, -CH?N- of amino acids and polyallylamine), 3.30 -  4.11 
(br, oH of amino acids), 6.95 - 7.70 (br, ArH of histidine); vmix (solid state/cm'1 ) 1556 
(w, C=Q (amide)), 2165 (w, C=N), 2925 (m, C-H), 3278 (w, N-H).
2424.2.4 Synthesis of Acid Product For Use as a Standard in HPLC 
4-(Ethanoic Acid-Phenylcarbamoyl)-Butyric Acid (129)90
4-Aminophenylacetic  acid  (1.20  g,  7.95  mmol)  was  suspended  in  DCM  (60  ml). 
Glutaric  anhydride (1.09  g, 9.54 mmol)  and triethylamine (2.43 ml,  17.5  mmol) were 
added and the mixture was stirred at reflux for 18 h. The mixture was then cooled and 
diluted with water (100 ml) and the organic layer was separated. The pH of the aqueous 
layer was adjusted to  1, using aq. HC1 (2 M), and then extracted with ethyl acetate (2 x 
120  ml).  The  organic  layers  were  combined  and  dried  over  MgSC>4  and  then 
concentrated in vacuo. The titled product was isolated as a cream solid (1.39 g,  6 6 %). 
m.p.  150 °C (lit.  168 - 169 °Cm)\ ]H NMR (300 MHz, CD3OD) SH /ppm  1.96 (m, 2H, 
CH2CH2CH2), 2.38 (m, 4H, CHzCHjCHj ), 3.55 (s, 2H, ArCRjCOOH), 7.20 (d, J = 8 .6 , 
2H, C(3)H, C(5)H), 7.48 (d, J = 8 .6 , 2H, C(2)H, C(6 )H); 13C NMR (75 MHz, CD3OD) 
5c/ppm  22.1  (H02CCH2CH2),  34.1  (H02CCH2CH2CH2-),  36.9  (H02CCH2-),  41.3 
(ArCH2C02-),  121.3  (C(3)  and  C(5)),  130.8  (C(2)  and  C(6 )),  131.8  (C(4)),  138.7
(C(l)),,  173.7 (ArNHC(O)-),  175.6,  176.8 (ArCH2C02- and H0 2C-); I'm,, (nujol/cm1 ) 
1593 (m, Ar), 1695 (s, C=0), 2854 (s, C-H), 3307 (m, N-H); m/z (FAB) 288 ( 23%, [M 
+ Na]+); HRMS found 288.0848, [M + Na]+ (CnH^NOsNa) requires 288.0848;
2434.2.5 Calibration of HPLC by the External Standard Method1 6 0
The compounds used as standards were synthesised as described previously.
HPLC  conditions:  Reverse  phase  C l8  column,  elution  of acetonitrile/water  (0.05  % 
TFA).  Solvent gradient  100% water to 95:5 acetonitrile/water. Flow rate  lml/min, UV 
detection at 254nm.
Calibration of Acid Product 129
Different concentrations of acid 129 were prepared in phosphate buffer (Table 4.2.1). 
The area of peak at Rt = 7.59 was measured.
Concentraton of acid 129 (mM) Area of acid peak
0 .2 1306
0.4 2165
0 .6 2791
0 .8 3714
1 .0 4338
Table 4.2.1
A plot of the area of the peak against the concentration was made and linear regression 
analysis performed (Equation 4.2.1):
y = 4596x 
Equation 4.2.1
where  y is the area of the acid and x is the concentration.
244Calibration of Ester 127
Different concentrations of ester 127 were prepared in phosphate buffer (Table 4.2.2). 
The area of peak at Rt = 11.90 was measured.
Concentraton of ester 127 (mM) Area of ester peak
0 .2 13679
0.4 20725
0 .6 28734
0 .8 36299
Table 4.2.2
A plot of the area of the peak against the concentration was made and linear regression 
analysis performed (Equation 4.2.2):
y = 47755x 
Equation 4.2.2
where  y is the area of the acid and x is the concentration.
Calibration of Ester 169
Different  concentrations  of  ester  169  were  prepared  in  a  1:1  mixture  of 
acetonitrile/phosphate  buffer  (Table  4.2.3).  The  area  of  peak  at  Rt  =  12.32  was 
measured.
245Concentraton of ester 169 (mM) Area of ester peak
0 .0 2 6844
0.04 9373
0.06 11610
0.08 13943
0 .1 0 16769
Table 4.2.3
A plot of the area of the peak against the concentration was made and linear regression 
analysis performed (Equation 4.2.3):
y = 181856x 
Equation 4.2.3 
where  y is the area of the acid and x is the concentration.
Calibration of Cinnamyl alcohol 180
Different  concentrations  of  cinnamyl  alcohol  were  prepared  in  a  1:1  mixture  of 
acetonitrile/phosphate  buffer  (Table  4.2.4).  The  area  of  peak  at  Rt  =  10.44  was 
measured.
246Concentraton of alcohol 180 (mM) Area of alcohol peak
0 .0 2 2801
0.04 4301
0.06 6721
0.08 8249
0 .1 0 8936
Table 4.2.4
A plot of the area of the peak against the concentration was made and linear regression 
analysis performed (Equation 4.2.4):
y -  107604x 
Equation 4.2.4
where  y is the area of the acid and x is the concentration.
2474.2.6 General Procedures for Ester Hydrolysis with Polymers
Control Reaction
A solution of ester in aqueous buffer (0.5  mM) was stirred at room temperature.  The 
change in ester concentration and acid product formation was monitored by HPLC  at 
time t = 0, t = 5, t = 8 , t =12, t = 15, t = 20 min and then every 30 min thereafter for 5 h, 
and then at 24 h.
General Procedure using buffers
Polymer (10 mg) was added to a solution of ester in aqueous buffer (0.5 mM, 1 ml) and 
the  mixture  stirred  at  room  temperature.  The  change  in  ester concentration  and  acid 
product formation was monitored by HPLC at time t = 0 , t = 5 , t =  8 , t =12, t = 15, t = 
20  min  and  then  every  30  min  thereafter  for  5  h,  and  then  at  24  h.  The results  are 
presented in Chapter 2.
Ester hydrolysis experiments at different ester concentrations (0.25 mM, 0.5 mM, 1 mM 
and 2 mM) were conducted using the above general procedure.
General Procedure using a mixture of organic solvent and buffer
Polymer  (10  mg)  was  added  to  a  stirred  solution  of ester  dissolved  in  a mixture  of 
aqueous buffer/solvent (1 ml) (ester concentration of 0.5 mM) and the mixture stirred at 
room temperature.  The change in ester concentration and acid product  formation was 
monitored by HPLC at time t = 0, t = 5, t = 8 , t =12, t = 15, t = 20 min and then every 30 
min thereafter for 5 h, and then at 24 h. The results are presented in Chapter 2.
2484.3 Artificial Aldolases
4.3.1 Synthesis of Artificial Aldolases With Incorporated Lysine
Polylysine  hydrobromide  (50.0  mg,  0.24  mmol)  was  suspended  in  a  mixture  of 
anhydrous dimethylformamide (0.96 ml) and 2,6-lutidine (0.24 ml, 2.06 mmol) under 
nitrogen.  After  stirring  at  room  temperature  for  5  min.,  the  solution  turned 
homogenious. The mixture was then cooled to 0 °C and glutaric anhydride (14 mg, 0.12 
mmol)  dissolved  in  dimethylformamide  (0.24  ml)  was  added  dropwise.  The mixture 
was then stirred at 0 °C  for  1   h and room temperature for 24 h. Dropwise addition of 
diethyl  ether/ethanol  ( 1 :1,  1 0  ml)  to  the  stirring  reaction  mixture,  resulted  in  the 
appearance  of  a  white  precipitate.  The  solid  was  filtered,  washed  with  diethyl 
ether/ethanol  (1:1,  3  x  20  ml)  and  dried  under  vacuum.  The  desired  polymer  was 
isolated as a white solid (72 mg). 1H NMR (300 MHz, DMSO) 5n/ppm 1.33 (br, CH? of 
polylysine),  1.55  (br,  CH2  of polylysine),  1.66  (br,  -CH2CH2CH2CO2H),  2.16  (br,  - 
CH2CH2CH2CO2H),  2.77  (br,  CH2N of polylysine),  4.24  (br,  oH of polylysine),  8.04
Polymer 207
O O
OH
(br, -NH2-);
249Polymer 210
n-m
NH NH
Lys(Fmoc)
Fmoc
OH
Polyallylamine  hydrochloride  (100  mg,  1.08  mmol)  was  treated  with  potassium 
hydroxide (70.0 mg, 1.24 mmol) in methanol (20 ml) at room temperature for 16 h. The 
solvent  was  removed  under  reduced  pressure  and  ethanol  (25  ml)  was  added  to  the 
residue.  The resulting white precipitate was removed by filtration and the filtrate was 
concentrated in vacuo to leave approximately 1 0ml of solvent.
FmocLys(Fmoc)OH (320 mg, 0.54 mmol), A^A^’-diisopropylcarbodiimide (0.10 ml, 0.65 
mmol) and 7V-hydroxysuccinimide (90.0 mg, 0.75 mmol) were dissolved in chloroform 
(20 ml) and stirred at room temperature for 5 h. This solution was added to the solution 
of polyallylamine  in  ethanol  (above).  Glutaric  anhydride  (60.0  mg,  0.54  mmol)  was 
then added and the mixture was  stirred at room temperature for 3  days.  The solvents 
were  removed  under  vacuum  and  the  remaining  white  residue  was  triturated  from 
chloroform/methanol (1:1, 40 ml). The isolated solid was washed with methanol (3 x 20 
ml) and dried under vacuum to yield the product as a white solid (140 mg), vmax (solid 
state/cm'1)  1539 (s, Ar (Fmoc groups)),  1711  (m, C=0 (amides and carboxylic acid)), 
2930 (s, C-H), 3306 (s, N-H).
250Polymer 211
0 = 3/   0 = * (
y   Lys
0 = \
OH
A solution of piperidine/dimethylformamide (2:8,  15 ml) was added to the polymer 210 
(120  mg)  and  the  flask  shaken  for 20 h.  The polymer was  isolated by  filtration and 
washed with  dimethylformamide  (3  x  20  ml)  and dichloromethane  (3  x  20 ml).  The 
white solid was dried under vacuum to yield the desired product (80.0 mg). 13C NMR 
(75 MHz, solid state) 5c/ppm 23.6-53.1 (br, CH and CH2 of polyallylamine, lysine and 
butyric acid),  175.4 (br, -C(O)NH-), 181.0 (br, -COOH); vm B X  (solid state/cm'1 ) 1558 (s, 
C=0 (amides)),  1693 (s, C=0 (carboxylic acid)), 2485 (s, O-H (carboxylic acid)), 2940 
(m, C-H), 3074 (m, [-NH3]+), 3397 (m, N-H).
2514.3.2  Synthesis  of  Catalytic  Units  Containing  Proline  for  Artificial 
Aldolase Catalysts
(2S,4R)-4-Hydroxy pyrrolidine-1,2-dicarboxylic acid 1-tert butyl ester (296)1 6 1
HO
OH
A solution of /ra«s-4-hydroxyproline (3.00 g, 23.0 mmol) in aqueous sodium carbonate 
(10% w/v, 24 ml) was added dropwise to a stirred mixture of di-/ert-butyl dicarbonate 
(4.74  g,  22.0 mmol)  in tetrahydrofuran/dioxane  (11  ml,  1:10).  The mixture was then 
stirred at room temperature for 17 h. Diethyl ether (100 ml) was added and the phases 
were separated. The aqueous phase was cooled to 0 °C and then acidified to pH 3 using 
concentrateted HC1.  The acidic  solution was extracted with ethyl acetate (3 x  70 ml). 
The combined organic  extracts were dried over MgSC>4  and concentrated in vacuo to 
yield the product as a viscous colourless oil (1.06 g, 20%). 1H NMR (300 MHz, CDCI3) 
6 H /ppm  1.37 (m, 9H, -C(CH3)3), 2.04 -  2.32 (m, 2H, H(3)), 3.38 -  3.54 (m, 2H, H(5)),
4.29  -  4.41  (m,  2H,  H(2),  H(4));13C  NMR (75  MHz,  CDC13)  6c/ppm 28.4  and 28.6 
(rotamers, -CH3), 38.1  and 39.0 (rotamers, C(3)), 54.6 and 54.8 (rotamers, C(2)), 57.8 
and 58.1  (rotamers, C(5)),  69.4 and 69.9 (rotamers, C(4)),  81.2 (-C(CH3)3),  154.6 and
155.7  (rotamers, -NCO2-),  175.8 and  177.3  (rotamers, -CO2H);  vm & x (DCM/cm1 )  1636 
(s, C=0 (Boc group)),  1672 (s, C=0 (carboxylic acid)), 2980 (w, C-H), 3055 (w, O-H), 
3423 (s, N-H); m/z (FAB) 254 (12%,  [M + Na]+); HRMS found 254.1008, [M + Na]+ 
(CioHnNOsNa) requires 254.1004; [or]D  - 38.8 0 (c 0.16, EtOH).
252(2S,4R)-4-Hydroxy-2-methoxycarbonyl pyrrolidinium chloride (297)162
HCI
Thionyl  chloride  (0.62  ml,  8.55  mmol)  was  added  dropwise  to  a  stirred  solution  of 
/ra«5-4 -hydroxyproline (1.00 g, 7.63 mmol) in methanol (14 ml) at 0 °C. The reaction 
was  allowed to warm to room temperature and then stirred for  1  h.  The mixture was 
then heated at reflux for 63 h. The resulting solution was concentrated and the residue 
was azeotroped with methanol to yield the product as a white solid (1 .1 0 g, 80%). m.p. 
162 °C (lit.  162-164 °C162); ]H NMR (300 MHz, CD3OD) SH /ppm 2.23 (m,  1H, H(3)), 
2.41  (m,  1H, H(3)),  3.33  (m,  1H, H(5)),  3.51  (m,  1H, H(5)),  3.86  (s, 3H, -CO2CH3), 
4.61  (m, 2H, H(2) and H(4));UC NMR (75 MHz, CDC13) Sc/ppm 39.5 (C(3)), 54.9 (- 
CH3),  55.8  (C(5)),  60.3  (C(2 )),  71.4  (C(4)),  171.3  (-CO2CH3);  r„,„ (nujol/cm'1 )  1742 
(m, C=0), 2855, 2924 (s, C-H), 3323 (m, N-H); m/z (Cf)  147 (45%, [M - Cl + 2H]+), 
146  (100%,  [M  -   Cl  +  H]+);  HRMS  found  147.0891,  [M  -  Cl  +  2H]+   (C6H13N03) 
requires 147.0895; [a]D  - 17.7 0 (c 0.90, EtOH), lit. - 24.3 0 (c 1.05, MeOH) . 162
(2S,4R)-4-Hydroxy pyrrolidine-1,2-dicarboxylic acid 1-tert butyl ester-2-methyl
ester (298)163
To  a  stirred  solution  of /ra«s-hydroxyproline  methyl  ester  297  (0.50  g,  2.75  mmol) 
dissolved  in dichloromethane  (4 ml),  triethylamine  (1.15  ml,  8.26 mmol) was  added. 
The mixture was cooled to 0 °C and di-te/t-butyl dicarbonate (0.66 g, 3.03 mmol) was 
added  and  the  mixture  was  stirred  for  30  min..  The  mixture  was  warmed  to  room
253temperature and stirring was continued for  17 h.  Dichloromethane (30 ml) was added 
and  the  mixture  was  washed  with  aqueous  HC1  (1  M,  50  ml),  saturated  aqueous 
NaHCC>3 (50 ml), water (50 ml) and brine (50 ml). The chlorinated layer was dried over 
MgSC>4 and the solvent removed to give a colourless oil (0.39 g, 58%). Rf = 0.46 (SiCh; 
ethyl acetate);  'H NMR (300 MHz,  CDC13) aH /ppm  1.20 and  1.25  (s,  9H, -C(CH3)3),
1.83  (m,  1H, H(3)),  1.98  (m,  1H, H(3»,  3.35  (m,  2H, H(5)),  3.43  (s,  3H, -CC^CHs),
4.18  (m,  2H,  H(2)  and  H(4));13C  NMR  (75  MHz,  CDC13)  6 c/ppm  28.1  and  28.3 
(rotamers, -C(CH)3), 38.3 and 39.0 (rotamers, C(3)), 52.0 and 52.1 (-CO2CH3), 54.4 and
54.6  (rotamers, C(5)),  57.6 and 58.0 (rotamers,  C(2)), 68.9 and 69.5  (rotamers, C(4)),
80.2  and  80.3  (rotamers,  -C(CH3)3),  154.0  and  154.6  (-NCO2-),  173.5  and  173.8  (- 
C0 2CH3);  ('max (DCM/cm1 )  1367 (s, C-(CH3)3),  1682  (s, C=0 (Boc group)),  1747 (s, 
C=0 (ester)), 2978 (s, C-H), 3435 (s, N-H); m/z (CI+) 246 (6 %,  [M + H]+), 146 (99%, 
[M -  Boc + H]+);  HRMS found 246.1337, [M + H]+ (C,,H2oN0 5) requires 246.1341; 
[a]D  - 56.3 ° (c 0.80, CHC13), lit. - 40.5 ° (c 0.80, CHC13) . 163
(2S,4R)-4-(tert-Butyl dimethyl silanyloxy) pyrrolidine-1,2-dicarboxylic acid 1-tert
butyl ester 2-methyl ester (299)129
The alcohol 298 (0.39 g,  1.59 mmol) was dissolved in dimethylformamide (0.5 ml) and 
imidazole (0.23  g, 3.34 mmol) and tert-butylchlorodimethylsilane (0.26 g,  1.75 mmol) 
were  added.  The  mixture  was  stirred  at  room  temperature  for  1.5  h.  The  resulting 
solution was diluted with diethyl ether ( 1 0  ml) and washed with water ( 1 0  ml), aqueous 
HC1 (1  M,  10 ml)  and saturated aqueous NaHCC>3  (10 ml).  The ether layer was dried 
over MgSC>4 and solvents removed to give the product as colourless oil (0.27 g, 47%). 
Rf = 0.84 (Si02; ethyl acetate); ]H NMR (400 MHz, CDC13,325 K) SH /ppm 0.03 (s, 6 H, 
-Si(CH3)2-), 0.83 (s, 9H, -SiC(CH3)3), 1.41 (s, 9H, -NC02C(CH3)3), 1.97 (m, 1H, H(3)), 
2.12  (m,  1H,  H(3)),  3.33  (m,  1H, H(5)),  3.48  (m,  1H, H(5)),  3.66 (s,  3H,  -C02CH3),
2544.31 and 4.37 (m, 2H, H(2) and H(4));13C NMR (100 MHz, CDC13,328 K) 8c/ppm -  4.6 
(-Si(CH3)2),  18.2  (-SiC(CH3)3),  26.0  (-SiC(CH3)3),  28.6  (-C02C(CH3)3),  40.4  (C(3)),
52.1  (-C02CH3),  55.0  (C(5)),  58.4  (C(2)),  70.4  (C(4)),  80.2  (-C02C(CH3)3),  173.7 (- 
C0 2CH3);  cm ax  (DCM/cm-1)  1096  (w,  Si-O),  1256  (w,  Si-CH3),  1366  (m,  C-(CH3)3), 
1705 (s, 0=0 (Boc group)),  1755 (s, 0=0 (ester)), 2932 (s, C-H); m/z (CI+) 360 (12%, 
[M + H]+); HRMS found 360.2211, [M + H]+ (Ci7H33N0 5Si) requires 360.2206; [ot]r> -
19.3  0  (c  0.11,  CHC13).  Anal.  (Ci7H33N 0 5Si)  found  C,  57.19;  H,  9.69;  N,  3.85%; 
requires C, 56.79; H, 9.25; N, 3.90%.
(2S,4R)-4-(ter* Butyl dimethyl silanyloxy) pyrrolidine-1,2-dicarboxylic acid 1 -tert
butyl ester (300)
Si'O
OH
To  a  solution  of ester  299  (0.27  g,  0.75  mmol)  in  methanol  (1.4  ml)  was  added  a 
mixture of NaOH (45.0 mg, 1.13 mmol) in water (0.5 ml). The reaction was then heated 
to 45 °C, and stirred for  1  h. The solution was cooled to 0 °C and then acidified with 
aqueous HC1 (5% v/v) to ~ pH 4. The acidic solution was extracted with diethyl ether (3 
x 5  ml).  The combined organic  extracts were dried over MgSC>4 and concentrated  in 
vacuo to yield the desired acid as a clear oil (90.0 mg, 36%). Rf = 0.53 (Si02; petroleum 
spirit/ethyl acetate;  1:1); *H NMR (300 MHz, CDCI3) dn/ppm 0.03 (s, 6H, -S^CH^-), 
0.81  (s,  9H,  -SiC(CH3)3),  1.36  and  1.41  (s,  9H,  -NC02C(CH3)3), 2.02  (m, 2H, H(3)), 
3.28 -  3.58  (m,  2H,  H(5)),  4.28  - 4.39 (m,  2H,  H(2)  and H(4));n C  NMR (75  MHz, 
CDC13) dc/ppm - 4.6 and - 3.5  (rotamers, -Si(CH3)2),  18.2 (-SiC(CH3)3), 25.9 and 26.0 
(rotamers,  -SiC(CH3)3),  28.5  and  28.6  (rotamers,  -C02C(CH3)3),  38.5  and  40.0 
(rotamers,  C(3)),  54.8  and  55.1  (rotamers,  C(5)),  58.1  and 58.2  (rotamers C(2)),  70.0 
and  70.4  (rotamers,  C(4)),  80.9  and  81.3  (rotamers,  -C02C(CH3)2),  154.3  and  156.1 
(rotamers, -NC02-),  176.7 and 178.7 (rotamers, -C02H); vmix (DCM/cm'1 ) 1096 (w, Si-
255O), 1256 (w, Si-CH3), 1682 (s, C=0 (Boc group)), 1736 (s, C=0 (ester)), 2932 (s, C-H); 
m/z (Cf) 346 (12%, [M + H]+), 246 (100%,  [M -  Boc + H]+); HRMS found 346.2053, 
[M  +  H]+  (C16H32NO5S1)  requires  346.2050;  Anal.  (Cl6H31N03Si.'/2H20)  found  C, 
54.61; H, 9.52; N, 4.04%; requires C, 54.21; H, 9.10; N, 3.95%;  [a)D  - 25.3  0 (c 0.32, 
MeOH).
(2S,4R)-4-(terf Butyl dimethyl silanyloxy)-2-((S)-l-methoxycarbonyl-2-phenyl 
ethylcarbamoyl) pyrrolidine-1-carboxylic acid tert butyl ester (311)
S i'O
O
Triethylamine (0.08 ml, 0.58 mmol), water (5 ml), 300 (200 mg, 0.58 mmol) and HOBt 
(80 mg,  0.58 mmol) were added sequentially to a solution of L-phenylalanine methyl 
ester (130 mg, 0.58 mmol) in dichloromethane (5 ml). The mixture was then cooled to 0 
°C and EDCI (120 mg, 0.64 mmol) was added. The solution was stirred for 15 min. and 
warmed  to  room  temperature,  and  subsequently  stirred  for  44  h.  The  mixture  was 
diluted with dichloromethane (20 ml) and organic layer washed with aqueous HC1 (0.5 
M,  20  ml),  followed by  saturated  aqueous NaHC03  (20  ml)  and brine  (20 ml).  The 
organic extracts were dried over MgSC>4 and solvents removed to give the product as a 
white solid (160 mg, 55%). m.p.  57 °C; *H NMR (300 MHz, CDC13) aH /ppm 0.01  (s, 
6H,  -Si(CH3)2),  0.81  (s,  9H,  -SiC(CH3)3),  1.38  (m,  9H,  -C0 2C(CH3)3),  1.78  (m,  1H, 
H(3)) 2.09 (m, 1H, H(3)), 2.96 (dd, J = 7.1, J = 13.9, 1H, -NHCHCH(H)Ph), 3.13 (dd, J 
= 5.6, J = 13.9,  1H, -NHCHCH(H)Ph), 3.24 (m,  1H, H(5)), 3.50 (m, 1H, H(5)), 3.65 (s, 
3H, -C02CH3), 4.17 (m, 2H, H(2) and H(4)), 4.79 (m,  1H, -NHCHC02CH3), 7.06 (m, 
2H, ArH), 7.20 (m, 3H, ArH), 7.31  (m,  1H, NH); 13C NMR (75 MHz, CDC13, 328 K) 
5c/ppm -  4.5 (-SiC(CH3)2),  18.2 (-SiC(CH3)3), 26.0 (-SiC(CH3)3), 28.6 (-C02C(CH3)3),
38.6  (-NHCHCH2Ph and C(3)),  52.3  (-C02CH3),  53.4 (-NHCHC02CH3), 55.1  (C(5)),
60.2  (C(2)), 70.6 (C(4)), 80.9 (-C02C(CH3)3),  127.2,  128.7 and 129.5 (5 x ArC),  136.5
256(1  X  quaternary ArC),  156.4  (-NC0 2C(CH3)3),  171.9  (-CO2CH3 and -€( 0 )NH-);  rm ax 
(DCM/cm-1)  1024 (m,  Si-O),  1265  (s,  Si-CH3),  1500 (w, Ar),  1678 (s, C=0 (amide)), 
1744 (m, C=0 (ester)), 2856 and 2932 (m, C-H), 3414 (s, N-H); m/z (CI+) 507 (8 %, [M 
+  H]+),  393  (80%,  [M  -   Boc  -  Me  +  H]+);  HRMS  found  507.2897,  [M  +  H]+ 
(C26H43N20 6Si) requires 507.2890; Anal. (C26H42N20 6Si) found C, 61.24; H, 8.50; N, 
5.43%; requires C, 61.24; H, 8.50; N, 5.43%.
A solution of triphosgene (2.10 g, 7.00 mmol) in anhydrous tetrahydrofuran (20 ml) was 
added to a solution of L-phenylalanine (3.16 g,  19.0 mmol) in tetrahydrofuran (40 ml) 
under  nitrogen.  The  resulting  solution  was  heated  to  50  °C  and  stirred  at  this 
temperature until the phenylalanine dissolved (ca.  3 h). After cooling, the solvent was 
removed under reduced pressure, to half of its original volume. Hexeane was then added 
until  a white precipitate  formed.  The  white precipitate was  isolated by  filtration and
washed  with  cold  hexane  (3  x  40  ml),  and  then  dried  under  vacuum.  The  desired 
product was  isolated  as  a white  solid (2.65  g,  72%).  m.p.  > 230  °C;  1 H  NMR (300 
MHz, CDC13) 5H /ppm 3.01 (m,  1H, -CH(H)Ph) and 3.22 (m,  1H, -CH(H)Ph), 4.53 (m, 
1H, -NHCHCO2-), 7.16 -  7.34 (m, 5H, ArH); 13C NMR (75 MHz, CDC13) Sc/ppm 37.7 
(-CH2Ph), 59.1 (-NHCHCO2-),  128.1,  129.3 and 129.7 (5 x ArC),  134.1 (1 x quaternary 
ArC),  152.7 (-NHCO2-),  169.3 (-NHCHCO2-);  (DCM/cm*1) 1653 (m, Ar), 1782 (s, 
C=0),  1850 (m, C=0), 3304 (m, N-H); m/z (Cf)  192 (8%,  [M + H]+); HRMS found 
192.0662, [M + H]+ (Ci0Hi0NO3) requires 192.0660.
4-Benzyl oxazolidine-2,5-dione (305)132
257Pyrrolidine-l,2-dicarboxylic acid 1-tert butyl ester (230)133
4  3
COOH
To L-proline (2.00 g, 17.0 mmol) in dioxane/water (2:1, 90 ml) was added triethylamine 
(3.63 ml, 26.0 mmol) and di-tert-butyl dicarbonate (5.69 g, 26.0 mmol) and the mixture 
stirred  at room  temperature  for 24 h.  Aqueous  sodium hydroxide (1  M,  100 ml)  and 
ethyl acetate (100 ml) were added and the layers were separated. The aqueous layer was 
acidified to pH 4 with concentrated aqueous HC1, and then extracted with ethyl acetate 
(3 x 50 ml). The combined organic extracts were washed with water (100 ml) and brine 
( 1 0 0  ml), dried over MgSC>4 and concentrated in vacuo to yield a clear oil.  Hot ethyl 
acetate was added to the oil and the flask left in the fridge overnight. This gave a white 
solid (di-tert-butyl dicarbonate), which was filtered off. Ethyl acetate was then removed 
from the filtrate to afford the product as a white solid (1.63 g, 44%).  m.p.  133 °C; 
NMR (300 MHz, CD3OD) 5H /ppm 1.45 (d, 7= 10.1, 9H, -C(CH3)3), 1.96 and 2.26 (m, 
4H, H(3), H(4)), 3.43  (m, 2H, H(5)), 4.20 (m,  1H, H(2)), 5.11  (br s,  1H, -C02H); 13C 
NMR (75  MHz,  CD3OD)  6 c/ppm  25.4  and 26.0  (rotamers,  -C(CH3)3), 29.4 and 29.6 
(rotamers,  C(4)),  31.8  and 32.6 (rotamers, C(3)), 48.3  and 48.6 (rotamers, C(5)), 61.0 
and  61.3  (rotamers,  C(2)),  82.0  and  82.2  (rotamers,  -C(CH3)3),  156.7  and  157.0 
(rotamers, -NC(0)2-), 177.1 and 177.5 (rotamers, -C02H) vm ax (DCM/cnf1 ) 1123 (m, C- 
O),  1693 (s, C O ), 2581  (w, OH (carboxylic acid)), 2970 (m, C-H), 3495 (s, OH); m/z 
(FAB) 216 (19%,  [M + H]+;
258(S)-2-(S)-(l-Methoxycarbonyl-2-pheiiyl ethylcarbamoyl) pyrrolidine-1-carboxylic
acid benzyl ester (244)164
Ethyl  chloroformate  (0.15  ml,  1.61  mmol)  in  tetrahydrofuran  (1  ml)  was  added 
dropwise  to  a  stirred  solution  of  Cbz-proline  (0.50  g,  2.01  mmol)  and  anhydrous 
triethylamine (0.28 ml, 2.01 mmol) in anhydrous tetrahydrofuran ( 6 ml) at -10 °C. The 
resulting suspension was stirred at -10 °C for 40 min..  Concurrently, to phenylalanine 
methyl  ester  hydrochloride  (0.35  g,  1.61  mmol)  in  tetrahydrofuran/dichloromethane 
(1:1,  1 0 ml), triethylamine (0 .2 2  ml,  1.61 mmol) was added and the solution was stirred 
at room temperature  for  30 min..  The mixture was then  added to the  above  solution 
containing  Cbz-proline,  at  -10  °C,  and  the  mixture  was  allowed  to  warm  room 
temperature.  Stirring was then continued  for  17  h at room temperature.  The  solvents 
were  then  removed  under  reduced  pressure  and  the  residue  was  dissolved  in 
dichloromethane (25  ml).  The mixture was washed with aqueous  H C 1   (0.5 M, 2 x 25 
ml), saturated aqueous N a H C C E   (2 x 25 ml), water (2 x 25 ml) and brine (2 x 25 ml). 
The chlorinated extract was dried over MgSC>4, filtered and concentrated in vacuo. The 
desired dipeptide was isolated as a colourless oil (0.50 g, 61%). Rf = 0.59 (Si02; ethyl 
acetate);  *H NMR (400 MHz,  C D C I 3 )   6H /ppm  1.73 (br m, 2H, H(4)),  1.89 (br m,  1H, 
H(3)), 2.12 (br m,  1H, H(3)), 2.94 (dd, J  = 7.0, J = 13.9,  1H, -NHCHCH(H)Ph), 3.10 
(dd,  J =  5.8,  J =  13.9,  1H,  -NHCHCH(H)Ph),  3.36  (m,  2H,  H(5)),  3.62  (s,  3H,  - 
C O 2 C H 3 ) ,  4.27 (m, 1H, H(l», 4.79 (m,  1H, -NHCHC02Me), 5.09 (s, 2H -CCbCIfcPh),
7.03  -   7.30  (m,  10H,  ArH);  13C  NMR  (75  MHz,  C D C I3 )   Sc/ppm  24.5  and  23.7 
(rotamers, C(4)), 27.9  and 30.8  (rotamers, C(3)), 37.9 (-NHCHCH2Ph), 46.8 and 47.1 
(rotamers, C(5)),  52.3  and 53.5 (rotamers, -CH3), 52.7 and 53.2 (-NHCHC(O)-), 60.2,
60.6  (C(2)),  67.3  (-NC02CH2Ph),  126.9-129.3  (10  x  ArC),  136.0  and  136.4  (2  x 
quaternary  ArC),  155.1  (-NC02CH2),  171.5  (-NHC(O)-),  171.7  (-C02CH3);  vm ax
259(neat/cm'1 )  1497 (m, Ar),  1651  (s, C=0 (amide)),  1711  (s, C=0 from (ester)), 2953 (s, 
C-H), 3323 (s, N-H); m/z (FAB) 411 (12%,  [M + H]+); [a]D  -  42.0 ° (c 1.0, MeOH), lit. 
-  36.2 ° (c 1.0, MeOH)165.
(S)-2-(S)-(l-Carboxy-2-phenyI ethylcarbamoyl) pyrrolidine-l-carboxylic acid
benzyl ester (245) 166
OH
Dipeptide 244  (1.37  g,  3.34 mmol) was dissolved in dioxane (11  mml) and water (11 
ml). Aqueous sodium hydroxide (4 M, 4 ml) was added dropwise and the mixture was 
stirred for 2.5 h. The organics were removed in vacuo and the resulting aqueous residue 
was  acidified  with  concentrated  HC1  (pH  2).  The  product  was  extracted  with  ethyl 
acetate (3x15 ml) and the combined organic extracts were washed with water (30 ml) 
and brine (30 ml). The organic layer was dried over MgS0 4 , filtered and concentrated to 
yield  the  desired  product  as  a  colourless  oil  (1.08  g,  82%).  Rf =  0.59  (Si0 2 ;  ethyl 
acetate); 'H NMR (400 MHz, CDC13) 328 K) SH /ppm 1.72 (br m, 2H, H(4)), 1.91 (br m, 
1H, H(3), 1.99 (br m, 1H,H(3)), 2.98 (dd, J =  7.1,7 = 14.0, 1H, NHCHCH(H)Ph), 3.18 
(dd, J= 5.6, J= 14.0, 1H, -NHCHCHtHlPhl. 3.34 (br m, 2H, H(5)), 4.27 (m, 1H, H(2)), 
4.80 (m,  1H, -NHCHC02H), 5.08 (s, 2H, -CO2CH2PI1), 6.93 -  7.28 (m, 10H, ArH); I3C 
NMR  (75  MHz,  CDCI3)  6c/ppm  23.2  and  24.3  (rotamers,  C(4)),  28.5  and  30.9 
(rotamers, C(3)), 37.4 (-NHCHCH2PI1), 46.9 and 47.4 (rotamers, C(5)), 52.9 and 53.2 
(rotamers, -NHCHC(O)-), 60.4 (C(2)), 67.6 (-NC02CH2Ph),  127.1  - 129.4 (10 x ArC),
136.2  ( 2 x quaternary ArC),  155.6 and 156.2 rptamers, -NCO2CH2-),  171.9 and 17.6 (- 
NHC(0)-),  173.8  (-CO2H);  j w   (DCM/cm1)  1499  (m,  Ar),  1641  (s,  C O   (amide)), 
1701  (s, C=0 (carboxylic acid)), 2968  (w, C-H), 3061  (w, O-H), 3321  (w, N-H);  m/z 
(FAB) 419 (2%,  [M + Na]+, 397 (12%,  [M + H]+);  [a]D  - 38.0 ° (c 2.0, CHCI3), lit. -
49.00  (c 2.0, CHCI3 ) .166
260(S)-2-((S)-l-Methoxycarbonyl-2-phenyl ethylcarbamoyl) pyrrolidine-l-carboxylic
acid tert butyl ester (246)167
Ethyl  chloroformate  (0.36  ml,  3.72  mmol)  in  anhydrous  tetrahydrofuran  (3  ml)  was 
added  dropwise  to  a  stirred  mixture  of Boc-proline  230  (1.00  g,  4.65  mmol)  and 
anhydrous  triethylamine  (0.65  ml,  4.65  mmol)  in tetrahydrofuran  (14 ml)  at -10 °C, 
under nitrogen. The resulting suspension was stirred at -10 °C for 40 min. Concurrently, 
triethylamine  (0.51  ml,  0.80  mmol)  was  added  to  a  stirred mixture  of phenylalanine 
methyl ester (0.80 g, 0.80 mmol) in tetrahydrofuran/dichloromethane (2 :1, 15 ml) at - 1 0  
°C.  The  mixture  was  stirred  for  30  min.  The  mixture  was  then  added  to  the  above 
solution containing Boc-proline, at -10 °C. The resulting mixture was allowed to warm 
to room temperature and stirring was continued for  17 h.  The solvents were removed 
under reduced pressure and resulting the residue was dissolved in dichloromethane (50 
ml). The mixture was washed with aqueous HC1 (0.5 M, 2 x 50 ml), saturated aqueous 
NaHCC>3 (2 x 50 ml), water (2 x 50 ml) and brine (2 x 50 ml). The chlorinated extract 
was dried over MgSC>4, filtered and concentrated in vacuo to yield the desired product 
as a white solid (1.64 g, 94%). m.p. 44 °C (lit. 71 °C167); Rf = 0.59 (Si02; ethyl acetate); 
'H NMR (400 MHz, CDC13,  328 K) oH /ppm  1.37 (s, 9H, -C(CH3)3),  1.74 (br m, 2H, 
H(4)),  1.87 (br m,  1H, H(3)), 2.00 (br m,  1H, H(3)), 2.93 (dd, J = 6.9, J = 13.9, 1H, - 
NHCHCH(H)Ph),  3.09  (dd,  J  =  5.8,  J =  13.9,  1H,  -NHCHCH(H)Ph),  3.22  (m,  2H, 
H(5)), 3.62 (s, 3H, -CO2CH3), 4.14 (m, 1H, H(2)), 4.76 (m, 1H, -NHCHCOjMe), 7.02 -  
7.20  (m,  5H,  ArH);  13C  NMR  (100  MHz,  CDCI3,  328  K)  5c/ppm  24.1  (C(4)),  25.7 
(C(3)),  28.4  (-C(CH3)3),  38.3  (-CHCH2Ph),  47.1  (C(5)),  52.1  (-CH3),  53.2  (- 
NHCHC(O)-),  59.2  (C(2)),  80.5  (-C(CH3)3),  127.0,  128.6  and  129.3  (ArC),  136.4 
(quaternary ArC), 171.8 and 172.0 (-C0 2 CH3, -NC(0)2- and -NHC(0)-; fmaj (DCM/cm' 
')  1367  (w,  C-(CH3)3),  1529  (m,  Ar),  1682  (s,  C=0 (amide)),  1746 (s,  C=0  (ester)), 
2976 (s, C-H),  3321  (s, N-H);  m/z (FAB) 377 (24%,  [M + H]+);  [«]D  - 52.9  0 (c 1.4,
261MeOH), lit. - 50.4 ° (c 1.4, MeOH) . 168
(S)-2-((S)-l-Carboxy-2-phenyl ethylcarbamoyl) pyrrolidine-l-carboxylic acid tert
butyl ester (247)
Dipeptide 246 (1.43 g, 3.81 mmol) was dissolved in dioxane (24 ml) and water (24 ml) 
and aqueous  sodium hydroxide  (4 M,  4.5  ml) was  added dropwise.  The mixture was 
then stirred at room temperature for 2 h. The solvents were removed in vacuo and the 
resulting aqueous residue was  acidified with concentrated aqueous HC1 to pH 4.  The 
acidic solution was extracted with ethyl acetate (3x15 ml). The organic extracts were 
then washed with water (30 ml) and brine (30 ml) and dried over MgS04. The solvent 
was  removed  in  vacuo  to  yield  a  colourless  oil.  The  oil  was  then  taken  up  into 
dichloromethane  and the  desired product was  precipitated by the  addition of hexane. 
The desired acid was isolated as white solid (1.38 g, 79%). m.p. 48 °C;  NMR (400 
MHz, CDC13, 328 K) 5H /ppm  1.34 and  1.38 (s, 9H, -C(CH3)3),  1.65 -  1.94 (br m, 4H, 
H(3)  and H(4)), 2.97  (dd,  J = 7.0, J =  14.0,  1H, -NHCHCH(H)Ph), 3.20 (br m,  3H, - 
NHCHCH(H)Ph and H(5)), 4.17 (m,  1H, H(2)), 4.79 (m,  1H, -NHCHC02CH3), 7.08 -
7.19  (m,  5H, ArH);  13C NMR (100 MHz, CDC13,  328 K) Sc/ppm 23.8 (C(4)), 28.5  (- 
C(CH3)3),  37.8  (-CHCH2Ph),  47.0  (C(5)),  53.1  (-NHCHC(O)-),  59.1  (C(2)),  81.1  (- 
C(CH3)3),  127.0,  128.5  and  129.5  (ArC),  136.5  (quaternary ArC),  155.4  (-NC(0)2-),
172.8  (-NHC(O)-),  173.3  (-C02OH);  vm„  (DCM/cm'1 )  1367  (w, C-(CH3)3),  1499 (w, 
Ar),  1736 (s, C=0), 2978 (s, C-H), 3333 (s, N-H);  m/z (FAB) 363 (12%,  [M + Hf), 
263 (100%, [M + H -  Boc]+); HRMS found 363.1923, [M + H]+ (Ci9H27N20 5) requires 
363.1920;  [a]D   -37.5  0  (c 0.8,  MeOH);  Anal.  (Ci9H26N20 5.H20)  found  C,  60.10;  H, 
7.79; N, 8.13%; requires C, 59.99; H, 7.42; N, 7.36%.
262(S)-2-((S)-l-Carboxy-2-phenyl-ethylcarbamoyl)-pyrrolidinium trifluoroacetate
(242)125
Dipeptide 247 (0.87 g, 2.40 mmol)) in trifluoroacetic acid/dichloromethane (1:1, 20 ml) 
was stirred at room temperature for 3.5  h.  The  solvents were removed under reduced 
pressure to yield a brown oil. The oil was dissolved in ethanol and neutralised (pH 7) 
with aqueous NaOH (10 M) and sodium acetate, until a white precipitate appeared. The 
solution was left in the fridge over 72 h. The solid was filtered off and washed with cold 
water, cold methanol and cold ether and then dried under vacuum to give the product as 
a white solid (0.27 g, 43%).  m.p. > 220 °C (lit. 244-246 °C125); 'H NMR (400 MHz, 
DMSO, 353 K) 5H /ppm 1.53 and 1.88 (br m, 4H, H(3) and H(4)), 2.66 (br m, 1H, H(5)),
2.84  (br  m,  1H,  H(5)),  2.97  (br  m,  1H,  -NHCHCH(H)Ph),  3.10  (br  m,  1H,  - 
NHCHCH(H)Ph,), 3.55  (br m,  1H, H(2)), 4.54 (br m,  1H, -NHCHC02H), 7.17 -  7.25 
(m, 5H, ArH); I'm,, (nujol/cm'1) 1572 (m, Ar),  1676 (m, C=0), 2923 (s, C-H), 3194 (w, 
O-H), 3400 (w, N-H); m/z (FAB) 263 (9%,  [M + H]+); [a]D  - 38.0 ° (c 2.0, aq. HC1 (2 
M)), lit. - 39.2 ° (c 4.9, aq. HC1 ( 6  M))125.
2634.3.3 Synthesis of Artificial Aldolases With Incorporated Proline
Resin 231
NBoc
Fmoc
Tentagel  resin (300 mg,  0.40 mmol/g) was  swelled in anhydrous dimethylformamide 
(40 ml) for 1  h and the solvent was then filtered. To Boc-proline (130 mg, 0.60 mmol) 
in anhydrous dimethylformamide (3 ml), under nitrogen, was sequentially added HATU 
(230  mg,  0.60  mmol)  and  A-ethyldiisopropylamine  (0.21  ml,  1.20  mmol). 
Concurrently,  Fmoc-Glycine  (180  mg,  0.60  mmol)  was  dissolved  in  anhydrous 
dimethylformamide  (3  ml),  under  nitrogen,  followed  by  the  sequential  addition  of 
HATU (230 mg, 0.60 mmol) and /V-ethyldiisopropylamine  (0.21 ml, 1.20 mmol). Both 
solutions were then stirred at room temperature for 5 min., then combined, and added to 
the tentagel resin. The resulting mixture was shaken at room temperature for 18 h. The 
Kaiser test  indicated the reaction  was  complete.  Therefore  the resin was  filtered  and 
washed  with  dimethylformamide  (2  x  30  ml),  dichloromethane  (2  x  30  ml), 
dimethylformamide  ( 2 0   ml),  dichloromethane  ( 2 0   ml)  and  then  dried  under vacuum. 
The desired resin was isolated as a solid (407 mg). The level of Fmoc substitution was 
calculated to be 0.24 mmol/g. This therefore indicated that the substituition of proline 
on the resin is 0.16 mmol/g.
264Resin 363
NBoc
The  resin  231  (400  mg,  0.24  mmol/g)  was  shaken  in  a  mixture  of
piperidine/dimethylformamide (2:8, 6 ml) at room temperature for 2 h. The Kaiser test 
was  negative.  The  resin  was  therefore  filtered  and  treated  with  a  further  6  ml  of 
piperidine/DMF (2:8) and shaken for a further 5 min.. This procedure was then repeated 
once more, after which time the Kaiser test indicated complete reaction. The resin was 
filtered  and  washed  with  dimethylformamide  (3  x  10  ml)  and  dichloromethane  (3  x 
10ml) and dried under vacuum. The desired resin was isolated as a solid (242 mg).
Resin 232
NBoc
> = °
HO
Resin 363 (230 mg, 0.24 mmol/g) was swelled in dichloromethane (40 ml) for 1  h. The 
resin  was  then  filtered  and  washed  with  dichloromethane  (2  x  10  ml).  Glutaric 
anhydride (60.0 mg, 0.55 mmol) in anhydrous dichloromethane (5 ml) was added to the 
resin under nitrogen.  The resulting mixture was  shaken at room temperature for  19 h, 
after which time, the Kaiser test indicated the reaction was complete. The resin was then 
filtered and washed with dichloromethane (100 ml) and then dried under vacuum. The 
desired resin was isolated as a solid (253 mg).
265Resin 233
}= o
HO
The  resin  232  (250  mg,  0.16  mmol/g)  was  added  to  a  mixture  of trifluoroacetic 
acid/dichloromethane (1:1, 6 ml). The mixture was shaken at room temperature for 2 h, 
after which time, the chloronil test indicated the reaction was complete. The resin was 
filtered and washed with dichloromethane  (5  x 20 ml)  and then dried under vacuum. 
The desired resin was isolated as a solid (253 mg).  vmax (solid state/cm'1)  1558 (w, Ar 
(tentagel)),  1602 (w, Ar (tentagel)),  1688 (m, C=0 (amide)),  1782 (s, C=0 (carboxylic 
acid)), 2554 (w, OH (carboxylic acid)), 2913 (s, C-H), 3389 (s, N-H);
Resin 234
Fmoc  Boc
Tentagel resin (3.00  g,  0.50 mmol/g) was  swelled in dimethylformamide  for 30 min. 
and  then  filtered.  Boc-glycine  (1.31  g,  7.50  mmol)  and  Fmoc-glycine  (2.23  g,  7.50 
mmol)  were  dissolved  in dimethylformamide  (30 ml)  and to this  solution was  added 
diisopropylcarbodiimide (3.28 ml, 21.0 mmol) followed by HOBt (2.03 g,  15.0 mmol). 
This mixture was then immediately added to the resin and the mixture shaken at room 
temperature for 23  h.  After this time, the Kaiser indicated the reaction was complete. 
The resin was filtered and washed with dimethylformamide (100 ml), dichloromethane
266(100 ml), dimethylformamide (100 ml) and dichloromethane (150 ml), then dried under 
vacuum to yield the desired resin (2.77 g). Fmoc substitution = 0.18 mmol/g.
Resin 235
NH  HN
O O
HN NH3+
CF3CO; Fmoc
Resin 234 (2.77 g, 0.32 mmol/g) was swelled in DCM (25 ml) for 30 minutes and then 
filtered.  A  solution of trifluoroacetic  acid/dichloromethane (1:1,  50 ml) was added to 
the resin and the mixture was shaken at room temperature for 24 h. After this time, the 
Kaiser test indicated the reaction was complete. The resin was filtered and washed with 
dichloromethane  (5  x  30  ml),  then  dried  under vacuum  to  yield  the  desired product
The resin 235 (2.77  g, 0.32 mmol/g) was washed with pyridine/dichloromethane (2:8, 
50 ml) and dichloromethane (3 x 50 ml), and then filtered.  Glutaric anhydride (0.57 g,
5.00  mmol) dissolved in chloroform (30 ml) was then added, and the flask was shaken 
at  room  temperature  for  63  h.  After  this  time,  the  Kaiser  test  indicated  incomplete 
reaction.  The resin was filtered, washed with dichloromethane (200 ml) and re-treated 
with  glutaric  anhydride  (0.57  g,  5.00  mmol)  dissolved  in chloroform  (30 ml)  for  an
(2.72 g).
Resin 236
Fmoc
NH  HN
OH
267additional 1.5 h. After which time, the Kaiser test indicated complete reaction. The resin 
was filtered, washed with dichloromethane (5 x 30 ml) and dried under vacuum to give 
the desired product (2.95 g). Fmoc substitution = 0 .1 2  mmol/g.
Resin 237
The  resin  236  (3.00  g,  0.12  mmol/g) was  treated with piperidine/dimethylformamide 
(2:8, 50 ml) and then shaken at room temperature for 4 h. After this time, the Kaiser test 
indicated  the reaction was  complete.  The resin was washed with dimethylformamide 
( 2 0 0   ml),  dichloromethane  ( 2 0 0   ml),  dimethylformamide  ( 1 0 0   ml),  dichloromethane 
(100 ml) and then dried under vacuum to afford the desired product (2.44 g).
Resin 364
O
HN NH
O  0 = *
O
HO
Resin 237  (2.40  g,  0.12 mmol/g) was  swelled in dimethylformamide for 30 min.  and 
then  filtered.  To  Boc-proline  (0.31  g,  1.44 mmol)  in dimethylformamide  (5  ml)  was 
added HOBt (0.19  g,  1.44 mmol) followed by diisopropylcarbodiimide (0.32 ml, 2.02
268mmol), and the mixture was stirred for 5 min.. This solution was then added to the resin 
and the suspension was shaken at room temperature for 18 h. After this time, the Kaiser 
test  indicated  the  reaction  was  complete.  The  resin  was  then  washed  with 
dimethylformamide  ( 2 0 0  ml), dichloromethane ( 2 0 0  ml), dimethylformamide ( 1 0 0  ml), 
dichloromethane  ( 1 0 0   ml)  and then dried under vacuum to  yield the  desired product 
(2.89 g).
Resin 238
Resin 364 (2.73 g, 0.12 mmol/g) was swelled in dichloromethane for 30 min. and was 
then filtered.  A mixture of trifluoroacetic acid/dichloromethane (1:1,  50 ml) was then 
added, and the suspension was shaken at room temperature for  6 h. The chloronil test 
indicated  the  reaction  was  complete.  The  resin  was  then  filtered,  and  washed  with 
dichloromethane  (5  x  30  ml),  then dried under  vacuum  to  yield  the  desired product 
(2.83 g).  1H NMR (400 MHz, solid state) SH /ppm  1.00 -  2.40 (br, H(3), H(4) and CH2 
of pentadioic acid), 3.20 -  3.90 (br, H(5), H of polyethylene glycol (tentagel) and oH of 
amino acids), 4.00 -  4.60 (br, H(2)), 6.20 -  8.60 (ArH of polystyrene (tentagel)).
269(4-Methyl-piperazin-l-yl)-acetic acid ethyl ester (289)
O
To A-methyl  piperazine  (2.34  ml,  21.0 mmol)  in benzene  (5  ml),  a solution of ethyl 
bromoacetate (1.17 ml,  11.0 ml) in benzene (5  ml) was added dropwise. The solution 
was then heated at reflux for  1 h. After cooling, a precipitate was removed by filtration 
and the resulting filtrate was concentrated in vacuo to yield the product as a pale yellow 
oil (1.02  g,  26%).  Rf =  0.17  (Si02; petroleum spirit/ethyl  acetate;  1:1)'H NMR (300 
MHz, CDCI3) 5H /ppm 1.18 (m, 3H, -CH2CH3), 2.21 (s, 3H, -NCH3), 2.41 (brm, 4H, 2 x 
-CH 2NCH3), 2.54 (br m, 4H, 2 x -CH 2CH2NCH3), 3.13 (s, 2H, -NCHzCOr), 4.10 (q, J 
=  7.1,  2H,  -CH2CH3);  13C  NMR (75  MHz,  CDC13)  6c/ppm  13.6  (-CH2CH3),  45.4  (- 
NCH3),  52.3  (2  x  -CH 2NCH3),  54.2  (2  x  -CH 2CH2NCH3),  58.7  and  59.7  (- 
NCH2C0 2CH2-),  169.3 (-C02-); *w  (neat/cm-1) 1747 (s, C=0), 2795 (s, N-CH2), 2937 
(s, C-H); m/z (CI+) 187 (8 8 %, [M + H]+), 186 (36%, [M]+); HRMS found 187.1448, [M 
+  H]+  (C9Hi9N20 2)  requires  187.1447;  Anal.  (C9Hi8N20 2.H20)  found  C,  52.52;  H, 
9.34; N, 13.95%, requires C, 52.92; H, 9.87; N, 13.71%;
(4-Methyl-piperazin-l-yl)-acetic acid (290)169
HO
Compound 289 (0.36 g, 1.93 mmol) was dissolved in water (10 ml) and heated at reflux 
for 18 h. The solvents were removed in vacuo to yield the product as a white solid (0.23 
g, 74%). m.p.  163 °C (lit.  160-161  °C169); 'H NMR (300 MHz, CD3OD) 6 H /ppm 2.32
270(s, 3H, -NCH3), 2.73 (br m, 8 H, 2 x -CH 2NCH3 and 2 x -CH2CH1NCH3), 3.01 (s, 2H, - 
NCH2-);  13C  NMR (75  MHz,  CD3OD)  5c/ppm 44.7  (-NCH3),  52.3  (2 x -CH2NCH3),
54.1  (2 x -CH 2CH2NCH3), 61.4 (-NCH2-),  174.5  (-C02H);  rm ax (nujol/cm'1 )  1641  (w, 
C=0),  2852  and  2937  (s,  C-H);  m/z  (CI+)  159  (100%,  [M  +  H]+),  158  (7%,  [M]+); 
HRMS found 159.1133, [M + H]+ (C7Hi5N20 2 ) requires 159.1133.
Resin 291
Boc
Resin 234  (4.41  g,  0.18 mmol/g) was  swelled in dimethylformamide for 30 min.  and 
then filtered.  To the resin was added a solution of piperidine/dimethylformamide (2:8, 
50 ml) and the mixture was shaken for 7 h. The Kaiser test indicated the reaction was 
complete.  The  resin  was  filtered  and  washed  with  dimethylformamide  (200  ml), 
dichloromethane ( 2 0 0  ml), dimethylformamide ( 1 0 0  ml), dichloromethane ( 2 0 0  ml) and 
dried under vacuum to yield the desired product (4.22 g). vmax (solid state/cm'1 ) 1678 (s, 
C=0 (amide)), 1715 (s, C=0 (Boc)), 2904 (s, C-H), 3345 (w, N-H).
271Resin 365
To compound 290 (0.22 g,  1.39 mmol) in dimethylformamide (20 ml), HOBt (0.19 g, 
1.39  mmol)  followed  by  diisopropylamine  (0.30  ml,  1.94  mmol)  were  added.  The 
solution was  stirred at room temperature for 20 min.  and then added to the resin 291 
(1.54 g, 0.18 mmol/g) which was previously swelled in dimethylformamide for 30 min.. 
The  reaction  mixture  was  shaken  at  room  temperature  for  19  h.  The  Kaiser  test 
indicated  the  reaction  was  complete.  The  resin  was  filtered  and  washed  with 
dimethylformamide ( 1 0 0  ml), dichloromethane ( 1 0 0  ml), dimethylformamide ( 1 0 0  ml), 
dichloromethane (100 ml) and dried under vacuum to give product 365 (1.63  g).  vmax 
(solid  state/cm'1)  1674  (s,  C=0  (amide)),  1715  (s,  C=0 (Boc  group)), 2878  (s, C-H), 
3348 (m, N-H).
272Resin 292
NH HN
O
HN
N
Resin 365 (1.37 g, 0.18 mmol/g) was swelled in dichloromethane for 30 min. and then 
filtered. The resulting resin was treated with trifluoroacetic acid/dichloromethane (1:1, 
30  ml)  and  the  mixture  shaken  for  4  h.  The  Kaiser  test  indicated  the  reaction  was 
complete.  The  resin was  filtered  and  washed with  dichloromethane  (5  x  50 ml)  and 
dried under vacuum to  give the product 292  (1.92  g).  vmax (solid state/cm'1 )  1692 (s, 
C=0 (amide)), 1782 (s, C=0 (TFA salt)), 2921 (s, C-H), 3373 (m, N-H).
Resin 366
Resin 292 (1.92 g, 0.22 mmol/g) was washed with a pyridine/dichloromethane solution 
(1:1, 100 ml) and then dichloromethane (5 x 40 ml).
273Boc-Proline (0.45  g, 2.10 mmol) was dissolved in dimethylformamide (20 ml),  HOBt 
(0.29 g,  2.10 mmol)  followed by diisopropylcarbodiimide (0.46 ml, 2.96 mmol) were 
added.  The  resulting  mixture  was  stirred  for  30  min.  at  room  temperature  and then 
added to the resin (above). The mixture was shaken at room temperature for 24 h. The 
Kaiser test indicated the reaction was complete. The resin was filtered and washed with 
dimethylformamide (3  x  30 ml), dichlorometane (3  x  30 ml), dimethylformamide (50 
ml)  and then dichloromethane (100 ml)  and dried under vacuum to  give product 366
Resin 366 (1.10 g, 0.22 mmol/g) was swelled in dichloromethane for 30 min. and then 
filtered.  The resin was then treated with trifluoroacetic  acid/dichloromethane (1:1,  30 
ml) and the mixture shaken for 6 h. The Kaiser test indicated the reaction was complete. 
The resin was filtered and washed with dichloromethane (5 x 50 ml) and dried under 
vacuum to give the product 293 (1.15 g).
(2 .2 1 g).
Resin 293
NH  HN
2744-[(S)-2-(ter*-Butyl-dimethyl-silanyloxy)-l-methoxycarbonyl-ethylcarbamoyl]-
butyric acid (323)
O
TBDMS-Serine  methyl  ester  322  (200  mg,  0.86  mmol)  was  dissolved  in  anhydrous 
dichloromethane  (4  ml).  Triethylamine  (0.15  ml,  1.08  mmol)  and  glutaric  anhydride 
(120 mg,  1.03 mmol) were added and the mixture was heated at reflux for 18 h. After 
cooling,  the  solution was  concentrated  in  vacuo.  The  crude residue was  dissolved in 
ethyl  acetate  (30 ml)  and washed with  aqueous HC1  (2M,  30 ml), water (30 ml)  and 
brine (30 ml)  and  dried over MgSC>4.  The solvent was removed in vacuo to yield the 
product as a clear oil (210 mg,  73%).  'H NMR (300 MHz, CDC13) SH /ppm -0.05  (s, 
6 H,  -Si(CH3)2),  0.74  (s,  9H,  -C(CH3)3),  1.90  (m,  3H,  C0 2CH(H)CH2CH2-), 2.29  (m, 
3H,  COjCHQDCILCIi!-),  3.63  (s,  3H,  -CC^CHj),  3.71  (dd, J = 3.2, J =  10.1,  1H,  - 
CH(H)OSi-), 3.94 (dd, 7=  2.9, J=  10.1, 1H, -CH(H)OSi-), 4.60 (m,  1H, -NHCHCO-), 
6.70  (m,  1H,  NH);  13C  NMR  (75  MHz,  CDC13)  oc/ppm  -   5.4  (-Si(CH3)2),  18.2  (- 
SiC(CH3)3),  20.7  (-NHC(0)CH2CH2-),  25.8  (-SiC(CH3)3),  33.0  (0 2CCH2CH2CH2-),
35.1  (02C  (CH2)2CH2-),  52.5  (-CH3),  54.4  (-NHCHC02-),  63.6  (-CH2OSi-),  171.2  (- 
NHC(0)-),  172.8 (-C02CH3),  177.2 (-C02H); rm ax (neat/cm"1)  1060 (s, Si-O),  1653 (s, 
C O  (amide)),  1740 (s, C=0 (acid and ester)), 2949 (s, C-H), 3333 (s, N-H); m/z (CI+) 
348  (100%,  [M  +  H]+);  HRMS  found  348.1834,  [M  +  H]+  (Ci4H28N06Si)  requires 
348.1842; [a]D  + 28.6 ° (c 0.44, MeOH).
275Resin 324
Fmoc
TBDMSO
The resin 235 (3.39 g, 0.17 mmol/g) was washed with pyridine/dichloromethane (2:8, 3 
x 50 ml) and dichloromethane (3 x 50 ml).
Acid 323  (1.00 g, 2.88 mmol) was dissolved in dimethylformamide (7 ml) and HOBt 
(0.39 g, 2.88 mmol),  followed by diisopropylcarbodiimide (0.63 ml, 4.06 mmol) were 
added. The solution was stirred for 5 min. and then added to the resin (above), and the 
resulting mixture was shaken at room temperature for 2 days. The Kaiser test indicated 
the  reaction  was  completed.  The  resin  was  filtered  and  washed  sequentially  with 
dimethylformamide (3 x 40 ml), dichloromethane (3 x 40 ml), dimethylformamide (50 
ml) and dichloromethane (100 ml). The resin was dried under vacuum to give product 
324 (2.23 g). Fmoc substitution = 0.23 mmol/g.
276Resin 367
TBDMSO
A solution of piperidine/dimethylformamide (2:8, 30 ml) was added to resin 324 (2.15 
g, 0.23 mmol/g) and the mixture was shaken at room temperature for 18 h. The Kaiser 
test indicated the reaction was complete. The resin was filtered and washed sequentially 
with dimethylformamide ( 2 0 0  ml), dichloromethane ( 2 0 0  ml), dimethylformamide ( 1 0 0  
ml) and dichloromethane (100 ml). The resin was dried under vacuum to give product 
367 (2.05 g).
Resin 368
TBDMSO
Resin 367 (1.94  g,  0.23  mmol/g) was  swelled in dimethylformamide  for 30 min.  and 
then filtered. To Boc-Proline (0.35 g, 1.65 mmol) in dimethylformamide (10 ml), HOBt 
(0.22 g,  1.65  mmol)  followed by diisopropylcarbodiimide (0.36 ml, 2.31  mmol) were 
added. The mixture was stirred for 5 min. and this solution was then added to the resin.
277The  resulting  mixture  was  shaken  at  room  temperature  for  20  h.  The  Kaiser  test 
indicated  the  reaction  was  complete.  The  resin  was  then  washed  sequentially  with 
dimethylformamide  ( 2 0 0  ml), dichloromethane  ( 2 0 0  ml), dimethylformamide ( 1 0 0  ml) 
and dichloromethane (100 ml). The resin was dried under vacuum to give 368 (2.11 g).
Resin 325
NH  HN
.xCF3C02H
C02Me
Resin 368 (2.05  g, 0.23 mmol/g) was swelled in DCM for 30 minutes. The resin was 
then  filtered  and  a  solution  of trifluoroacetic  acid/dichloromethane  (1:1,  50 ml)  was 
added. The reaction mixture was shaken at room temperature for 5 h. The chloronil test 
indicated  that  the  reaction  was  complete.  The  resin  was  filtered  and  washed  with 
dichloromethane (5 x 30 ml) then dried under vacuum to give product 325 (2.15 g).
278Resin 326
NH  HN
co2 h
Resin 325 (1.00 g, 0.17 mmol/g) was swelled in dioxane for 30 min. and then filtered. 
To the resin, a cooled solution (~0 °C) of aqueous NaOH (lM)/dioxane (1:3, 20 ml) was 
added.  The  reaction  mixture  was  left  to  stand  at  0  °C  for  1  h.  Malachite  green test 
indicated the reaction was completed.  The resin was  filtered and washed sequentially 
with water (3 x 50 ml), dioxane (50 ml), methanol (50 ml) and dichloromethane (3 x 50 
ml). The resin was dried under vacuum to give product 326 (0.83 g).
Resin 212
Tentagel resin (0.50  g,  0.40 mmol/g) was washed with dichloromethane (3  x  10 mL) 
using a Merrifield bubbler.  A mixture of glutaric  anhydride (11.0 mg,  0.10 mmol) in 
anhydrous dichloromethane ( 8 ml) was added under nitrogen and the Merrifield bubbler 
shaken at room temperature  for 24 h.  The resin was  filtered and washed sequentially 
with dichloromethane  ( 2  x  1 0 ml), tetrahydrofuran  ( 2 x  1 0 ml), methanol  (2 x  1 0 ml) 
and dichloromethane (2x10 ml) and then dried under vacuum to give the resin (0.54 g).
279Resin 287
t
NH
O
O
OH
Tentagel resin (0.57  g,  0.40 mmol/g) was swelled in chloroform for 30 min. and then 
filtered. A solution of glutaric anhydride (0.26 g, 2.28 mmol) in chloroform (4 ml) was 
then added and the mixture was shaken at room temperature for 24 h. After this time, 
the Kaiser test indicated complete reaction. The resin was then filtered, and washed with 
chloroform (10 x  10 ml) and dried under vacuum to yield the desired product (0.70 g). 
Vmax (solid state/cm'1 )  1669 (m, C=0 (amide)),  1729 (m, C=0 (carboxylic acid)), 2867 
(s, C-H), 3512 (m, N-H).
Tentagel resin  (1.05  g,  0.40 mmol/g) was  swelled in dimethylformamide for 30 min. 
and then filtered.
Boc-Proline (0.45 g, 2.10 mmol) was dissolved in dimethylformamide (5 ml) and HOBt 
(0.28  g, 2.10 mmol)  followed by diisopropylcarbodiimide (0.46 ml, 2.94 mmol) were
Resin 285
T
280added.  The  solution was  immediately added  to  the  resin  and the mixture  shaken  at 
room temperature for 17 h. After this time, the Kaiser test indicated incomplete reaction. 
The resin was filtered, washed with dimethylformamide (3 x 40 ml) and then re-treated 
with the above reagents.  The mixture was subsequently shaken for an additional 2 h, 
after which time, the Kaiser test indicated complete reaction. The resin was then filtered 
and  washed  with  dimethylformamide  (2  x  30  ml),  dichloromethane  (2  x  30  ml), 
dimethylformamide (50 ml) and dichloromethane (100 ml). The resin was dried under 
vacuum to yield the desired product (1.30 g).
A mixture of trifluoroacetic acid/dichloromethane (1:1, 40 ml) was added to resin 285 
(1.10 g,  0.40 mmol/g)  and the resulting mixture shaken at room temperature for 3  h. 
After this time, the chloronil test indicated completion of the reaction.  The resin was 
then  washed  with  a  mixture  of  trifluoroacetic  acid/dichloromethane  (1:1,  40  ml), 
dichloromethane (7x10 ml) and dried under vacuum to yield the desired product (1.13 
g);  NMR (400 MHz, solid state) 5n/ppm 1.00 -  2.45 (br, H(3) and H(4)), 3.25 -  3.90 
(br, H(5) and H of polyethylene glycol (tentagel)), 4.15 -  4.45  (br, H(2)), 6.20 -  8.60 
(ArH of polystyrene (tentagel));  vmax (solid state/cm'1)  1687 (w, C=0), 2914 (s, C-H), 
3391 (s, N-H).
Resin 286
t
281Polymer 239
n-m
NH NH
OH
Polyallylamine  hydrochloride  (0.18  g,  3.16  mmol)  was  treated  with  potassium 
hydroxide (0.13 mg, 2.32 mmol) in methanol (40 ml) at room temperature for 16 h. The 
solvent  was  removed  under  reduced  pressure  and  ethanol  (35  ml)  was  added  to  the 
residue.  The resulting white precipitate was removed by filtration and the filtrate was 
concentrated  in  vacuo  to  leave  approximately  10  ml  of solvent.  To  the mixture was 
added chloroform (10 ml), followed by glutaric anhydride (0.18 g,  1.58 mmol) and the 
reaction mixture was stirred for 6 h at room temperature.
Concurrently,  diisopropylcarbodiimide  (0.32  ml,  2.05  mmol),  followed  by  N- 
hydroxysuccinimide (0.27 g, 2.37 mmol) were added to a solution of Boc-proline  (0.34 
g,  1.58  mmol)  in  chloroform  (10  ml).  The  resulting  solution  was  stirred  at  room 
temperature  for  6  h.  The  mixture  was  then  added  to  the  solution  containing 
polyallylamine (above) and stirring was continued for 18 h. The solvents were removed 
under  reduced  pressure  and  the  residue  was  washed  with  chloroform  (3  x  20  ml), 
methanol (3 x 20 ml) and chloroform (2 x 20 ml). The resulting solid was dried under 
vacuum to give the desired product as a white powder (430 mg).  13C NMR (75 MHz, 
solid  state)  5c/ppm  23.5  and  25.4  (br,  -C(CH3)3),  28.9  -   49.9  (br,  CH  and  CH2  of 
polyallylamine, CH2 of butyric acid and CH and CH2 of proline ), 80.5 (br, -C(CH3)3), 
158.2 (br, -NC(0)OC(CH3)3), 174.9 (br, -C(0)NH- and -COOH);
282Polymer 240
> H   NH
0=<  o=<
NH,+  CFXOO-
OH
A mixture of polymer 239 (400 mg) and trifluoroacetic acid/dichloromethane (1:1, 20 
ml) was shaken at room temperature for 2.5 h. The polymer was filtered, washed with 
dichloromethane (5  x  30 ml)  and then dried under vacuum.  The desired polymer was 
isolated as a white powder (470 mg).  13C NMR (75  MHz,  solid state) 5c/ppm 22.1  -
43.3  (br,  CH  and  CH2 of polyallylamine,  CH2  of butyric  acid  and  CH  and  CH2  of 
proline),  115.4  -   118.6  (br,  -CF3COO),  162.2  (-C(O)NH-  (proline)),  176.0  (br,  - 
C(0)NHCH2- and -COOH); vmax (solid state/cm’1)  1378,  1238 (s, C-F),  1693 (m, C=0 
(amides and carboxylic acid)), 2913  (m, C-H), 3072 (m, O-H (carboxylic acid)), 3367 
(m, N-H);
4.3.4 Synthesis of Racemic Aidol Products
To  a stirred  solution of 3-nitrobenzaldehyde (3.00 g,  20.0 mmol) in acetone (38 ml), 
aqueous NaOH (1% w/v, 3.80 ml) was added dropwise at 0 °C. Stirring was continued
4-Hydroxy-4-(3-nitro-phenyl)-butan-2-one (267)
OH  O
NO.
283at this temperature for an additional  15 min.. The solution was then neutralised (pH 7; 
by  addition  of aqueous  HC1  (0.5  M))  and  concentrated  in  vacuo.  The  residue  was 
suspended in water (40 ml) and extracted with diethyl ether (3 x 40 ml). The combined 
organic extracts were washed with brine (100 ml), dried over MgSOz*, and evaporated in 
vacuo.  Purification  by  flash  chromatography  (Si0 2 ;  gradient;  petroleum  spirit/ethyl 
acetate (3:1) to petroleum spirit/ethyl acetate (1:2)) gave the desired product as a brown 
oil (0.87 g, 21%).  Rf = 0.41  (SiC>2; petroleum spirit/ethyl acetate;  1:1);  !H NMR (300 
MHz,  CDCls) 5H /ppm 2.21  (s,  3H,  -CH3), 2.80 (m, 2H,  -CH2C(0 )CH3), 3.73  (m,  1H, 
OH),  5.18  (m,  1H, -ArCH(OH)-),  7.51,  7.68,  8.09 and 8.21  (m, 4H, ArH);  13C NMR 
(75  MHz,  CDC13)  5c/ppm  31.0  (-CH3),  51.8  (-CH2C(0)CH3),  69.1  (-ArCH(OH)-),
121.0,  122.8,  129.8  and  132.1  (4  x ArC),  145.2  and  148.6  (C(l)  and C(3)),  208.9  (- 
CH2C(0)CH3);  vmax (neat/cm'1)  1070 (s, C-O),  1500 (w, Ar),  1522 (s, N=0),  1601  (w, 
At), 1709 (s, C=0), 2907 (m, C-H), 3427 (s, O-H); m/z (CI+) 192 (6 8 %, [M -  H20]+).
4-Hydroxy-4-(thiophen-3-yl)-butan-2-oiie (259)
OH  O
To a stirred solution of 3-thiophenecarboxaldehyde (3.00 ml, 33.0 mmol) in acetone (62 
ml),  aqueous  NaOH  (1%  w/v,  6.2  ml)  was  added  dropwise  at  0  °C.  Stirring  was 
continued  at  this  temperature  for  an  additional  15  min..  The  solution  was  then 
neutralised (pH 7; by addition of aqueous HC1 (0.5 M)) and concentrated in vacuo. The 
residue was suspended in water (30 ml)  and extracted with diethyl ether (3 x 30 ml). 
The combined organic  extracts were washed with brine  ( 1 0 0  ml),  dried over MgSCU, 
and  evaporated  in  vacuo.  Purification  by  flash  chromatography  (Si0 2 ;  gradient; 
petroleum  spirit/ethyl  acetate  (3:1)  to  petroleum  spirit/ethyl  acetate  (1:1))  gave  the 
desired product as a brown liquid (2.96 g, 53%). Rf = 0.49 (SiC>2; petroleum spirit:ethyl 
acetate;  1:1);  NMR (300 MHz, CDC13)  6H /ppm 2.10 (s, 3H, -CIT,), 2.79 (m, 2H, - 
CH2C(0 )CH3), 3.74 (m, 1H, OH), 5.15 (m, 1H, -ArCH(OH)-), 6.99 (m, 1H, H(4)), 7.12
284(m,  1H, H(2)),  7.23  (m,  1H, H(5));  13C  NMR (75 MHz, CDC13) 5c/ppm 30.8 (-CH3),
51.3  (-CH2C(0)CH3),  66.3  (-ArCH(OH)-),  120.9,  125.6  and  126.3  (C(4),  C(5)  and 
C(2)),  144.5  (C(3)),  208.9  (-CH2C(0)CH3);  „m ax  (neat/cm'1 )  1070  (s,  C-O),  1705  (s, 
C=0),  2901  (m,  C-H),  3416  (s,  O-H);  m/z  (El)  170  (42%,  [M]+);  HRMS  found 
170.0389, [M]+ (C8H10O2S) requires 170.0396.
4-(4-Chloro-phenyl)-4-hydroxy-butan-2-one (220)170
OH  O
To a stirred solution of 4-chlorobenzaldehyde (3.00 g, 21.0 mmol) in acetone (38 ml), 
aqueous NaOH (1% w/v, 3.8 ml) was added dropwise at 0 °C. Stirring was continued at 
this temperature for an additional  15 min.. The solution was then neutralised (pH 7; by 
addition  of  aqueous  HC1  (0.5  M))  and  concentrated  in  vacuo.  The  residue  was 
suspended  in  water  (30  ml)  and  then  extracted  with  diethyl  ether  (3  x  30  ml).  The 
combined organic  extracts  were washed with brine  (100 ml),  dried over MgSC>4  and 
evaporated in  vacuo.  Purification by flash chromatography (Si02;  gradient; petroleum 
spirit/ethyl acetate (3:1) to petroleum spirit/ethyl acetate (1:1)) gave the desired product 
as a yellow oil (2.91  g, 69%). Rf = 0.50 (Si02; petroleum spirit/ethyl acetate;  1:1); *H 
NMR (300 MHz, CDC13) 5H /ppm 2.01 (s, 3H, -CH3), 2.58 (m, 2H, -CH2C(0)CH3), 3.98 
(m, 1H, OH), 4.94 (m,  1H, -ArCH(OH)-), 7.15-7.18 (m, 4H, ArH); l3C NMR (75 MHz, 
CDCI3) 8c/ppm 30.6 (-CH3), 51.8 (-CH2C(0)CH3), 68.9 (-ArCH(OH)-), 127.1  (C(3) and 
C(5)),  128.4  (C(2)  and C(6 )),  132.9 (C(4)),  141.8  (C(l)),  208.5  (-CH2C(0)CH3);  vm„ 
(DCM/cm1)  1076 (s, C-O),  1497 (s, Ar),  1601  (s, Ar),  1709 (s, C=0), 2905 (m, C-H), 
3427 (s, O-H); m/z (El)  198 (25%, [M]+); HRMS found  198.0442, [M]+ (Ci0H„C1O4) 
requires 198.0442.
2854-(l-Hydroxy-3-oxo-butyl)-benzoic acid methyl ester (261)
.O
O
To a stirred solution of 4-acetoxybenzaldehyde (3.00 g, 18.0 mmol) in acetone (33 ml), 
aqueous NaOH (1% w/v, 3.3 ml) was added dropwise at 0 °C. Stirring was continued at 
this  temperature  for  an  additional  15  min..  The  solution  was  neutralised  (pH  7;  by 
addition  of aqueous  HC1  (0.5  M))  and  then  concentrated  in  vacuo.  The  residue was 
suspended in water (30 ml) and extracted with diethyl ether (3 x 30 ml). The combined 
organic extracts were washed with brine (100 ml), dried over MgSC>4, and evaporated in 
vacuo.  Purification  by  flash  chromatography  (SiC>2;  gradient;  petroleum  spirit/ethyl 
acetate (3:1) to petroleum spirit/ethyl acetate (2:1)) gave the desired product as a white 
solid (1.13 g, 28%). m.p. 60 °C; Rf = 0.42 (SiC>2; petroleum spirit/ethyl acetate; 1:1); 
NMR (300 MHz, CDC13) 6H /ppm 2.14 (s, 3H, -CH3), 2.75 (m, 2H, -CH2C(0 )CH3), 3.72 
(m,  1H, OH), 3.84 (s, 3H, -C0 2CH3), 5.15 (m,  1H, -ArCH(OH)-), 7.37 (d, J= 8.4, 2H, 
H(3)  and  H(5)),  7.93  (d, J =  8.4,  2H,  H(2)  and  H(6 ));  13C  NMR (75  MHz,  CDC13) 
5c/ppm 40.0 (-CH3), 52.0 (-CH2C(0)CH3), 52.3 (-C02CH3), 69.6 (-ArCH(OH)-),  125.8 
(2  x  ArC),  130.0  (C(l)),  130.3  (2  x  ArC),  148.3  (C(4)),  167.1  (-C02CH3),  208.8  (- 
CH2C(0)CH3); vmax (DCM/cm1 ) 1074 (s, C-O),  1502 and 1611  (s, Ar),  1693 (s, C=0), 
2951  (w,  C-H),  3493  (s,  O-H);  m/z (El) 222  (64%,  [M]+);  HRMS  found 222.08901, 
[M]+ (C12H14O4) requires 222.08866.
4-Hydroxy-4-(2-nitro-phenyl)-butan-2-one (269)1 7 1
OH  O
3  ' ^ 2
To  a stirred solution of 2-nitrobenzaldehyde  (3.00 g,  20.0 mmol) in acetone (38 ml), 
aqueous NaOH (1% w/v, 3.8 ml) was added dropwise at 0 °C. Stirring was continued at
286this temperature for an additional  15 min.. The solution was then neutralised (pH 7; by 
addition  of  aqueous  HC1  (0.5  M))  and  concentrated  in  vacuo.  The  residue  was 
suspended in water (30 ml) and extracted with diethyl ether (3 x 30 ml). The combined 
organic extracts were washed with brine (100 ml), dried over MgSO.* and evaporated in 
vacuo.  Purification  by  flash  chromatography  (SiC>2;  gradient;  petroleum  spirit/ethyl 
acetate (3:1) to petroleum spirit/ethyl acetate (1:2)) gave the desired product as a brown 
oil (2.49 g, 60%).  Rf = 0.43  (Si02; petroleum spirit/ethyl acetate;  1:1); 'H NMR (300 
MHz, CDCI3) oH /ppm 2.14 (s, 3H, -CH3), 2.68 (m, 1H, -CH(H)C(0)CH3, 2.98 (m, 1H, - 
CH(H)C(0)CH3),  3.93  (m,  1H, OH),  5.61  (m,  1H, -ArCH(OH)-), 7.38  (m,  1H, ArH), 
7.60 (m,  1H,  ArH),  7.84  (m,  2H,  ArH);  13C  NMR (75  MHz,  CDC13) <Vppm  30.5  (- 
CH3),  51.4 (-CH2C(0)CH3), 65.6 (-ArCH(OH)-),  124.5 (C(3)),  128.3  and  128.4 (C(4) 
and  C(6 )),  133.9  (C(5)),  138.8  (C(l)),  147.2  (C(2)),  208.7  (-CH2C(0)CH3);  vm„ 
(neat/cm1) 1043 (m, C-O),  1526,  1574 and  1611  (m, Ar),  1701  (s, C=0), 2860 (w, C- 
H),  2947  (w,  C-H),  3416  (s,  O-H);  m/z  (Cl)  210  (48%,  [M  +  H]+);  HRMS  found 
210.0756, [M + H]+ (Ci0H12NO4) requires 210.0761.
4-(4-Bromo-phenyl)-4-hydroxy-butan-2-one (251)
170
OH  O
To a stirred solution of 4-bromobenzaldehyde (3.00 g, 32.0 mmol) in acetone (60 ml), 
aqueous NaOH (1% w/v, 6.00 ml) was added dropwise at 0 °C. The mixture was then 
stirred for 20 min.. The solution was then neutralised (pH 7; by addition of aqueous HC1 
(0.5  M))  and  concentrated  in  vacuo.  The  resulting  brown  residue  was  suspended  in 
water  (50  ml)  and  extracted  with  ethyl  acetate  (3  x  70  ml).  The  combined  organic 
extracts  were  dried  over  MgS0 4 ,  filtered  and  concentrated.  Purification  by  flash 
chromatography  (SKV,  gradient;  petroleum  spirit/ethyl  acetate  (3:1)  to  petroleum 
spirit/ethyl acetate (1:1))  gave the desired product as a brown oil (3.94 g, 26%).  Rf = 
0.50 (SiC>2;  petroleum spirit/ethyl  acetate;  1:1);  *H  NMR (300 MHz,  CDCI3)  dn/ppm 
2.18  (s,  3H,  -CH3),  2.80  (m,  2 H,  -CH2C(0 )CH3),  3.45  (s,  1H,  OH),  5.12  (m,  1H,  -
287ArCH(OH)-), 7.25 (m, 2H, H(3) and H(5)), 7.39 (m, 2H, H(2) and H(6 )); 13C NMR (75 
MHz,  CDC13)  5c/ppm  31.1  (-CH3),  52.1  (-CH2C(0)CH3),  69.5  (-ArCH(OH)-),  121.7 
(C(4)),  127.7  (C(3)  and  C(5)),  132.0  (C(2)  and  C(6 )),  142.1  (C(l)),  209.2  (- 
CH2C(0)CH3); i w  (neat/cm'1) 1020 (s, C-O), 1491 (s, Ar), 1709 (s, C=0), 2885 (w, C- 
H),  3427  (s,  O-H);  );  m/z  (CI+)  243  (12%,  [M  +  H]+),  187  (96%,  [M  -  
(CH2C(0)CH3)]+); HRMS found 243.0016, [M + H]+ (Ci0H]2BrO2) requires 243.0020.
4-(l-Hydroxy-3-oxo-butyl)-benzonitrile (271)170
OH  O
To a stirred solution of 4-cyanobenzaldehyde (4.00 g, 31.0 mmol) in acetone (48 ml), 
aqueous NaOH (1% w/v, 5.70 ml) was added dropwise at 0 °C. The mixture was then 
stirred for 15 min.. The solution was then neutralised (pH 7; by addition of aqueous HC1 
(0.5  M))  and  concentrated  in  vacuo.  The  resulting  brown  residue  was  suspended  in 
water  (50  ml)  and  extracted  with  diethyl  ether  (3  x  80  ml).  The  combined  organic 
extracts  were  dried  over  MgS0 4 ,  filtered  and  concentrated.  Purification  by  flash 
chromatography  (Si0 2 ;  gradient;  petroleum  spirit/ethyl  acetate  (3:1)  to  petroleum 
spirit/ethyl acetate (1:2)) gave the desired product as a white solid (0.81  g,  14%). m.p. 
90  °C;  Rf  =  0.26  (Si02;  petroleum  spirit/ethyl  acetate;  1:1);  NMR  (300  MHz, 
CDC13) SH /ppm 2.18 (s, 3H, -CH3), 2.80 (d, J = 6.2, 2H, -CH2C(0 )CH3), 3.68 (br s, 1H, 
OH), 5.18 (m,  1H, -ArCH(OH)-), 7.45 (d, J= 8.3, 2H, H(3) and H(5)), 7.60 (d, J= 8.4, 
2H,  H(2)  and  H(6 ));  13C  NMR  (75  MHz,  CDC13)  Sc/ppm  30.7  (-CH3),  51.6  (- 
CH2C(0)CH3),  69.0  (-ArCH(OH)-),  111.3  (C(l)),  118.8  (-CN),  126.4  (C(3),  C(5)), 
132.4 (C(2) and C(6 )),  148.2 (C(4)), 208.5 (-CH2C(0)CH3); vmax (DCM/cm'1)  1076 (s, 
C-O),  1504 and  1609 (m, Ar),  1709 (s, C=0), 2230 (s, C *0, 2897 (w, C-H), 3435 (s, 
O-H);  m/z  (Cf)  190  (100%,  [M  +  H]+);  HRMS  found  190.0869,  [M  +  H]+ 
(CiiHhN02) requiresl90.0868.
2884-Hydroxy-4-(4-nitro phenyl) butan-2-one (116)127
To  a stirred solution of 4-nitrobenzaldehyde  (4.00 g,  26.0 mmol)  in acetone (48  ml), 
aqueous NaOH  (1% w/v,  4.80 ml) was  added  at 0 °C.  Stirring was continued for  15 
min., at which point a black solution formed. The mixture was then neutralised (pH 7; 
by addition of aqueous HC1 (0.5 M)) and concentrated in vacuo.  The resulting brown 
residue was suspended in water (50 ml)  and extracted with diethyl ether (3  x 80 ml). 
The combined organic layers were dried over MgS0 4  and concentrated to give the crude 
product  as  a  brown  solid.  Purification  by  flash  chromatography  (SiC>2;  gradient; 
petroleum  spirit/ethyl  acetate  (3:1)  to  petroleum  spirit/ethyl  acetate  (1:1))  gave  the 
desired product as a yellow solid (2.54 g, 46%). m.p. 59 °C (lit. 59-61 °C127); Rf = 0.26 
(SiC>2; petroleum spirit/ethyl acetate;  1:1);  NMR (300 MHz, CDCI3) Sn/ppm 2.18 (s, 
3H, -CH2C(0)CH3), 2.81  (d, J= 6.2, 2H, -CH2C(0 )CH3), 3.79 (br s,  1H, -ArCH(OH)- 
), 5.22 (t, J= 6.1,  1H, -ArCH(OH)-), 7.49 (d, J  = 7.0, 2H, H(3) and H(5)), 8.13 (d, J =
7.0,  2H,  H(2)  and H(6 ));  13C  NMR  (75  MHz,  CDC13)  5c/ppm  30.9  (-CH2C(0)CH3), 
51.8  (-CH2C(0)CH3),  69.1  (-ArCH(OH)-),  123.9  (C(3)  and  C(5)),  126.7  (C(2)  and 
C(6 )), 147.4 ( C(4)),  150.5 (C(l)), 208.8 (-CH2C(0)CH3); vmax (DCM/cnf1 ) 1078 (s, C- 
O), 1340 (s, N 02), 1518 (s, N 02),  1600 (s, Ar), 1710 (s, C=0), 2907 (m, C-H), 3447 (s, 
O-H); m/z (C f) 210 (82%,  [M + H]+); HRMS found 210.0770, [M + H]+ (Ci0Hi2NO4) 
requires 210.0766.
2894.3.5 General Procedures for Aldol Reactions
General Procedure for the Formation of Aldol Products with Resins 
Control Reaction
Aldehyde (10 mg, 1 eqv.) was added to a stirred solution of tentagel resin (2 mol%) and 
A-methylmorpholine  (1.52  eqv.)  in  ketone  (1  ml).  The  reaction  was  stirred  at room 
temperature for 18 h. Ethyl acetate (5 ml) was added to the mixture and the resin filtered 
and washed with ethyl  acetate (2x5  ml).  The combined organic  filtrate was washed 
with aqueous saturated ammonium chloride (2x15 ml), followed by brine (2x15 ml). 
The organic extracts were dried over MgSC>4 and evaporated in vacuo.
General Procedure
Aldehyde  (10  mg,  1   eqv.)  was  added to  a stirred  solution of resin  (2  mol%)  and N- 
methylmorpholine  (1.52  eqv.)  in  ketone  (1  ml)  and  the  reaction  stirred  at  room 
temperature for  18 h.  Ethyl acetate (5 ml) was added to the mixture and the resin was 
filtered and then washed with ethyl  acetate (2x5  ml).  The combined organic  filtrate 
was washed with aqueous saturated ammonium chloride (2x15 ml), followed by brine 
(2x15 ml). The organic extracts were dried over MgSC>4 and evaporated in vacuo. The 
purification procedure is the same as for the corresponding aldol product racemates in 
Chapter 4.
290[a]D  Values for the Enantiomeric Mixtures of the Aldol Products with 
Aldol Catalyst 238
All  the  other  analytical  data  for  the  products  below,  matched  the  data  for  the 
corresponding racemates in Chapter 4.
4-(4-Chloro-phenyl)-4-hydroxy-butan-2-one 220
Cl
[a]D  + 13.5 ° (c 0.48, CHC13) 
Literature value:
Cl
[a]D  + 70.5 ° (c 0.50, CHC13)170
4-Hydroxy-4-(4-nitro-phenyl)-butan-2-oiie 116
OH  O
[a]D  + 23.7 ° (c 0.51, CHC13)
Chiral HPLC  (OB,  80:20 Heptane/Isopropanol,  0.25  ml/min), Rt = 33.61  min (74%, 
Enantiomer A), Rt = 36.54 min (26%, Enantiomer B), ee = 48%.
291Literature value:
OH  O
[«]D  + 61.6 ° (c 0.51, CHCI3 )118
4-(4-Bromo-phenyl)-4-hydroxy-butan-2-one 251
OH  O
Br  ^
[ « ] d  0 .0  0
Chiral HPLC (OD, 95:5 Heptane/EtOH,  1  ml/min), Rt = 2.80 min (50%, Enantiomer 
A), Rt = 3.10 min (50%, Enantiomer B).
4-(l -Hydroxy-3-oxo-butyl)-benzonitrile 271
OH  O
[a]D  + 40.8 0 (c 0.48, CHCI3)
Chiral  HPLC  (OB,  90:10  Heptane/EtOH,  0.25  ml/min),  Rt  =  12.43  min  (76%, 
Enantiomer A), Rt = 15.50 min (24%, Enantiomer B), ee = 51%.
292Literature value:
NC
[a]D  + 74.3 ° (c 0.48, CHCI3 )170
4-Hydroxy-4-(thiophen-3-yl)-butan-2-one 259
OH  O
[«JD  - 6 .8 ° (c 0.88, CHC13)
Chiral HPLC (OB, 95:5 Heptane/EtOH,  1   ml/min), Rt = 2.78 min (15%, Enantiomer 
A), Rt = 3.15 min (85%, Enantiomer B), ee = 69%.
4-(l-Hydroxy-3-oxo-butyl)-benzoic acid methyl ester 261
OH  O
O
N o 0.0°
Chiral  HPLC  (OB,  95:5  Heptane/Isopropanol,  1  ml/min),  Rt  =  2.83  min  (50%, 
Enantiomer A), Rt = 3.14 min (50%, Enantiomer B).
2934-Hydroxy-4-(2-nitro-phenyl)-butan-2-one 269
OH  O
NO.
[«]d - 13.8 ° (c 0.94, CHC13)
4-Hydroxy-4-(3-nitro-phenyl)-butan-2-one 267
OH  O
N02  
[0f]D  0.00
Chiral  HPLC  (OB,  94:6  Heptane/Isopropanol,  1  ml/min),  Rt  =  2.79  min  (15%, 
Enantiomer A), Rt = 3.11 min (85%, Enantiomer B).
[a]D  Values for the Enantiomeric Mixtures of the Aldol Products with 
Aldolase Catalyst 325
4-Hydroxy-4-(4-nitro-phenyl)-butan-2-one 116
OH  O
[a]D  + 23.7°(c 0.51, CHCI3)
2944-(l-Hydroxy-3-oxo-butyl)-benzoic acid methyl ester 261
OH  O
O
[a]D  0.0°
4-(4-Chloro-phenyl)-4>hydroxy-butan-2-one 220
OH  O
[a]D  + 15.4 ° (c 0.48, CHC13)
[a]D  Values for the Enantiomeric Mixtures of the Aldol Products with 
Aldolase Catalyst 326
4-Hydroxy-4“(4-nitro-phenyl)-butan-2-one 116
OH  O
[a]D  + 23.5 ° (c 0.51, CHC13)4-(l-Hydroxy-3-oxo-butyl)-benzoic acid methyl ester 261
O
[ot]D  + 7.8 ° (c 0.41, CHC13)
4-(4-Chloro-phenyl)-4-hydroxy-butan-2-one 220
OH  O
cr  ^
[a]D  - 6.5 0 (c 0.48, CHC13)
2964.3.6 Synthesis of Sulfoxide Transition State Analogues
(S)-(-)Menthyl /Moluenesulfinate (319)
136
o  ! +
o
11
/?ara-Toluene sulfinic acid (2.00 g,  11.0 mmol) was added portionwise to a solution of 
thionyl chloride (4.10 ml, 56.0 mmol) in benzene at 0 °C. The mixture was then allowed 
to  warm  to  room  tempearature  and  then  the  volatiles  were  removed  under  reduced 
pressure. The residue was dissolved in anhydrous ether (20 ml) and cooled to 0 °C under 
nitrogen.  A  solution  of (-)menthol  (1.93  g,  12.0  mmol)  in pyridine  (2  ml)  was  then 
added dropwise.  After the  addition was  complete,  the  mixture was  stirred  for  3  h at 
room tmperature. Water (20 ml) was added and the layers were separated. The organic 
layer was washed with aqueous HC1 (10 % v/v, 20 ml) and brine (20 ml) and dried over 
MgSC>4. The solvent was evaporated and the remaining residue dissolved in acetone ( 8  
ml) and five drops of concentrated aqueous HC1 were added. The mixture was allowed 
to  stand in the  freezer (-18  °C)  for 2  days.  The resulting  solid was isolated and then 
recrystallised from acetone and dried under vacuum. The desired product was isolated 
as a white crystalline solid (1.02 g, 31%). m.p.  106 °C (lit.  110 °C136); Rf = 0.83 (Si02; 
ethyl acetate/petroleum spirit;  1:1);  NMR (300 MHz, CDCI3) de/ppm 0.71  (d, J = 
6.9, 3H, H(5)CH3), 0.85 (d, J = 7.1, 3H, -CHCH3), 0.95 (d, J= 6.5, 3H, -CHCH3), 1.01 
-   1.46  (m,  5H,  H(2),  H(3),  HH(6 )  and  H(5)),  1.67  (m,  2H,  H(4)),  2.14  (m,  1H,  - 
CH(CH3)2), 2.27 (m, 1H, HH(6 )), 2.40 (s, 3H, ArCH3), 4.10 (m,  1H, H(l)), 7.30 (d, /  =
8.0,  2H, H(9) and H(ll)), 7.59 (d, J  = 8.1, 2H, H(8) and H(12));  13C NMR (75 MHz, 
CDC13)  6 c/ppm  15.8 (C(5)CH3), 21.1, 21.7, 22.3  (ArCH3  and CH(CH3)2), 23.5  (C(3)),
25.6  (-CH(CH3)2), 32.0 (C(5)), 34.4 (C(4)), 43.3 (C(6 )), 48.2 (C(2)), 80.3 (C(l)),  125.3 
(C(8)  and  C(1 2)),  129.9  (C(9)  and  C(ll)),  142.6,  143.6  (C(7)  and  C(1 0));  vmax 
(DCM/cm'1)  1040 (w, S=0),  1495 (s, Ar),  1593 (s, Ar), 2924 (s, C-H); m/z (FAB) 295 
(19%,  [M + H]+); [a]D  - 207 0 (c 2.0, acetone), lit. - 201 0 (c 2.0, acetone) . 136
297(+)-l-Methanesulfmyl-4-methyl benzene (321)136
Methyl  magnesium  iodide  in  diethyl  ether  (1.7  M,  1.50  ml,  2.49  mmol)  was  added 
dropwise  to  a  stirred  mixture  of (-)-(S)-menthyl-/?-toluenesulfinate  319  (0.50  g,  1.78 
mmol) in anhydrous ether (3.5 ml) and tetrahydrofuran (1.5 ml) at 0 °C under nitrogen. 
After the addition, the mixture was allowed to warm to room temperature and stirring 
was continued for 4 h. The reaction was quenched by the addition of saturated aqueous 
ammonium chloride solution (5 ml) and the resulting layers were separated. The organic 
layer was washed with brine (5  ml),  dried over MgSC>4,  and  solvents removed under 
reduced pressure. The oily residue was suspended in hot hexane, until the formation of a 
yellow precipitate was observed. After cooling at 4 °C for 18 h, the resulting solid was 
isolated and recrystallised  from ether/hexane.  The desired sulfoxide was isolated as a 
white solid (70.0 mg, 27%). m.p. 73 °C (lit. 73 - 74 °C136); Rf = 0.40 (Si02; petroleum 
spirit/ethyl  acetate;  1:2);  ‘H  NMR (300  MHz,  CDClj)  SH /ppm 2.38  (s,  3H, CH3Ar-), 
2.68 (s, 3H, ArS(0)CH3)),  7.24 (d, J=  6.5, H(3) and H(5)),  7 .5  l(d, ./ = 7.4, 2H, H(2) 
and  H(6 ));  13C  NMR  (75  MHz,  CDC13)  oc/ppm  21.3  (CH3Ar-),  44.0  (ArS(0)CH3),
123.6  (C(2)  and  C(6 )),  130.0  (C(3)  and  C(5)),  141.5  (C(4)),  142.6  (C(l));  vm„ 
(DCM/cm'1) 1036 (s, S=0),  1599 (w, Ar), 2914 (w, C-H); m/z (Cf) 155 (100%,  [M + 
H]+); [«1d + 194 ° (c 1.5, CHC13), lit. + 145 ° (c 1.5, CHC13) . 172
298Dimethylphosphorylmethyl />-tolyl sulfoxide (320)137
O  O
Dimethyl methanephosphonate (0.38  ml,  3.56 mmol)  in anhydrous tetrahydrofuran  ( 6  
ml) was stirred at -78 °C under nitrogen. «-Butyllithium in hexanes (2.32 M,  1.69 ml, 
3.91 mmol) was added dropwise and stirring was continued for 30 min.. (-)-(S)-Menthyl 
/?-toluenesulfinate 321  (0.50 g,  1.78 mmol) dissolved in THF (3.5 ml) was added and 
stirring was continued at -78 °C for a further 15 min.. The mixture was then warmed to 
-20  °C  and  the  reaction  quenched  by  the  addition  of saturated  aqueous  ammonium 
chloride  (10  ml).  The  volitiles  were  removed  in  vacuo  and  the  resulting  aqueous 
mixture was washed with petroleum spirit (25 ml) and then extracted with chloroform 
(3  x  15  ml).  The  chloroform  extracts  were  combined,  dried  over  MgSC>4  and 
concentrated  under  reduced  pressure  to  yield  the  crude  material  as  a  colourless  oil, 
which was used immediately in the next step without further purification.
Diisopropylamine  (0.42  ml,  2.99  mmol)  in  anhydrous  tetrahydrofuran  (23  ml)  was 
cooled  to  -78  °C  under nitrogen.  «-Butyllithium  in  hexanes  (2.17  M,  1.31  ml,  2.84 
mmol) was added and the reaction was stirred for 15 min.. The solution was warmed to 
0 °C and stirred at this temperature for 30 min. The mixture was then re-cooled to -78 
°C  and the  sulfoxide  321  (230 mg,  1.49 mmol)  in tetrahydrofuran  (5  ml) was  added 
dropwise. After the addition, the mixture was allowed to warm up to 0 °C and stirred for
(+)-l-(Toluene-4-sulfmyl)-propan-2-one (316)173
O  O
2991 h. Ethyl acetate (0.22 ml, 2.24 mmol) was then added and stirring was continued for 2 
h. The reaction was quenched by the addition of saturated aqueous ammonium chloride 
(30  ml)  and  the  resulting  organic  layer  was  separated.  The  aqueous  layer  was  then 
acidified with aqueous HC1 (10% v/v) to ~ pH4 and extracted with dichloromethane (30 
ml).  The  organic  extracts  were  combined  and  dried  over MgSC>4.  The  solvents were 
removed in vacuo to yield the product as a yellow solid (97.6 mg, 33%). m.p. 33 °C (lit. 
38  °C173);  Rf = 0.21  (Si02;  ethyl  acetate/petroleum spirit;  1:1);  'H  NMR (300 MHz, 
CDCI3)  8 H /ppm  2.05  (s,  3H,  CHjAr-),  2.24  (s,  3H,  -CH2C(0)CH3),  3.75  (s,  2H,  - 
CSAO)-), 7.16 (d, J = 8.1, 2H, H(2) and H(6 )), 7.38 (d, 7=  8.1, 2H, H(3) and H(5)); 
l3C  NMR  (75  MHz,  CDCI3)  Sc/ppm  20.9  (CH3Ar-),  31.5  (-C(0)CH3),  68.3  (- 
CH2C(0)CH3),  123.7 (C(3) and C(5)) and 129.8 (C(2) and C(6)),  139.1  and 140.8 (2 x 
quaternary ArC), 199.3 (-CH2C(0)CH3); »w  (DCM/cm'1 ) 1042 (s, S=0), 1597 (w, Ar), 
1711  (s,  C=0),  2924  (m,  C-H);  m/z  (Cf)  197  (36%,  [M  + H]+),  139 (100%,  [M -  
(CH2C(0)CH3)]+); HRMS  found  197.0633,  [M + H]+ (CioH130 2S) requires  197.0636; 
[c k] d + 267 0 (c 1.0, acetone), lit. + 255 0 (c 1.0, acetone) . 173
1 -Methyl-4-|((/:)-prop-1 -ene)-l-sulfinyl]-benzene (317)174
To a crude mixture of 320 (4.05 g,  15.0 mmol) dissolved in anhydrous tetrahydrofuran 
(50 ml), tt-butyllithium in hexanes (1.80 M,  16.1  ml, 29.0 mmol) was added at -78 °C, 
under nitrogen. Stirring was continued for 90 min. and the mixture was then warmed 0 
°C,  and  stirred  for  an  additional  30  min..  The  mixture  was  cooled  to  -78  °C  and  a 
solution of acetaldehyde  (1.46 ml,  26.0 mmol)  in tetrahydrofuran  (15  ml) was  added 
dropwise.  After the  addition, the mixture was then warmed to room temperature and 
stirred for 3 h. Water (50 ml) was added and the organics were removed under reduced 
pressure.  The  aqueous  residue  was  extracted  with  chloroform  (3  x  50  ml)  and  the 
organic extracts were washed with water (150 ml) and dried over MgSC>4, filtered and 
concentrated.  Purification  by  flash  chromatography  (SiC>2;  gradient;  petroleum 
spirit/ethyl acetate (3:1) to ethyl acetate/methanol (8:2)) yielded the product as a clear
300oil (0.40 g,  14%). Rf = 0.53 (Si02; ethyl acetate); 'H NMR (300 MHz, CDC13) SH /ppm 
1.75  (m,  3H,  -CH=CHCH3),  2.26 (s,  3H, CH3Ar-), 6.12 (m,  1H, -S(O)CH-), 6.45  (m, 
1H, -CHCH3) ),  7.17 (d, J =  8.1, 2H, H(2) and H(6 )),  7.37 (d, J = 8.1, 2H, H(3) and 
H(5));  13C  NMR (75  MHz,  CDC13)  6c/ppm  17.7  (-CHCHCHj),  21.3  (CH3Ar-),  124.4 
(C(3) and C(5)) and 129.9 (C(2) and C(6 )),  136.0 (-CHCHCH-,),  136.4 (C(l)), 141.2 (- 
CHCHCH3), 141.4 (C(4)); vmax (neat/cm1) 1042 (s, S=0), 1493, 1595 (m, Ar), 1632 (m, 
C=C), 2918 (m, C-H); m/z (Cf) 181 (100%,  [M + H]+); HRMS found 181.0688, [M + 
H]+ (CioHnOS) requires  181.0687;  [tt]D  + 285.3  0 (c 0.03, CHC13), lit. +  198 ° (c not 
stated, EtOH) . 174
3014.3.7 NMR Binding Studies
Measurement of Diffusion Coefficient of Sulfoxide TSAs (316 and 317) 
and Amino Acids Using Pulsed Field Gradient Techniques
The diffusion coefficients were measured according to the literature procedure.96
3 mM solutions of each Boc protected amino acid and 30 mM solutions of each TSA 
(316  and 317) were prepared in CDCI3  (0.5  mL)  and diffusion coefficients measured 
using PFG-NMR spectroscopy.
Sample mixtures containing one protected amino acid and one TSA were also prepared, 
where the concentration  of the  amino  acid was  3  mM  and that of the  TSA  30 mM. 
Diffusion coefficients were then measured using PFG-NMR spectroscopy.
All of the diffusion measurements were perfomed at 298 K.
The results are presented in Chapter 3.
3024.3.8 Supramolecular Chemistry
(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl) acetic acid (339)175
O
OH
Uracil  (0.25  g,  2.23  mmol),  chloroacetic  acid  (0.38  g,  3.97  mmol)  and  potassium 
hydroxide (0.55 g, 9.80 mmol) were added to water (5 ml) and the mixture was heated 
at reflux  for  2.5  h.  After  cooling,  the  resulting  solution  was  acidified  to  pH  2  with 
concentrated aqueous HC1. The solution was left to stand in the fridge for 3 days, after 
which time,  a white  solid had precipitated.  The  solid was  isolated by filtration,  then 
washed with dichloromethane, and dried under vacuum to give the product as a white 
solid (0.20 g, 67%)). m.p. > 230 °C (lit. 292-293 °C176); 'H NMR (300 MHz, DMSO) 
6 H /ppm 4.44 (s, 2H, -CH2CO2H), 5.62 (d,J = 7.7,  1H, -C(0)CH=CH-), 7.63 (d, J = 7.8, 
1H, -C(0)CH=CH-); UC NMR (75 MHz, DMSO)  6c/ppm 49.8 (-CH2C0 2H),  102.0 (- 
C(0)CH=CH-),  147.3  (-NHC(0)CH=CH-),  152.2  (-NHC(O)N-),  165.1  and  170.8  (- 
C(0)CH=CH- and -C02H); iw  (DCM/cnf1 ) 1688 (m, C=0), 2853 and 2916 (s, C-H); 
m/z (CI+)  171  (75%,  [M + H]+),  170 (5%,  [M]+);  HRMS  found  171.0406,  [M + H]+ 
(C6H7N2O4) requires 171.0406.
3035-Methoxycarbonyl pentyl ammonium chloride (343)
O
Cl  h 3n
+
Thionyl chloride (3.64 ml, 50.0 mmol) was added to methanol (25 ml) at 0 °C and the 
solution was  stirred  at  this  temperature  for 20  min..  To  this  solution  6 -aminocaproic 
acid (3.00 g, 23.0 mmol) was then added. The solution was allowed to warm to room 
temperature and stirred for 3.5  h.  The volatiles were removed under reduced pressure 
and the resulting solid was recrystallised from hexane/ethyl acetate and a few drops of 
methanol  to  obtain  the  final  product  as  a  white  solid  (2.09  g,  63%).  m.p.  79  °C 
(EtOAc/hexane/MeOH);  'H  NMR  (300  MHz,  CDCI3)  5H /ppm  1.35  (m,  2H, 
H2NCH2CH2CH2-),  1.56 (m, 2H, H2NCH2CH2-),  1.72  (m, 2H, H2N(CH2 )3CH2-), 2.24 
(t, J = 7.2, 2H, H2N(CH2)4CH2-), 2.94 (br m, 2H, H2NCH2-), 3.56 (s, 3H, -CH3), 8.05 
(br s, 3H, -NHj+);  UC NMR (75 MHz, CDC13) 5c/ppm 24.0 (H2NCH2CH2CH2-), 25.7 
(H2NCH2CH2-), 26.9 (H2N(CH2)3CH2-), 33.4 (H2N(CH2)4CH2-), 39.6 (H2NCH2-), 51.4 
(-CH3), 173.8 (-C02CH3);  (DCM/cm1 ) 1728 (s, C=0), 2852 (s, C-H), 3447 (w, N- 
H);); m/z (CI+) 146 (63%,  [M - Cl]*); HRMS found  146.1791, [M - Cl]+ (C7Hi6N02) 
requires 146.1181.
6-[(2,6-Dioxo-l,2,3,6-tetrahydro-pyrimidine-4-carbonyl)-amino]-hexanoic acid
methyl ester (345)
A solution of orotic acid (0.50 g, 3.21  mmol),  6 -amino-hexanoic acid methyl ester 343 
(0.46  g,  3.21  mmol),  A-methyl  morpholine  (0.35  ml,  3.21  mmol)  and  1- 
(ethoxycarbonyl)-2-ethoxy-l,  2-dihydroquinoline  (0.79  g,  3.21  mmol)  in  anhydrous 
dimethylformamide  (7  ml)  was  stirred  at  55  °C  for  18  h.  The  reaction mixture was
O
O
304concentrated in vacuo and the resulting residue was triturated with water, followed by 
ethyl acetate.  The isolated solid was recrystallized from methanol to yield the desired 
product  as  a brown  solid  (74  mg,  8 %).  m.p.  >  200  °C;  Rf =  0 .1 0   (Si02;  petroleum 
spirit/ethyl  acetate;  1:1);  ‘H  NMR  (300  MHz,  CD3OD)  5H /ppm  1.37  (m,  2H,  - 
NHCH2CH2CH2-), 1.61 (m, 4H, -NHCH2CH2CH2CH2-), 2.33 (m, 2 H, -NH(CH2)4CH2-), 
3.30 (m, 3H, -NHCHh and -NH-), 3.64 (s, 3H, -CH3), 6.07 (s,  1H, -C(0)CH=C-);  13C 
NMR  (125  MHz,  CD3OD)  6 c/ppm  26.4  (-NHCH2CH2CH2-),  28.2  and  30.5  (- 
NHCH2CH2CH2CH2-), 35.5  (-NH(CH2)4CH2-), 41.7 (-NHCH2-), 52.9 (-CH3),  101.6 (- 
C(0)CH=C-),  147.8  (-C(0)CH=C-),  153.6  (-NHC(O)NH-),  162.7  (-CH=CC(0)NH-),
167.8  (-C(0)CH=C-),  176.8  (-C02CH3);  rm ax  (nujol/crn1 )  1651  (s,  C=C),  1732  (s, 
C=0),  2853  and  2932  (s,  C-H),  3306  (m,  N-H);  m/z  (C f)  284  (100%,  [M  +  H]+); 
HRMS  found  284.1246,  [M  +  H]+   (Ci2Hl8N30 5)  requires  284.1246.  Anal. 
(Ci2Hi7N30 5)  found  C,  50.34;  H,  5.98;  N,  14.58%;  requires  C,  50.88;  H,  6.05;  N, 
14.83%.
Dodecanoic acid (6-amino-pyridin-2-yl) amide (340)
177
NH2
H   1   2
2,  6 -  Diaminopyridine  (1.00  g, 9.17  mmol)  and triethylamine  (1.28  ml,  9.17 mmol) 
were dissolved in anhydrous tetrahydrofuran (15 ml) and the solution cooled to 0 °C. A 
solution of lauroyl chloride (2.29 ml, 9.63 mmol) in tetrahydrofuran (1.5 ml) was added 
dropwise and the solution stirred for 50 min..  The mixture was then warmed to room 
temperature and stirring was continued for 24 h. The reaction mixture was filtered and 
evaporated to dryness. Purification by flash chromatography (SiC>2; gradient; petroleum 
spirit/ethyl acetate, (3:1) to petroleum spirit/ethyl acetate,  (1:2)) gave the product as a 
white solid (1.14 g, 43%). m.p. 51  °C; Rf = 0.41  (Si0 2 ; ethyl acetate/petroleum spirit; 
1:1);  'H  NMR  (300  MHz,  CDC13)  6H /ppm  0.82  (m,  3H,  CH3-),  1.19  (m,  16H, 
CH3(CH2)8~),  1.57 (m, 2H, -NHC^JCHjCPfc-), 2.24 (m, 2H, -NHCfOJCHj-), 4.48 (br
305s, 2H, -NH2), 6.16 (d, J=  8.0,  1H, H(5)), 7.32 (m, 1H, H(3)), 7.47 (m,  1H, H(4)), 8.34 
(br s,  1H, N-H); 13C NMR (75 MHz, CDCI3) Sc/ppm  14.3 (CH3-), 22.9, 25.7, 29.4 and
29.8  (peaks  overlap,  CH3(CH2)8-  ),  32.1  (-NHC(0)CH2CH2),  37.8  (-NHC(0)CH2-),
103.4  and  104.3  (C(5)  and  C(3)),  140.3  (C(4)),  150.3  (C(2)),  157.4  (C(6 )),  172.2  (- 
NHC(0)-);  Fmax (DCM/cm'1 )  1533  (s,  Ar),  1574 (s, Ar),  1620 (s, Ar),  1682 (s, C O ), 
2852 and 2924 (s, C-H); m/z (Cl3) 292 (100%,  [M + H]+); HRMS found 292.2385, [M 
+ H]+ (Cl7H3oN3o) requires 292.2389.
(2,6-Amino-pyridin-2-ylcarbamoyl)-pyrrolldine-l-carboxyllc acid tert-butyl ester
(337)
4
O  o
J.  A  H   Y \ H   1   H   \  ? 1 0
N
o = <   11
O o
Dicyclohexylcarbodiimide  (2.27  g,  11.0  mmol)  was  added  to  a  solution  of  2,  6 - 
diaminopyridine  (0.25  g,  2.30  mmol)  and  Boc-proline  (2.47  g,  11.5  mmol)  in 
dimethylformamide (10 ml). The resulting mixture was stirred at room temperature for 
72 h. The urea by-product was filtered off and ethyl acetate (50 ml) was added to the 
filtrate.  The  resulting  solution  was  washed  with  aqueous  HC1  (1  M,  2  x  50  ml), 
saturated  aqueous  Na2CC>3  (4  x  50  ml)  and  brine  (2  x  50  ml)  and  then  dried  over 
MgSC>4.  The  solvents  were  removed  in  vacuo  and  the  resulting  brown  foam  was 
purified by flash chromatography (Si0 2 ; gradient; petroleum spirit/ethyl acetate, (3:1) to 
ethyl  acetate/methanol,  (8:2))  to  yield  the  desired  product  as  a  white  solid  (0.44  g, 
38%).  m.p.  > 230  °C;  Rf = 0.25  (Si0 2 ;  petroleum  spirit/ethyl  acetate;  1:1)  NMR 
(400  MHz,  CDC13,  328  K)  5H /ppm  1.39  (s,  18H,  2  x  -C(CH3)3),  1.85  (m,  4H,  2  x 
H(10)), 2.05 (br m, 2H, H(9)), 2.23 (br m, 2H, H(9)), 3.43 (m, 4H, 2 x H(ll)), 4.32 (m, 
2H, 2 x H(8 )), 7.58 (m, 1H, H(4)), 7.79 (d, J= 6.0, 2H, H(3), H(5)), 8.61  (br s, 2H, 2 x 
N-H); 13C NMR (100 MHz, CDC13, 328 K) 5c/ppm 24.4 (2 x C(9), 2 x C(10)), 28.6 (2 x
306-C(CH3)3), 47.4 (2  X  C(ll)), 61.7 (2 x C(8 )), 81.0 (2 x -C(CH3)2),  109.6 (C(3), C(5)), 
140.5  (C(4)),  149.9  (2  x  quaternary  ArC),  155.0  (2  x  -C 0 2C(CH3)3),  171.0  (2  x  -  
NHC(O)-);  Pm „   (DCM/cm1)  1522 and  1585  (m, Ar),  1693 (s,  C=0), 2980 (m, C-H), 
3418  (s,  N-H);  mix  (CI+)  504  (5%,  [M  +  H]+),  503  (  10%,  [M]+);  HRMS  found 
504.2827, [M + H]+ (C25H38N50 6 ) requires 504.2821; [a]D  + 235 ° (c 0.02, MeOH).
Pyrrolidinium-2-carboxylic acid (2, 6-methylamino-pyridin-2-yl) amide di-
trifluoroacetate (333)
Compound  337  (79.0  mg,  0.16  mmol)  was  dissolved  in  a  solution  of trifluoroacetic 
acid/dichloromethane  (1:1,  5  ml)  and  then  stirred  at  room  temperature  for  6  h.  The 
volatiles were removed under reduced pressure to yield the product as a clear oil (53.0 
mg, 64%).  *H NMR (300 MHz, CD3OD) 5H /ppm  1.73  (m,  6 H, H(9) and 2 x H(10)), 
2.16 (m, 2H, H(9)), 3.02 (m, 4H, 2 x H(1 1)), 4.13 (m, 2H, 2 x H(8)), 7.41 (m, 3H, H(3), 
H(4) and H(5)); 13C NMR (75 MHz, CD3OD) 5c/ppm 25.9 (2 x C(10)), 31.9 (2 x C(9)),
48.4  (2  x  C(ll)),  62.6  (2  x  C(8 )),  112.4  (C(3)  and  C(5)),  118.1  (CF3COO-),  142.5 
(C(4)),  151.8  (2  x  quaternary  ArC),  161.9  (q,  CF3COO-),  169.4  (-NHC(O)-);  vmax 
(DCM/cm1 )  1589 (m,  Ar),  1674 (s, C=0), 2989 (w, C-H),  3447 (w, N-H);  mix (CC) 
306 (10%, [M -  2TFA + H]+), 305 (93%, [M -  2TFA]+); HRMS found 306.1935, [M -  
2TFA + H]+ (Ci5H24N50 2) requires 306.1930; [a]D  + 205 ° (c 0.02, MeOH).
307REFERENCES
308Reference List
(1)  Voet, D.; Voet, J. G. Biochemistry, John  Wiley and Sons, Second Edition 1994.
(2)  Copeland, R. A. Enzymes, 2ndEdn,  Wiley-VCH, Inc. 2000.
(3)  Pauling, L. Nature 1948, 161, 707-709.
(4)  Davis, A. M.; Teague, S. J. Angewandte Chemie International Edition 1999, 38, 
736-749.
(5)  Mader, M. M.; Bartlett, P. A. Chemical Reviews 1997, 97, 1281-1301.
(6)  Heginbotham, L.; Mackinnon, R. Neuron 1992, 8, 483-491.
(7)  Motherwell, W. B.; Bingham, M. J.; Six, Y. Tetrahedron 2001, 57, 4663-4686.
(8)  Fersht, A. R.; Shi, J. P.; Knilljones, J.; Lowe, D. M.; Wilkinson, A. J.; Blow, D. 
M.; Brick, P.; Carter, P.; Waye, M. M. Y.; Winter, G. Nature 1985, 314, 235- 
238.
(9)  Street, I. P.; Armstrong, C. R.; Withers, S. G. Biochemistry 1986, 25, 6021- 
6027.
(10)  Cudd, A.; Fridovich, I. Journal of  Biological Chemistry 1982, 257, 1443-1447.
(11)  Tong, L.; Pav, S.; Mui, S.; Lamarre, D.; Yoakim, C.; Beaulieu, P.; Anderson, P. 
C. Structure 1995, 3, 33-40.
(12)  Ma, J. C.; Dougherty, D. A. Chemical Reviews 1997, 97, 1303-1324.
(13)  Kirby, A. J. Accounts of Chemical Research 1997, 30, 290-296.
(14)  Blow, D. M. Accounts of Chemical Research 1976, 9, 145-152.
(15)  Perona, J. J.; Craik, C. S. Protein Science 1995, 4, 337-360.
(16)  Kirby, A. J. Angewandte Chemie International Edition 1996, 35, 707-724.
(17)  Breslow, R.; Doherty, J. B.; Guillot, G.; Lipsey, C. Journal of the American 
Chemical Society 1978,100, 3227-3229.
(18)  Mattei, P.; Diederich, F. Helvetica Chimica Acta 1997, 80, 1555-1588.
(19)  Mattei, P.; Diederich, F. Angewandte Chemie International Edition 1996, 35, 
1341-1345.
(20)  Reetz, M. T.; Becker, M. H.; Klein, H. W.; Stockigt, D. Angewandte Chemie 
International Edition 1999, 38, 1758-1761.
309(21)  Enjalbal, C.; Martinez, J.; Aubagnac, J. L. Mass Spectrometry Reviews 2000,19, 
139-161.
(22)  Jencks, W. P. Catalysis in Chemistry and Enzymology, McGraw Hill, New York 
1969.
(23)  Tramontane), A.; Janda, K. D.; Lemer, R. A. Science 1986, 234, 1566-1570.
(24)  Pollack, S. J.; Jacobs, J. W.; Schultz, P. G. Science 1986, 234, 1570-1573.
(25)  Barbas, C. F.; Heine, A.; Zhong, G. F.; Hoffmann, T.; Gramatikova, S.; 
Bjomestedt, R.; List, B.; Anderson, J.; Stura, E. A.; Wilson, I. A.; Lemer, R. A. 
Science 1997, 278, 2085-2092.
(26)  Anslyn, E.; Breslow, R. Journal of the American Chemical Society 1989, 111, 
8931-8932.
(27)  Breslow, R.; Greenspoon, N.; Guo, T.; Zarzycki, R. Journal of the American 
Chemical Society 1989, 111, 8296-8297.
(28)  Breslow, R.; Chung, S. Journal of the American Chemical Society 1990,112, 
9659-9660.
(29)  Tabushi, I.; Kuroda, Y.; Shimokawa, K. Journal of the American Chemical 
Society 1979,101, 1614-1615.
(30)  Yan, J. M.; Breslow, R. Tetrahedron Letters 2000, 41, 2059-2062.
(31)  Breslow, R.; Yang, J.; Yan, J. M. Tetrahedron 2002, 58, 653-659.
(32)  Sedewitz, B.; Schleifer, K. H.; Gotz, F. Journal of  Bacteriology 1984, 160, 273- 
278.
(33)  Muller, Y. A.; Schulz, G. E. Science 1993, 259, 965-967.
(34)  Breslow, R.; Fang, Z. L. Tetrahedron Letters 2002, 43, 5197-5200.
(35)  Marty, M.; Clyde-Watson, Z.; Twyman, L. J.; Nakash, M.; Sanders, K. M. 
Chemical Communications 1998, 2265-2266.
(36)  Clyde-Watson, Z.; Vidal-Ferran, A.; Twyman, L. J.; Walter, C. J.; McCallien, D. 
W. J.; Fanni, S.; Bampos, N.; Wylie, R. S.; Sanders, J. K. M. New Journal of 
Chemistry 1998, 22, 493-502.
(37)  Nakash, M.; Sanders, J. K. M. Journal of Organic Chemistry 2000, 65, 7266- 
7271.
(38)  Nakash, M.; Clyde-Watson, Z.; Feeder, N.; Davies, J. E.; Teat, S. J.; Sanders, J. 
K. M. Journal of the American Chemical Society 2000, 122, 5286-5293.
(39)  Dewar, M. J. S.; Wade, L. E. Journal of the American Chemical Society 1977,
99y  4417.4424.
310(40)  Ulrich, H. D.; Mundroff, E.; Santarsiero, B. D.; Driggers, E. M.; Stevens, R. C.; 
Schultz, P. G. Nature 1997, 389, 271-275.
(41)  Hilvert, D.; Hill, K. W.; Nared, K. D.; Auditor, M. T. M. Journal of the 
American Chemical Society 1989, 111, 9261-9262.
(42)  Li, T. G.; Janda, K. D.; Lemer, R. A. Nature 1996, 379, 326-327.
(43)  Romesberg, F. E.; Flanagan, M. E.; Uno, T.; Schultz, P. G. Journal of the 
American Chemical Society 1998,120, 5160-5167.
(44)  Li, T. Y.; Janda, K. D.; Ashley, J. A.; Lemer, R. A. Science 1994, 264, 1289- 
1293.
(45)  Wentworth, P.; Liu, Y. Q.; Wentworth, A. D.; Fan, P.; Foley, M. J.; Janda, K. D. 
Proceedings of the National Academy of Sciences of the United States of 
America 1998, 95, 5971-5975.
(46)  Wirsching, P.; Ashley, J. A.; Lo, C. H. L.; Janda, K. D.; Lemer, R. A. Science 
1995,270, 1775-1782.
(47)  Hoffmann, T.; Zhong, G. F.; List, B.; Shabat, D.; Anderson, J.; Gramatikova, S.; 
Lemer, R. A.; Barbas, C. F. Journal of the American Chemical Society 1998,
120,2768-2779.
(48)  Nicholas, K. M.; Wentworth, P.; Harwig, C. W.; Wentworth, A. D.; Shafton, A.; 
Janda, K. D. Proceedings of the National Academy of Sciences of the United 
States of  America 2002, 99, 2648-2653.
(49)  Smith, G. P.; Petrenko, V. A. Chemical Reviews 1997, 97, 391-410.
(50)  Hanes, J.; Pluckthun, A. Proceedings of the National Academy of  Sciences of the 
United States of  America 1997, 94, 4937-4942.
(51)  Taylor, S. J.; Morken, J. P. Science 1998, 280, 267-270.
(52)  Whitcombe, M. J.; Alexander, C.; Vulfson, E. N. Synlett 2000, 911-923.
(53)  Bystrom, S. E.; Boije, A.; Akermark, B. Journal of the American Chemical 
Society 1993,115, 2081-2083.
(54)  Liu, J. Q.; Wulff, G. Angewandte Chemie-International Edition 2004, 43, 1287- 
1290.
(55)  Phillips, M. A.; Fletterick, R.; Rutter, W. J. Journal of  Biological Chemistry 
1990, 265, 20692-20698.
(56)  Jacobs, J.; Schultz, P. G.; Sugasawara, R.; Powell, M. Journal of the American 
Chemical Society 1987,109, 2174-2176.
(57)  Visnjevski, A.; Schomacker, R.; Yilmaz, E.; Bruggemann, O. Catalysis 
Communications 2005, 6, 601-606.
311(58)  Robinson, D. K.; Mosbach, K. Journal of the Chemical Society-Chemical 
Communications 1989, 969-970.
(59)  Wulff, G.; Gross, T.; Schonfeld, R. Angewandte Chemie-International Edition in 
English 1997, 36, 1962-1964.
(60)  Motherwell, W. B.; Bingham, M. J.; Pothier, J.; Six, Y. Tetrahedron 2004, 60, 
3231-3241.
(61)  Alexander, C.; Smith, C. R.; Whitcombe, M. J.; Vulfson, E. N. Journal of the 
American Chemical Society 1999,121, 6640-6651.
(62)  Letsinger, R. L.; Savereid, T. J. Journal of the American Chemical Society 1962, 
84, 3122-&.
(63)  Klotz, I. M.; Sloniews, A. R. Biochemical and Biophysical Research 
Communications 1968, 31, 421-&.
(64)  Klotz, I. M.; Royer, G. P.; Scarpa, I. S. Proceedings of the National Academy of 
Sciences of the United States of  America 1971, 68, 263-&.
(65)  Bruice, T. C.; Schmir, G. L. Journal of the American Chemical Society 1957, 79, 
1663-1667.
(66)  Suh, J.; Oh, S. Journal of Organic Chemistry 2000, 65, 7534-7540.
(67)  Tahirov, T. H.; Oki, H.; Tsukihara, T.; Ogasahara, K.; Yutani, K.; Ogata, K.;
Izu, Y.; Tsunasawa, S.; Kato, I. Journal of  Molecular Biology 1998, 284, 101- 
124.
(68)  Paul-Soto, R.; Bauer, R.; Frere, J. M.; Galleni, M.; Meyer-Klaucke, W.; Nolting, 
H.; Rossolini, G. M.; de Seny, D.; Hernandez-Valladares, M.; Zeppezauer, M.; 
Adolph, H. W. Journal of  Biological Chemistry 1999, 274, 13242-13249.
(69)  Mock, W. L.; Liu, Y. Y. Journal of  Biological Chemistry 1995, 270, 18437- 
18446.
(70)  Moon, S. J.; Jeon, J. W.; Kim, H.; Suh, M. P.; Suh, J. Journal of the American 
Chemical Society 2000,122, 7742-7749.
(71)  Gao C.; Lavey B.J.; Lo C.H.L.; Datta A.; Wentworth P.; Janda, K. D. Journal of 
the American Chemical Society 1998,120, 2211-2217.
(72)  Williams, N. H.; Takasaki, B.; Wall, M.; Chin, J. Accounts of Chemical 
Research 1999, 32, 485-493.
(73)  Hettich, R.; Schneider, H. J. Journal of the American Chemical Society 1997,
119, 5638-5647.
(74)  Jeung, C. S.; Kim, C. H.; Min, K.; Suh, S. W.; Suh, J. Bioorganic and Medicinal 
Chemistry Letters 2001,11, 2401-2404.
312(75)  Menger, F. M.; Eliseev, A. V.; Migulin, V. A. Journal of Organic Chemistry 
1995, 60, 6666-6667.
(76)  Menger, F. M.; Ding, J.; Barragan, V. Journal of Organic Chemistry 1998, 63, 
7578-7579.
(77)  Menger, F. M.; West, C. A.; Ding, J. Chemical Communications 1997, 633-634.
(78)  Dekok, P. M. T.; Bastiaansen, L. A. M.; Vanlier, P. M.; Vekemans, J. A. J. M.; 
Buck, H. M. Journal of Organic Chemistry 1989, 54, 1313-1320.
(79)  Reetz, M. T. Angewandte Chemie-International Edition 2001, 40, 284-310.
(80)  Cadwell, R. C.; Joyce, G. F. Pcr-Methods and Applications 1994, 3, S136-S140.
(81)  Stemmer, W. P. C. Nature 1994, 370, 389-391.
(82)  Reetz, M. T.; Becker, M. H.; Kuhling, K. M.; Holzwarth, A. Angewandte 
Chemie-International Edition 1998, 37, 2647-2650.
(83)  Reetz, M. T. Tetrahedron 2002, 58, 6595-6602.
(84)  Fersht, A. R. Biochemistry 1987, 26, 8031-8037.
(85)  Gerlt, J. A. Chemical Reviews 1987, 87, 1079-1105.
(86)  Hirose, Y.; Kariya, K.; Nakanishi, Y.; Kurono, Y.; Achiwa, K. Tetrahedron 
Letters 1995, 36, 1063-1066.
(87)  Reetz, M. T.; Brunner, B.; Schneider, T.; Schulz, F.; Clouthier, C. M.; Kayser, 
M. M. Angewandte Chemie-International Edition 2004, 43, 4075-4078.
(88)  Taschner, M. J.; Black, D. J. Journal of the American Chemical Society 1988, 
110, 6892-6893.
(89)  Stewart, J. D.; Reed, K. W.; Zhu, J.; Chen, G.; Kayser, M. M. Journal of 
Organic Chemistry 1996, 61, 7652-7653.
(90)  Atkinson, C. A. PhD Thesis,  University of  London 2001.
(91)  Motherwell, W. B.; Atkinson, C. E.; Aliev, A. E.; Wong, S. Y. F.; Warrington, 
B. H. Angewandte Chemie-International Edition 2004, 43, 1225-1228.
(92)  Clayden, J.; Greeves, N.; Warren, S.; Wothers, P.  'Organic Chemistry', Oxford 
University Press 2001.
(93)  Wolfenden, R. Annual Review of  Biophysics and Bioengineering 1976, 5, 271- 
306.
(94)  Wu, D.; Chen, A.; Johnson, C. S. Journal of  Magnetic Resonance 1995,115, 
260-264.
(95)  Fielding, L. Tetrahedron 2000, 56, 6170.
313(96)  Atkinson, C. E.; Aliev, A. E.; Motherwell, W. B. Chemistry-A European 
Journal 2003, 9, 1714-1723.
(97)  Fersht, A. R.  'Structure and Mechanisms in Protein Science.A Guide to Enzyme 
Catalysis and Protein Folding',  W.H.Freeman, New York 1999.
(98)  Chan, W. C.; White, P. D. Fmoc Solid Phase Peptide Synthesis, Oxford 
University Press 2000.
(99)  Tanaka, N.; Nakagawa, K.; Iwasaki, H.; Hosoya, K.; Kimata, K.; Araki, T.; 
Patterson, D. G. Journal of Chromatography A 1997, 781, 139-150.
(100)  Bergeron, R. J.; McManis, J. S. Journal of Organic Chemistry 1988, 53, 3108- 
3111.
(101)  Delaney, E. J.; Wood, L. E.; Klotz, I. M. Journal of the American Chemical 
Society 1982,104, 799-807.
(102)  Angell, Y. M.; Garciaecheverria, C.; Rich, D. H. Tetrahedron Letters 1994, 35, 
5981-5984.
(103)  Sarabu, R.; Lovey, K.; Madison, V. S.; Fry, D. C.; Greeley, D. N.; Cook, C. M.; 
Olson, G. L. Tetrahedron 1993, 49, 3629-3640.
(104)  Zervas, L.; Theodoropoulos, D. M. Journal of the American Chemical Society 
1956, 78, 1359-1363.
(105)  Boxus, T.; Touillaux, R.; Dive, G.; Marchand-Brynaert, J. Bioorganic & 
Medicinal Chemistry 1998, 6, 1577-1595.
(106)  Sheehan, J. C.; Preston, J.; Cruicksh, P. A. Journal of the American Chemical 
Society 1965, 87, 2492-&.
(107)  Castro, B.; Dormoy, J. R.; Dourtoglou, B.; Evin, G.; Selve, C.; Ziegler, J. C. 
Synthesis-Stuttgart 1976, 751-752.
(108)  Bofill, J. M.; Albericio, F. Tetrahedron Letters 1999, 40, 2641-2644.
(109)  Falomi, M.; Giacomelli, G.; Porcheddu, A.; Dettori, G. European Journal of 
Organic Chemistry 2000, 3217-3222.
(110)  Felix, A. M.; Heimer, E. P.; Lambros, T. J.; Tzougraki, C.; Meienhofer, J. 
Journal of Organic Chemistry 1978, 43, 4194-4196.
(111)  www.rapp-polymere.com 2003.
(112)  Third International lectronic Conference on Synthetic Organic Chemistry, 
www.mdpi.ors 1999.
(113)  Thoma, G.; Patton, J. T.; Magnani, J. L.; Ernst, B.; Ohrlein, R.; Duthaler, R. O. 
Journal of the American Chemical Society 1999,121, 5919-5929.
314(114)  Hajos, Z. G.; Parrish, D. R. Journal of Organic Chemistry 1974, 39, 1615-1621.
(115)  List, B.; Lemer, R. A.; Barbas, C. F. Journal of the American Chemical Society 
2000,122, 2395-2396.
(116)  Zimmerman, H. E.; Traxler, M. D. Journal of the American Chemical Society 
1957, 79, 1920-1923.
(117)  Northrup, A. B.; MacMillan, D. W. C. Journal of the American Chemical 
Society 2002,124, 6798-6799.
(118)  Tang, Z.; Jiang, F.; Yu, L. T.; Cui, X.; Gong, L. Z.; Mi, A. Q.; Jiang, Y. Z.; Wu, 
Y. D. Journal of the American Chemical Society 2003,125, 5262-5263.
(119)  Cobb, A. J. A.; Shaw, D. M.; Longbottom, D. A.; Gold, J. B.; Ley, S. V.
Organic & Biomolecular Chemistry 2005, 3, 84-96.
(120)  List, B. Journal of the American Chemical Society 2000, 122, 9336-9337.
(121)  Ladlow, M.; Legge, C. H.; Neudeck, T.; Pipe, A. J.; Sheppard, T.; Yang, L. Q.
L. Chemical Communications 2003, 2048-2049.
(122)  Shi, L. X.; Sun, Q.; Ge, Z. M.; Zhu, Y. Q.; Cheng, T. M.; Li, R. T. Synlett 2004, 
2215-2217.
(123)  Challis, B. C.; Milligan, J. R.; Mitchell, R. C. Journal of the Chemical Society- 
Perkin Transactions 1 1990, 3103-3108.
(124)  Pfeiffer, F. R.; Chambers, P. A.; Hilbert, E. E.; Woodward, P. W.; Ackerman, D. 
M. Journal of  Medicinal Chemistry 1984, 27, 325-341.
(125)  Schwarz, H.; Bumpus, F. M.; Page, I. H. Journal of the American Chemical 
Society 1957, 79, 5697-5703.
(126)  Clemente, F. R.; Houk, K. N. Angewandte Chemie-International Edition 2004, 
43, 5766-5768.
(127)  Shokat, K.; Uno, T.; Schultz, P. G. Journal of the American Chemical Society 
1994,116, 2261-2270.
(128)  Lin, C. C.; Shimazaki, M.; Heck, M. P.; Aoki, S.; Wang, R.; Kimura, T.; Ritzen, 
H.; Takayama, S.; Wu, S. H.; WeitzSchmidt, G.; Wong, C. H. Journal of the 
American Chemical Society 1996,118, 6826-6840.
(129)  Rosen, T.; Chu, D. T. W.; Lico, I. M.; Fernandes, P. B.; Marsh, K.; Shen, L.; 
Cepa, V. G.; Pemet, A. G. Journal of  Medicinal Chemistry 1988, 31, 1598-1611.
(130)  Sato, T.; Kawasaki, S.; Oda, N.; Yagi, S.; El Bialy, S. A. A.; Uenishi, J.; 
Yamauchi, M.; Ikeda, M. Journal of the Chemical Society-Perkin Transactions 
7 2001,2623-2631.
315(131)  Iyer, S.; Liebeskind, L. S. Journal of the American Chemical Society 1987, 109, 
2759-2770.
(132)  Rivero, I. A.; Heredia, S.; Ochoa, A. Synthetic Communications 2001, 31, 2169- 
2175.
(133)  Synthesis Notes Nova Biochem Catalog 2002.
(134)  Zhong, G. F.; Lemer, R. A.; Barbas, C. F. Angewandte Chemie-International 
Edition 1999, 38, 3738-3741.
(135)  Amo, M.; Domingo, L. R. Organic & Biomolecular Chemistry 2003,1, 637- 
643.
(136)  Solladie, G.; Hutt, J.; Girardin, A. Synthesis 1987, 173.
(137)  Solladie, G. Synthesis 1981, 185-196.
(138)  Solladie, G.; Demailly, G.; Greek, C. Journal of Organic Chemistry 1985, 50, 
1552-1554.
(139)  Dale, S. H.; Elsegood, M. R. J. Acta Crystallographica Section E-Structure 
Reports Online 2003, 59, 01205-01207.
(140)  Pasha, M. K.; Dimmock, J. R.; Hollenberg, M. D.; Sharma, R. K. Biochemical 
Pharmacology 2002, 64, 1461-1467.
(141)  Pirkle, W. H.; Hoekstra, M. S. Journal of the American Chemical Society 1976, 
98, 1832-1839.
(142)  Hilton, S. T. Unpublished results. Thanks to Steve Hilton for synthesising 
TBDMS protected serine. 2005.
(143)  Greene, T. W.; Wuts, P. G. M. Protective groups in organic synthesis (third 
edition), John Wiley and Sons, Inc.  1999.
(144)  Li, X. Q.; Feng, D. J.; Jiang, X. K.; Li, Z. T. Tetrahedron 2004, 60, 8275-8284.
(145)  Kotera, M.; Lehn, J. M.; Vigneron, J. P. Tetrahedron 1995, 51, 1953-1972.
(146)  Gulikkrzywicki, T.; Fouquey, C.; Lehn, J. M. Proceedings of  the National 
Academy of Sciences of the United States of  America 1993, 90, 163-167.
(147)  Lehn, J. M.; Mascal, M.; Decian, A.; Fischer, J. Journal of the Chemical 
Society-Chemical Communications 1990, 479-481.
(148)  Bmnsveld, L.; Folmer, B. J. B.; Meijer, E. W.; Sijbesma, R. P. Chemical 
Reviews 2001,101, 4071-4097.
(149)  Jacobsen, J. R.; Cochran, A. G.; Stephans, J. C.; King, D. S.; Schultz, P. G. 
Journal of the American Chemical Society 1995,117, 5453-5461.
316(150)  Beijer, F. H.; Sijbesma, R. P.; Kooijman, H.; Spek, A. L.; Meijer, E. W. Journal 
of the American Chemical Society 1998,120, 6761-6769.
(151)  Berl, V.; Schmutz, M.; Krische, M. J.; Khoury, R. G.; Lehn, J. M. Chemistry-A 
European Journal 2002, 8, 1227-1244.
(152)  Ti, J. S.; Steinfeld, A. S.; Naider, F.; Gulumoglu, A.; Lewis, S. V.; Becker, J. M. 
Journal of  Medicinal Chemistry 1980, 23, 913-918.
(153)  Janda, K. D.; Ashley, J. A.; Jones, T. M.; McLeod, D. A.; Schloeder, D. M.; 
Weinhouse, M. I.; Lemer, R. A.; Gibbs, R. A.; Benkovic, P. A.; Hilhorst, R.; 
Benkovic, S. J. Journal of the American Chemical Society 1991,113, 291-297.
(154)  Jacobson, K. A.; Barone, S.; Kammula, U.; Stiles, G. L. Journal of  Medicinal 
Chemistry 1989, 32, 1043-1051.
(155)  Zhu, Z. L.; Espenson, J. H. Journal of Organic Chemistry 1995, 60, 7728-7732.
(156)  Cuevas-Yanez, E.; Muchowski, J. M.; Cmz-Almanza, R. Tetrahedron 2004, 60, 
1505-1511.
(157)  Wasner, M.; Suhadolnik, R. J.; Horvath, S. E.; Adelson, M. E.; Kon, N.; Guan, 
M. X.; Henderson, E. E.; Pfleiderer, W. Helvetica ChimicaActa 1997, 80, 1061- 
1072.
(158)  Zaramella, S.; Heinonen, P.; Yeheskiely, E.; Stromberg, R. Journal of Organic 
Chemistry 2003, 68, 7521-7523.
(159)  Adamczyk, M.; Grote, J. Tetrahedron Letters 2000, 41, 807-809.
(160)  Lindsay, S. High Performance Liquid Chromatography: Analytical Chemistry 
by Open Learning,  Wiley, New York 1992.
(161)  Nakamura, T.; Matsuyama, H.; Kamigata, N.; Iyoda, M. Journal of Organic 
Chemistry 1992, 57, 3783-3789.
(162)  Bisang, C.; Jiang, L. Y.; Freund, E.; Emery, F.; Bauch, C.; Matile, H.; Pluschke, 
G.; Robinson, J. A. Journal of the American Chemical Society 1998,120, 7439- 
7449.
(163)  Greenwood, E. S.; Hitchcock, P. B.; Parsons, P. J. Tetrahedron 2003, 59, 3307- 
3314.
(164)  Roberts, S. L.; Furlan, R. L. E.; Otto, S.; Sanders, J. K. M. Organic & 
Biomolecular Chemistry 2003,1, 1625-1633.
(165)  Singh, U.; Ghosh, S. K.; Chadha, M. S.; Mamdapur, V. R. Tetrahedron Letters 
1991, 32, 255-258.
(166)  Scwyzer, R.; Iselin, B.; Kappeler, H.; Riniker, B.; Rittel, W.; Zuber, H. 
Helvetica ChimicaActa 1958, 41, 1273-1286.
317(167)  Carpino, L. A.; Mansour, E. M. E.; Sadataalaee, D. Journal of Organic 
Chemistry 1991, 56, 2611-2614.
(168)  Mohapatra, D. K.; Datta, A. Journal of Organic Chemistry 1999, 64, 6879-6880.
(169)  Rautio, J.; Nevalainen, T.; Taipale, H.; Vepsalainen, J.; Gynther, J.; Laine, K.; 
Jarvinen, T. Journal of  Medicinal Chemistry 2000, 43, 1489-1494.
(170)  Tang, Z.; Yang, Z. H.; Chen, X. H.; Cun, L. F.; Mi, A. Q.; Jiang, Y. Z.; Gong, L. 
Z. Journal of the American Chemical Society 2005,127, 9285-9289.
(171)  Tsogoeva, S. B.; Wei, S. Tetrahedron:Asymmetry 2005,16, 1947-1951.
(172)  Khiar, N.; Araujo, C. S.; Alcudia, F.; Fernandez, I. Journal of Organic 
Chemistry 2002, 67, 345-356.
(173)  Banfi, L.; Colombo, L.; Gennari, C.; Annunziata, R.; Cozzi, F. Synthesis 1982, 
829-831.
(174)  Oppolzer, W.; Froelich, O.; WiauxZamar, C.; Bemardinelli, G. Tetrahedron 
Letters 1997, 38, 2825-2828.
(175)  Schwergold, C.; Depecker, G.; Di Giorgio, C.; Patino, N.; Jossinet, F.; 
Ehresmann, B.; Terreux, R.; Cabrol-Bass, D.; Condom, R. Tetrahedron 2002, 
58, 5675-5687.
(176)  Baker, B. R.; Chheda, G. B. Journal of  Pharmaceutical Sciences 1965, 54, 25- 
30.
(177)  Zhiqiang, S.; Yuliang, L.; Gong, H.; Liu, M.; Xiao, S.; Liu, H.; Li, FI.; Xiao, S.; 
Zhu, D. Organic Letters 2002, 4, 1179-1182.
3188
*
 
 
 
:
proton64.ucl  CDC13  v2  w bm   42
n f \ J V 0 1 f \ J « l O Q Q 3 0 lP
n(\jT,ruc\jf\joo'T«  ^9l Sc 2,r l’ ,aj'1N otfiouj  51  N  in  in  m  7   v   ry  r\j  m  m  o   v
Polymer 157
n-m-l
His(Trt) 0 '  'Lys(Fmoc)0  CA
Fmoc  Arg(Pbf)
Arg(Pbf) 
Fmoc
Fmoc
Current  Oata  Parameters
NAME Jun18-2003
EXPNO 80
PR0CN0 1
F2  -  Acquisition  Parameters
Date. 20030618
Time 19.02
INSTRUM amx300
PR0BH0 5  m m   QNP  1H
PULPROG zg30
TD 67306
SOLVENT CDC13
RO 20
NS  . 64
RO 20
SNH 8771.930  Hz
FIORES 0.130329  Hz
AO 3.8364921  sec
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DN 57.000  usee
DE 81.43  usee
TE 300.0  K
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PI 6.80  usee
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SI 131072
SF 299.8727940  MHz
N O W EM
SS8 0
LB 0.15  Hz
GB 0
PC 1.00
SR 2794.00  Hz
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F1P 10.000  ppm
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lj.ys(Fmcx:)0  < jJA   0   His 
Fmoc  Arg  Fmoc
• x C F jC O jH
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F2  -  Acquisition  Parameters
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AO 3.8364921  sec
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DM 57.000  usee
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PI 6.80  usee
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NUCLEUS 1H
F2  -  Processing  parameters
SI 131072
SF 299.8739764  MHz
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SS8 0
LB 0.15  Hz
GB 0
PC 1.00
SR 3976.36  HZ
10  NMR  plot  parameters
CX 32.00  cm
F1P 10.000  ppm
FI 2998.74  Hz
F2P 0.000  ppm
F2 0.00  Hz
PPMCM 0.31250  ppm/cm
H2CM 93.71062  Hz/cmts/b44
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rwn-t HN' HN‘ HN‘
His Lys
Arg
Arg
Current  Q ifa  Parameters 
NAME  Feb24-2004
EXPNO  140
PROCNO  i
F2  -  Acquisition  Parameters
Date_ 20040224
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SI 131072
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GB 0
PC 1.00
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10  NMR  plot  parameters
CX 32.00  cm
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FI 2998.74  Hz
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F2 0.00  Hz
PPMCM 0.31250  ppm/cm
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PC 1.00
SR 3976.36  Hz
10  NMR  plot  parameters
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0.00  Hz 
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EXPNO  25
PROCNO  1
F2  -  Acquisition  Parameters
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LI 1
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SFOl
NUCLEUS
75.4755000  MHz
F2  -  Processing  parameters
SI 16384
SF 75.4674443  M HZ
NON EM
SS8 0
LB 10.00  Hz
GB 0
PC 1.00
SR -555.71  Hz
10  NMR  plot  parameters
CX 30.00  cm
F IP 250.000  ppm
FI 18866.86  Hz
F2P -50.000  ppm
F2 -3773.37  Hz
PPMCM 10.00000  ppm/cm
H2CM 754.67444  Hz/cmPolymer 238
T T 4